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Abstract 
Nickel Catalyzed Homoallylation Reactions and Synthesis of Potent 
Inhibitors of YopH 
Mahesh Prasad Paudyal 
Doctor of Philosophy 
University of Missouri-St. Louis 
Prof. Christopher D. Spilling, Advisor 
 
This work has been divided into two different projects; a) the development of 
diastereoselective homoallylation reaction and its application in the synthesis of cytotoxic 
natural products called amphidinolides C, C2 and F and b) a library synthesis of potent 
and specific inhibitors of the YopH of Yersinia pestis. 
Homoallylation and its application in total synthesis: Bis-homoallylic alcohols are 
important synthetic intermediates in a number of chemical transformations. The nickel-
catalyzed reductive coupling of carbonyl compounds with dienes (homoallylation) is one 
of the important methods for the synthesis of bis-homoallylic alcohols. The 
homoallylation reaction of diene with novel substrates, hemiacetals and epoxyaldehydes, 
gave good diastereoselectivity. Cross metathesis of bis-homoallylic alcohols with 
acrylates using Grubbs catalyst produced ε-hydroxy-α,β-unsaturated esters. The ε-
hydroxy-α,β-unsaturated esters undergo base catalyzed cyclization to yield the 2,3,5-
trisubstituted tetrahydrofuran moiety. This protocol was efficiently applied in the 
Paudyal, Mahesh, 2012, UMSL, p.iii 
 
synthesis of C1-C9 fragment of the anti-tumor compounds known as amphidinolides C, 
C2 and F.  
    
During the course of this synthesis, the homoallylation reaction was investigated and an 
efficient method of controlling the π-facial selectivity using chiral dienes was found. The 
scope of this method was explored using various chiral dienes along with a variety of 
aldehydes. A matched combination of chiral diene and aldehyde gave more than 5:1 
diastereoselectivity of bis-homoallylic alcohols 10 and more than 99:1 regioselectivity.  
 
 Synthesis of YopH protein inhibitors: YopH is a virulent protein excreted by 
pathogenic bacteria Yersinia pestis (the causative agent of the Black Death). A series of 
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bidentate ligands were designed to investigate the structure activity relationship of these 
ligands towards the inhibition of YopH. Several of these ligands were synthesized and 
tested against different protein tyrosine phosphotases (PTPs). All inhibitors prepared 
showed very good activity against YopH and some other human phosphatases (low to 
mid micro-molar range). In addition, a rapid synthesis of salicylic acid containing 
heterocyclic building blocks utilizing palladium catalyzed cross-coupling reactions has 
been achieved. This methodology can be modified to target different phosphatase 
enzymes enabling their application towards the development of new drugs.  
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1. CHAPTER I 
Synthesis of C1-C9 Fragment of Amphidinolides C, C2 and F 
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1.1. General Objective 
Substituted tetrahydrofurans are frequently occurring substructures present in several 
biologically active molecules and natural products. 2,5-disubstituted and 2,3,5-
trisubstituted tetrahydrofurans are embedded in a broad array of natural products such as 
annonaceous acetogenins
1
 (mucocine 1.1), antibiotic polyethers,
2 
oxasqualenoids,
3
 and 
macrodiolides
4
. Some specific examples of compounds are amphidinolides,
5 
gymnodimine 1.2,
6
 tetronasin 1.3,
7
 monensin 1.4,
8
 and boromycin,
9
 amongst others 
(Figure 1.1). Because of the varied activities of these molecules as antitumor, 
antimicrobial, antibacterial agents, considerable efforts have been made by the synthetic 
community towards the construction of substituted tetrahydrofurans. The general 
objective of this chapter of the thesis is to report the methods developed towards the 
stereoselective synthesis of 2,3,5-trisubstituted tetrahydrofurans present in various natural 
products.  
 
Figure 1.1. Some Substituted Tetrahydrofuran Containing Natural Products 
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1.2. Introduction 
Amphidinolides are a series of cytotoxic macrolides possessing complex and unique 
structural features. These natural products are isolated from the marine dinoflagellate 
Amphidinium sp. which is symbiotic with the Okinawan acoel flatworms Amphiscolops 
sp.
5
 Amphidinolides C, C2 and F possess cytotoxicity against human skin cancer cell 
lines and murine lymphoma cells (Scheme 1.1). Embedded within these amphidinolides 
are two tetrahydrofurans: trans-2,5-disubstituted and 2,3,5-trisubstituted 
tetrahydrofurans. In efforts towards the total synthesis of these amphidinolides, we 
needed to develop a protocol for the efficient synthesis of the 2,3,5-trisubstituted 
tetrahydrofuran moiety.  
 
Scheme 1.1. Amphidinolides C, C2, and F and Retrosynthesis of Southern Fragment 
We envisioned that if the appropriate bis-homoallylic alcohols could be synthesized (by 
the reaction of a properly functionalized aldehyde with a suitable diene), these alcohols 
could be cyclized to trisubstituted tetrahydrofurans with correct stereochemistry.  
In this chapter, we report the nickel catalyzed reductive coupling of different aldehydes, 
hemiacetals and epoxyaldehydes with isoprene to give bis-homoallylic alcohols (Scheme 
1.2). Cross metathesis with acrylates using Grubbs catalyst produced ε-hydroxy-α,β-
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unsaturated esters. These esters undergo base catalyzed cyclization to yield the 2,3,5-
trisubstituted tetrahydrofuran moiety present in amphidinolides C, C2 and F. 
 
Scheme 1.2. General Representation of Homoallylation, Cross Metathesis and 
Cyclization Reactions 
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1.3. General methods for the synthesis of 2,3,5-trisubstituted tetrahydrofurans 
Various methods have been developed for the stereoselective synthesis of trisubstituted 
tetrahydrofurans.
10
 Oxidation of dienes and hydroxy alkenes, intramolecular addition of 
alcohols and protected diols to epoxides and alkenes, olefin metathesis, [3+2] 
cycloaddition and other annulation reactions are some of the most frequently used 
methods. Here, we describe some of these methods developed for the synthesis of 
trisubstituted tetrahydrofurans and, where possible, give their application in natural 
product synthesis. 
1.3.1.  Intramolecular nucleophilic addition/substitution reactions 
1.3.1.1. Intramolecular nucleophilic addition/substitution of hydroxyl 
nucleophiles 
Nucleophilic substitution chemistry has been utilized in the formation of tetrahydrofurans 
and 2,3,5-trisubstituted tetrahydrofuran moieties of natural products. Thomas and 
Gruttadauria
11
 developed a HClO4-catalyzed synthesis of 3-phenylselenyl-2,5-cis-
disubstituted tetrahydrofurans 1.18 from hydroxyselenide precursors (Scheme 1.3). This 
reaction is believed to proceed via formation of an intermediate selenonium ion followed 
by cyclization (5-endo/exo mode). As shown below, when a mixture of regioisomeric 
selenides 1.15 and 1.16 was treated with HClO4, both regioisomers were converted to the 
same diastereomer 1.18, through a common intermediate 1.17. Loss of the TIPS-
protecting group leading to tetrahydrofuran-2-yl-alcohol 1.19 was also observed.  
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Scheme 1.3. HClO4 Catalyzed Tetrahydrofuran Synthesis from Hydroxyselenide 
Precursor 
In a report of the total synthesis of amphidinolide T3, Zhao and coworkers described the 
SN2 type cyclization reaction to obtain the 2,3,5-trisubstituted tetrahydrofuran moiety 
(Scheme 1.4).
12
 Treatment of 1.20 with potassium hydroxide in a mixed solvent of 
diglyme and ethylene glycol at 40 
o
C removed the acetate group, which on subsequent 
cyclization gave desired 3-methy-trans-2,5-disubstituted tetrahydrofuran 1.21 as a single 
isomer in excellent yield. The tetrahydrofuran 1.21 was then converted in a number of 
steps to one of the key building blocks 1.22 of amphidinolide T3. 
 
 Scheme 1.4. Base Mediated SN2 Type Cyclization of 1.20 
A similar nucleophilic substitution (SN2) has been employed by Mohapatra in the 
stereoselective synthesis of the C1-C9 fragment of amphidinolide C.
13
As shown below, 
conversion of the hydroxyl group of 1.24 to a better leaving group (OMs) followed by 
Sharpless Asymmetric Dihydroxylation (SAD) produced a syn-diol, which underwent 
concomitant cyclization (displacement of the OMs group by OH) (Scheme 1.5). This 
produced the tetrahydrofuran moiety 1.27 in excellent yield as a single diastereomer with 
correct stereochemistry of C1-C9 fragment of amphidinolide C 1.28. 
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Scheme 1.5. Intramolecular Cyclization of 1.25 to Produce Tetrahydrofuran of 
Amphidinolide C 
1.3.1.2. Intramolecular additions of alcohol to epoxide 
In 1978, Kishi introduced a method for the synthesis of substituted tetrahydrofurans from 
epoxy-alcohols. He utilized this method in the total synthesis of polyether antibiotics 
such as the lasalocids and the monensins.
14
 The epoxide mixture 1.30, obtained by the 
reaction of alkene 1.29 with VO(acac)2 and 
t
BuOOH, was treated with acetic acid to 
produce tetrahydrofurans 1.31a and 1.31b with diastereoselectivity greater than 20:1 
(a:b) (Scheme 1.6). It was found that the transition state (1.33) for the formation of the 
minor epoxide suffers from more steric congestion due to the interaction of the methyl 
and ethyl groups than the transition state (1.32) for the formation of the major epoxide. In 
other words, transition state 1.32 best fulfills the steric and geometrical constraints for the 
epoxidation and hence gives the trans-tetrahydrofuran 1.31a as the major isomer.  
 
Scheme 1.6. Intramolecular Addition of an Alcohol to an Epoxide 
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Borhan has investigated on structural factors that control regio- and stereoselectivity on 
Lewis-acid mediated cyclizations of protected epoxy diols.
15 
He showed that the 
regioselectivity can be controlled by the appropriate choice of acid promoter and pedant 
groups adjacent to the epoxide. For example, substrate 1.34 having a C1-hydroxyl group 
is converted via 5-exo-cyclization to product 1.35 upon sequential treatment with 
BF3·Et2O followed by Ac2O (Scheme 1.7). However, when a substrate bearing a C1-
thiophenyl substituent (1.36) is cyclized, the regioselectivity can be reversed with the 
formation of formal 5-endo-cyclization product (1.38). This selectivity change can be 
attributed to the formation of an intermediate episulphonium ion 1.37, which then 
undergoes an electronically favorable 5-endo-cyclization to give 1.38.
16
 
 
Scheme 1.7. Pedant Group Effect on the Cyclization of Epoxy-alcohols 
1.3.1.3. Intramolecular addition of oxygen nucleophiles of acetonides to 
epoxide/Iodide 
Various oxygen containing functional groups like acetonides, epoxides, etc. have been 
utilized as nucleophiles in tetrahydrofuran forming reactions. During the synthesis of 
monensin, Stille employed a silver triflate mediated intramolecular alkylation of an 
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acetonide oxygen atom with a tethered alkyl iodide (1.39) to construct the 
tetrahydrofuran (1.41) with loss of acetone (Scheme 1.8).
17
  
 
Scheme 1.8. Silver Mediated Intramolecular Cyclization of Iodoacetal 1.39 
Parsons observed the Lewis acid mediated ring opening of the epoxide by the tethered 
acetonide to obtain tetrahydrofuran.
18
 When the epoxyacetal 1.42 was treated with 
trimethylaluminium (AlMe3) in CH2Cl2, 3-methyl-cis-2,5-disubstituted tetrahydrofuran 
1.45 was formed as a single diastereomer (Scheme 1.9). Trimethylaluminium facilitates 
the ring opening of the epoxide by the tethered acetonide to generate oxonium ion 1.44 
which upon methylation (via AlMe3) yielded tetrahydrofuran 1.45. 
 
Scheme 1.9. Lewis Acid Mediated Intramolecular Cyclization of an Epoxyacetal 
1.3.2. Intramolecular addition involving oxonium ions 
1.3.2.1. Intramolecular addition of nucleophilic alkenes/alkynes to oxonium ions 
Generation of reactive oxonium ion intermediates, followed by the intramolecular capture 
of this ion by a tethered alkene (or alkyne) is another common approach for the 
construction of tetrahydrofurans. Cho and coworkers reported the synthesis of 2,3,5-
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trisubstituted tetrahydrofurans from terminally substituted alkynyl alcohols and various 
aldehydes via Prins-type cyclizations.
19
As shown below, homopropargylic alcohol 1.46 
underwent Prins-type cyclization with 1.1 equivalent of benzaldehyde in the presence of 
TMSOTf (3.0 equiv.) in Et2O to give the all-cis-configured product 1.48 in a reasonable 
yield (Scheme 1.10). However, when CH2Cl2 was used as the solvent instead of Et2O, the 
tetrahydrofuran analog with an exocyclic vinyl triflate moiety 1.49 was obtained with 
higher yield.  
 
Scheme 1.10. Nucleophilic Alkyne Addition to Oxonium Ion 
A plausible mechanism for these reactions has been proposed. The addition of the alkynyl 
alcohol 1.46 to an aldehyde 1.47 forms an oxocarbenium ion 1.50 (where both phenyl 
groups adopt pseudoequatorial position to avoid steric hindrance) which, after Prins-type 
cyclization, forms the transient vinyl cation 1.51 (Scheme 1.11). In CH2Cl2 solution, the 
exocyclic vinyl cation 1.51 is trapped by the triflate anion giving the exocyclic vinyl 
triflate 1.49. On the other hand, in Et2O solution, the exocyclic vinyl cation 1.51 would 
be stabilized by the ether solvent and trapped by TMSOH to give TMS-enol 1.53 which 
is hydrolyzed during workup to the corresponding product 1.48. 
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Scheme 1.11. Mechanism for the Nucleophilic Alkyne Addition to Oxonium Ion 
Loh and coworkers described a In(OTf)3-catalyzed oxonium-ene type cyclization to 
construct substituted tetrahydrofuran rings.
20
 For example, when alcohol 1.54 was treated 
with benzaldehyde 1.47 in the presence of a catalytic amount of In(OTf)3, tetrahydrofuran 
1.55 was obtained in 77% yield (dr 92:8) (Scheme 1.12). This reaction proceeds through 
an intermediate oxonium ion 1.56, in which the substituents occupy the pseudoequatorial 
orientation, resulting in the observed stereoselectivity.  
 
Scheme 1.12. Nucleophilic Alkene Addition to an Oxonium Ion 
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Allylsilanes have been often utilized as the nucleophilic alkene component in oxonium 
ion addition reactions that afford tetrahydrofurans. Sarkar and coworkers synthesized 
2,3,5-trisubstituted tetrahydrofurans by Lewis acid catalyzed one-pot reactions of 
silylmethyl allylic silanes and aldehydes (Scheme 1.13).
21
 In an example shown below, 
treatment of aldehyde 1.58 with 1-silylmethyl allylic silane 1.57 in the presence of 
BF3·OEt2 gave 1.59 as a single diastereomer via the shown intermediates.  
 
Scheme 1.13. Nucleophilic Alkene Addition to an Oxonium Ion 
1.3.2.2. Nucleophilic addition to cyclic oxonium ions obtained from γ-lactols 
Addition of nucleophilic reagents to five-membered ring oxonium ions derived from γ-
lactol is a very common approach used in the synthesis of tetrahydrofurans.
22,23
 Grignard 
reagent,
24
 organozinc reagents
25
 etc are some of the frequently used nucleophilic reagents 
for this purpose.  
Woerpel and coworkers investigated the diastereoselectivity of the nucleophilic addition 
to five-membered rings derived from oxasilacyclopentane acetals
26 
and γ-lactol 
derivatives.
27
 They studied the relationship of the size of the C2-substituent on the 
diastereoselectivity of the allylsilane additions to oxonium ions derived from 2,2,4-
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trisubstituted lactols.
 
For example, treatment of 1.63a with allyltrimethylsilane and SnBr4 
produces a 64:36 mixture of 1.65a and 1.66a (Scheme 1.14). In case of 1.63a, transition 
state 1.67 is the predominant conformer in which both the substituent are in the pseudo-
equatorial position to avoid a 1,3-diaxial interaction. In this conformer, the nucleophile 
can approach from both faces, leading to low diastereoselectivity. Introduction of a 
second isopropyl group (1.63b) improves the diastereoselectivity in favor of 1.66b (5:95). 
The improved selectivity arises from the 1,3-diaxial interaction in transition state 1.68 
which blocks attack from the lower face of the envelop conformation. 
 
Scheme 1.14. Nucleophilic Addition of Allylsilane to Lactol Derived Cyclic Oxonium 
Ions 1.67 and 1.68 
Jamison employed a similar concept in the stereoselective synthesis of one of the 
tetrahydrofuran moieties of the amphidinolides T1 and T4.
28
 The desired oxocarbenium 
ion precursor was made by the stereoselective addition of a chiral (Z)-crotyl borane 1.70 
to an aldehyde 1.69 (Scheme 1.15). The crotylation product, upon hydroboration-
oxidation, gave a diol which was oxidatively cyclized to give lactone 1.71. DIBAL-H 
reduction of the lactone 1.71 to lactol 1.72 and subsequent treatment with allenylsilane 
1.73 in the presence of BF3.Et2O furnished the desired tetrahydrofuran 1.74 with very 
high diastereoselectivity (>95:5) and in 41% yield. The yield of this reaction was 
Paudyal, Mahesh, 2012, UMSL, p.14 
 
 
increased following a two-step conversion of lactol 1.72 to tetrahydrofuran 1.74: 
treatment of lactol 1.72 with allenylstannane 1.75 followed by Sonogashira coupling of 
the resultant terminal alkyne 1.76 with iodobenzene. 
 
Scheme 1.15. Nucleophilic Addition of Allenylsilane and Allenylstannane to Lactol 1.72 
1.3.3.  [3+2] cycloaddition and annulations reactions 
Substituted tetrahydrofuran synthesis by [3+2] cycloaddition reaction of diazo 
compounds and alkenes involving rhodium-catalysts is also a frequently used approach.
29
 
These reactions proceed through 1,3-dipolar cycloadditions between an alkene 
(inactivated or electron-rich) and carbonyl ylide generated in situ. In an example reported 
by Jamison, coupling of aldehyde 1.79 (cobalt carbonyl clusters containing aldehyde) 
with methyl acrylate 1.80a and diazo compound 1.81 produces tetrahydrofurans 1.82a 
and 1.83a with 53:47 regioselectivity (>20:1 diastereoselectivity of the major isomer) 
(Scheme 1.16).
30
 The same reaction with electron rich alkene 1.80b improved the 
regioselectivity (182b:1.83b = 82:18). 
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Scheme 1.16. A [3+2] Cycloaddition Reaction of Aldehyde 1.79 with Different Dienes 
A [3+2] annulation reaction of allylsilane and aldehydes to produce 2,3,5-trisubstituted 
tetrahydrofurans has been reported by Roush and coworkers. This multicomponent 
coupling involves a three-step coupling of two aldehydes with allyl boronate.
31
 They 
showed that a change in Lewis acid could change the selectivity of the tetrahydrofuran 
ring.  
For example, the reaction of allyl boronate 1.85 with aldehyde 1.84 followed by the 
protection of the resulting alcohol with a TES group gave intermediate product 1.86 
(Scheme 1.17). Compound 1.86 upon reacting with α-benzyloxyacetaldehyde 1.87, in the 
presence of BF3
.
Et2O, afforded cis-2,5-disubstituted tetrahydrofuran 1.88 with excellent 
>20:1 diastereoselectivity. On the other hand, when SnCl4 was used instead of BF3
.
Et2O, 
the trans-2,5-disubstituted tetrahydrofuran 1.89 was obtained with the same level of 
selectivity. This concept has been utilized in the stereoselective synthesis of asimicin, an 
Annonaceous acetogenin having a trans-threo-trans bis-tetrahydrofuran core.
32
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Scheme 1.17. A [3+2] Annulation Reaction of an Allyl Silane with an Aldehyde 
The stereochemical outcome can be explained on the basis of syn-clinical transition states 
(where the carbon bearing the silicon substituent is syn to the carbonyl oxygen). 
Transition states 1.90 are the lowest energy transition states available in the BF3-
catalyzed reactions of this type (Figure 1.2).
33 
The transitions states 1.90 and 1.91 are less 
sterically demanding and the lowest energy transition states (formed in the presence of 
BF3
.
Et2O and SnCl4 respectively). These transition states lead to the formation of cis- and 
trans-tetrahydrofurans, 1.88 and 1.89, respectively as the major products.  
 
Figure 1.2. Transition States of [3+2] Annulation Reactions 
During the synthesis of the C1-C9 fragment of amphidinolide C, Roush and coworkers 
employed the [3+2] annulation reaction for the synthesis of the 2,3,5-trisubstituted 
tetrahydrofuran.
34 
The crotylsilane 1.93 underwent the SnCl4-promoted [3+2] annulation 
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with ethyl glyoxalate 1.94 to give the required 3-methyl-trans-2,5-disubstituted 
tetrahydrofuran 1.95 (Scheme 1.18). The silyl moiety at C-4 (ring numbering) of 1.96 
was later removed (protiodesilylation) using modified Hudrlik conditions (TBAF, 
KO
t
Bu, DMSO, H2O, 18-crown-6).
35
 
 
Scheme 1.18. Synthesis of trans-Tetrahydrofuran Ring of C1-C9 Fragment of 
Amphidinolide C by [3+2] Annulation Reaction 
1.3.4.  Oxidation of alkene 
Synthesis of hydroxylated tetrahydrofuran derivatives by the oxidative cyclizations of 
alkenes have been reported various times.
36
 In an example shown below, the oxidative 
cyclization of cyclohexene diol 1.99 was carried out using modified Schreiber 
ozonolysis
37
 to give bicyclic acyloxy acetal-lactone 1.100 in 4:1 dr (75% yield) (Scheme 
1.19).
38
 Lactone 1.100 was then converted to the 2,3,5-trisubstituted tetrahydrofuran 
1.101 by subsequent allylation and reduction. Tetrahydrofuran derivative 1.101 is the 
intermediate compound for the synthesis of the F ring of Halichondrin B, an anticancer 
compound isolated from marine sponges Halichondria.
39
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Scheme 1.19. Synthesis of Tetrahydrofuran Ring by the Oxidation of Alkene 
1.3.5.  Iodoetherification 
Guindon and coworkers synthesized 2,3,5-trisubstituted tetrahydrofurans from both syn 
and anti-diols having an electron withdrawing group at the allylic position.
40
 They 
studied the impact of stereoelectronic effects and allylic 1,3-strain in controlling the 
cyclofunctionalization reaction when a hydroxyl group is at the allylic position. Syn-diol 
1.103, upon treatment with iodine and NaHCO3 gave cis-tetrahydrofuran 1.105 in 86% 
yield after 6 h whereas anti-diol 1.106 produced trans-tetrahydrofuran 1.108 in less than 
20% yield after 24 h (best yield, 55% in CH3CN after 36 h) (Scheme 1.20).  
The difference in reactivity of syn and anti diols can be explained from the reaction 
transition states. The transition state 1.107 obtained from anti-diol 1.106 has a higher 
energy than 1.104 (obtained from syn-diol 1.103) due to the development of a 
transannular diaxial interaction. As a result, syn-diol 1.103 will react faster than anti-diol 
1.106. 
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Scheme 1.20. Iodoetherification of Hydroxyalkenes 
The concept of iodoetherification has been applied by White for the synthesis of the 
tetrahydrofuran moiety of (-)-gymnodimine.
41
 Intermediate compound 1.110 upon 
treating with iodine in acetonitrile underwent highly stereoselective cyclization to give 
2,5-cis-tetrahydrofuran 1.111 as a single isomer (Scheme 1.21). However, cyclization of 
1.116 under the same conditions produced the 2,5-trans-tetrahydrofuran 1.117 as a sole 
diastereomer. These results support the Barlett-Rychnovsky mechanism for the 
cyclization of acyclic alkenols which postulates that increasing the steric bulk attached to 
the oxygen incorporated into the tetrahydrofuran favors the 2,5-cis-tetrahydrofuran.
42
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Scheme 1.21. Application of Iodoetherification in the Synthesis of the Tetrahydrofuran 
Ring of Gymnodimine 
1.3.6. Alkene carboetherification 
Semmelhack developed a palladium catalyzed cyclization of unsaturated alcohols with 
subsequent methoxycarbonylation at the C1’ position to produce a tetrahydrofuran 
methyl ester.
43
 As shown below, when 1.118 was treated with a catalytic amount of PdCl2 
and excess CuCl2 under a CO atmosphere in methanol, a 9:1 mixture of 1.119 and 1.120 
was obtained (Scheme 1.22). The reaction proceeds via activation of alkene by Pd(II) to 
give 1.121, nucleophilic attack of the tethered alcohol to give ring product 1.122, CO 
insertion to allylpalladium complex to give 1.123 followed by reductive elimination to 
produce the tetrahydrofurans. 
The reaction will favor the cis- or trans-tetrahydrofuran depending upon the 
configuration at C1 center of hydroxyalkene (Scheme 1.22). For example, anti-precursor 
1.118 proceeded via transition state 1.121 arising from the confirmation with minimum 
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non-bonding interaction. Therefore, the reaction led to the formation of trans-2,5-
disubstituted tetrahydrofuran as a major product (90:10 trans:cis). On the other hand, the 
reaction of syn-precursor 1.124 proceeded via the transition state 1.127 forming the cis-
isomer 1.125 with 87:13 cis:trans selectivity.  
 
Scheme 1.22. Palladium Catalyzed Carboetherification of syn- and anti-Hydroxyalkenes 
1.3.7. Olefin metathesis 
Olefin metathesis is becoming a widely used method for the construction of the 
tetrahydrofurans.
44
 Plumet studied the effect of the homoallylic substituents in the 
regiochemistry of the combination of ring opening and selective cross coupling 
metathesis, as a means of 2,3,5-trisubstituted tetrahydrofurans syntheses.
45
 He showed 
that 2-substituted-7-oxanobornenes (with a bulky C2-endo-substituent) can undergo ring-
opening/cross-metathesis (ROCM) to provide 2,3,5-trisubstituted tetrahydrofurans. As an 
example, 2-substituted-7-oxanobornenes 1.128, upon treating with allyl acetate in the 
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presence of Grubbs first-generation catalyst 1.129, afforded regioisomers 1.132 and 1.135 
in a ratio of 81:19 (Scheme 1.23).  
A plausible mechanism for this regioselectivity differentiation has been postulated. The 
irreversible cycloaddition of the carbene species [M]=CH2 to the C=C double bond of the 
bicyclic alkene 1.128 forms metallacyclobutanes 1.130 and 1.133. The ring-opening of 
these metallacyclobutanes lead to the formation of new carbene species 1.131 and 1.134, 
respectively which then undergo cycloaddition with another alkene to afford (after 
hydrogenation) the tetrahydrofurans 1.132 and 1.135. Since metallacyclobutane 1.130 is 
formed in preference to 1.133 for steric reasons, regioselectivity is in favor of product 
1.132. 
 
Scheme 1.23. THF Synthesis from 2-endo-Substituted 7-Oxanobornenes 
The approach of ROCM reactions between unsymmetrical oxanorbornene derivatives and 
olefins has also been investigated by Liu and coworkers.
46
 They also studied the effect of 
the endo-substituent on the regioselectivity. As shown below (Scheme 1.24), reaction of 
oxanorbornene 1.136 (with an endo-tosyl group) with the electron-rich olefin 1.137 in the 
presence of Grubbs second catalyst 1.138 afforded tetrahydrofuran 1.139 as a single 
Paudyal, Mahesh, 2012, UMSL, p.23 
 
 
isomer, but oxanorbornene 1.140 (with exo-tosyl group), under the same conditions, 
produced tetrahydrofuran 1.141a and 1.141b with 9:1 regioselectivity. 
 
Scheme 1.24. Effects of Substituent Orientation of 7-Oxonobornens during 
Tetrahydrofuran Synthesis 
Arjona observed that a more complex structure can be synthesized by the combination of 
ring-opening (ROM), ring-closing (RCM) and cross-metathesis (CM).
47
 A cis-fused 2,6-
dioxa[4.3.0]nonane skeleton (substructure present in many natural products and 
annulated nucleotide antibiotics)
48
 was synthesized following this chemistry. As shown 
below, treatment of compound 1.142 with the allyl acetate in the presence of Grubbs I 
catalyst gave bicyclic product 1.145 by a tandem ROCM and RCM process (Scheme 
1.25). 
 
Scheme 1.25. Synthesis of Tetrahydrofuran Ring by Tandem ROCM and RCM 
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1.4. Synthesis of 2,3,5-trisubstituted tetrahydrofurans present in natural 
products 
1.4.1. Monensin and boromycin via bromoetherification 
Kishi et al. reported the first stereocontrolled total synthesis of monensin,
49
 a member of 
more than 40 naturally occurring polyether antibiotics.
50
 The 2,3,5-trisubstituted 
tetrahydrofuran moiety embedded in this natural product was synthesized by N-
bromosuccinimide (NBS) mediated cyclization of bis-homoallylic alcohol 1.148 (Scheme 
1.26). Intermediate 1.148 was obtained by the Wittig reaction of lactol 1.146 and ylide 
1.147. The formation of the trans- isomer is described by the decreased steric effect 
experienced by 1.150a (leading to trans-product) in comparison to 1.150b that gives cis-
isomer. 
 
Scheme 1.26. NBS Mediated Cyclization of Homoallylic Alcohol 1.148 
N-bromosuccinimide promoted cyclization
51
 has been utilized in the synthesis of 
substituted tetrahydrofurans of other natural products. For example, during the total 
synthesis of boromycin,
9
 an ionophoric metabolite of Streptomyces antibioticus, White 
and coworkers treated diol 1.152 with N-bromosuccinimide in Et2O-CH3CN to give a 
Paudyal, Mahesh, 2012, UMSL, p.25 
 
 
pair of easily separated bromooxalanes 1.153 (Scheme 1.27). The major isomer was 
reduced with tributylstannane to give desired 2,3,5-trisubstituted tetrahydrofuran 1.154.  
 
Scheme 1.27. NBS Mediated Cyclization of Diol 1.152 to Give Bromooxalanes 
1.4.2. Tetronasin via intramolecular addition of alcohol to epoxide 
Tetronasin (ICI M-139603) is a polyether ionophore antibiotic produced by Streptomyces 
longisporoflavus.
7
 In the first total synthesis of tetronasin, Hori and coworkers described 
the synthesis of a substituted tetrahydrofuran by the intramolecular addition of alcohol to 
epoxide (Scheme 1.28).
52
 The intermediate syn/anti homoallylic alcohol 1.157 was 
synthesized by the reaction of hexanal derivative 1.155 and crotylboronate 1.156. 
Treatment of compound 1.157 with TBAF in THF induced a desilylation/epoxide 
formation/ring closure sequence to provide the 3-methyl-2,5-trans-tetrahydrofuran 1.160 
in 78%. 
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Scheme 1.28. Tetrahydrofuran Synthesis of Tetronasin by Intramolecular Addition of an 
Alcohol to an Epoxide 
Ley and coworkers also used an epoxide opening in the synthesis of the tetrahydrofuran 
of tetronasin.
53
 Treatment of the intermediate TBS-epoxide 1.163 with TBAF at 60 
o
C 
removed the TBS group with concomitant intramolecular epoxide ring opening and 
produced tetrahydrofuran 1.164 with the appropriate stereochemistry for tetronasin in an 
excellent 93% yield (Scheme 1.29). 
 
Scheme 1.29. Intramolecular SN2 Cyclization 
1.4.3. Gymnodimine by acid-catalyzed cyclization 
Gymnodimines are marine toxins first isolated in 1995 from Tiostrea chilensis oysters 
collected off the coast of New Zealand.
6
 All the members of these spirocyclic imine 
containing natural products contain the 2,3,5-trisubstituted tetrahydrofuran moiety. Romo 
and coworkers discussed the synthesis of this moiety in their report in the first total 
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synthesis of gymnodimine.
54
 Treatment of 1.167 with a catalytic amount of para-
toluenesulfonic acid (p-TsOH) in MeOH removed the silyl group which underwent 
concomitant cyclization to provide the epimeric furanoses 1.168 (Scheme 1.30). 
Allylation of 1.168 with allyl trimethylsilane 1.169 in the presence of BF3
.
Et2O provided 
the allylated tetrahydrofuran 1.170 in moderate diastereoselectivity (dr, 4:1).  
 
Scheme 1.30. p-TsOH Catalyzed Cyclization of Homoallylic Alcohol 
A similar concept of acid catalyzed cyclization has been described by Kishi for the 
substituted tetrahydrofuran synthesis present in gymnodimine.
55
 This one step synthesis 
improved the diastereoselectivity of cis/trans tetrahydrofuran formation compared to the 
above mentioned two step procedure. 
 
Scheme 1.31. Acid Catalyzed Cyclization of 1.171 to Give the Tetrahydrofuran of the 
Gymnodimine 
1.5. Tetrahydrofurans synthesis embedded within amphidinolides 
Amphidinolides are a series of cytotoxic macrolides possessing complex and unique 
structural features. These natural products are isolated from the marine dinoflagellate 
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Amphidinium sp. which is symbiotic with the Okinawa acoel flatworms Amphiscolops 
sp.
5
 Kobayashi and coworkers have isolated more than 39 members of this family and 
many of them contain one or more substituted tetrahydrofurans. Herein, we will describe 
the synthesis of 2,3,5-trisubstituted tetrahydrofurans reported by various groups. 
1.5.1.  Amphidinolide K 
 
Figure 1.3. Amphidinolide K 
The synthesis of the cis-2,5-disubstituted-3-methylenetetrahydrofuran ring present in 
amphidinolide K has been described by Williams and coworkers.
56
 Intermediate 
compound 1.174 was first converted to the corresponding mesylate followed by 
methanolysis of the benzoyl group (Scheme 1.32). This facilitated the intramolecular 
backside displacement of the mesylate group at C12 producing the desired 3-methylene-
cis-2,5-disubstituted tetrahydrofuran 1.175. 
 
Scheme 1.32. Base Mediated SN2 Type Cyclization of 1.174 
In a related study, William and coworkers described the diastereoselective synthesis of 
cis-2,5-disubstituted-3-methylenetetrahydrofurans via Pd(0)-catalyzed cyclization of 
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monobenzylated 2-methylene-1,4-diols (Scheme 1.33).
57
 When a solution of anti-1,4-diol 
1.176 (1.0 equiv., in THF) was slowly added to a mixture of NaH (1.0 equiv.), 
trimethyltin chloride (Me3SnCl) (1.0 equiv.) and Pd(OAc)2/PPh3 (20 mol%) in THF at 60 
o
C, cis-2,5-disubstituted tetrahydrofuran 1.177 was formed with an 8:1 cis:trans ratio. 
Me3SnCl was used as an additive that accelerated the reaction. Under the same 
conditions, syn-1,4-diol derivative 1.178 also afforded an 8:1 ratio of cis- and trans-2,5-
disubstituted tetrahydrofurans 1.179. However, the major isomer 1.177 has an antipodal 
relationship to 1.179 (same but opposite optical rotation values). 
 
Scheme 1.33. Pd(0) Catalyzed Cyclization of syn- and anti-1,4-Diols 
The synthesis of the substituted tetrahydrofuran ring of amphidinolide K has also been 
described by Lee et al.
58
 The intermediate β-alkoxyacrylate 1.181 was prepared in 2 steps 
from the known homopropargylic alcohol 1.180 (Scheme 1.34).
59
 Compound 1.181 
underwent radical cyclization in the presence of tributylstannane and triethylborane to 
give the 3-methylene-cis-2,5-disubstituted tetrahydrofuran 1.182 as a major diastereomer 
(cis:trans 16:1) after acidic destannylation. 
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Scheme 1.34. Radical Cyclization of β-alkoxyacrylate 1.181 to Produce Tetrahydrofuran 
Ring of Amphidinolide K 
 
1.5.2.  Amphidinolide T 
 
Figure 1.4. Different Members of Amphidinolide T 
Synthesis of the 2,3,5-trisubstituted tetrahydrofuran found in different members of 
amphidinolide T has been described by many groups. Abbineni and coworkers 
investigated the oxy-Michael cyclization of 1.188 at different reaction conditions.
60
 
Cyclization of 1.188 in the presence of NaOMe in MeOH at -15 
o
C gave the highest 
trans-selectivity (entry 4, Scheme 1.35) with concomitant transesterification.  
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Scheme 1.35. Cyclization of Hydroxy Ester 1.188 at Different Basic Conditions 
Ghosh and coworkers described the synthesis of the tetrahydrofuran of amphidinolide T1 
from the lactone 1.193 which is obtained by the acid promoted lactonization of γ-hydroxy 
cyanide 1.192 (Scheme 1.36).
61
 Reduction of lactone 1.193 with DIBAL-H followed by 
reaction with trimethylsilylethanol and catalytic p-TsOH afforded trisubstituted 
tetrahydrofuran 1.194 as a 3.5:1 diastereomeric mixture.  
 
Scheme 1.36. p-TsOH Catalyzed Nucleophilic Addition of Alcohol to lactol 1.193 
A similar strategy has been applied by Fürstner to synthesize the tetrahydrofuran moiety 
of amphidinolide T4.
62
 Intermediate nitrile 1.196 (prepared in 4 steps from commercially 
available starting material 1.195) was converted to lactol 1.197 by treating with DIBAL-
H followed by acidic work-up (Scheme 1.37). Lactol 1.197 was converted to sulfone 
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1.198 upon treatment with an excess of phenylsulphonic acid (PhSO2H) in the presence 
of CaCl2 (as the dehydrating agent). SnCl4 mediated coupling of sulfone 1.198 with TBS-
enol ether 1.199 afforded the required trans-tetrahydrofuran 1.200 a major diastereomer 
(trans:cis = 26:1). 
 
Scheme 1.37. Synthesis of Tetrahydrofuran 1.200 of Amphidinolide T4 
1.5.3. Amphidinolides C, C2 and F 
 
Figure 1.5. Amphidinolides C, C2 and F 
Several reports have been published on the synthesis of the tetrahydrofuran moiety of 
amphidinolides C, C2 and F. Kobayashi and coworkers synthesized the C1-C7 fragment 
to aid in the absolute configuration assignment of 12 chiral stereocenters in 
amphidinolide C (Scheme 1.38).
63
 The 6-benzyloxymethyl-4-methyl-γ-butyrolactone 
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1.202 (obtained from D-glutamic acid 1.201
64
) was reduced to a lactol and the lactol was 
converted to an α,β-unsaturated ester 1.203 by Witting reaction. The unsaturated ester 
1.203 was converted to tetrahydrofuran 1.204 (via a diastereoselective Michael addition) 
by treating with TBAF in THF. 
 
Scheme 1.38. TBAF Mediated Cyclization of Homoallylic Alcohol 1.203 
An analogous strategy of cyclization of an unsaturated ester by TBAF has been employed 
by Roush and coworkers.
65
 When unsaturated ester 1.206 was treated with TBAF in THF, 
it afforded 3-methyl-2,5-trans-tetrahydrofuran 1.207 (an example of Michael cyclization) 
in excellent diastereoselectivity (trans:cis 9:1) with simultaneous removal of the TBS 
group (Scheme 1.39). The transition states (1.208a and 1.208b) show that the formation 
of the trans-isomer minimizes A1,3-strain. 
 
Scheme 1.39. TBAF Mediated Cyclization 
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A completely different approach has been functionalized by Ferrie and coworkers for the 
trisubstituted tetrahydrofuran synthesis of amphidinolide C.
66
 The vinyloguous 
Mukaiyama aldol reaction of chiral aldehyde 1.209 with silyloxyfuran 1.210 gave 
unsaturated lactone 1.211 (Scheme 1.40). The hydrogenation of lactone 1.211 gave 1.212 
with excellent diastereoselectivity setting the stereochemistry at the C-3 position. The 
lactol derivative 1.213 was prepared by reduction followed by acylation. C-glycosylation 
of lactol derivative 1.213 with an acetyl oxazolidinethione 1.214 produced trans-2,5-
disubstituted tetrahydrofuran 1.215 (60% yield). 
 
Scheme 1.40. Synthesis of Trisubstituted Tetrahydrofuran Ring by C-glycosylation of 
Lactol 1.213 
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1.6. Results and discussion 
1.6.1. Introduction 
Since 1986, Kobayashi and coworkers have isolated and characterized over 30 members 
of a structurally diverse group of natural products named amphidinolides.
5
 These unique 
macrolides are isolated from symbiotic marine dinoflagellate Amphidinium species. 
These Amphidinium species are, in turn, separated from inside cells of Okinawan 
flatworms Amphiscolops sp. All amphidinolides, to some extent, possess cytotoxic 
activity against cancer cell lines.  
Amphidinolide C (1.5) (Figure 1.6), one of the most cytotoxic members of this family, 
was first isolated from the Y-5 strain of Amphidinium sp.
67
 Embedded within this 
macrolide are two trans-tetrahydrofurans, a vicinally located carbon branch, and 12 
stereocenters. Amphidinolide C is known to possess cytotoxic activity against human 
tumor cell lines. The IC50 values of this macrolide are 0.0058 and 0.0046 µg/mL against 
murine lymphoma L1210 and epidermoid carcinoma KB cells, respectively, in vitro. 
 
Figure 1.6. Amphidinolides C, C2 and F 
Amphidinolides C2
68
 (1.6) and F
69
 (1.7) contain the same macrocylic ring as 
amphidinolide C, but differ in the side chain structure (Figure 1.6). Amphidinolide C2 
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has an acetate group at the C29 position instead of a hydroxyl group, whereas 
amphidinolide F has a methyl group at the C28 position. Interestingly, amphidinolides C2 
and F show significantly lower activities against murine lymphoma L1210 and 
epidermoid carcinoma KB cell lines (0.8 and 3.0 µg/mL, respectively, for 1.6; 1.5 and 3.2 
µg/mL, respectively, for 1.7). This suggests that the C25-C34 side chain and allylic 
hydroxyl group have a significant impact on the biological role of amphidinolides C, C2, 
and F. 
Due to their unique structural scaffold and potential clinical importance, amphidinolides 
have attracted a significant interest among synthetic chemists. Herein, we will report the 
synthesis of the C1-C9 fragment of amphidinolides C, C2, and F. 
1.6.2. Retrosynthetic analysis 
In our retrosynthetic analysis of amphidinolide C, the molecule is divided into four 
different sub units (Figure 1.7). After completion of the synthesis of these subunits, the 
northern fragment 1.216 will be coupled to the aldehyde side chain 1.217a (or 1.217b) by 
Horner-Wadsworth-Emmons (HWE) olefination reaction. The western fragment sulfone 
1.218 will be deprotonated to give a sulfone anion and added to the northern fragment. 
Coupling of the southern fragment 1.219 will be done by the macrocyclic Stille coupling 
followed by DCC esterification or vice versa.   
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Figure 1.7. Retrosynthetic Analysis of Amphidinolides C, C2 and F 
The C1-C9 fragment 1.219, one of the core subunits of amphidinolide C, contains one 
trisubstituted 2,5-trans tetrahydrofuran and a side chain containing an 1,2-anti-diol. The 
retrosynthetic analysis of this fragment is given below (Scheme 1.41). Unfolding of the 
ring reveals that an alcohol with 1,3-anti stereochemistry and double bond in proper 
position cyclizes to produce the tetrahydrofuran ring. In the forward sense, the 
tetrahydrofuran can be formed by addition of the alcohol across the alkene. The cis 
orientation of R
2
 and methyl groups, during cyclization forces the third stereocenter 
(position 2) in trans-position relative to the existing stereocenters (positions 3 and 5), 
resulting in the required 2,5-trans tetrahydrofuran ring. The alcohol can potentially be 
prepared from a properly functionalized aldehyde following well documented nickel 
chemistry. 
 
Scheme 1.41. Retrosynthetic Analysis of C1-C9 1.219 Fragment of Amphidinolide C 
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1.6.3. Nickel catalyzed homoallylation 
Tamura et al. reported extensive work on the nickel catalyzed homoallylation of 
aldehydes and ketones. In homoallylation, an aldehyde (or a ketone) reacts with a diene 
in the presence of a nickel catalyst and triethyl borane as a promoter and reducing agent 
to produce a hydroxyalkene (Scheme 1.42).
70
 The reductive coupling occurs between the 
carbonyl group of aldehyde and the C1-C2 bond of diene. A hydride that stems from the 
ethyl group of BEt3 or ZnEt2 is delivered at the C2 position of the diene with excellent 
regio– and stereoselectivity, favoring the 1,3-anti stereochemistry predominantly. (Note: 
Homoallylation reaction and its mechanism will be discussed in detail in chapter II). 
 
Scheme 1.42. Homoallylation of an Aldehyde 1.11 with Isoprene 1.12 
1.6.4. Synthesis of model racemic tetrahydrofuran ring 
1.6.4.1. Homoallylation of benzaldehyde and Pd-catalyzed cyclization 
The known homoallylation of benzaldehyde was used for a model study. Benzaldehyde 
reacts with isoprene catalyzed by Ni(acac)2 and promoted by triethyl borane (Et3B) to 
afford homoallyl alcohol 1.223 with a 1,3-anti to syn ratio of >15:1 in 90% yield 
(Scheme 1.43). Semmelhack and coworker have shown that hydroxyalkenes similar to 
1.223 undergo Pd(II)-catalyzed intramolecular cyclization.
43
 Reaction of hydroxyalkene 
1.223 with Pd (II) catalyst, copper (II) chloride and carbon monoxide 
(methoxycarbonylation) gave trans-2,5-disubstituted tetrahydrofuran 1.224 in 68% yield 
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(trans:cis = 9:1) with the correct relative stereochemistry of three stereocenters of the 
tetrahydrofuran ring (Scheme 1.43).  
 
Scheme 1.43. Homoallylation and Subsequent Cyclization of Benzaldehyde 
1.6.4.2. Cross metathesis and base catalyzed cyclization 
An alternate approach to the tetrahydrofuran ring was envisioned in which the hydroxy 
alkene 1.223 was converted to an unsaturated ester. The required ester 1.225 was first 
prepared by the Grubbs cross metathesis of the alkenol 1.223 with methyl acrylate 1.80 
using Grubbs second generation catalyst and copper (I) iodide in 79% yield (Scheme 
1.44).
71 
Cyclization of 1.225 promoted by 1,8-diazabicyclo [5.4.0] undec-7-ene (DBU) in 
CH2Cl2 gave trans-2,5-disubstituted tetrahydrofuran ring 1.224 as a single diastereomer 
in excellent 93% yield. Formation of 1.225 as a single isomer can be explained by the 
preferred transition state 1.226. Transition state 1.227, which gives cis-tetrahydrofuran 
ring, suffers from steric congestion. Thus, using either method, the required trans-2,5-
disubstituted tetrahydrofuran ring with correct relative stereochemistry was achieved. 
 
Scheme 1.44. Grubbs Cross Metathesis Followed by Cyclization of the Resulting Ester 
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1.6.5. Homoallylation of lactols obtained from erythronolactone with isoprene 
1.6.5.1. Homoallylation of TBS protected hemiacetal 1.229 
The successful racemic synthesis of the 2,5-trans-tetrahydrofuran ring left two 
challenges: synthesis of a non-racemic tetrahydrofuran ring and introduction of a side 
chain containing anti-1,2-diol. To assemble all these requirements, tert-
butyldimethylsilyl (TBS) protected hemiacetal (lactol) 1.229 was chosen as a 
homoallylation substrate. Hemiacetal 1.229 was prepared in two steps from the 
commercially available erythronolactone 1.228 (Scheme 1.45).
72
 Homoallylation of 
hemiacetal 1.229 with isoprene 1.12 under standard homoallylation conditions provided 
diastereomers 1.230a and 1.230b, which were separable by silica gel column 
chromatography, in 63% combined yield with 1:6 diastereoselectivity (based on yield 
after chromatography). The major diastereomer 1.230b was crystalline and could be 
recrystallized to give X-ray quality crystals. 
 
Scheme 1.45. Homoallylation of Erythronolactol 1.228 with Isoprene 1.12 
The crystal structure of major diastereomer 1.230b clearly shows that the silyloxy groups 
at C2 and C3 are anti and the hydroxyl and methyl groups at C4 and C6 are anti (Figure 
1.8). However, the silyloxy at C3 and the hydroxy at C4 have the wrong relative 
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configuration (anti), and thus, the minor isomer 1.230a must have the correct relative 
(3,4-syn) and absolute configuration required for amphidinolide C. 
 
 
 
 
 
 
 
 
The observed diastereofacial selectivity was much higher than expected for the 
homoallylation reaction. In the limited number of chiral aldehydes investigated by 
Tamaru et al., the diastereofacial selectivity with respect to the aldehyde was typically 
very low (1:1 to 1.6:1).
73
 The formation of the major isomer 1.230b appears to follow the 
trend observed by Evans et al. in the aldol reactions of a series of alkoxy and bisalkoxy 
aldehydes.
74,75
  
Undaunted by this setback, the cyclization of both diastereomers 1.230 was investigated. 
The Semmelhack Pd-catalyzed cyclization/methoxycarbonylation of major isomer 1.230b 
failed to yield the tetrahydrofuran 1.233a (Scheme 1.46). 
Figure 1.8. Crystal structure of 1.230a 
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Scheme 1.46. Attempted Pd-Catalyzed Cyclization of Major Isomer 1.230b 
Therefore, an alternate chain extension and cyclization method was examined. Cross-
metathesis of both the minor isomer 1.230a and the major isomer 1.230b with methyl 
acrylate 1.80 gave α,β-unsaturated methyl esters 1.231a and 1.231b, respectively 
(Scheme 1.47). Cyclization of 1.231a and 2.231b using DBU afforded the 
tetrahydrofurans 1.232a and 1.233a in excellent yields. 
 
Scheme 1.47. Cross Metathesis Followed by Cyclization of Hydroxyalkenes 
Some migration of a silyl group was observed during the cyclization process. The TBS 
group migrated from the secondary to the primary position (Scheme 1.48). Silyl 
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migration is a frequently encountered process.
76
 It was found that in the presence of a 
strong base and polar solvent (method A), the migration was faster in comparison to a 
weak base and less polar solvent (method B).
  
 
Scheme 1.48. TBS Group Migration During the Cyclization of 1.231b 
The migration of a silyl group was investigated by the change in 
13
C chemical shifts of 
hydroxyl containing carbons in the starting alcohols and their acetylated derivatives. Both 
isomers 1.233a and 1.233b were acetylated by reacting with acetic anhydride in the 
presence of DMAP and pyridine (Scheme 1.49). The primary carbon (C-1) of 1.233a 
resonated at 64.0 ppm and the secondary carbon (C-2) of 1.233b resonated at 65.8 ppm. 
Upon acetylation, C-1 (primary carbon) of 1.233aa moves downfield to resonate at 66.4 
ppm but the C-2 (secondary carbon) of 1.233bb moves upfield to resonate at 61.9 ppm.
77
 
It is also supported by the chemical absorption value hydrogen in 
1
H NMR. In 1.233bb, 
the secondary proton (H-2) resonates at 4.9 ppm as multiplet which is not present in 
1.233aa where all protons resonate are below 4.3 ppm. The multiplet nature of H-2 in 
1.233bb also supports the fact that C-2 TBS group migrates, not the C-3 TBS group 
because the H-3 would have been a doublet of doublet instead of multiplet. 
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Scheme 1.49. Acetylation of Alcohols 
1.6.5.2. Homoallylation of acetonide protected hemiacetal 1.229  
In order to avoid protecting group migration and perhaps to affect a more favorable 
stereochemical outcome, an alternate protecting group was examined. Homoallylation of 
acetonide protected hemiacetal 1.235
78
 gave a mixture of diastereomers 1.236a and 
1.236b (1:3) (Scheme 1.50). The diastereomers were difficult to separate and required 
repeated silica gel column chromatography. 
 
Scheme 1.50. Homoallylation of Erythronolactol 1.234 
Cross metathesis of the major diastereomer 1.236b with methyl acrylate 1.80 (Scheme 
1.51) followed by cyclization with DBU gave 1.238 in 80% yield. 
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Scheme 1.51. Cross Metathesis and Subsequent Cyclization of 1.236b 
To compare the configuration of the tetrahydrofurans 1.238 and 1.233a, obtained from 
the acetonide-protected hemiacetal 1.234 and the TBS-protected hemiacetal 1.229, the 
protecting groups were removed (Scheme 1.52). The TBS- groups were cleaved using 
HF/pyridine in MeOH (method A) that provided triol 1.239. The acetonide group was 
removed using Amberlyst 15 resin in MeOH to give the identical triol 1.239. 
The 
1
H and 
13
C NMR spectra of the triol 1.239 obtained by the removal of both 1.233a 
and 1.238 were identical, suggesting that the tetrahydrofuran obtained from both 
hemiacetals have the same configuration. 
 
Scheme 1.52. Removal of the TBS and Acetonide Groups 
The triol 1.239 has the correct orientation of the hydroxyl groups compared to the 
required fragment 1.240. However, although the relative stereochemistry of stereocenters 
(2, 3 and 5) of the tetrahydrofuran ring is correct, the absolute configuration is reverse 
(Scheme 1.52). 
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1.6.6. Homoallylation of epoxyaldehydes with isoprene 
Epoxides are versatile functional groups. An epoxide can be opened with water to reveal 
a diol or alternatively it can be oxidatively cleaved to obtain an aldehyde. Due to this fact 
epoxyaldehyde 1.242 was chosen as our next substrate for homoallylation. Oxidation of 
commercially available (2R, 3R)-3-phenylglycidol (epoxycinnamyl alcohol) 1.241 by 
Moffat oxidation method gave (2R, 3R)-3-phenylglycidal 1.242 in 73% yield.
79
 
Homoallylation of 1.242 with isoprene gave a separable mixture of diastereomers 1.243a 
and 1.243b in 2.5:1 ratio and 63% combined yield (Scheme 1.53). 
 
Scheme 1.53. Homoallylation of Epoxycinnamaldehyde 1.241 with Isoprene 
The absolute stereochemistry of 1.243 was determined by the Mosher ester method.
80
 
Both diastereomeric alcohols 1.243a and 1.243b were treated with (R)-MTPA-chloride 
(MTPA-chloride= α-methoxy-α-(trifluoromethyl) phenylacetyl chloride) in the presence 
of pyridine and DMAP to give the (S)- Mosher ester 1.244a and 1.244b, respectively in 
good yields (Scheme 1.54) . 
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Scheme 1.54. Mosher Ester Formation 
On the basis of the generally accepted confirmation model for Mosher esters (Scheme 
1.55), the trifluoromethyl group and the carbonyl hydrogen (Hc) are eclipsed with 
carbonyl oxygen. The R
1
-group in the (S)-MTPA ester 1.245a will be shielded by the 
phenyl group (of MTPA) when the chiral alcohol has (R)-configuration. The chemical 
shift of proton signals of R
1
-group (Ha, Hb) will consequently be upfield (smaller value in 
δ) and proton signal of Hd will be downfield (larger δ value). In case of another (S)-
MTPA ester 1.245b, the R
2
 group is shielded (He moved upfield and the closest proton Hb 
of R
2
-group moved downfield (change in Ha is insignificant). However, in the later case 
(1.244b), the change in chemical shift values of other protons were not as consistent as in 
the earlier case (1.244a). The chemical shift values of protons (Table 1.1) support these 
predictions. Therefore, 1.244a has R-configuration at OH-containing center and 1.244b 
has S-configuration at the same center.  
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Scheme 1.55. Conformation Model of Mosher Esters from Alcohol 1.245 
Table 1.1. Chemical Shift Values of Different Protons Present in Mosher Ester 
 1.243a (DS-1) 1.243b (DS-2) 
 SM 
1.243a 
(ppm) 
S-ester 
1.244a 
(ppm) 
Δδ 
(ppm) 
SM 
1.243b 
(ppm) 
S-ester 
1.244b 
(ppm) 
Δδ 
(ppm) 
Ha 3.98 3.82 -0.16 3.88 3.85 -0.03 
Hb 3.09 2.93 -0.16 3.05 3.18 +0.15 
Hc 4.03 5.11 +1.08 3.73 5.05 +1.32 
Hd 1.57 1.75 +0.18 1.61 1.67 +0.06 
Hd’ 1.69 1.91 +0.22 1.65 1.79 +0.14 
He 2.45 2.35 -0.10 2.40 2.15 -0.15 
Me 1.06 1.06 0.00 1.06 1.02 -0.04 
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The major isomer 1.243a with absolute configuration (3R, 5R) was the required 
diastereomer to obtain the tetrahydrofuran ring of correct stereochemistry of C1-C9 
fragment of amphidinolide C.  
Attempted cyclization of 1.243a catalyzed by palladium (II) with concomitant chain 
extension with carbon monoxide was carried out as described earlier (Section 1.6.5.1). 
However, the epoxide ring was opened by MeOH producing 1.246 (Scheme 1.56).  
 
Scheme 1.56. Attempted Cyclization of Hydroxyalkene 1.243a 
Cross metathesis of 1.243a with methyl acrylate 1.80 (or ethyl acrylate 1.247) gave α,β-
unsaturated methyl (or ethyl) ester 1.248a (or 1.248b), which on cyclization with DBU, 
gave 1.249a (or 1.249b) as a single isomer in 70% (or 80%) yield (Scheme 1.57).  
 
Scheme 1.57. Cross Metathesis and Subsequent Cyclization of bis-Homoallylic Alcohols 
Oxidative cleavage of epoxide ring of 1.249a by NaIO4 in acetonitrile/water
81
 gave 
aldehyde 1.250a (Scheme 1.58). The pure aldehyde 1.250a could be isolated by SiO2 
column chromatography. However, the crude aldehyde 1.250a was subjected to 
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NaBH4/MeOH reduction, without purification, to afford the stable alcohol 1.251a with 
63% overall yield over 2 steps in >95% ee. 
 
Scheme 1.58. Epoxide Ring Cleavage and Subsequent Reduction 
The tetrahydrofuran ring 1.251a has the correct relative and absolute configuration of the 
stereocenters as required for the synthesis of the C1-C9 (southern) fragment of 
amphidinolide C. 
Epoxide 1.249a was also opened with Amberlyst 15 resin in THF-water that produced 
diastereomers 1.252a and 1.252b in equal amount (Scheme 1.59). 
 
Scheme 1.59. Acid Mediated Epoxide Ring Opening by H2O 
1.6.7. Coupling of tetrahydrofuran aldehyde 1.250a with the proper side chain 
partner 
With the completion of the synthesis of tetrahydrofuran aldehyde 1.250, the next goal 
was to couple aldehyde 1.250 with a properly functionalized fragment to complete the 
synthesis of the C1-C9 fragment of amphidinolide C (Scheme 1.60). For this synthesis, 
we needed a synthetic equivalent of 1.253. Several approaches were studied. 
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Scheme 1.60. Coupling of Aldehyde with Properly Functionalized Side Chain Fragment 
1.6.7.1. Coupling of 1.250 with diacetate/bromodiacetate 
The coupling of tetrahydrofuran aldehyde 1.250 with diacetate of acrolein 1.256 and 
bromoacrolein 1.258 were carried out following the literature procedures (Scheme 
1.61).
82,83
  
 
Scheme 1.61. Synthesis of Diacetate of Acrolein 1.255 and Bromoacrolein 1.257 
Szabo reported the palladium catalyzed coupling of diacetate 1.256 with different 
aldehydes (Scheme 1.62) in the presence of stoichiometric amount of different achiral 
and chiral boronates.
84
 For example, diacetate 1.256 upon treating with 4-
nitobenzaldehdye 1.259 and a palladium catalyst with a stoichiometric amount of 
B2(pin)2 1.261 (or chiral boronate 1.262) afforded homoallylic alcohol 1.260 as a single 
diastereomer (anti diastereoselectivity) (Scheme 1.62).  
In our hands, the reaction of benzaldehyde with the diacetate under the same conditions 
with achiral boronate 1.261 produced only anti-homoallylic alcohol 1.263. Furthermore, 
cyclohexanecarboxaldehyde 1.264 produced homoallylic alcohol 1.265 as a single 
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diastereomer in 61% yield (Scheme 1.62). Unfortunately, the diacetate of bromoacrolein 
1.258 did not react with any of these aldehydes. 
 
Scheme 1.62. Pd-Catalyzed Coupling of Diacetate 1.256 with Different Aldehydes 
In another attempt, the allylation reactions between aldehydes and diacetate were carried 
out in the presence of a catalytic amount of palladium and diethylzinc (as a reducing 
agent).
85,86
 When cyclohexanecarboxaldehyde 1.264 (1.0 equiv.) was reacted with 
diacetate 1.256 (1.2 equiv.) in the presence of 5 mol% Pd(PPh3)4 and diethyl zinc (2.4 
equiv.), it produced a 3:1 mixture of 1.265a and 1.266 (Scheme 1.63). Benzaldehyde 
1.47, on the other hand, produced diol 1.267 as a single isolated product. Again, none of 
these aldehydes reacted with bromodiacetate 1.258. 
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Scheme 1.63. Pd-Catalyzed Reaction of Allyl Diacetate in the Presence of Diethylzinc 
Tetrahydrofuran aldehyde 1.250, however, did not react with any of these diacetates 
under various reaction conditions. 
1.6.7.2. Coupling of aldehyde 1.250 with diacetates 1.271 and 1.272 
With the unsuccessful results of the coupling of tetrahydrofuran aldehyde 1.250 with 
diacetates 1.256 and 1.258, different diacetates (1.271 and 1.272) derived from TMS-
protected propargyl aldehydes were designed. The known aldehyde 1.270
87
 was 
converted to diacetate 1.271 using the same conditions as above (Scheme 1.64).
83
 This 
diacetate 1.271 was converted to diacetate 1.272 by the removal of TMS using TBAF in 
THF. Unfortunately, none of the aldehydes reacted with either of these diacetates under 
different reaction conditions tested (Condition A: Pd2(dba)3, B2(pin)2, DMSO; Condition 
B: Pd(PPh3)4, Et2Zn, THF).
84,85 
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Scheme 1.64. Preparation of Diacetates 1.271 and 1.272 from Propargyl Aldehyde 1.268 
1.6.7.3. Coupling of aldehyde 1.248 different coupling partner 
Tetrahydrofuran (THP) protected TMS-propagylic alcohol 1.275 was chosen as the next 
coupling partner. It was synthesized following a literature procedure
88
 and first coupled 
with benzaldehyde 1.47, after deprotonation with n-BuLi in THF (Scheme 1.65). The 
mono-protected diol 1.276 was formed as a mixture of syn- and anti-isomers (1:2) in 41% 
yield. Removal of the THP group using pyridinium p-toluene sulfonate (PPTS) in 
methanol gave diol 1.277 showing the same ratio of isomers. 
 
Scheme 1.65. Synthesis of THP Protected TMS-Propagylic Alcohol 1.275 and Coupling 
with Benzaldehyde 
In the next step, the THP protected TMS-propagylic alcohol 1.275 was coupled with 
cyclohexanecarboxaldehyde 1.264 (Scheme 1.66) to produce mono-protected diol 1.278 
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(syn:anti = 1:2) along with an unidentified product in a 1:1 ratio with 1.278. Removal of 
the THP group using PPTS in methanol followed by 1,2-diol protection using 2,2-
dimethoxypropane in the presence of a catalytic amount of p-toluenesulfonic acid (p-
TsOH) gave 1.280. The diol protected product 1.280 and recovered unreacted diol 1.279 
has same ratio (1:2) of syn:anti isomers that confirms the same ratio in product 1.278. 
However, attempts to couple tetrahydrofuran aldehyde 1.250 with the THP protected 
TMS-propagylic alcohol 1.275 was not successful. 
 
Scheme 1.66. Coupling of Cyclohexanecarboxaldehyde 1.264 with 1.275 
1.6.8. Stereoselective epoxide opening: New route for the C1-C9 fragment synthesis 
All the attempts to couple the tetrahydrofuran aldehyde 1.250 with properly 
functionalized coupling partners for the side chain of the C1-C9 fragment of 
amphidinolide C were futile. Therefore, a different strategy of stereoselective epoxide 
ring opening of α-acetoxy aldehyde 1.287 was envisioned. The known aldehyde 1.285 
was prepared in four steps from commercially available benzyl-mono-protected cis-diol 
1.281 (Scheme 1.67).
89
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Scheme 1.67. Synthesis of Epoxyaldehyde 1.281  
Homoallylation of epoxyaldehyde 1.285 with isoprene 1.12 produced a column 
inseparable mixture of bis-homoallylic alcohol 1.286 with 1:1 diastereoselectivity in low 
yield (Scheme 1.68). The mixture of diastereomers 1.286 was acetylated. Careful SiO2 
column chromatography separated the acetylated diastereomers 1.287a and 1.287b. 
 
Scheme 1.68. Homoallylation and Subsequent Acetylation of Epoxyaldehyde  
It was postulated that the epoxide ring could be stereoselectively opened with the 
assistance of the acetate group to give 1.288 (Scheme 1.69).
90
 We expected that 
compound 1.288 could then be converted to the C1-C9 fragment of amphidinolide C 
1.254.  
 
Scheme 1.69. Expected epoxide opening of 1.287a 
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Therefore, one of the acetylated diastereomers 1.287a was treated with BF3·Et2O in dry 
ether and stirred at room temperature (rt) for 20 h (Scheme 1.70). Since the proton NMR 
of the crude material of this reaction did not show the epoxide, it was subjected to 
deacetylation with 1% HCl in MeOH. Surprisingly, the main product isolated after SiO2 
column chromatography did not have a benzyl group. It is probable that there is double 
neighboring group assistance from the benzyl and acetyl group leading to the formation 
of the “debenzylated” tetrahydrofuran 1.290.  The formation of tetrahydrofuran ring 
1.290 was verified from the shift in position of protons (Ha and Hb) in the acetylated 
derivative 1.291, incorporation of two acetyl groups in 1.291, 2D 
1
H and 
13
C NMR.  
 
Scheme 1.70. Stereoselective Ring Opening of 1.287a 
A plausible mechanism has been proposed for this transformation (Scheme 1.71). The α-
acetoxy group attacks the Lewis acid activated epoxide from the lower face to give the 
dioxolane cation 1.292. This is followed by the attack of the benzyl oxygen producing 
intermediate 1.293 that subsequently loses the benzyl group to give the tetrahydrofuran 
derivative 1.294. Reaction of 1.294 with HCl in methanol removes the acetate group 
producing diol 1.290.  
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Scheme 1.71. A Proposed Mechanism for the Formation of the Tetrahydrofuran 
Derivative 1.290 
1.6.9. Attempted Homoallylation of an aldehyde carrying all the functionalities 
present in the C1-C9 fragment of amphidinolide C 
In search of a better functionalized aldehyde for the synthesis of the C1-C9 fragment, the 
aldehyde 1.299 with a terminal acetylene was chosen. It seemed that upon 
homoallylation, the bis-homoallylic derivative obtained would bring all the essential 
functionalities present in this fragment. 
The Bestmann-Ohira reagent
91
 was prepared by the reaction of p-toluenesulfonyl azide 
1.296 with the phosphonate 1.295 using literature procedures (Scheme 1.72).
92,93
 
Treatment of lactol 1.235 with the Bestmann-Ohira reagent 1.297 in the presence of 
K2CO3 in methanol gave 1.298 in 64% yield.  
 
Scheme 1.72. Synthesis of Terminal Alkyne Derivative 1.298 of Alcohol 1.235 
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Unfortunately, all the attempts to oxidize 1.298 to aldehyde 1.299 were futile because of 
the over-oxidation of the aldehyde 1.299 to the ester 1.300 in low yield.  
 
Scheme 1.73. Over-oxidation of Alcohol 1.298 to Ester 1.300 
Ermolenko and coworkers have also observed the over-oxidation product during the PCC 
oxidation of (R)-2,3-O-isopropylideneglycerol 1.67 (Scheme 1.74).
94
 They found that the 
oxidation of alcohol 1.301 using PCC in CH2Cl2 gave ester 1.302 in a 5:2 ratio with the 
required aldehyde 1.303. The reaction in multigram scale followed by the careful 
distillation afforded the aldehyde 1.303 in 30% yield.  
 
Scheme 1.74. Over-oxidation of Alcohol 1.301 to ester 1.302 
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1.7. Summary 
1) Homoallylation of aldehydes, hemiacetals and epoxyaldehydes with isoprene were 
carried out. Hemiacetal derivatives and epoxyaldehydes were the first substrates of 
homoallylation reactions. In most cases, the resulted diastereomers were separable by 
careful SiO2 column chromatography. These reactions proceeded with excellent 
regioselectivity and low to very good diastereoselectivity. 
2) Homoallylation of benzaldehyde with isoprene gave bis-homoallylic alcohol with 
excellent regio- and stereoselectivity. Palladium catalyzed cyclization of the bis-
homoallylic alcohol followed by subsequent methoxycarbonylation obtained the 2,3,5-
trisubstituted tetrahydrofuran ring in good yield. Alternatively, Grubbs cross-metathesis 
of the bis-homoallylic alcohol with alkyl acrylate followed by DBU cyclization of the ε-
hydroxy-α,β-unsaturated ester also obtained the same 2,3,5-trisubstituted tetrahydrofuran 
ring. The tetrahydrofuran ring had the same relative stereochemistry as the 
tetrahydrofuran ring present in C1-C9 fragment of amphidinolide C. 
3) The bis-homoallylic alcohols obtained from the homoallylation of TBS-protected 
hemiacetal with isoprene were subjected for Grubbs cross metathesis and DBU 
cyclization. The tetrahydrofuran ring obtained from the minor diastereomer had the same 
relative and absolute stereochemistry found in C1-C9 fragment of amphidinolide C. 
Therefore, the overall yield of this fragment synthesis was low. 
4) Homoallylation of epoxy-cinnamaldehyde with isoprene produced two diastereomers 
in favor of the required diastereomer being the major one. The major diastereomer was 
converted to tetrahydrofuran aldehyde which has been elaborated to the C1-C9 fragment 
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of amphidinolide C by other groups. This is the shortest reported route for the synthesis 
of such tetrahydrofuran rings. 
5) Attempted coupling of tetrahydrofuran aldehyde with different coupling partners 
bearing the essential functionalities of C1-C9 fragment of amphidinolide C were 
unsuccessful, although different other aldehydes (benzaldehyde, nitrobenzaldehyde, 
cyclohexanecarboxaldehyde etc.) obtained satisfactory results. 
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1.8. General Experimental 
Glassware used for all experiments were oven-dried and all reactions were carried out 
under argon atmosphere unless otherwise mentioned. All reaction solvents were purified 
prior to use: CH2Cl2, MeOH, MeCN were dried by distillation over calcium hydride and 
THF over sodium-benzophenone ketyl. Reagent grade DMF was obtained from Sigma-
Aldrich and used without further purification. 
Proton (
1
H) NMR spectra were recorded at 300 or 500 MHz and 
13
C NMR spectra at 75 
MHz.
 
Proton NMR spectra were referenced to residual CDCl3 (7.27 ppm) and 
13
C {
1
H} 
NMR spectra were referenced to the center line of CDCl3 (77.23 ppm). Crystal 
structure(s) were determined on a Bruker Apex- II CCD single crystal diffractometer. 
Optical rotations were measured on a polarimeter using a glass cell with 2 mL capacity 
and 10 cm path length. Infrared spectra were recorded on FTIR instrument using NaCl 
plates (liquids, oils) or using an ATR attachment (solids). 
General procedure for homoallylation: Into a flask containing Ni(acac)2 (0.1 mmol) in 
dry THF (3 mL) was added isoprene (4.0 mmol) and the resulting solution was stirred at 
room temperature for 10 min.  A solution of aldehyde (1.0 mmol) in dry THF (2 mL) and 
Et3B (1.0 M solution in hexane, 2.4 mmol) were added sequentially. The homogeneous 
mixture was stirred under argon atmosphere at room temperature for 70 to 90 h 
(monitored by 
1
H NMR), then it was diluted with EtOAc. The mixture was washed with 
2M HCl, saturated NaHCO3, and saturated brine solutions sequentially. The organic layer 
was dried over anhydrous MgSO4, concentrated in vacuo and purified by column 
chromatography (SiO2, hexanes:EtOAc). 
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General procedure for Grubbs cross metathesis: To a round bottom flask equipped 
with a reflux condenser was charged Grubbs second generation catalyst (7 mol %) and 
copper iodide (10 mol %). A solution of alkenol (1.0 equiv.) in freshly distilled CH2Cl2 
was added followed by methyl acrylate (2.0 equiv). The flask was immersed in an oil 
bath preheated to 40 
o
C for 4 h (TLC analysis). The solvent was evaporated in vacuo and 
the crude product was purified by column chromatography (SiO2, hexanes:EtOAc). 
General procedure for cyclization by DBU: To a stirred solution of alkenol (1.0 equiv.) 
in freshly distilled CH2Cl2 at 0 
o
C was added 1,8-diazabicyclo[5.4.0]-undec-7-ene (DBU, 
1.2 equiv.). The resulting solution was stirred at 0 
o
C for 1 h and then at room 
temperature for another 1 h (TLC analysis). The reaction was quenched by addition of the 
saturated aq. NH4Cl solution and extracted with EtOAc. The organic layer was separated 
and washed with brine solution, dried over Na2SO4 and concentrated in vacuo. The crude 
product was purified by column chromatography (SiO2, hexanes:EtOAc). 
 
(±) Methyl 2-(3-methyl-5-phenyltetrahydrofuran-2-yl)acetate (1.224): A round 
bottom flask was charged copper (II) chloride (0.296 g, 2.20 mmol) and PdCl2(CH3CN)2 
(0.026 g, 0.10 mmol). The flask was flushed with carbon monoxide 3 times and then dry 
MeOH (3 mL) was added. To this mixture was added a solution of hydroxyalkene 1.223 
(0.176 g, 1.00 mmol) in MeOH (1 mL) followed by trimethylorthoformate (0.1 mL, 1.0 
mmol). The mixture was then stirred at rt for 6 h (TLC analysis) under an atmosphere of 
carbon monoxide (balloon). The solvent was evaporated in vacuo and the residue was 
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extracted with pentane.  The pentane was concentrated in vacuo and the product was 
purified by column chromatography to afford 1.224 as colorless oil (0.159 g, 68%). 
The unsaturated ester 1.225 (0.08 g, 0.341 mmol) and DBU (56 µL, 0.376 mmol) were 
reacted in dry CH2Cl2 (2 mL) following the general procedure for cyclization to give 
1.224 as a colorless oil (0.075 g, 93%).  
IR (neat, NaCl) 2955, 1740 cm
-1
; 
1
H NMR (CDCl3): δ 7.14-7.25 (5H, m), 4.97 (1H, dd, J 
= 6.0, 9.8 Hz), 4.01-4.08 (1H, m), 3.64 (3H, s), 2.54-2.59 (2H, m), 2.39-2.50 (1H, m), 
2.02-2.13 (1H, m), 1.45-1.61 (1H, m), 1.01 (3H, d, J = 6.5 Hz); 
13
C {
1
H} NMR (CDCl3): 
δ 172.3, 143.9, 128.7, 127.5, 126.1, 82.7, 80.4, 52.1, 44.9, 40.9, 39.7, 16.7; HRMS (FAB, 
MNa
+
) calcd for C14H18O3Na: 257.1154. Found 257.1159. 
 
(±) (E)-Methyl 6-hydroxy-4-methyl-6-phenylhex-2-enoate (1.225): Grubbs second 
generation catalyst (0.034 g, 0.040 mmol), copper iodide (0.011 g, 0.057 mmol), hydroxy 
alkene 1.223 (0.100 g, 0.567 mmol) and methyl acrylate (0.10 mL, 1.13 mmol) were 
reacted in dry CH2Cl2 (3 mL) following the general procedure to afford 1.225 as a 
colorless oil (0.105 g, 79%).  
IR (neat, NaCl) 3447, 3022, 2950, 2915, 1722 cm
-1
; 
1
H NMR (CDCl3): δ 7.29-7.40 (5H, 
m), 6.94 (1H, dd, J = 8.0, 15.7 Hz), 5.78 (1H, dd, J = 1.1, 15.7 Hz), 4.68-4.74 (1H, m), 
3.74 (3H, s), 2.43 (1H, app sep, J = 6.9 Hz), 1.91-2.05 (1H, m), 1.87 (1H, d, J = 3.2 Hz), 
1.65-1.74 (1H, m), 1.11 (3H, d, J = 6.7 Hz); 
13
C {
1
H} NMR (CDCl3): δ 167.6, 154.7, 
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144.7, 129.0, 128.3, 126.4, 119.9, 76.5, 72.8, 51.9, 45.4, 33.8, 19.8; HRMS (FAB, MNa
+
) 
calcd for C14H18O3Na: 257.1154. Found 257.1162. 
 
(3R,4R)-3,4-bis(tert-butyldimethylsilyloxy)tetrahydrofuran-2-ol (1.229): TBS-
erythrono lactone 1.229a (3.0 g, 8.6 mmol, 1.0 equiv.) and DIBAL-H (1.0 M solution in 
hexane, 25.9 mL, 3.0 equiv.) were reacted in dry CH2Cl2 (150 mL) at -78 
o
C following 
the literature procedure.Error! Bookmark not defined. Purification by column 
hromatography (SiO2, hexanes: EtOAc) afforded 1.229 as a colorless oil (2.3 g, 77%).  
IR (neat, NaCl) 3417, 2955, 2923 cm
-1
; 
1
H NMR (CDCl3): δ 5.05 (1H, dd, J = 4.3, 7.4 
Hz), 4.24 (1H, d, J = 11.7 Hz), 4.15-4.19 (1H, m), 3.92-3.98 (3H, m), 0.95 (9H, s), 0.91 
(9H, s), 0.15 (6H, s), 0.11 (3H, s), 0.09 (3H, s); 
13
C {
1
H} NMR (CDCl3): δ 97.1, 73.4, 
73.1, 72.5, 26.1, 25.9, 18.5, 18.3, - 4.4, -4.5, -4.6, -4.81; HRMS (FAB, MNa
+
) calcd for 
C16H36O4Si2Na: 371.2050. Found 371.2058. 
 
(2R,3S,4R,6R) and (2R,3S,4S,6S) 2,3-bis(tert-butyldimethylsilyloxy)-6-methyloct-7-
ene-1,4-diol (1.230a and 1.230b): Ni(acac)2 (0.026 g, 0.10 mmol), isoprene (0.4 mL, 4 
mmol), lactol 1.229 (0.348 g, 1.00 mmol), and Et3B (1.0 M solution in hexanes, 2.4 
mmol) were reacted in dry THF (5 mL) following the general procedure for 
homoallylation to afford two diastereomers 1.230a as a liquid and 1.230b as a colorless 
solid (dr, 1:6) (0.263 g, 63% combined yield).  
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1.230b, major isomer: IR (neat, NaCl) 3340, 2958, 2926, 2856 cm
-1
; 
1
H NMR (CDCl3): δ 
5.79 (1H, ddd, J = 7.7, 10.2, 17.2 Hz), 4.94-5.06 (2H, m), 3.86-3.91(1H, m), 3.75-3.81 
(2H, m), 3.69-3.71 (1H, m), 3.51 (1H, brd s), 3.07 (1H, brd, s), 2.67 (1H, s), 2.35 (1H, 
sep, J = 6.4 Hz), 1.45-1.66 (2H, m), 1.04 (3H, d, J = 6.7 Hz), 0.92 (9H, s), 0.91 (9H, s), 
0.12 (9H, s), 0.09 (3H, s); 
13
C {
1
H} NMR (CDCl3): δ 144.9, 113.1, 78.2, 74.0, 72.2, 63.0, 
39.0, 35.1, 26.1, 20.1, 18.4, -4.0, -4.2, -4.3, -4.6; HRMS (FAB, MH
+
) calcd for 
C21H47O4Si2: 419.3013. Found 419.3024. 
1.230a, minor isomer: 
1
H NMR (CDCl3): δ 5.77 (1H, ddd, J = 7.4, 10.3, 17.2 Hz), 4.91-
5.01 (2H, m), 3.69-3.77 (4H, m),  3.51 (1H, brd d, J = 8.3 Hz), 2.81 (1H, brd s), 2.48 (1H, 
brd s), 2.34 (1H, sep, J = 6.9 Hz), 1.55-1.74 (1H, m), 1.23-1.40 (1H, m), 1.04 (3H, d, J = 
6.7 Hz), 0.93 (9H, s), 0.92 (9H, s), 0.18 (3H, s), 0.14 (3H, s), 0.13 (6H, s); 
13
C {
1
H} 
NMR (CDCl3): δ 144.7, 112.9, 75.7, 75.5, 69.3, 62.5, 41.7, 34.5, 26.4, 26.2, 19.8, 18.6, 
18.4, -3.7, -4.3, -4.4. 
 
(4R,6R,7S,8R,E) Methyl 7,8-bis(tert-butyldimethylsilyloxy)-6,9-dihydroxy-4-
methylnon-2-enoate (1.231a): Grubbs second generation catalyst (9.9 mg, 12 µmol), 
copper iodide (3.2 mg, 17 µmol), hydroxy alkene 1.230a (70 mg, 167 µmol) and methyl 
acrylate (50 µL, 501 µmol) were reacted in dry CH2Cl2 (1.2 mL) following the general 
procedure for cross metathesis to yield 1.231a as a colorless oil (47 mg, 60%). 
IR (neat, NaCl) 3469, 2958, 2922, 2852, 1728 cm
-1
; 
1
H NMR (CDCl3): δ 6.95 (1H, dd, J 
= 7.5, 15.7 Hz), 5.80 (1H, dd, J = 1.1, 15.7 Hz), 3.67-3.78 (4H, m), 3.73 (3H, s), 3.57 
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(1H, dd, J = 2.4, 11.0 Hz), 2.58 (1H, app sep, J = 7.1 Hz), 2.51 (2H, s), 1.65-1.74 (1H, 
m), 1.31-1.39 (1H, m), 1.09 (3H, d, J = 6.7 Hz), 0.92 (9H, s), 0.91 (9H, s), 0.17 (3H, s), 
0.13 (3H, s), 0.11 (6H, s); 
13
C {
1
H} NMR (CDCl3): δ 167.5, 154.8, 119.2, 75.4, 75.1, 
68.8, 62.5, 51.6, 40.8, 33.0, 26.3, 26.1, 18.6, 18.3, -3.9, -4.2, -4.3, -4.5; HRMS (FAB, 
MNa
+
) calcd for C23H48O6Si2Na: 499.2887. Found 499.2884. 
 
(4S,6S,7S,8R,E) Methyl 7,8-bis(tert-butyldimethylsilyloxy)-6,9-dihydroxy-4-
methylnon-2-enoate (1.231b): Grubbs second generation catalyst (4.3 mg, 5.0 µmol), 
copper iodide (1.3 mg, 7.2 µmol), hydroxy alkene 1.230b (30 mg, 72 µmol) and methyl 
acrylate (13 µL, 143 µmol) were reacted in dry CH2Cl2 (0.5 mL) following the general 
procedure for cross metathesis to yield 1.230b as a colorless solid (22 mg, 65%). 
IR (neat, NaCl) 3298, 2952, 2929, 2857, 1726 cm
-1
; 
1
H NMR (CDCl3): δ 6.96 (1H, dd, J 
= 7.6, 15.7 Hz), 5.82 (1H, dd, J = 0.9, 15.7 Hz), 3.83-3.87 (1H, m), 3.73 (3H, s), 3.70-
3.79 (2H, m), 3.63 (1H, dd, J = 2.4, 5.1 Hz), 3.52 (1H, brd d, J = 10.0 Hz), 2.76 (2H, brd 
s), 2.61 (1H, app sep, J = 6.7 Hz), 1.60-1.70 (1H, m), 1.44-1.52 (1H, m), 1.08 (3H, d, J = 
6.7Hz), 0.91 (9H, s), 0.90 (9H, s), 0.12 (9H, s), 0.09 (3H, s); 
13
C {
1
H} NMR (CDCl3): δ  
167.7, 155.1, 119.4, 78.2, 74.9, 71.6, 63.4, 51.9, 38.6, 33.5, 26.3, 18.8, 18.6, 18.5, -3.8, -
4.0, -4.2, -4.4; HRMS (FAB, MNa
+
) calcd for C23H48O6Si2Na: 499.2887. Found 
499.2876. 
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Methyl-(2S,3R,5R){3-methyl-5-[(1S,2R)-3-hydroxy-1,2-bis(tert-
butyldimethylsilyloxy) prop-1-yl]-tetrahydrofuran-2-yl)acetate (1.232a) and Methyl-
(2S,3R,5R){3-methyl-5-[(1R,2R)-2-hydroxy-1,3-bis(tert-butyldimethylsilyloxy)prop-
1-yl]-tetrahydrofuran-2-yl)acetate (1.232b): Unsaturated ester 1.231a (28 mg, 59 
µmol), DBU (10 µL, 65 µmol) were reacted in dry CH2Cl2 (0.5 mL) following the 
general procedure for cyclization (also see procedure for 1.233a/1.233b below). Careful 
chromatography of the crude product afforded 1.232a and 1.232b in a 1:2 ratio as a 
colorless oil (26 mg, combined yield 95%).  
1.232a: IR (neat, NaCl) 3500, 2954, 2924, 2844, 1748 cm
-1
; 
1
H NMR (CDCl3, 500 
MHz): δ 4.18-4.22 (1H, m), 3.88-3.92 (1H, m), 3.73 (1H, dd, J = 7.1, 11.6 Hz), 3.69 (3H, 
s), 3.66-3.69 (2H, m), 3.46 (1H, dd, J = 5.6, 9.1 Hz), 2.71 (1H, d, J = 5.8 Hz), 2.53 (1H, 
dd, J = 5.0, 15.0 Hz), 2.50 (1H, dd, J = 7.2, 14.9 Hz), 2.04-2.09 (1H, m), 1.96-2.03 (1H, 
m), 1.65 (1H, app q, J = 11.0 Hz), 1.06 (3H, d, J = 6.4 Hz), 0.91 (9H, s), 0.89 (9H, s), 
0.09 (3H, s), 0.08 (3H, s), 0.07 (6H, s); 
13
C {
1
H} NMR (CDCl3): δ 172.1, 82.2, 75.0 (2C), 
73.7, 66.0, 51.8, 40.3, 39.8, 37.2, 26.2, 26.1, 18.6, 18.4, 16.5, -4.1, -4.7, -5.2; HRMS 
(FAB, MH
+
) calcd for C23H49O6Si2: 477.3067. Found 477.3067. 
1.232b: IR (neat, NaCl) 3486, 2947, 2931, 2849, 1755 cm
-1
; 
1
H NMR (CDCl3): δ 4.11-
4.18 (1H, m), 3.87 (1H, td, J = 3.8, 8.8 Hz), 3.66-3.73 (4H, m), 3.68 (3H, s), 3.19 (1H, d, 
J = 3.7 Hz), 2.55 (1H, dd, J = 3.9, 14.9 Hz), 2.42 (1H, dd, J = 8.5, 14.9 Hz), 2.05-2.14 
(1H, m), 1.86-1.93 (1H, m), 1.55-1.66 (1H, m), 1.04 (3H, d, J = 6.5 Hz), 0.91 (9H, s), 
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0.90 (9H, s), 0.11 (3H, s), 0.07 (9H, s); 
13
C {
1
H} NMR (CDCl3): δ 172.0, 81.8, 79.5, 
74.7, 74.1, 64.4, 51.8, 40.0, 39.4, 37.0, 26.2, 26.1, 18.53, 18.49, 15.9, -4.2, -4.5, -5.1; 
HRMS (FAB, MNa
+
) calcd for C23H48O6Si2Na: 499.2887. Found 499.2880. 
 
Methyl(2R,3S,5S){3-methyl-5-[(1S,2R)-3-hydroxy-1,2-bis(tert-
butyldimethylsilyloxy)prop-1-yl]-tetrahydrofuran-2-yl)acetate (1.233a) and 
Methyl(2R,3S,5S){3-methyl-5-[(1R,2R)-2-hydroxy-1,3-bis(tert-
butyldimethylsilyloxy)prop-1-yl]-tetrahydrofuran-2-yl)acetate (1.233b): Unsaturated 
ester 1.231b (10 mg, 21 µmol), DBU (3.0 µL, 23 µmol) were reacted in dry CH2Cl2 (0.2 
mL) following the general procedure for cyclization. TLC analysis initially showed only 
one product spot, but as the reaction proceeded an additional product formed. After 2 h, 
the reaction was partitioned between saturated NH4Cl solution and EtOAc. The layers 
were separated and the aq. layer was re-extracted with EtOAC. The combined organic 
layers were washed with brine, dried, and concentrated in vacuo. Careful chromatography 
of the crude product afforded 1.233a and 1.233b in a 1:2 ratio as a colorless oil (9.5 mg, 
combined yield 95%).  
1.233a: IR (neat, NaCl) 3490, 2956, 2929, 1739 cm
-1
; 
1
H NMR (CDCl3): δ 4.08-4.14 
(1H, m), 3.78-3.85 (1H, m), 3.69 (3H, s), 3.60-3.74 (4H, m), 2.54 (1H, dd, J = 3.8, 14.7 
Hz), 2.42 (1H, dd, J = 8.5, 14.7 Hz), 2.11 (1H, app t, J = 6.0 Hz), 1.98-2.08 (1H, m), 
1.87-1.96 (1H, m), 1.54-1.65 (1H, m), 1.05 (3H, d, J = 6.3 Hz), 0.91 (18H, s), 0.13 (3H, 
s), 0.10 (9H, s); 
13
C {
1
H} NMR (CDCl3): δ 172.4, 81.9, 79.2, 76.5, 74.9, 64.0, 52.0, 40.5, 
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40.0, 36.7, 26.4, 26.3, 18.6, 18.5, 16.6, -3.9, -4.1, -4.2; HRMS (FAB, MH
+
) calcd for 
C23H49O6Si2: 477.3068. Found 477.3061. 
1.233b: 
1
H NMR (CDCl3): δ 4.18-4.24 (1H, m), 3.78-3.85 (2H, m), 3.73 (1H, dd, J = 3.5, 
9.9 Hz), 3.68 (3H, s), 3.59 (1H, dd, J = 6.9, 9.9 Hz), 3.53-3.52 (1H, m), 2.53 (1H, dd, J = 
3.9, 14.6 Hz), 2.38-2.48 (2H, m), 1.87-2.05 (2H, m), 1.61-1.73 (1H, m), 1.04 (3H, d, J = 
6.2 Hz), 0.91 (18H, s), 0.10 (3H, s), 0.07 (9H, s); 
13
C {
1
H} NMR (CDCl3): δ 172.3, 82.2, 
78.9, 75.2, 74.0, 65.8, 52.0, 40.3, 39.8, 36.1, 26.3, 26.2, 18.7, 18.6, 16.8, -3.7, -4.5, -5.0. 
 
(3aR,6aR)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-ol (1.235): (-)-2,3-o-
isopropylidene-D-erythronolactone 1.234 (3.0 g, 0.019 mol, 1.0 equiv.) and DIBAL-H 
(1.0 M solution in hexanes, 22.8 mL, 1.2 equiv.) were reacted in dry CH2Cl2 (50 mL) 
following the literature procedure
78
 to afford 1.235 as a colorless crystalline solid (2.55 g, 
84%). 
Major anomer: IR (neat, NaCl) 3421, 2993, 2945 cm
-1
; 
1
H NMR ( CDCl3): δ 5.42 (1H, d, 
J = 1.9 Hz), 4.85 (1H, dd, J = 3.4, 5.9 Hz), 4.58 (1H, d, J = 5.9 Hz), 3.91-4.10 (2H, m), 
2.98 (1H, s), 1.47 (3H, s), 1.32 (3H, s); 
13
C {
1
H} NMR (CDCl3): δ 112.5, 102.0, 85.3, 
80.1, 72.1, 26.4, 25.1; HRMS (FAB, MH
+
) calcd for C7H13O4: 160.0736. Found 
160.0735.  
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(1S,3S)-1-((4S,5R)-5-(hydroxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-3-methylpent-
4-en-1-ol (1.236b): Ni(acac)2 (0.051 g, 0.20 mmol), isoprene (0.8 mL, 8 mmol), lactol 
1.235 (0.32 g, 2.0 mmol), Et3B (1.0 M solution in hexane, 4.8 mL, 4.8 mmol) were 
reacted in dry THF (10 mL) following the general procedure for homoallylation. After 90 
h, the reaction failed to reach completion (TLC and 
1
H NMR). Work up and purification 
afforded a mixture of diastereomers (dr 1:3, 0.3 g, combined yield 65%). Careful 
repeated purification gave pure 1.236b. 
1.236b, major isomer: IR (neat, NaCl) 3421, 2993, 2945 cm
-1
; 
1
H ( CDCl3): δ 5.88 (1H, 
ddd, J = 7.9, 10.2, 17.4 Hz), 4.99-5.17 (2H, m), 4.29-4.35 (1H, m), 3.94-4.00 (2H, m), 
3.90 (1H, dd, J = 7.9, 11.5 Hz), 3.76 (1H, dd, J = 4.5, 11.5 Hz), 2.85 (1H, brd s), 2.46 
(1H, app sep, J = 4.8 Hz), 1.79-1.86 (1H, m), 1.46-1.68 (1H, m), 1.43 (3H, s), 1.37 (3H, 
s), 1.08 (3H, d, J = 6.7 Hz); 
13
C {
1
H} NMR (CDCl3): δ 145.2, 112.5, 109.9, 80.1, 76.0, 
69.9, 63.5, 41.4, 33.7, 27.8, 25.2, 19.3. HRMS (FAB, MH
+
) calcd for C12H23O4: 
231.1596. Found 231.1589. 
 
(4S,6S,E) Methyl 6-hydroxy-6-((4S,5R)-5-(hydroxymethyl)-2,2-dimethyl-1,3-
dioxolan-4-yl)-4-methylhex-2-enoate (1.237): Grubbs second generation catalyst (7.7 
mg, 9.1 µmol), copper iodide (2.5 mg, 13 µmol), hydroxy alkene 1.236b (30 mg, 0.13 
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mmol) and methyl acrylate (23 µL, 0.26 mmol) were reacted in dry CH2Cl2 (0.5 mL) 
following the general procedure for cross metathesis to afford 1.237  as a colorless oil 
(0.023 g, 62%).  
IR (neat, NaCl) 3422, 2932, 1721, 1710 cm
-1
; 
1
H NMR (CDCl3): δ 7.00 (1H, dd, J = 7.5, 
15.7 Hz), 5.85 (1H, dd, J = 1.2, 15.7 Hz), 4.28 (1H, quin, J = 4.3 Hz), 3.84-3.99 (3H, m), 
3.74 (3H, s), 3.67-3.80 (1H, m), 3.07 (1H, d, J = 3.5 Hz), 2.68 (1H, app sep, J = 7.5 Hz), 
2.42 (1H, m), 1.73-1.84 (1H, m), 1.58-1.66 (1H, m), 1.41 (3H, s), 1.35 (3H, s), 1.11 (3H, 
d, J = 6.7 Hz); 
13
C {
1
H} NMR (CDCl3): δ 167.7, 155.3, 119.4, 108.7, 80.8, 67.9, 61.5, 
51.8, 40.6, 33.2, 28.4, 25.8, 19.1; HRMS (FAB, MNa
+
) calcd for C14H24O6Na: 311.1471. 
Found 311.1465. 
 
Methyl-2-((2R,3S,5S)-5-((4S,5R)-5-(hydroxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-
3-methyltetrahydrofuran-2-yl)acetate (1.238): Unsaturated ester 1.237 (10 mg, 35 
µmol) and DBU (5.7 µL, 38 µmol) were reacted in dry CH2Cl2 (0.2 mL) following the 
general procedure for cyclization to give 1.238 as a colorless oil (8.0 mg, 80%). 
IR (neat, NaCl) 3490, 2956, 2929, 1739 cm
-1
; 
1
H NMR (CDCl3): δ 4.34 (1H, dt, J = 5.4, 
8.4 Hz), 4.10 (1H, ddd, J = 5.9, 9.1, 9.4), 3.99 (1H, dd, J = 5.6, 9.7 Hz), 3.87 (1H, dd, J = 
3.2, 9.2 Hz), 3.74-3.82 (2H, m), 3.70 (3H, s), 3.37 (1H, dd, J = 5.4, 9.2 Hz), 2.60 (1H, dd, 
J = 3.2, 15.5 Hz), 2.43 (1H, dd, J = 9.1, 15.5 Hz), 2.37 (1H, ddd, J = 6.4, 6.5, 12.7 Hz), 
1.87-2.02 (1H, m), 1.46-1.64 (1H, m), 1.38 (3H, s), 1.35 (3H, s), 1.06 (3H, d, J = 6.5 Hz); 
13
C {
1
H} NMR (CDCl3): δ 172.0, 108.7, 82.4, 80.7, 77. 9, 76.3, 60.8, 52.3, 40.1, 39.9, 
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39.2, 28.3, 25.7, 16.3; HRMS (FAB, MNa
+
) calcd for C14H24O6Na: 311.1471. Found 
311.1490. 
 
Methyl-2-((2R,3S,5S)-3-methyl-5-((1R,2R)-1,2,3-trihydroxypropyl) 
tetrahydrofuran-2-yl)acetate (1.239): To a stirred solution of 1.233a (25 mg, 0.052 
mmol, 1.0 equiv.) in dry MeOH (0.5 mL) at room temperature was added HF-pyridine 
(23 µL, 0.26 mmol, 5.0 equiv.) and the mixture was stirred for 40 h (TLC analysis). The 
mixture was partitioned between water and EtOAc. The layers were separated and the aq. 
layer was re-extracted with EtOAC. The combined organic layers were washed with 
brine solution and dried over Na2SO4. The solution was concentrated in vacuo and the 
crude product was purified by column chromatography (SiO2, hexanes: EtOAc) to afford 
1.239 as a colorless oil (9.0 mg, 70%). 
To a RBF containing 1.238 (10 mg, 35 µmol, 1.0 equiv.) and amberlyst 15 resin (10 mg, 
1.0 equiv.) was added dry MeOH (0.2 mL) and the resulting mixture was stirred for 5 h 
(TLC analysis). The mixture was partitioned between water and EtOAc. The layers were 
separated and the aq. layer was re-extracted with EtOAC. The combined organic layers 
were dried over anhydrous Na2SO4, concentrated and purified by column 
chromatography (SiO2, hexanes: EtOAc) to afford 1.239 as a colorless oil (6.0 mg, 60%).  
IR (neat, NaCl) 3401, 3328, 2951, 2924, 1709 cm
-1
; 
1
H NMR (CDCl3): δ 4.10 (1H, dt, J 
= 6.6, 9.0 Hz), 2.88 (1H, dd, J = 3.2, 8.9 Hz), 3.80-3.84 (2H, m), 3.70-3.75 (1H, m), 3.70 
(3H, s), 3.62 (1H, brd d, J = 6.3 Hz), 3.40 (1H, brd s), 2.82 (2H, brd s), 2.60 (1H, dd, J = 
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3.3, 15.6 Hz), 2.44 (1H, dd, J = 8.9, 15.6 Hz), 2.32 (1H, ddd, J = 6.4, 6.6, 12.7 Hz), 1.90-
2.0 (1H, m), 1.56-1.66 (1H, m), 1.06 (3H, d, J = 6.5 Hz); 
13
C {
1
H} NMR (CDCl3): δ 
172.1, 82.1, 79.4, 74.4, 73.4, 63.7, 52.1, 39.8, 39.0, 38.1, 16.2; HRMS (FAB, MNa
+
) 
calcd for C11H20O6Na: 271.1157. Found 271.1160. 
 
(1R,3R)-3-methyl-1-((2R,3R)-3-phenyloxiran-2-yl)pent-4-en-1-ol (1.243a) and 
(1S,3S)-3-methyl-1-((2R,3R)-3-phenyloxiran-2-yl)pent-4-en-1-ol (1.243b): 
Epoxycinnamaldehyde 1.242 (0.33 g, 2.2 mmol), Ni(acac)2 (0.057 g, 0.22 mmol), 
isoprene (0.9 mL, 8.9 mmol) and Et3B (1.0 M solution in hexanes, 5.3 mL, 5.3 mmol) 
were reacted in dry THF (10 mL) following the general procedure for homoallylation to 
obtain 1.243 as a colorless oil (dr 2.5:1) (0.303 g, combined yield 63%). The 
diastereomers were separated by further chromatography. The absolute configuration of 
diastereomers was determined by the Mosher ester method. 
(1.243a, major isomer) IR (neat, NaCl) 3422, 3062, 2963, 2928 cm
-1
; 
1
H NMR (CDCl3): 
δ 7.27-7.37 (5H, m), 5.80 (1H, ddd, J = 7.5, 10.3, 17.4 Hz), 4.94-5.08 (2H, m), 3.99-4.05 
(1H, m), 3.97 (1H, d, J = 2.1 Hz), 3.10 (1H, dd, J = 2.3, 3.0 Hz), 2.44 (1H, app sep, J = 
6.8 Hz), 2.11 (1H, d, J = 2.4 Hz), 1.64-1.74 (1H, m), 1.56-1.60 (1H, m), 1.07 (3H, d, J = 
6.7 Hz); 
13
C {
1
H} NMR (CDCl3): δ 144.5, 137.1, 128.7, 128.4, 125.9, 113.2, 67.2, 65.1, 
54.9, 40.3, 34.5, 20.0; HRMS (FAB, MNa
+
) calcd for C14H18O2Na: 241.1204. Found 
241.1213. 
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(1.243b, minor isomer) IR (neat, NaCl) 3428, 3068, 2963, 2928 cm
-1
; 
1
H NMR (CDCl3): 
δ 7.27-7.37 (5H, m), 5.78 (1H, ddd, J = 7.7, 10.3, 17.4 Hz), 4.97-5.09 (2H, m), 3.89 (1H, 
d, J = 2.1 Hz), 3.72 (1H, app quin, J = 7.1 Hz), 3.05 (1H, dd, J = 2.1, 4.9 Hz), 2.40 (1H, 
app sep, J = 6.8 Hz), 2.02 (1H, d, J = 5.5 Hz), 1.70-1.80 (1H, m), 1.53-1.62 (1H, m), 1.07 
(3H, d, J = 6.7 Hz); 
13
C {
1
H} NMR (CDCl3): δ 144.4, 136.9, 128.8, 128.6, 125.9, 113.5, 
69.6, 65.8, 56.9, 41.2, 34.6, 20.5. 
 
(S)-(1R,3R)-3-methyl-1-((2R,3R)-3-phenyloxiran-2-yl)pent-4-en-1-yl 3,3,3-trifluoro-
2-methoxy-2-phenylpropanoate (1.244a): To a stirred solution of 1.243a (0.023 mmol, 
0.005 g) in dry CH2Cl2 (0.5 mL) under argon at rt was added N,N-dimethylamino 
pyridine (DMAP) (1 small crystal), pyridine (0.034 mmol, 3 µL) and (R)-MTPA chloride 
(0.034 mmol, 6 µL) sequentially. It was then stirred for 16 h at that temperature when the 
TLC analysis showed the reaction was complete. About 1 mL of water was added, the 
layers separated, the aq. layer was extracted with EtOAc (5 mL, 3X) and the combined 
organic layers were dried over anhydrous Na2SO4. The crude product was purified by 
column chromatography (SiO2, hexanes:EtOAc) to give 1.244a as a colorless liquid 
(0.008 g, 80%). 
1
H NMR (CDCl3): δ 7.21-7.36 (10H, m), 5.74 (1H, ddd, J = 7.4, 10.3, 17.4 Hz), 4.94-
5.14 (3H, m), 3.83 (1H, d, J = 1.9 Hz), 3.57 (3H, s), 2.94 (1H, dd, J = 1.9, 5.7 Hz), 2.35 
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(1H, app sep, J = 7.0 Hz), 1.91 (1H, ddd, J = 6.6, 8.5, 14.4 Hz), 1.76-1.82 (1H, m), 1.07 
(3H, d, J = 6.7 Hz). 
 
(S)-(1S,3S)-3-methyl-1-((2R,3R)-3-phenyloxiran-2-yl)pent-4-en-1-yl 3,3,3-trifluoro-
2-methoxy-2-phenylpropanoate (1.243b): Alcohol 1.243b (0.023 mmol, 0.005 g), 
DMAP (1 small crystal), pyridine (0.034 mmol, 3 µL) and (R)-MTPA chloride (0.034 
mmol, 6 µL) were reacted in dry CH2Cl2 (0.5 mL) following the same procedure as above 
for compound 1.244a to obtain 1.244b as a colorless liquid (0.007 g, 70%). 
1
H NMR (CDCl3): δ 7.24-7.44 (10H, m), 5.71 (1H, ddd, J = 8.0, 10.2, 17.5 Hz), 4.99-
5.10 (3H, m), 3.85 (1H, d, J = 1.7 Hz), 3.64 (3H, s), 3.18 (1H, dd, J = 1.7, 7.2 Hz), 2.15 
(1H, app sep, J = 7.0 Hz), 1.76-1.91 (1H, m), 1.61-1.69 (1H, m), 1.02 (3H, d, J = 6.7 Hz). 
 
(4R,6R,E)-methyl 6-hydroxy-4-methyl-6-((2R,3R)-3-phenyloxiran-2-yl)hex-2-enoate 
(1.248a): Grubbs second generation catalyst (0.068 g, 0.08 mmol), copper iodide (0.022 
g, 0.11 mmol) hydroxy alkene 1.243a (0.250 g, 1.15 mmol) and methyl acrylate (0.5 mL, 
5.7 mmol) were reacted in dry CH2Cl2 (5 mL) following the general procedure for cross 
metathesis to obtain 1.248a as a colorless oil (0.182 g, 58%).  
IR (neat, NaCl) 3460, 3035, 2962, 2917, 1722 cm
-1
; 
1
H NMR (CDCl3): δ 7.18-7.31 (5H, 
m), 6.87 (1H, dd, J = 7.6, 15.7 Hz), 5.75 (1H, dd, J = 0.9, 15.8 Hz), 3.92-3.96 (1H, m), 
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3.88 (1H, d, J = 2.0 Hz), 3.64 (3H, s), 3.00 (1H, t, J = 2.5 Hz), 2.60 (1H, app sep, J = 7.0 
Hz), 1.99 (1H, brd s), 1.60-1.70 (1H, m), 1.46-1.55 (1H, m), 1.05 (3H, d, J = 6.7 Hz); 
13
C 
{
1
H} NMR (CDCl3): δ 167.4, 154.2, 136.8, 128.7, 128.5, 126.2, 119.6, 66.6, 64.9, 54.9, 
51.7, 39.5, 32.9, 18.9; HRMS (FAB, MNa
+
) calcd for C16H20O4Na: 299.1259. Found 
299.1255. 
 
(4R,6R,E)-Ethyl 6-hydroxy-4-methyl-6-((2R,3R)-3-phenyloxiran-2-yl)hex-2-enoate 
(1.248b): Grubbs second generation catalyst (0.082 g, 0.096 mmol), copper iodide (0.026 
g, 0.14 mmol), hydroxy alkene 1.243a (0.3 g, 1.4 mmol) and ethyl acrylate (0.3 mL, 2.7 
mmol) were reacted in dry CH2Cl2 (5 mL) following the general procedure for cross 
metathesis to afford 1.248b as a colorless oil (0.23 g, 59%).  
IR (neat, NaCl) 3447, 2976, 2921, 1722 cm
-1
; 
1
H NMR (CDCl3): δ 7.18-7.29 (5H, m), 
6.87 (1H, dd, J = 7.5, 15.7 Hz), 5.75 (1H, dd, J = 1.2, 15.7 Hz), 4.10 (2H, q, J = 7.1 Hz), 
3.92-3.97 (1H, m), 3.87 (1H, d, J = 2.1 Hz), 3.00 (1H, t, J = 2.3 Hz), 2.60 (1H, app sep, J 
= 6.7 Hz), 2.00 (1H, s), 1.50-1.71 (2H, m), 1.21 (3H, t, J = 7.1 Hz), 1.05 (3H, d, J = 6.7 
Hz); 
13
C {
1
H} NMR (CDCl3): δ 167.0, 153.9, 136.9, 128.8, 128.6, 125.9, 120.0, 66.6, 
64.9, 60.5, 54.8, 39.4, 32.9, 18.9, 14.5; HRMS (FAB, MNa
+
) calcd for C17H22O4Na: 
313.1416. Found 313.1407. 
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Methyl2-((2S,3R,5R)-3-methyl-5-((2R,3R)-3-phenyloxiran-2-yl)tetrahydrofura-2-yl) 
acetate (1.249a): Unsaturated ester 1.248a (0.10 g, 0.36 mmol), DBU (59 µL, 0.40 
mmol) were reacted in dry CH2Cl2 (2 mL) following the general procedure for 
cyclization to afford 1.249a as a colorless oil (0.07 g, 70%).  
IR (neat, NaCl) 2959, 2869, 1738 cm
-1
; 
1
H NMR (CDCl3): δ 7.27-7.36 (5H, m), 4.10-4.16 
(1H, m), 3.88-3.95 (1H, m), 3.78 (1H, d, J = 2.0 Hz), 3.72 (3H, s), 3.12 (1H, dd, J = 2.0, 
4.2 Hz), 2.60 (1H, dd, J = 4.4, 15.2 Hz), 2.51 (1H, dd, J = 7.6, 15.2 Hz), 2.29 (1H, dt, J = 
6.9, 12.4 Hz), 1.97-2.08 (1H, m), 1.53-1.63 (1H, m), 1.09 (3H, d, J = 6.5 Hz); 
13
C {
1
H} 
NMR (CDCl3): δ 171.9, 137.2, 128.6, 128.4, 125.9, 82.2, 77.3, 64.1, 56.9, 52.0, 39.7, 
39.1, 37.1, 16.3; HRMS (FAB, MNa
+
) calcd for C16H20O4Na: 299.1253. Found 299.1207. 
 
Ethyl-2-((2S,3R,5R)-3-methyl-5-((2R,3R)-3-phenyloxiran-2-yl) tetrahydrofuran-2-
yl)acetate (1.249b): Unsaturated ester 1.248b (0. 15 g, 0.52 mmol) and DBU (85 µL, 
0.57 mmol) were reacted in dry CH2Cl2 (3 mL) following the general procedure for 
cyclization to give 1.249b as a colorless oil (0.12 g, 80%).  
IR (neat, NaCl) 2960, 1735 cm
-1
; 
1
H NMR (CDCl3): δ 7.18-7.26 (5H, m), 4.09 (2H, q, J = 
7.1 Hz), 4.01-4.06 (1H, m), 3.80-3.87 (1H, m), 3.70 (1H, d, J = 2.0 Hz), 3.03 (1H, dd, J = 
2.0, 4.2 Hz), 2.49 (1H, dd, J = 4.7, 15.2 Hz), 2.41 (1H, dd, J = 7.4, 15.4 Hz), 2.20 (1H, dt, 
J = 6.8, 12.4 Hz), 1.88-1.99 (1H, m), 1.44-1.54 (1H, m), 1.19 (3H, t, J = 7.1 Hz), 1.00 
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(3H, d, J = 6.6 Hz); 
13
C {
1
H} NMR (CDCl3): δ 171.4, 137.1, 128.6, 128.3, 125.9, 82.2, 
64.1, 60.7, 56.8, 39.7, 39.3, 37.1, 16.3, 14.4; HRMS (FAB, MNa
+
) calcd for C17H22O4Na: 
313.1416. Found 313.1415. 
 
Ethyl 2-((2S,3R,5R)-5-formyl-3-methyltetrahydrofuran-2-yl)acetate (1.250b): To a 
stirred solution of 1.249b (29 mg, 0.10 mmol, 1.0 equiv.) in acetonitrile and water (2:1) 
(0.9 mL) was added NaIO4 (64 mg, 0.30 mmol, 3.0 equiv.) in one portion and the 
resulting mixture was stirred at rt. After 22 h (TLC analysis), the mixture was partitioned 
between saturated sodium bicarbonate solution and CH2Cl2. The layers were separated 
and the aqueous layer was re-extracted with CH2Cl2. The combined organic phase was 
washed with brine solution, dried over anhydrous Na2SO4, and concentrated in vacuo to 
afford the crude aldehyde (20 mg) which after purification by column chromatography 
(SiO2, hexanes:EtOAc) gave 1.250b as a colorless oil (15 mg, 75%). This aldehyde was 
used directly for the further reactions due to its instability. 
1
H NMR (CDCl3): δ 9.68 (1H, d, J = 2.2 Hz), 4.32 (1H, ddd, J = 2.1, 8.1, 8.3 Hz), 4.19 
(2H, q, J = 7.1 Hz), 3.98 (1H, td, J = 4.5, 8.0 Hz), 2.60 (1H, dd, J = 4.5, 15.3 Hz), 2.53 
(1H, dd, J = 7.7, 15.3 Hz), 2.38 (1H, dt, J = 7.5, 15.1 Hz), 1.99-2.10 (1H, m), 1.58-1.68 
(1H, m), 1.29 (3H, t, J = 7.1 Hz), 1.06 (3H, d, J = 6.4 Hz). 
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Methyl2-((2S,3R,5R)-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)acetate 
(1.251a): Epoxide 1.249a (10 mg, 0.036 mmol), NaIO4 (23 mg, 0.11 mmol) were reacted 
in acetonitrile and water (2:1) (0.3 mL) following the procedure described for 1.250b to 
give the crude aldehyde 1.250a which was used for the next step without further 
purification. 
To a stirred solution of the crude aldehyde 1.250a (6.0 mg, 0.032 mmol, 1.0 equiv.) in 
dry MeOH (0.3 mL) at -78 
o
C was added NaBH4 (1.5 mg, 39 µmol, 1.2 equiv.) and the 
resulting mixture was stirred at -78 
o
C for 30 min.  The reaction mixture was diluted with 
water and extracted with CH2Cl2. The combined organic layers were washed with brine, 
dried over anhydrous Na2SO4, concentrated in vacuo, and purified by column 
chromatography (SiO2, hexanes:EtOAc) to afford 1.251a as a colorless oil (4.0 mg, 64% 
over 2 steps). 
IR (neat, NaCl) 3451, 2954, 2923, 2852, 1736 cm
-1
; 
1
H NMR (CDCl3): δ 4.10-4.17 (1H, 
m), 3.87 (1H, ddd, J = 4.2, 8.2, 8.4 Hz), 3.72 (3H, s), 3.68 (1H, dd, J = 2.9, 11.8 Hz), 
3.50 (1H, dd, J = 5.6, 11.6 Hz), 2.58 (1H, dd, J = 4.2, 15.2 Hz), 2.49 (1H, dd, J = 7.9, 
15.2 Hz), 2.10 (1H, ddd, J = 7.0, 7.1, 11.8 Hz), 1.92-2.03 (1H, m), 1.62 (1H, brd s), 1.45 
(1H, ddd, J = 9.6, 10.4, 11.8 Hz), 1.06 (3H, d, J = 6.4 Hz); 
13
C {
1
H} NMR (CDCl3): δ 
172.1, 81.8, 79.0, 65.1, 51.9, 40.2, 39.3, 36.4, 16.5; HRMS (FAB, MH
+
) calcd for 
C9H17O4: 189.1127. Found 189.1126. 
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GC analysis: 
 column Rt-BDEXcst, rate 5 deg/min, Initial temp.120 
o
C, Final temp. 200 
o
C 
Racemic: 38.5 min (area 47.7%) 38.9 min (area 46.2%) 
Non-racemic (1.251a): 38.5 min (area 89.9%) 39.0 min (area 5.2%), e.e. = >95%  
 
Ethyl 2-((2S,3R,5R)-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)acetate 
(1.251b): Epoxide 1.249b (0.070 g, 0.24 mmol) and NaIO4 (0.155 g, 0.724 mmol) were 
reacted in acetonitrile and water (2:1) (1.5 mL) following the procedure described for 
1.250a to yield the crude aldehyde 2.250b which was reduced without further 
purification. 
Aldehyde 1.250b (0.045 g, 0.22 mmol) and NaBH4 (0.01 g, 0.27 mmol) were reacted in 
dry MeOH (2 mL) following the procedure described for 1.251a to afford 1.251b as a 
colorless oil (0.03 g, 64% over 2 steps). 
IR (neat, NaCl) 3451, 2954, 1736 cm
-1
; 
1
H NMR (CDCl3): δ 4.17 (2H, q, J = 7.1 Hz), 
4.08-4.14 (1H, m), 3.87 (1H, ddd, J = 4.3, 8.1, 8.4 Hz), 3.67 (1H, dd, J = 3.0, 11.7 Hz), 
3.50 (1H, dd, J = 5.7, 11.7 Hz), 2.56 (1H, dd, J = 4.3, 15.2 Hz), 2.47 (1H, dd, J = 7.9, 
15.2 Hz), 2.10 (1H, ddd, J = 7.0, 7.1, 11.9 Hz), 1.95-2.03 (1H, m), 1.77 (1H, brd s), 1.44 
(1H, ddd, J = 9.6, 10.3, 11.8 Hz), 1.28 (3H, t, J = 7.1 Hz), 1.06 (3H, d, J = 6.4 Hz); 
13
C 
{
1
H} NMR (CDCl3): δ 171.8, 81.8, 79.0, 65.1, 60.8, 40.1, 39.5, 36.4, 16.5, 14.4; HRMS 
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(FAB, MNa
+
) calcd for C10H18O4Na: 225.1102. Found 225.1114; [α]D  -37.3 (c 0.4, 
CHCl3), Literature value [α]D -44.9 (c 3.00, CHCl3). 
 
methyl2-((2S,3R,5R)-5-((1S,2R)-1,2-dihydroxy-2-phenylethyl)-3-
methyltetrahydrofuran-2-yl)acetate compound (1.252a) and methyl 2-((2S,3R,5R)-5-
((1S,2S)-1,2-dihydroxy-2-phenylethyl)-3-ethyltetrahydrofuran-2-yl)acetate (1.252b): 
To a stirred solution of racemic 1.249a (0.01 g, 0.036 mmol) in THF/H2O (0.5 mL each) 
at rt was added Amberlyst 15 resin (after washing with dry CH2Cl2) (0.005 g) and stirred 
for 16 h when the TLC analysis showed completion of the reaction. Ethyl acetate (5 mL) 
was added, the layers separated, the aq. layer extracted with more EtOAc (5 mL, 3X) and 
the combined organic layers were dried over anhydrous Na2SO4. The crude product was 
purified by column chromatography (SiO2, hexanes:EtOAc) two obtain to diastereomers 
1.252a and 1.252b as a colorless liquid (1:1) (0.008 g, combined yield 80%). 
1.252a: 
1
H NMR (CDCl3): δ 7.27-7.42 (5H, m), 4.74 (1H, d, J = 6.9 Hz), 3.90-4.02 (2H, 
m), 3.67-3.76 (1H, m), 3.72 (3H, s), 3.59 (1H, brd s), 2.60 (1H, dd, J = 3.8, 15.4 Hz), 
2.48 (1H, dd, J = 8.6, 15.4 Hz), 2.31 (1H, app quin, J = 6.5 Hz), 1.92-1.97 (1H, m), 1.56-
1.67 (1H, m), 1.07 (3H, d, J = 6.5 Hz). 
13
C {
1
H} NMR (CDCl3): δ 171.9, 140.4, 128.7, 
128.4, 127.4, 82.1, 80.6, 77.0, 76.4, 52.0, 39.8, 39.2, 38.4, 16.3. 
1.252b: 
1
H NMR (CDCl3): δ 7.27-7.37 (5H, m), 4.64 (1H, d, J = 5.8 Hz), 3.87-3.94 (2H, 
m), 3.79-3.85 (1H, m), 3.70 (3H, s), 3.16 (1H, brd s), 2.55 (1H, dd, J = 3.8, 15.3 Hz), 
2.42 (1H, dd, J = 8.4, 15.4 Hz), 2.05-2.13 (1H, m), 1.89-1.97 (1H, m), 1.72 (1H, q, J = 
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11.2 Hz), 1.59 (1H, brd s), 1.07 (3H, d, J = 6.4 Hz). 
13
C {
1
H} NMR (CDCl3): δ 172.0, 
140.4, 128.7, 128.3, 127.0, 82.0, 79.0, 76.6, 74.3, 52.0, 40.1, 39.3, 35.4, 16.3. 
 
1-cyclohexyl-1-hydroxybut-3-en-2-yl-acetate (1.265): Cyclohexanecarboxaldehyde 
1.264 (0.01 mL, 0.089 mmol), diacetate 1.256 (0.026 g, 0.178 mmol), Pd2(dba)3 (0.004 g, 
0.004 mmol), and B2(pin)2 (0.025 g, 0.107 mmol) were reacted in dry DMSO (1 mL) 
following the literature procedure
84
 to obtain 1.265 as a colorless oil (0.011 g, 61%). 
1
H NMR (CDCl3): δ 5.92 (1H, ddd, J = 6.9, 10.5, 17.4 Hz), 5.34-5.42 (3H, m), 3.48-3.53 
(1H, m), 2.11 (3H, s), 1.95-2.05 (1H, m), 1.68-1.81 (4H, m), 1.35-1.42 (1H, m), 1.17-
1.30 (4H, m), 1.00-1.13 (1H, m). 
13
C {
1
H} NMR (CDCl3): δ 170.1, 132.0, 120.2, 76.9, 
76.0, 39.9, 29.2, 28.7, 26.5, 26.2, 26.0, 21.5. 
 
1-cyclohexyl-1-hydroxybut-3-en-2-yl-acetate (1.265a) and 1-cyclohexylbut-3-ene-1,2-
diol (1.266): Cyclohexanecarboxaldehyde 1.264 (0.024 mL, 0.200 mmol), diacetate 
1.256 (0.038 g, 0.240 mmol), Pd(PPh3)4 (0.012 g, 0.010 mmol), and diethylzinc (10% 
w/v in hexanes, 0.60 mL) were reacted in dry THF (0.5 mL) following the literature 
procedure
85
 to obtain 1.265a and 1.266 (3:1) as a colorless oil (0.016 g, 38%, only 
1.265a). 
1.165a:
 1
H NMR (CDCl3): δ 5.90 (1H, ddd, J = 6.7, 10.3, 17.1 Hz), 5.23-5.36 (2H, m), 
4.81 (1H, dd, J = 4.3, 6.8 Hz), 4.30 (1H, app q, J = 5.2 Hz), 2.20 (1H, t, J = 3.8 Hz), 2.09 
(3H, s), 1.63-1.77 (6H, m), 1.05-1.24 (5H, m).  
Paudyal, Mahesh, 2012, UMSL, p.84 
 
 
1.166: 
1
H NMR (CDCl3): δ 6.00 (1H, ddd, J = 6.5, 10.4, 17.1 Hz), 5.30-5.41 (2H, m), 
4.23-4.26 (1H, m), 3.40-3.45 (1H, m), 2.01-2.06 (2H, m), 1.66-1.75 (6H, m), 1.05-1.26 
(5H, m). 
 
1-phenylbut-3-ene-1,2-diol (1.267): Benzaldehyde 1.47 (0.02 mL, 0.200 mmol), 
diacetate 1.256 (0.038 g, 0.240 mmol), Pd(PPh3)4 (0.012 g, 0.010 mmol), and diethylzinc 
(10% w/v in hexanes, 0.60 mL) were reacted in dry THF (0.5 mL) following the literature 
procedure to obtain
85
 1.267 as a colorless oil (0.011 g, 34%). 
1
H NMR (CDCl3): δ 7.31-7.38 (5H, m), 5.81 (1H, ddd, J = 6.5, 12.9, 17.2 Hz), 5.23-5.33 
(2H, m), 4.78 (1H, t, J = 4.2 Hz), 4.35 (1H, app q, J = 5.4 Hz), 2.36 (1H, d, J = 3.8 Hz), 
1.98 (1H, d, J = 4.8 Hz); 
13
C {
1
H} NMR (CDCl3): δ 140.1, 136.1, 128.6, 128.2, 126.9, 
118.2, 77.8, 76.7. 
 
3-(trimethylsilyl)prop-2-yne-1,1-diyl diacetate (1.271): Aldehyde 1.270 (0.700 g, 5.55 
mmol), acetic anhydride (2 mL, 21.2 mmol), and FeCl3 (0.04 g, 0.247 mmol) were 
reacted following the literature procedure to produce
83
 diacetate 1.271 as a colorless oil 
(0.901 g, 56%). 
IR (neat, NaCl) 2961, 1766 cm
-1
; 
1
H NMR (CDCl3): δ 7.20 (1H, s), 2.08 (6H, s), 0.17 
(9H); 
13
C NMR (CDCl3) δ 168.1, 96.8, 92.9, 79.2, 20.8, -0.4.  
 
Prop-2-yne-1,1-diyl diacetate (1.272): To a stirred solution of diacetate 1.272 (0.100 g, 
0.347 mmol) in dry THF (2 mL) at 0 
o
C was added TBAF (1.0 M solution in THF) 
Paudyal, Mahesh, 2012, UMSL, p.85 
 
 
dropwise and stirred for 10 minutes at that temperature when the TLC analysis showed 
the reaction was complete. About 1 mL water and 5 mL CH2Cl2 was added, the layers 
separated and the organic layer was extracted with CH2Cl2 (5 mL, 3X). The combined 
organic layers were washed with brine, dried over anhydrous Na2SO4 and concentrated in 
vacuo. The crude was purified by column chromatography (SiO2, hexanes:EtOAc) to 
give 1.272 as a colorless oil (0.044 g, 83%). 
1
H NMR (CDCl3): δ 7.23 (1H, d, J = 1.8 Hz), 2.67 (1H, d, J = 1.8 Hz), 2.13 (6H, s); 
13
C 
NMR (CDCl3) δ 168.0, 79.0, 76.4, 75.5, 20.6. 
 
1-Phenyl-2-((tetrahydro-2H-pyran-2-yl)oxy)-4-(trimethylsilyl)but-3-yn-1-ol (1.276): 
To a stirred solution of 1.275 (0.023 g, 0.120 mmol) in dry THF at -78 
o
C was added n-
BuLi (2.5 M in hexanes, 44 µL, 0.110 mmol) dropwise and the reaction was stirred at 
that temperature for 30 min. Benzaldehyde 1.47 (10 µL, 0.10 mmol) was added dropwise 
to this solution and the reaction was stirred for one more hour when the TLC analysis 
showed the reaction was complete. A few drops of aq. solution of NaHCO3 was added, 
the layers separated and the aq. layer was extracted with Et2O (5 mL, 3X). The combined 
organic layers were washed with water and brine, dried over anhydrous Na2SO4 and 
concentrated. The crude product was purified by column chromatography (SiO2, 
hexanes:EtOAc) to give 1.276 as a colorless liquid as a mixture of syn- and anti-isomers 
(1:2) (0.013 g, combined yield 41%) along with some unidentifiable product. 
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Major Isomer: 
1
H NMR (CDCl3): δ 7.27-7.48 (5H, m), 4.97 (1H, d, J = 2.9 Hz), 4.85 
(1H, app q, J = 3.8 Hz), 4.52 (1H, t, J = 5.2 Hz), 3.46-3.68 (1H, m), 3.29-3.41 (1H, m), 
2.93 (1H, d, J = 3.9 Hz), 1.53-1.67 (6H, m), 0.18 (9H, s). 
 
1-phenyl-4-(trimethylsilyl)but-3-yne-1,2-diol (1.277): To a stirred solution of THP-
mono-protected diol 1.276 (0.008 g, 0.025 mmol) in dry MeOH (0.5 mL) at rt was added 
pyridinium p-toluene sulfonate (PPTS) (0.008 g, 0.031 mmol) and stirred at that 
temperature for 19 h (TLC analysis). Brine and water (1 mL each) was added, the layers 
separated and the aq. layer was extracted with Et2O (5 mL, 3X). The combined organic 
layer were washed with water and brine and dried over Na2SO4. The crude product was 
purified by column chromatography (SiO2, hexanes:EtOAc) to give a colorless liquid 
1.277 as a mixture of syn- and anti-isomers (1:2) (0.005 g, 85%). 
Major Isomer: 
1
H NMR (CDCl3): δ 4.82 (1H, t, J = 4.8 Hz), 4.52 (1H, dd, J = 4.5, 6.8 
Hz), 2.60 (1H, d, J = 5.2 Hz), 2.28 (1H, d, J = 6.9 Hz), 0.15 (9H, s);
 13
C {
1
H} NMR 
(CDCl3): δ 138.9, 128.4, 127.2, 127.0, 102.5, 93.2, 76.5, 68.2, -0.1.   
 
1-cyclohexyl-2-((tetrahydro-2H-pyran-2-yl)oxy)-4-(trimethylsilyl)but-3-yn-1-ol 
(1.278): Cyclohexanecarboxaldehyde 1.264 (24 µL, 0.20 mmol), THP- protected TMS 
propagylic alcohol 1.275 (0.046 g, 0.240 mmol), n-BuLi (2.5 M in hexanes, 88 µL, 0.22 
mmol) and THF (1.0 mL) were reacted as described above to give a colorless liquid 
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1.278 as a mixture of syn- and anti-isomers (1:2) (0.022, 34%) along with some 
unidentifiable product. 
Major Isomer: 
1
H NMR (CDCl3): δ 5.00 (1H, d, J = 2.6 Hz), 4.53 (1H, d, J = 4.0 Hz), 
3.73-3.81 (1H, m), 3.48-3.58 (2H, m), 2.32 (1H, d, J = 3.7 Hz), 2.03-2.14 (1H, m), 1.56-
1.80 (10H, m), 1.01-1.30 (6H, m), 0.19 (9H, s); 
13
C {
1
H} NMR (CDCl3): δ 101.1, 95.9, 
92.9, 77.1, 68.2, 62.6, 40.4, 30.5, 29.3, 28.8, 26.7, 26.4, 26.1, 25.6, 19.4, 0.15. HRMS 
(FAB, MNa) calcd for C18H33O3Si: 325.2199. Found 325.2202. 
 
1-cyclohexyl-4-(trimethylsilyl)but-3-yne-1,2-diol (1.279): The THP-mono-protected 
diol 1.278 (0.010 g, 0.031 mmol) and PPTS (0.009 g, 0.037 mmol) were reacted in dry 
MeOH (0.5 mL) as described above to give a colorless liquid 1.279 as a mixture of cis 
and trans-isomers (1:2) (0.006 g, combined yield 86%). 
Major Isomer: 
1
H NMR (CDCl3): δ 4.44 (1H, dd, J = 3.8, 7.2 Hz), 3.33-3.40 (1H, m), 
2.55 (1H, d, J = 8.0 Hz), 2.33 (1H, d, J = 11.8 Hz), 2.02-2.05 (1H, m), 1.60-1.87 (4H, m), 
1.05-1.26 (6H, m), 0.19 (9H, s). 
 
((5-cyclohexyl-2,2-dimethyl-1,3-dioxolan-4-yl)ethynyl)trimethylsilane (1.280): To a 
stirred solution of 1.279 (0.008 g, 0.033 mmol) in dry DMF (0.5 mL) at rt was added p-
toluenesulfonic acid (p-TsOH) (0.001 g, 0.005 mmol) and 2,2-dimethoxypropane (10 µL, 
0.083 mmol) sequentially and stirred at that temperature for 14 h. A few drops of aq. 
NaHCO3 was added, the layers separated and the aq. layer was extracted with Et2O (5 
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mL, 3X). The combined organic layers were washed with brine, dried over anhydrous 
Na2SO4 and concentrated in vacuo. The crude product was purified by column 
chromatography (SiO2, hexanes:EtOAc) to isolate the colorless liquid 1.280 as a mixture 
of syn- and anti-isomers (1.2:2) (0.005 g, 71% b.r.s.m.). 
Major Isomer: 
1
H NMR (CDCl3): δ 4.68 (1H, d, J = 5.3 Hz), 3.68 (1H, dd, J = 5.3, 9.3 
Hz), 1.93.2.08 (1H, m), 1.69-1.78 (6H, m), 1.54 (3H, s), 1.34 (3H, s), 1.08-1.29 (4H, m), 
0.18 (9H, s). 
 
(1R,3R)-1-((2R,3R)-3-((benzyloxy)methyl)oxiran-2-yl)-3-methylpent-4-en-1-ol 
(1.286): Ni(acac)2 (0.080 g, 0.312 mmol), isoprene 1.12 (1.3 mL, 12.0 mmol), aldehyde  
1.285 (0.600 g, 3.124 mmol), and Et3B (1.0 M solution in hexanes, 7.50 mmol) were 
reacted in dry THF (15 mL) following the general procedure for homoallylation to afford 
the column inseparable mixture of two diastereomers 1.286 as a colorless liquid (dr 1:1) 
(0.250 g, combined yield 31%). 
Major isomer: IR (neat, NaCl) 3435, 2964, 2921, 1120 cm
-1
; 
1
H NMR (CDCl3): δ 7.27-
7.37 (5H, m), 5.79 (1H, ddd, J = 7.5, 10.3, 17.6 Hz), 4.94-5.07 (2H, m), 4.56 (2H, ABq, J 
= 12.0 Hz,  = 0.05 ppm), 3.79 (1H, dd, J = 2.8, 11.6 Hz), 3.51 (1H, dd, J = 5.4, 15.3 
Hz), 3.28 (1H, app quin, J = 2.5 Hz), 2.97 (1H, dd, J = 2.1, 3.3 Hz), 2.28 (1H, app sep, J 
= 6.9 Hz), 2.04 (1H, brd s), 1.44-1.60 (1H, m), 1.61-1.75 (1H, m), 1.05 (3H, d, J = 6.7 
Hz); 
13
C {
1
H} NMR (CDCl3): δ 144.5, 138.0, 128.6, 127.9, 127.8, 113.1, 73.4, 69.8, 66.8, 
58.2, 53.7, 40.3, 34.4, 19.9: HRMS (FAB, MNa) calcd for C16H22O3Na: 285.1453. Found 
285.11569. 
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(1R,3R)-1-((2R,3R)-3-((benzyloxy)methyl)oxiran-2-yl)-3-methylpent-4-en-1-yl 
acetate (1.287a) and (1S,3S)-1-((2R,3R)-3-((benzyloxy)methyl)oxiran-2-yl)-3-
methylpent-4-en-1-yl acetate (1.287b): To a stirred solution of diastereomeric mixture 
1.286 (0.200 g, 0.763 mmol) in dry CH2Cl2 at rt was added DMAP (0.009 g, 0.076 
mmol). The reaction mixture was then cooled to 0 
o
C at stirred for 5 minutes before 
adding pyridine (7 µL, 0.915 mmol). After stirring for 5 more minutes at that 
temperature, acetic anhydride (107 µL, 1.14 mmol) was added and continued stirring. 
The TLC analysis after an additional 30 minutes showed no starting material left. A few 
drops of water were added, the layers separated, and the organic layer washed with brine 
and dried over anhydrous Na2SO4. The crude product was purified by column 
chromatography (SiO2, hexanes:EtOAc) to give 1.287a and 1.287b (separately) as a 
colorless liquid (0.160 g, 69%). 
1.287a: IR (neat, NaCl) 2963, 2932, 1741 cm
-1
; 
1
H NMR (CDCl3): δ 7.27-7.36 (5H, m), 
5.73 (1H, ddd, J = 7.5, 10.3, 17.5 Hz), 4.91-5.04 (2H, m), 4.87 (1H, dd, J = 4.6, 9.1 Hz), 
4.56 (2H, ABq, J = 12.0 Hz,  = 0.05 ppm),, 3.75 (1H, dd, J = 2.8, 11.7 Hz), 3.47 (1H, 
dd, J = 5.4, 11.6 Hz), 3.20 (1H, app quin, J = 2.6 Hz), 2.93 (1H, dd, J = 2.1, 5.1 Hz), 2.28 
(1H, app sep, J = 7.2 Hz), 2.05 (3H, s), 1.70-1.81 (1H, m), 1.54-1.64 (1H, m), 1.02 (3H, 
d, J = 6.7 Hz); 
13
C {
1
H} NMR (CDCl3): δ 170.4, 143.8, 138.0, 128.6, 128.0, 127.9, 113.2, 
73.5, 70.8, 69.6, 56.0, 55.6, 38.1, 34.4, 21.2, 20.1; HRMS (FAB, MNa) calcd for 
C18H24O4Na: 327.1572. Found 327.1541. 
1.287b: IR (neat, NaCl) 2954, 2924, 1746 cm
-1
; 
1
H NMR (CDCl3): δ 7.27-7.36 (5H, m), 
5.72 (1H, ddd, J = 7.8, 10.2, 17.5 Hz), 4.94-5.05 (2H, m), 4.88 (1H, dd, J = 5.9, 13.3 Hz), 
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4.58 (2H, dd, J = 12.0, 16.3 Hz), 3.75 (1H, dd, J = 3.0, 11.7 Hz), 3.51 (1H, dd, J = 5.1, 
13.7 Hz), 3.13 (1H, app quin, J = 2.4 Hz), 3.02 (1H, dd, J = 2.2, 5.6 Hz), 2.26 (1H, app 
sep, J = 7.4 Hz), 2.06 (3H, s), 1.69-1.82 (1H, m), 1.56-1.65 (1H, m), 1.03 (3H, d, J = 6.7 
Hz); 
13
C {
1
H} NMR (CDCl3): δ 170.4, 143.6, 137.9, 128.6, 128.0, 127.9, 113.7, 73.5, 
71.5, 69.6, 56.5, 55.4, 38.1, 34.7, 21.3, 20.9. 
 
2-(2-methylbut-3-en-1-yl)tetrahydrofuran-3,4-diol (1.290): To a stirred solution of α-
acetoxy epoxide 1.287a (0.01 g, 0.033 mmol) in dry Et2O at rt was added BF3·Et2O (29 
µL, 0.230 mmol) and stirred at that temperature for 20 h. A few drops of aq. NaHCO3 
were added, the layers separated, and the combined organic layers were washed with 
brine and dried over anhydrous Na2SO4. Proton NMR of the crude product showed no 
epoxide peaks. This crude product (0.012 g, quant.) was set up for the further reaction 
without any purification. 
To the above crude product was added 0.5 mL of 1% HCl in MeOH and stirred at rt for 
26 h. A few drops of aq. NaHCO3 were added and the layers separated. The combined 
organic layers were washed with brine, dried over anhydrous Na2SO4 and concentrated in 
vacuo. Column chromatography (SiO2, hexanes:EtOAc) of the crude product produced 
pure 1.290 as a colorless liquid (0.005 g, 45%). Some benzyl containing unidentifiable 
compound was also isolated. 
1
H NMR (CDCl3): δ 5.70 (1H, ddd, J = 8.1, 10.2, 17.2 Hz), 4.94-5.09 (2H, m), 4.20-4.30 
(1H, m), 4.13 (1H, dd, J = 5.3, 10.4 Hz), 3.67-3.86 (3H, m), 2.39 (1H, app sep, J = 6.9), 
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2.33 (2H, brd d, J = 5.3 Hz), 1.50-1.69 (2H, m), 1.06 (3H, d, J = 6.8 Hz); 
13
C {
1
H} NMR 
(CDCl3): δ 144.0, 113.9, 80.8, 76.4, 73.0, 71.2, 40.6, 35.5, 21.5. 
 
2-(2-methylbut-3-en-1-yl)tetrahydrofuran-3,4-diyl diacetate (1.291): Diol 1.290 
(0.005 g, 0.030 mmol), DMAP (1 small crystal), pyridine (10 µL, 0.132 mmol) and acetic 
anhydride (14 µL, 0.150 mmol) were reacted in dry CH2Cl2 (1 mL) rt following the 
acetylation procedure described above to produce 1.291 as a colorless liquid (0.006 g, 86 
%).  
IR (neat, NaCl) 2966, 2920, 1748 cm
-1
; 
1
H NMR (CDCl3): δ 5.67 (1H, ddd, J = 8.2, 10.1, 
18.1 Hz), 5.32 (1H, dd, J = 5.5, 10.0 Hz), 4.84-4.89 (1H, m), 4.21 (1H, dd, J = 5.6, 10.2 
Hz), 3.92 (1H, dd, J = 6.9, 12.9 Hz), 3.78 (1H, dd, J = 4.2, 10.2 Hz), 2.34 (1H, app sep, J 
= 7.6 Hz), 2.09 (6H, s), 1.52-1.56 92H, m), 1.05 (3H, d, J = 6.8 Hz); 
13
C {
1
H} NMR 
(CDCl3): δ 170.3, 143.4, 114.1, 78.4, 75.6, 71.4, 70.5, 40.3, 35.3, 21.4, 21.0, 20.9. 
 
((4R,5S)-5-ethynyl-2,2-dimethyl-1,3-dioxolan-4-yl)methanol (1.298): Lactol 1.235 
(0.032 g, 0.200 mmol), Bestmann-Ohira reagent 1.297 (0.050 g, 0.260 mmol), and 
K2CO3 (0.036 g, 0.260 mmol) were reacted in dry MeOH (2 mL) following the literature 
procedure
91
 to give 1.298 as a colorless liquid (0.02 g, 64%). 
1
H NMR (CDCl3): δ 4.60 (1H, dd, J = 2.1, 7.6 Hz), 4.19 (1H, td, J = 3.3, 7.6 Hz), 3.93 
(1H, dd, J = 3.0, 4.3 Hz), 3.89 (1H, dd, J = 3.1, 4.3 Hz), 3.65-3.72 (1H, m), 2.54 (1H, d, J 
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= 2.10 Hz), 1.85-1.95 (1H, m), 1.51 (3H, s), 1.45 (3H, s); 
13
C {
1
H} NMR (CDCl3): δ 
110.9, 82.0, 80.8, 75.0, 66.3, 60.9, 26.9, 26.3. 
 
(4S,5S)-((4S,5R)-5-ethynyl-2,2-dimethyl-1,3-dioxolan-4-yl)methyl 5-ethynyl-2,2-
dimethyl-1,3-dioxolane-4-carboxylate (1.300): To a stirred solution of alcohol 1.298 
(0.008 g, 0.05 mmol) in dry CH2Cl2 (1 mL) was added powdered 3Å molecular sieves 
(0.02 g), NMO (0.012 g, 0.100 mmol), and TPAP (5 mol%, 0.001 g) sequentially and 
stirred at rt. After 10 minutes (TLC analysis), the solvent was evaporated and the crude 
product was purified by column chromatography (SiO2, hexanes:EtOAc) to afford 1.300 
as a colorless liquid (0.006, 35%). 
IR (neat, NaCl) 3269, 2926, 2129, 1734 cm
-1
; 
1
H NMR (CDCl3): δ 4.90 (1H, dd, J = 2.1, 
5.9 Hz), 4.67 (1H, d, J = 5.9 Hz), 4.54 (1H, dd, J = 2.1, 6.9 Hz), 4.46-4.50 (1H, m), 4.29-
4.35 (2H, m), 2.62 (1H, d, J = 2.1 Hz), 2.58 (1H, d, J = 2.1 Hz), 1.57 (3H, s), 1.56 (3H, 
s), 1.51 (3H, s), 1.50 (3H, s), 1.50 (3H, s). 
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2. CHAPTER II 
Homoallylation of Various Chiral and Achiral Pentadienoates with 
Chiral and Achiral Aldehydes 
 
 
 
 
 
Paudyal, Mahesh, 2012, UMSL, p.102 
 
 
2.1.  General Objective 
Carbon-carbon bond formation is the most fundamental process in synthetic organic 
chemistry. The development of new and efficient protocols for the formation of carbon-
carbon bonds for application in the rapid construction of complex natural and unnatural 
products has always been a formidable and enduring challenge in organic synthesis.  
The vinylation, allylation and homoallylation of carbonyl compounds to produce allylic, 
homoallylic and bis-homoallylic alcohols, respectively are important reactions for the 
formation of carbon-carbon bonds. Various methods including asymmetric variants have 
been developed for the alkenylation and allylation reactions.
1 
On the other hand, 
homoallylation of carbonyl compounds has achieved less attention, partly because of the 
limited availability of homoallylation methods and the limited variety of homoallylating 
agents CH2=CHCH2CH2M, which are restricted to highly electropositive metals such as 
Li, Mg, Zr etc.
2 
The development of nickel-catalyzed reductive coupling reactions of 
carbonyl compounds and 1,3-dienes has proven to be a successful tool for the synthesis 
of bis-homoallylic alcohols. However, very limited asymmetric variations of these 
reactions are known. The general objective of this chapter of the thesis is to develop 
diastereoselective versions of homoallylation reactions. 
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2.2.  Introduction 
Recently we showed that (described in chapter 1) bis-homoallylic alcohols 2.3 could be 
synthesized with good to excellent diastereoselectivity by reacting aldehydes 2.1 
(hemiacetals or epoxyaldehydes) with isoprene 2.2 (Scheme 2.1).
3 
The bis-homoallylic 
alcohol 2.3 obtained could be converted to trisubstituted tetrahydrofuran (THF) ring 2.4 
in two steps: Grubbs cross metathesis with an alkyl acrylate followed by DBU 
cyclization. 
 
Scheme 2.1. Representation of Homoallylation, Cross Metathesis and Cyclization  
It is conceivable that the metathesis reaction can be eliminated by conducting the 
reductive alkylation with a diene carboxylate ester (pentadienoates) 2.6 (Scheme 2.2). 
Reductive addition of a diene carboxylate ester (or amide) 2.6 would lead directly to the 
hydroxyl unsaturated ester 2.5 required for cyclization. Based on the various substituent 
patterns explored by Tamaru, it was predicted that the major product would result from 
the reaction at the 3,4-bond. The inclusion of the ester or amide moiety within the diene 
allows for the addition of a chiral auxiliary to control the π-facial selectivity with respect 
to the aldehyde. 
 
Scheme 2.2. Retrosynthesis of ε-Hydroxy-α,β-Unsaturated Ester 2.5 
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Herein, reaction of achiral and chiral aldehydes with achiral and chiral diene carboxylate 
esters which produce bis-homoallylic alcohols in excellent regioselectivity (>99:1) and 
modest diastereoselectivity (upto 5:1) will be discussed (Scheme 2.3). 
 
Scheme 2.3. Representation of the Homoallylation of an Aldehyde and a Pentadienoate 
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2.3.  Nickel catalyzed reductive coupling reactions 
2.3.1. Coupling of carbonyl compounds with alkynes: Allylic alcohols preparation 
2.3.1.1.  Intramolecular coupling of carbonyl compounds with alkynes 
In 1997, Montgomery and coworkers reported the first example of a nickel catalyzed 
reductive coupling of aldehydes with alkynes to obtain cyclic allylic alcohols 2.11 and 
2.12 (Scheme 2.4).
4 
They observed that 5-alkynal 2.10 (1.0 equiv.) undergoes alkylative 
cyclization upon treatment with Ni(cod)2 (5 mol %) and a variety of organozinc reagents 
(2.5-3.0 equiv.) at 0 
o
C in THF to give allylic alcohol 2.11 with a exocyclic 
tetrasubstituted alkene. However, in the presence of a catalytic phosphine additive (PBu3, 
4.0 equiv. relative to Ni(Cod)2), the reductive cyclization product 2.12 (transfer of H 
instead of ethyl group from diethylzinc) was observed.  
 
Scheme 2.4. Alkylative and Reductive Cyclizations of 5-Alkynyl 2.10 
The proposed mechanism of this transformation involves the oxidative coupling of an 
alkyne and aldehyde with nickel(0) to obtain oxanickelacycle 2.14 (Scheme 2.5). This is 
followed by transmetalation of the organozinc to produce vinyl nickel species 2.15. 
Reductive elimination of 2.15 produces alkylative cyclization product 2.16. On the other 
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hand, β-hydride elimination of 2.15 prior to reductive elimination in the presence of 
tributylphosphine affords the reductive cyclization product 2.18.
5 
 
Scheme 2.5. Proposed Mechanism for Ynal Cyclization 
Montgomery observed that with more complex substrates, the direct 1,2-addition of 
diethylzinc to the aldehyde caused a significant problem. To avoid this problem of direct 
1,2-addition, they developed an efficient method of reductive cyclization using 
triethylsilane as a reducing agent and tributylphosphine as a ligand (Scheme 2.6).
6
 An 
example shown below gives silyl protected allylic alcohol 2.20 with excellent 
diastereoselectivity and yield. This concept can be employed for the stereoselective 
synthesis of a variety of quinolizidine, indolizidine, and pyrrolizidine alkaloids.
6
 
 
Scheme 2.6. Ni(0) Catalyzed Cyclization of Silyl Protected Ynal 2.19 
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2.3.1.2. Intermolecular coupling of carbonyl compounds with alkynes 
The nickel catalyzed alkylative coupling product of alkynes and aldehydes were reported 
by Montgomery et al. which uses a stoichiometric amount of dialkylzinc as a reducing 
agent.
4 
As shown below, benzaldehyde 2.21 (3.0 equiv.) reacts with octynal-1 2.22 (1.0 
equiv.) in the presence of catalytic Ni(0) (20 mol%) and dimethylzinc (2.5 equiv.) as a 
reducing agent to produce 2.23 as a single regio- and stereoisomer in 74% yield. 
 
Scheme 2.7. Three Component Coupling of Aldehyde, Alkyne and Dimethylzinc 
However, the first example of intermolecular reductive coupling of aldehydes and 
alkynes (catalyzed by Ni(cod)2/PBu3 and reduced by Et3B) was reported by Jamison and 
coworkers.
7
 For example, treatment of n-butanal 2.24 (1.0 equiv.) with 1-phenylpropyne 
2.25 (1.0 equiv.) in the presence of Ni(cod)2 (10 mol%), Bu3P (0.2 equiv.), and 
triethylborane (2.0 equiv.) in toluene gives 2.26 in 88% yield and 98:2 regioselectivity 
(Scheme 2.8).  
 
Scheme 2.8. Intermolecular Reductive Coupling of an Aldehyde and an Alkyne 
In the mean time, Takai and coworkers reported a reductive coupling of an aldehyde and 
a terminal alkyne with CrCl2, a catalytic amount of NiCl2 and triphenylphosphine to 
produce 1,2-disubstituted allylic alcohol regioselectively.
8
 To give an example, 4-phenyl-
1-butyne 2.27 (2.5 equiv.) was reacted with nonanal 2.28 (1.0 equiv.) in the presence of 
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CrCl2 (5.0 equiv.), a catalytic amount of NiCl2 (25 mol %), and triphenylphosphine (50 
mol %) in DMF/water for 8 h to give allylic alcohols 2.29 and 2.30 in 95:5 
regioselectivity (Scheme 2.9). An excess amount (2-3 equiv.) of alkyne was needed to 
avoid cyclotrimerization of alkynes, a side reaction. 
 
Scheme 2.9. Reductive Coupling of a Terminal Alkyne and an Aldehyde 
In 2003, Jamison reported the first examples of catalytic, enantioselective reductive 
couplings of alkynes and aldehydes employing a menthyl-based monodentate phosphine 
ligand 2.32 (neo-menthyldiphenylphosphine, (+)-NMDPP).
9
 For example, treatment of 
iso-butanal 2.31 (2.0 equiv.) with 1-phenylpropyne 2.25 (1.0 equiv.) using catalytic 
Ni(cod)2 (10 mol %), ligand 2.32 (20 mol %) and Et3B (2.0 equiv.) in 1:1 mixture of 
EtOAc/DMI (1,3-dimethylimidazolidinone) at -25 
o
C for 36 h produced allylic alcohol 
2.33 with 90% ee and >95:5 regioselectivity (Scheme 2.10). 
 
Scheme 2.10. Enantioselective Reductive Coupling of an Aldehyde and an Alkyne 
A number of diastereoselective reductive coupling reactions of alkyne and aldehyde are 
reported by both the Jamison and Montgomery groups.
10
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2.3.2. Coupling of carbonyl compounds with 1,3-dienes: Homoallylic and bis-
homoallylic alcohols preparation 
The reductive coupling reactions of aldehydes (and ketones) with 1,3-dienes are 
developed and extended by Mori and coworkers, Tamaru and coworkers and others. 
2.3.2.1. Intramolecular coupling of 1,3-dienes and carbonyl compounds 
Mori reported that 1,3-dienes undergo regio- and stereoselective reductive cyclization 
with a tethered carbonyl group in the presence of a stoichiometric amount of Ni(0) 
produced by reducing Ni(acac)2/PPh3 with dibalH (Scheme 2.11).
11
 For example, 
treatment of aldehyde 2.38 (or ketone 2.39) with a stoichiometric amount of hydride 
nickel complex 2.35, prepared in situ from Ni(acac)2 (100 mol%) and 2.0 equivalent of 
dibalH in the presence of PPh3 (200 mol%) gave 2.40 as the only product (or a mixture of 
2.41a and 2.41b) (Scheme 2.12). 
 
Scheme 2.11. Representation of Ni(0) Catalyzed Intramolecular Cyclization 
 
Scheme 2.12. Intramolecular Reductive Coupling of 1,3-Dienes and Aldehyde 
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These cyclization reactions follow the proposed mechanism (Scheme 2.13): a 
stoichiometric amount of hydride nickel complex 2.35 is generated from Ni(acac)2 and 
PPh3 by treatment with DIBAL-H.
11
 The nickel complex 2.35 reacts with the diene to 
form a π-allylnickel complex 2.42 which reacts with the aldehyde 2.38 in the side chain 
giving the nickel complex 2.43. Upon acid hydrolysis, the cyclized product 2.40 is 
obtained stereoselectively with respect to the three carbon centers of the cyclopentane 
ring.  
 
 
Scheme 2.13. Mechanism of Intramolecular Reductive Cyclization Reaction 
Mori was also able to establish a catalytic variant of this reductive cyclization reaction 
preparing π-allylnickel complex 2.35 (X = SiEt3) formed from a 1,3-diene and zerovalent 
nickel complex in the presence of Et3SiH.
11
 For example, when compound 2.38 is treated 
with a catalytic amounts of Ni(cod)2, (10 mol%), PPh3 (20 mol%), and Et3SiH (5.0 
equiv.), 2.46 is obtained in 70% yield (Scheme 2.14). This reaction proceeds via a π-allyl 
intermediate 2.44 to give 2.46 with an internal double bond in the side chain. 
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Scheme 2.14. Proposed Mechanism for the Catalytic Cyclization of 2.38 
On the other hand, when 2.38 is cyclized using a catalytic amount of Ni(cod)2 (5 mol%) 
and PPh3 (10 mol%) in the presence of 
i
Bu2-ALAC (Diisobutylaluminum 
acetylacetonate) (1.5 equiv.), a cyclized product 2.41b having a terminal olefin on the 
side chain can be selectively produced with 84% yield (Scheme 2.15).
12 
It was proposed 
that in the presence of 
i
Bu2-ALAC, the reaction proceeds via a transmetalation of the 
nickelacycle 2.47, formed by oxidative cycloaddition of 2.38 to Ni(0) complex and 
i
Bu2- 
ALAC. 
 
Scheme 2.15. Proposed Mechanism of Catalytic Cyclization of 2.38  
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It was found that the addition of 1,3-cyclohexyldiene (1,3-CHD) to the reaction mixture 
under the same reaction conditions affected the regiochemistry of olefin on the side chain 
and 2.37 having a terminal olefin on the side chain was exclusively produced.
13
 The Mori 
group has successfully applied the concept of nickel catalyzed cyclization in the formal 
total synthesis of (-)-Elaeokanine C 2.51 (Scheme 2.16).
14
 
 
Scheme 2.16. Application of Ni(0) Catalyzed Cyclization in the Total Synthesis 
2.3.2.2. Intermolecular coupling of 1,3-dienes and carbonyl compounds 
Extensive explorations have been published in the literature towards the Ni(0) catalyzed 
intermolecular coupling of 1,3-dienes and carbonyl compounds.  
Baker and Crimmin reported the nickel-catalyzed and nickel-promoted reaction of 2 
equiv. of 1,3-butadiene with 1.0 equiv. aldehydes to produce homoallylic alcohols as 2:1 
adducts with good selectivity.
15
 For example, reaction of acetaldehyde 2.52 (1.0 equiv.) 
and butadiene 2.53 (5.0 equiv.) in the presence of Ni(cod)2 (25 mol %) and an 
organophosphorous ligand (25 mol %) at 0 
o
C for 16 h gave a mixture of 4 products 
whose ratio was dependent on nature of the ligand used (Scheme 2.17). 
Triphenylphosphine 2.54 and the nickel complex show a preference for the linear alcohol 
whereas the branched alcohol can be formed as a major isomer using tributylphosphine 
2.55 and a variety of other phosphines.  
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Scheme 2.17. Ni(0) Catalyzed Reaction of Acetaldehyde with Butadiene  
Mori prepared homoallylic alcohol derivatives in a regio- and stereoselective manner.
16
 
For example, when a toluene solution of diene 2.60 (1.0 equiv.), benzaldehyde 2.21 (1.0 
equiv.), and Et3SiH (5.0 equiv.) was stirred in the presence of Ni(cod)2 (20 mol %) and 
PPh3 (40 mol %) at 50 
o
C for 17 h, triethylsilyl substituted homoallylic alcohol 2.61 was 
obtained as a sole product in 84% yield (Scheme 2.18). 
 
Scheme 2.18. Ni(0) Catalyzed Reductive Coupling of a Diene and an Aldehyde 
The same group also developed the Ni(0) catalyzed reactions of dienes having a silicon 
moiety and aldehydes which yield E- and Z-allylsilanes in a highly stereoselective 
manner.
17 
It was found that when silyl-diene 2.63 was refluxed with aldehyde 2.62 in 
toluene in the presence of silane using catalytic amounts of Ni(cod)2 having PPh3, E-
allylsilane 2.64 was obtained in good yield (Scheme 2.19). However, when the reaction 
mixture was heated in THF in the presence of Ni(cod)2, imidazolium salt 2.66, Cs2CO3 
and PPh3, Z-allylsilane 2.65 was formed as the sole product. 
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Scheme 2.19. Stereoselective Formation of E- and Z- Allylsilanes 
 Jamison and Molinaro introduced Ni(0) catalyzed inter- and intramolecular reductive 
coupling of epoxides and alkynes with triethylborane as reducing agent.
18
 As shown 
below, when phenylpropyne 2.67 (1.0 equiv.) is treated with epoxide 3.68 (2.0 equiv.) in 
the presence of Ni(cod)2 (10 mol %), Bu3P (20 mol %), and Et3B (2.0 equiv.), 
homoallylic alcohol 2.69 is produced with >95:5 regioselectivity at both alkyne and 
epoxide in 71% yield (Scheme 2.20).  
 
Scheme 2.20. Ni(0) Catalyzed Reductive coupling of an Alkyne and an Epoxide 
Various cyclization reactions to form five- and six-membered rings were also reported by 
the same group. The addition always occurred at the unsubstituted epoxide position (endo 
attack) (Scheme 2.21).  
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Scheme 2.21. Reductive Intramolecular Cyclization of Alkyne-Epoxide 
The mechanism of this selectivity involves the regioselective oxidative addition of the 
phosphine-nickel(0) complex into the less hindered C-O bond of the epoxide 2.72 to form 
the nickelaoxetane intermediate 2.73 (Scheme 2.22). This is followed by alkyne insertion 
(cyclization) to give 2.74 and ethyl transfer from Et3B to nickel giving intermediate 2.75. 
Subsequent β-hydride elimination gives 2.76 followed by reductive elimination to give 
the observed product 2.77.  
 
Scheme 2.22. Mechanism of Ni(0) Catalyzed Intramolecular Cyclization 
Tamaru et al. developed a regio- and stereoselective nickel catalyzed coupling of 
carbonyl compounds and 1,3-dienes using organoboron or organozinc reagents.
19
 This 
reaction corresponds to a reductive coupling of the C1-C2 double bond of isoprene and 
the carbonyl group of the aldehyde to give bis-homoallylic alcohol with very high 1,3-
anti (or 1,2-anti) diastereoselectivity (Scheme 2.23). 
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Scheme 2.23. Intermolecular Reductive Coupling of Diene and Benzaldehyde 
The reaction is remarkable in many respects; 1) isoprene reacts with benzaldehyde 
exclusively at the C1 position of the diene moiety with an exclusive delivery of hydrogen 
at C2, 2) the reaction exhibits high 1,3-diastereoselectivity giving 1,3-anti-2.79 in 
preference to 1,3-syn-2.81 (15:1), 3) the 1:1 adduct of diene and aldehyde selectively is 
surprising because of the property of nickel complexes to promote oligomerization of 
simple dienes giving 2:1 and 3:1 adducts also.
15,20
  
To give a specific example of such reductive coupling when benzaldehyde 2.21 (1.0 
equiv.) is treated with isoprene 2.2 (4.0 equiv.) and Et3B (2.4 equiv.) in the presence of 
Ni(acac)2 in THF at rt, it provides the bis-homoallylic alcohol 2.82 (1:1 adduct of the 
diene and benzaldehyde) exclusively with 90% yield (Scheme 2.24).
19a
  
 
Scheme 2.24. Homoallylation of Benzaldehyde 2.21 with Isoprene 2.2 
A plausible mechanism for this reductive coupling is outlined in scheme 2.25. The 
difference in the electron densities of the diene termini might control the regioselectivity 
and the terminal position bearing the highest electron density would react with the 
aldehyde (this will be discussed in detail in section 2.4.2). An oxanickellacyclopentane 
intermediate 2.86 is formed, from the transition state 2.85, through oxidative cyclization 
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of a Ni(0) species across isoprene and an aldehyde. In the transition state 2.85, the 
aldehyde is arranged to place the oxygen to the vacant site of the s-trans-diene-Ni(0) 
complex and alkyl group in a quasi-equatorial position to avoid a quasi-1,3-diaxial 
repulsion (between an aldehyde R and isoprene Me) that an alternate orientation of alkyl 
group might experience. The oxidative cyclization is enhanced by coordination of Et3B 
(or Et2Zn) to an aldehyde. One ethyl group is transferred from B to Ni followed by an 
ionic Ni-O bond cleavage to give an intermediate 2.87. Intermediate 2.87 then undergoes 
β-hydrogen elimination to produce intermediate 2.88. Reductive elimination of 2.88 
delivers the hydrogen at the allylic position bound to the nickel with retention of 
configuration to finally produce a nickel(0)(ethylene) complex 2.89, bis-homoallylic 
alcohol with 1,3-anti stereochemistry.  
 
Scheme 2.25. Mechanism for the Ni(0)-Catalyzed Homoallylation of an Aldehyde 
The use of Et2Zn as a reducing agent and promoter is particularly effective for the 
reaction of saturated aldehydes and ketones, where the Et3B is unsuccessful.
19b
 
On the other hand, these couplings with Me2Zn or Me3B led to the formation of 
homoallylic alcohols (Scheme 2.26).
21
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Scheme 2.26. Ni(0) Catalyzed Coupling (Me3B or Me2Zn as Reducing Agents) 
Tamaru has extended the application of reductive coupling reaction (homoallylation) by 
taking a number of different types of diene and aldehydes.
19d
 However, in the limited 
examples of chiral aldehydes studied by Tamaru gave very low π-facial selectivity (1:1 to 
1.6:1) with respect to aldehyde. 
 
Scheme 2.27. Low Diastereoselectivity Reported by Tamaru 
In some examples shown by Loh and coworkers,
22
 the cyclic dienes can also undergo a 
reductive coupling reaction with an aldehyde which Tamaru et al.
19d
 reported to be 
unreactive (or less reactive). It was shown that aldehydes like 2.98 can react with cyclic 
dienes like 2.99 in the presence of a catalytic amount of nickel and diethylzinc (as a 
promoting and reducing agent) to produce bis-homoallylic alcohols like 2.100 (Scheme 
2.28).  
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Scheme 2.28. Homoallylation of Aldehyde 2.98 with Cyclohexa-1,3-diene 2.99 
We reported the nickel catalyzed diastereoselective homoallylation reactions of 1,3-
dienes with hemiacetals and epoxyaldehydes (Scheme 2.29).
3 
These were novel 
electrophiles used for this type of reductive coupling. For example, the TBS and 
acetonide protected hemiacetals 2.101a and 2.101b produced bis-homoallylic alcohols 
2.102 and 2.103 in 1:6 and 1:3 diastereomeric ratios, respectively under normal 
homoallylation conditions with isoprene 2.2 developed by Tamaru et al., albeit at longer 
reaction time. Homoallylation of isoprene 2.82 with epoxy-cinnamaldehyde 2.104 
obtained bis-homoallylic alcohols 2.105a and 2.105b in 2.5:1 ratio. The bis-homoallylic 
alcohols obtained were used for the synthesis of C1-C6 fragment of cytotoxic natural 
products amphidinolides C, C2 and F (discussed in Chapter 1). 
 
Scheme 2.29. Homoallylation of Hemiacetals and Epoxyaldehyde with Isoprene 
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2.3.3. Asymmetric reductive coupling reactions 
2.3.3.1. Intramolecular asymmetric cyclization 
The Mori group reported the first example of nickel(0) catalyzed intramolecular 
asymmetric cyclizations of 1,3-dienes and tethered aldehydes in the presence of silanes 
employing a chiral monodentate phosphorane ligand.
23
 For example, when dienal 2.106 
(1.0 equiv.) was cyclized using Ni(cod)2 (10 mol %) and chiral phosphorane 2.107 (20 
mol %) in the presence of (EtO)3SiH (5.0 equiv.) in CH3CN, it produced a mixture of 
silyl protected homoallylic alcohol 2.108 and bis-homoallylic alcohol 2.109 in >50/1 
ratio with 73% ee (at 2.108) and 83% combined yield (Scheme 2.30). 
 
Scheme 2.30. Asymmetric Cyclization of a 1,3-Diene and a Tethered Aldehyde 
2.3.3.2. Intermolecular asymmetric coupling 
The asymmetric version of the nickel catalyzed intermolecular reductive coupling of 1,3-
dienes and aldehydes was first reported by Zhou and coworkers.
24 The 6,6’-disubstituted 
spirobiindane phosphoramidite ligands showed low to excellent enantioselectivities (up 
to 96 %) in these coupling reactions. For example, when 1,4-diphenylbuta-1,3-diene 
2.110 (1.0 equiv.) was treated with benzaldehyde 2.21 (2.0 equiv.) in the presence of 
Ni(acac)2 (5 mol %), ligand 2.111 (6 mol %) and diethylzinc (2.4 equiv.), bis-homoallylic 
alcohol 2.112 was obtained in 96% ee and >99:1 anti/syn diastereoselectivity (scheme 
2.31). 
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Scheme 2.31. Intermolecular Asymmetric Reductive Coupling 
2.3.4. Diastereoselective addition of aldehyde and diene promoted by diboron 
reagent 
Recently, Morken and coworkers have shown that the intermolecular reductive coupling 
of aldehydes or ketones with dienes can be facilitated by the use of diboron reagents as 
the reducing agent.
25 
These reactions proceed with excellent regio- and stereoselectively. 
As shown in the example below, benzaldehyde 2.21 (1.0 equiv.) upon treating with diene 
2.113 (1.1 equiv.) in the presence of Ni(cod)2 (10 mol %), PCy3 (15 mol %) and 
bis(pinacolato)diboron (1.2 equiv.), produced homoallylic alcohol 2.114a and bis-
homoallylic alcohol 2.114b (Scheme 2.32). However, when P(SiMe3)3 was employed as 
a ligand, a remarkable switch on regioselectivity was observed.  
 
Scheme 2.32. Boron Reagent Mediated Asymmetric Intermolecular Coupling 
The authors proposed that the difference in regioselectivity observed with these ligands 
may arise from electronic rather than steric differences.
25a
 The reaction mechanism 
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proceeds in accordance with the mechanistic studies by Ogoshi:
 
oxidative 
cyclometalation to give 2.115, subsequent transmetalation gives 2.116 and reductive 
elimination releases 2.117 and/or 2.118 from the catalyst, forming the C-B bond.
26
 The 
authors proposed that the large cone angle of P(SiMe3)3 (178
o
) and its ability to act as an 
electron acceptor may facilitate the reductive elimination of 2.118 from 2.116, before 
allyl isomerization required for the formation of 2.117 (Scheme 2.33). 
 
Scheme 2.33. Proposed Mechanism for the Diboron Reagent Promoted Intermolecular 
Coupling 
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2.4.  Results and discussion 
It is envisioned that the metathesis step (route 1) can be eliminated by conducting the 
reductive alkylation with the diene carboxylate ester (route 2) (Scheme 2.34). Reductive 
addition of a diene carboxylate ester 2.6 would lead directly to the hydroxyl unsaturated 
ester 2.5 required for cyclization. Based on the various substituent patterns explored by 
Tamaru, it was predicted that the major product would result from reaction of the 3,4-
double bond.
19
 The inclusion of the ester or amide moiety within the diene also allows for 
the addition of a chiral auxiliary to control the π-facial selectivity with respect to the 
aldehyde. 
 
Scheme 2.34. Retrosynthetic analysis of Hydroxyl Unsaturated Ester 2.5  
2.4.1. Homoallylation with chiral and achiral dienecarboxamide 
The homoallylation reaction of benzaldehyde with a simple dienecarboxamide 2.121, 
prepared by the Horner-Wadsworth-Emmons (HWE) reaction of N,N-dimethyl 
phosphonoacetate 2.119
27
 with methacrolein 2.120, was investigated (Scheme 2.35). This 
produced both regioisomers (1,2- and 3,4-addition products) 2.122a and 2.122b, 
respectively with low selectivity (1:1).  
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Scheme 2.35. Preparation of Dienecarboxamide 2.121 and Homoallylation with 
Benzaldehyde 
The crystal structure of regioisomer 2.122b shows that the newly formed stereocenters 
have anti-relative stereochemistry (Figure 2.1). Since the 3,4-addition product in all the 
examples reported by Tamaru
19
 and Spilling
3
 (Scheme 2.29) had anti-stereochemistry, 
product 2.122a will probably have an anti-relationship. 
 
Figure 2.1. Crystal Structure of 2.122b 
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Having shown that the simple dienecarboxamide 2.121 would undergo a homoallylation 
reaction, derivatives containing Evans and Oppolzer’s chiral auxiliaries were tested next. 
Introduced by Evans, Evans’ chiral auxiliaries have been proven to be an excellent chiral 
inducer and they have been used in a number of reactions.
28
 
Evans et al. presented an application of these auxiliaries in the diastereoselective 
synthesis of alcohols in 1991.
29 
Reaction of 2.123 having Evans’ chiral auxiliary with iso-
butyraldehyde in the presence of dibutylborontriflate and Et3B produced 2.125 with more 
than 99:1 diastereoselectivity and 83% yield (Scheme 2.36). The excellent stereochemical 
outcome was determined by the formation Z-enolate and orientation of benzyl group in 
2.126. 
 
Scheme 2.36. Addition of Aldehyde 2.124 to the Enolate 2.126 
More recently, Wu et al. utilized Evans’ chiral auxiliary in a fragment synthesis of the 
antiviral compound called Brefeldin A 2.127 (Scheme 2.37).
28d
 Fragment A 2.128 of 
Brefeldin A was synthesized in steps starting from the reaction of dithiol derivative 2.132 
and aldehyde 2.133 to produce a 2.134 as a single diastereomer. 
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Scheme 2.37. Retrosynthesis of Brefeldin A 2.127 and Synthesis of Fragment A 
In the search for chiral inducers for the homoallylation reaction, three different imide 
derivatives (Evans’ chiral auxiliaries) were synthesized (Scheme 2.38). Diene imide 
derivatives 2.137 and 2.138 were synthesized by the HWE reaction of corresponding 
phosphono-acetates
30
 2.135 and 2.136, respectively, whereas the derivative 2.143 was 
obtained in three steps starting from 5,5-diphenyl-4-benzyl oxazolidin-2-one 2.139. 
Unfortunately, all these imide derivatives were completely unreactive with benzaldehyde 
2.21 (Scheme 2.39). 
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Scheme 2.38. Synthesis of Diene Derivatives of Evans’ Chiral Auxiliaries 
 
Scheme 2.39. Reaction of Imide Diene Derivatives and Benzaldehyde 
With the disappointing results from imide diene derivatives, we turned our attention 
towards dienes derived from Oppolzer’s chiral auxiliaries. Since the developments 
reported by Oppolzer, he and others have beautifully applied the topological bias of the 
camphor skeleton in their advantage for the synthesis of enantioenriched products.
31
 
In the early stage of its development, Oppolzer et al. showed that β-substituted carboxylic 
acids 2.147 can be synthesized with excellent enantioselectivity using camphor 
sulfonamide derivative 2.144. Treatment of 2.144 with organocopper reagent 2.145 in the 
presence of nBu3P furnished the 1,4-adduct 2.146 with 80% yield and 98% ee with 
complete recovery of the auxiliary 2.148 (Scheme 2.40).
32
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Scheme 2.40. Application of Oppolzer’s Chiral Auxiliary  
Recently, Fraser et al. reported the Et2BOTf promoted anti selective aldol additions 
employing Oppolzer’s sultam (Scheme 2.41).33 The propionyl sultam 2.149 (1.0 equiv.) 
in CH2Cl2 at -78 
o
C was treated with 
i
Pr2NEt and varying equivalents of Et2BOTf. 
Propanal 2.51 (1.0 equiv.) was then added to the resulting solution. This reaction 
proceeded with excellent (upto 97:3) diastereoselectivity and good to excellent yield. The 
Et2BOTf was generated in situ from triethylborane and trifluoromethane sulphonic acid 
(1:1). 
 
Scheme 2.41. An Example of Aldol Reaction Employing the Oppolzer Auxiliary 
The Ni(0) catalyzed reductive coupling of diene 2.155 with the Oppolzer sultam moiety 
was carried with benzaldehyde 2.21 (Scheme 2.42). The diene 2.155 was obtained by the 
HWE reaction of known phosphono-acetate 2.154
34
 with methacrolein 2.120. After the 
homoallylation, only one regioisomer resulted from the addition of aldehyde across the 
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1,2-double bond, which was isolated in low yield. This clearly indicated that such 
substrates are only moderately reactive towards reductive coupling. 
 
Scheme 2.42. Synthesis of Diene 2.155 and its Coupling with Benzaldehyde 
2.4.2. Homoallylation with chiral and achiral dienecarboxylate esters 
With the disappointing results from dienes having chiral imides and sultam moieties, we 
turned our attention towards chiral dienecarboxylate esters (4-methyl substituted 
pentadienoates). The homoallylation of achiral dienecarboxylate esters with 
benzaldehyde were the starting reactions to test the chemistry. Achiral pentadienoates 
2.157a and 2.157b were synthesized by the HWE reaction of methacrolein 2.120 with 
phosphono-acetates (Scheme 2.42). Pentadienoates underwent a smooth homoallylation 
reaction with benzaldehyde to give the desired regioisomers (3,4-addition products) 2.158 
in a 3:1 ratio with the 1,2-addition products 2.159.  
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Scheme 2.43. Synthesis of Pentadienoates and Homoallylation with Benzaldehyde 
Rationale for 1,2- and 3,4-attack giving two regioisomers: 
It seems that the regioselectivity is controlled by the difference in electron densities of the 
diene termini. This can be rationalized by examining the diene resonance structures and 
placing the anion and cation in the most stable positions as shown in Scheme 2.44. The 
position bearing the highest electron density (anion) would react with the aldehyde.  
For example, isoprene 2.2 and 2.160 has the highest electron density at the terminal 
carbon (shown by arrow, 2.2a and 2.160a respectively), so only one regioisomer is 
obtained. On the other hand, 1,3-pentadiene 2.162 has two potential reacting sites that 
give two regioisomers (1:2.4) upon reacting with benzaldehyde.
19a
 
 
 
Scheme 2.44. Diene Resonance Structures and Homoallylation Reaction 
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In case of the unsymmetrical disubstituted dienes such as 2.163, 2.164 and 2.165, a single 
regioisomer is obtained because there is only one nucleophilic center (Scheme 2.45).
19a
 
However, in other cases like 2.157a, there are two potential reacting sites that produce 
two regioisomers.
3
 The 3:1 selectivity in case of 2.157a favoring 2.158a is probably 
stemming from steric reasons (Scheme 2.43). 
 
Scheme 2.45. Diene Resonance Structures and Homoallylation Reaction 
After obtaining successful results with achiral pentadienoates towards homoallylation, 
some chiral pentadienoate derivatives were synthesized and tested. 
The trans-2-phenylcyclohexanol was introduced by Whitesell and coworkers in 1985.
35
 
They investigated the ene-reaction of the glyoxylate ester of trans-2-phenylcyclohexanol 
2.167. It was shown that when 2.167 was reacted with 1-hexene 2.168 in the presence of 
SnCl4, it produced 2.169 as a single diastereomer in 78% yield (Scheme 2.46). This 
auxiliary showed the same level of asymmetric induction abilities as 8-phenylmenthol.  
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Scheme 2.46. Reaction of trans-2-phenyl Cyclohexanol Derived Glyoxylate Ester with 
2.168 
The phenyl cyclohexanol chiral auxiliary has been utilized in the total synthesis of natural 
products like (-)-Specionin
36 
2.170 and in the stereoselective synthesis of meso-2,6-
diaminopimelic Acid
36
 2.171 (Figure 2.2). 
 
Figure 2.2. Natural Products Synthesized Using trans-2-Phenyl Cyclohexanol 
Recently Miller et al. used this auxiliary in the fragment synthesis of antimicrobial 
natural products (-)–Guanacastepene E 2.175 and Heptemerone B 1.176 (Scheme 2.47).37 
 
Scheme 2.47. Application of trans-2-Phenyl Cyclohexanol Derivative in Natural Product 
Synthesis 
The trans-2-phenylcyclohexanol derived pentadienoate 2.179 was obtained in two steps 
from the known acetyl bromide
38 
2.177 (Scheme 2.48). Homoallylation of 2.179 with 
benzaldehyde gave both regioisomers 2.180a (3,4-addition) and 2.180b (1,2-addition) in 
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3:1 selectivity. The diastereoselectivity within the minor product 2.180b (1:4) was more 
than the diastereoselectivity of major product 2.180a (1:1). This difference comes from 
the proximity of phenyl group to the 1,2-double bond imposing more π-facial selectivity 
than 3,4-double bond. 
 
Scheme 2.48. Homoallylation of Pentadienoate 2.179 with Benzaldehyde 
The pentadienoate derived from Oppolzer’s chiral auxiliary with the sulphonamide 
moiety 2.183 was chosen because of the availability of both enantiomers. The known 
chloroacetyl ester derivative
39 
2.181 was converted to the desired chiral pentadienoate 
derivative 2.183 in two steps and homoallylation with benzaldehyde was carried out 
(Scheme 2.49). In this case the regioselectivity was improved over trans-2-
phenylcyclohexanol derived pentadienoate 2.179 (from 3:1 to 6:1). The 1,2-addition 
product 2.184b was isolated as a single diastereomer whereas the 3,4-addition product 
2.184a was formed as a 1:1 mixture. These results suggest that the cyclohexyl groups are 
posing steric hindrance on the 1,2-double bond but it is far away to affect the addition on 
the 3,4-double bond. 
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Scheme 2.49. Homoallylation of Pentadienoate 1.283 with Benzaldehyde 
Since the introduction by Corey in 1975,
40a
 8-phenylmenthol has proved to be a versatile 
chiral auxiliary and has been extensively used. A variety of ether and ester derivatives of 
this auxiliary have been shown to undergo Diels-alder
40a,b
, [2+2] cycloaddition
40c
, 
ene
40d,e
, 1,2-addition
40f
, 1,4-addition
40g,h
 reactions with excellent diastereoselectivity (de 
> 90%). 
Jean d’Angelo utilized the 8-phenylmenthyl derivative for the asymmetric synthesis of β-
amino ester group.
41
 The use of 8-(β-naphthyl menthyl) derivative of crotonate for β-
amino esters synthesis gave essentially complete diastereofacial control (>99% 
diastereoselectivity) (Scheme 2.48). The stereochemical outcome was explained by the 
“π-stacking” model in which the aryl group of the inducer shields one face of the 
crotonate unit, directing the amine addition to the other face.  
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Scheme 2.50. Diastereoselective Synthesis of β-Amino Ester Using Menthyl Derived 
Crotonate 
More recently, Tsutsumi and coworkers developed a fairly efficient method of increasing 
the diastereoselectivity of the [2+2] photocycloaddition of cyclohexanone to ethylene.
42
 
They showed that chiral cyclohexenone 2.189 containing the (-)-8-(β-naphthyl)menthyl 
group, shields a diastereoface effectively to produce the cyclobutane 2.190 with very 
good 83% diastereoselectivity.  
 
Scheme 2.51. Diastereoselective [2+2] Cycloaddition 
In search of a more effective chiral inducer for diastereoselective homoallylation 
reaction, a number of dienes having 8-arylmenthol derived diene carboxylate esters 
(pentadienoates) were synthesized (Scheme 2.52). All 8-arylmenthols were prepared 
from commercial R-(+)-pulegone using slightly modified Corey’s procedure40a except 8-
(β-naphthyl)menthol 2.193 and 8-(4-phenylphenyl)menthol 2.194 which had to be 
prepared by lithium aluminum hydride reduction of their corresponding methone.
43
 The 
menthol derivatives were first reacted with bromoacetylchloride 2.140 to obtain the 
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corresponding acetyl bromides. An Arbuzov reaction of these acetyl bromides with 
trimethylphosphite followed by HWE reaction with methacrolein 2.120 gave the required 
chiral dienes 2.191c-2.195c in good to excellent yields (Table 2.1).  
 
Scheme 2.52. Synthesis of 8-Menthyl Derived Pentadienoates 
Table 2.1. Synthesis of 8-Menthyl Derived Pentadienoates 
Alcohol Step 1 
(Product a) 
Step 2 
(Product b) 
Step 3 
(Product c) 
R t (h)/yield (%) t (h)/yield (%) t (h)/yield (%) 
H 2.191 X = Br, known 45, 80 0.4, 64 
Phenyl 2.192 X= Cl, known 80, 78 2, 88 
Naphthyl 2.193 4, 88 49, 96 1, 79 
Biphenyl 2.194 18, 90 43, 94 0.5, 87 
p-tButylphenyl 2.195 18, 89 61, 82 0.5, 88 
 
Reactions of the pentadienoates with benzaldehyde, Ni(acac)2 and diethylzinc showed 
good to excellent regioselectivity and modest diastereoselectivity (Scheme 2.53, Table 
2.2). As expected, the increase in the size of the R group increased the regioselectivity. 
The naphthyl group with extended π-conjugation (entry 3), gave highest regioselectivity 
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(2.198a:2.198b = 10:1). Except 2.196b, all the other minor regioisomers (2.197b-2.200b) 
were isolated as a single diastereomer. 
Diastereoselectivity within the major regioisomer (2.196a-2.200a): As expected, the 
phenyl menthol derived pentadienoate 2.192c (entry 2) gave higher induction than 
menthol derived pentadienoate 2.191c (entry 1) (dr of major product, 4:1 versus 2:1.5). 
This π-facial selectivity comes from the steric hindrance caused by the phenyl group 
which is unavailable with the hydrogen atom. But in a much surprising and dramatic way, 
the naphthyl menthol derived pentadienoate 2.193c (naphthyl group with extended π-
conjugation and bigger than the phenyl) gave a lower level of π-facial selectivity than the 
phenyl derivative 2.192c.
41 
Pentadienoate 2.194a having a biphenyl group also did not 
improve the diastereoselectivity (entry 4). However, the p-
t
butyl phenyl menthol derived 
pentadienoate 2.195c (entry 5) showed some improvement in diastereoselectivity (4.5:1).  
 
Scheme 2.53. Homoallylation of Different Pentadienoates with Benzaldehyde 
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Table 2.2. Results of Homoallylation of Pentadienoates with Benzaldehyde 
 
Absolute configuration determination: 
The absolute stereochemistry of major isomer 2.200a was determined by the Mosher 
ester method.
44 
Alcohol 2.200a was treated with both enantiomers of Mosher chloride 
(MTPA-chloride = α-methoxy-α-(trifluoromethyl)phenylacetyl chloride) (R-chloride 
2.201a and S-chloride 2.201b) in the presence of pyridine and DMAP to give the Mosher 
ester 2.202a and 2.202b respectively in very good yields (Scheme 2.54). 
Entry R 2.196a-2.200a 
major product 
(dr) 
2.196b-2.200b 
minor product 
(dr) 
a:b % yield 
(combined) 
1 H 
2.191c 
2:1.5 2:1 5:1 69 
2 Phenyl 
2.192c 
4:1 exclusive 7:1 75 
3 Naphthyl 
2.193c 
2.5:1 exclusive 10:1 68 
4 Biphenyl 
2.194c 
3.2:1 exclusive 6:1 60 
5 p-
t
butylphenyl 
2.195c 
4.5:1 exclusive 7:1 72 
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Scheme 2.54. Synthesis of Mosher Ester 
On the basis of the generally accepted confirmation model for Mosher esters (Scheme 
2.55), the trifluoromethyl group and the carbinyl hydrogen are eclipsed with carbonyl 
oxygen.
45
 The R-group in the (S)-MTPA ester 2.203a will be shielded by the phenyl 
group (of MTPA) when the chiral alcohol has (S)-configuration. The chemical shift of 
proton signals of the R-group will consequently be upfield (smaller δ value). In case of 
(R)-MTPA ester 2.203b, the phenyl group will be shielded so the proton signals of R-
group will move downfield (higher δ value). 
 
Scheme 2.55. Conformation Model of Mosher Esters from Alcohol 2.200a 
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The chemical shift values of protons (Ha, Hb, Hc, and methyl) support this prediction 
(Table 2.3). All these protons are upfield (lower δ value) in case of the S-ester and 
downfield (higher δ value) in case of the R-ester. Therefore, the newly formed 
stereocenter must have S-configuration (Scheme 2.55).  
Table 2.3. NMR Data of Proton Signal of 2.200 and its Mosher Esters 
 Hc (ppm) Δδ (ppm) Hc Me Ha (ppm) Hb (ppm) 
S.M. 2.200a 2.24  1.00 5.16 6.71 
S-ester 2.203a 1.90 +0.34 0.96 5.11 6.60 
R-ester 2.203b 2.28 -0.04 1.10 5.23 6.74 
 
The homoallylation reaction of pentadienoate 2.195c with benzaldehyde was carried out 
at varied temperatures and solvents. Reactions were run at three different temperatures; -
20 
o
C, 5 
o
C and 50 
o
C, which showed no change in regioselectivity and diastereofacial 
selectivity. However, at -20 
o
C the reaction was only about 50% complete after stirring 
for an hour whereas all other reactions were complete within 15 minutes. With all the 
solvents tested (Table 2.4), tetrahydrofuran (THF) was the best for the homoallylation 
reaction. Interestingly, only the minor regioisomer 2.200b was isolated when the reaction 
was carried out in acetonitrile. Therefore, all the homoallylation reactions discussed 
henceforth are carried out in THF at room temperature. 
Table 2.4. Solvents Effect on Homoallylation of Pentadienoate 2.195c and Benzaldehyde 
Solvent dr of major isomer 2.200a Polarity Index of Solvent 
Tetrahydrofuran 4:1 4.0 
Dichloromethane 3.3:1 3.1 
Toluene 2.3:1 2.4 
Dioxane 3.0:1 4.8 
 
Since the 4-
t
butylphenyl menthol derived pentadienoate 2.195c gave the highest 
diastereofacial selectivity with benzaldehyde, it was taken as a probe pentadienoate. The 
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results of homoallylation of this pentadienoate with a number of aldehydes (Scheme 
2.56) are summarized in Table 2.5.  
All other aldehydes, with the exception of pentanal 2.110 (entry 8), gave predominantly 
the 3,4-addition product with the regioselectivity from 5:1 (entry 2 and 7) to exclusive 
product (entry 10). The bulky aldehyde showed a tremendous effect on the 
regioselectivity. For example, 2-methoxyaldehyde 2.207 had 12:1 selectivity of 3,4- to 
1,2-addition product (entry 5) and 2,2-dimethylpropanal 2.212 gave only 3,4- addition 
product (entry 10).  
Unfortunately, the changes in diastereoselectivity were only modest. The nature and size 
of the aromatic ring (entry 1, 2 and 6), nature of substituent in the aromatic ring (electron 
withdrawing or donating group) (entry 3, 4 and 5) and increasing the bulkiness at α-
position of the aldehyde (entry 10) did not have a pronounced effect on diastereofacial 
selectivity. Surprising and very intriguing results were shown by 
cyclohexanecarboxaldehyde 2.209 (entry 7) giving almost the same diastereoselectivity 
as pentanal 2.210 (entry 8), and 2-methoxybenzaldehyde 2.207 (entry 5) giving less 
diastereoselectivity than benzaldehyde 3.21 (entry 1). In theory, 
cyclohexanecarboxaldehyde 2.209 and 2-methoxy benzaldehyde 2.207 should have 
higher π-facial selectivity than pentanal 2.209 and benzaldehyde 3.21 respectively, owing 
to the steric hindrance on the aldehyde group.  
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Scheme 2.56. Homoallylation of Pentadienoate 2.195c with Different Aldehydes 
2.4.3. DBU cyclization of bis-homoallylic alcohol 
The major isomer 2.200a obtained by the reaction of benzaldehyde 2.21 with 
pentadienoate 2.195c was subjected to DBU cyclization (Scheme 2.57).
3
 It underwent a 
very smooth cyclization with an excellent yield of 94%. During cyclization, the rate of 
cyclization of the diastereomers was also studied. After completion of about 50% 
reaction (TLC analysis), proton NMR analysis of the crude product showed the same 
ratio of characteristic diastereomeric peaks as in the starting bis-homoallylic alcohol 
2.200a. The cyclized product 2.213 and recovered starting material 2.200a both 
preserved the diastereoselectivity leading to a conclusion that both diastereomers undergo 
the cyclization at the same rate.  
 
Scheme 2.57. DBU Cyclization of bis-Homoallylic Alcohol 2.200a 
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Table 2.5. Homoallylation of Pentadienoate 2.195c with Various Aldehydes 
Entry R’CHO a (dr) a:b % yield (combined) 
1 
2.21  
4.5:1 7:1 72 
2 
3.196  
2.2:1 5:1 70 
3 
3.197  
2.7:1 6:1 71 
4 
3.198  
3.1:1 6:1 70 
5 
3.199  
2.8:1 12:1 75 
6 
3.200  
3.3:1 6:1 76 
7 
3.201  
2.2:1 5:1 70 
8 
3.202  
2.4:1 2:1 79 
9 
3.203  
2.5:1 6:1 76 
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10 
3.204  
4.5:1 Only a 70 
2.4.4. Homoallylation of simple and chiral dienes with chiral aldehydes 
Effects of chiral aldehydes on diastereofacial selectivity during homoallylation reactions 
were also studied. Both enantiomers of Steve Ley aldehyde were synthesized for this 
study (Scheme 2.58).
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Scheme 2.58. Synthesis of R- and S- Aldehydes 
Homoallylation of R-aldehyde 2.216 with different dienes was carried out (Scheme 2.59). 
These reactions went smoothly and gave 3:1 diastereoselectivity with both isoprene 2.2 
and 
t
butyl pentadienoate 2.223. 
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Scheme 2.59. Homoallylation of R-aldehyde with Isoprene and 
t
Butyl- pentadienoate 
The stereochemistry of newly formed stereocenters was assigned by correlating with the 
known stereochemistry. The newly formed hydroxyl stereocenter in the major 
diastereomer (obtained from the homoallylation of TBS-, acetonide-protected 
hemiacetals and epoxy aldehyde with isoprene) was determined to be anti with the 
existing α-stereocenter (Scheme 2.29).3 Assuming that these aldehydes also form similar 
transition states during homoallylation, the stereo-chemistry in the major isomer (2.222a 
and 2.224a) should be anti between the hydroxyl and the α-stereocenter of the aldehyde 
2.216. 
The homoallylation of R-aldehyde 2.216 with chiral pentadienoate 2.225 produced two 
column separable diastereomers 2.226a and 2.226b with good (5:1) diastereoselectivity 
(Scheme 2.60).  
 
Scheme 2.60. Homoallylation of R-aldehyde with Chiral Pentadienoate 
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In order to determine the stereochemistry of newly formed stereocenters of the major 
isomer 2.226a, both 2.222a and 2.226a were converted to tetrahydrofuran (THF) methyl 
ester 2.220 (Scheme 2.61). Cross metathesis of 2.222a with methyl acrylate produced 
ester 2.228. The ester 2.228 on subsequent cyclization with NaOMe/MeOH afforded the 
THF methyl ester 2.229a. The major isomer 2.226a was also converted to THF ester 
2.229a in two steps: ester hydrolysis by NaOEt/EtOH to give the acid followed by the 
conversion of the acid to methyl ester 2.229b by TMS diazomethane in methanol and 
diethyl ether. Since both THF esters 2.229a and 2.229b have the same optical rotation 
value and similar proton and carbon NMR spectra, the major diastereomer 2.226a 
obtained from R-aldehyde 2.216 and chiral diene 2.225 must have the same (anti) 
stereochemistry (between hydroxyl and existing α-stereocenter of aldehyde) similar to the 
major diastereomer 2.222a (obtained from R-aldehyde 2.216 and isoprene 2.2). 
 
Scheme 2.61. Synthesis of THF Methyl Ester 2.229a and 2.229b 
Not surprisingly, homoallylation of S- aldehyde 2.221 gave the same 3:1 
diastereoselectivity with isoprene 2.2 (as R-aldehyde) but the selectivity decreased with 
chiral pentadienoate 2.225 (Scheme 2.62). 
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Scheme 2.62. Homoallylation of S-aldehyde 2.221 with Isoprene and Chiral 
Pentadienoate 
In order to determine the stereochemistry of major diastereomer 2.231a, the THF methyl 
ester 2.233c was compared with the THF methyl esters 2.233a and 2.233b obtained from 
diastereomers 2.230a and 2.230b, respectively (Scheme 2.63). The THF methyl ester 
2.233c has same optical rotation and identical proton and carbon NMR spectra with the 
THF methyl ester 2.233b obtained from minor isomer 2.230b. It shows that the major 
diastereomer 2.231a must have the same (syn) relationship between newly formed 
hydroxyl group and existing α-stereocenter of the aldehyde as the minor diastereomer 
2.230b (obtained from S-aldehyde 2.221 and isoprene 2.2). 
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Scheme 2.63. Synthesis of THF Methyl Esters 
The difference in diastereoselectivity between R- and S- aldehyde with chiral 
pentadienoate 2.225 can be best explained by whether the existing stereocenters are 
reinforcing or opposing each other during coupling.
47
 In case of R-aldehyde 2.216 and 
chiral pentadienoate 2.225, the stereochemical outcome is reinforced by each other giving 
high selectivity, called a “matched case”. But for S-aldehyde 2.221 and chiral 
pentadienoate 2.225, they are opposing each other which reduce the selectivity, called a 
“mis-matched case”. In the latter case, the pentadienoate 2.225 “wins” which is proved 
by the fact that the minor isomer 2.330b has the same stereochemistry with the major 
isomer 2.231a (Scheme 2.59). 
 
 
 
Paudyal, Mahesh, 2012, UMSL, p.149 
 
 
2.5.  Summary 
1) Homoallylation of aldehydes with achiral pentadienoates and dienecarboxamide were 
studied. Achiral pentadienoates underwent a smooth homoallylation with benzaldehyde 
to afford regioisomers with 1:3 selectivity favoring the 3,4-addition. On the other hand, 
achiral dienecarboxamide reacted slowly with benzaldehyde with low yield and lower 
regioselectivity. 
2) Homoallylation of benzaldehyde with chiral dienecarboxamide containing Oppolzer’s 
chiral auxiliary gave only the 1,2-product in low yield while diene imide derivatives 
having Evans’ chiral auxiliaries were completely unreactive. On the other hand, chiral 
pentadienoates derived from trans-2-phenyl cyclohexanol and Oppolzer’s chiral 
auxiliaries underwent smooth homoallylation with benzaldehyde with good to excellent 
regioselectivity but poor diastereoselectivity.  
3) A number of 8-arylmenthol derived pentadienoates were synthesized. Homoallylation 
of these pentadienoates with benzaldehyde gave excellent regioselectivity and modest 
diastereoselectivity. The p-
t
butylphenyl menthol derived pentadienoate gave the highest 
diastereoselectivity within the major diastereomer (3,4-addition product). Homoallylation 
of various aldehydes with p-
t
butylphenyl menthol derived pentadienoate was studied. 
4) Chiral Steve Ley aldehydes were synthesized following known literature procedures. 
Homoallylation of both R and S-aldehydes with achiral diene and pentadienoate gave 3:1 
diastereoselectivity. However, these aldehydes show diastereodifferentiation with the 
chiral pentadienoate. When reacted with p-
t
butylphenyl menthol derived pentadienoate, 
R-aldehyde gave higher (5:1) diastereoselectivity than S-aldehyde (2:1).  
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2.6.  General Experimental 
Glassware used for all experiments were oven-dried and all reactions were carried out 
under argon atmosphere unless otherwise mentioned. All reaction solvents were purified 
prior to use: CH2Cl2, MeOH, MeCN were dried by distillation over calcium hydride and 
THF over sodium-benzophenone ketyl. Reagent grade DMF was obtained from Sigma-
Aldrich and used without further purification. 
Proton (
1
H) NMR spectra were recorded at 300 or 500 MHz and 
13
C NMR spectra at 75 
MHz.
 
Proton NMR spectra were referenced to residual CDCl3 (7.27 ppm) and 
13
C {
1
H} 
NMR spectra were referenced to the center line of CDCl3 (77.23 ppm). Crystal 
structure(s) were determined on a Bruker Apex- II CCD single crystal diffractometer. 
Optical rotations were measured on a polarimeter using a glass cell with 2 mL capacity 
and 10 cm path length. Infrared spectra were recorded on FTIR instrument using NaCl 
plates (liquids, oils) or using an ATR attachment (solids). 
General procedure for homoallylation: Into a flask containing Ni(acac)2 (0.1 mmol) in 
dry THF (3 mL) was added the corresponding diene (2.0 mmol) and the resulting solution 
was stirred at room temperature for 10 min. A solution of aldehyde (1.0 mmol) in dry 
THF (2 mL) and Et2Zn (1.0 M solution in hexanes, 2.4 mmol) were added sequentially. 
The homogeneous mixture was stirred under argon atmosphere at room temperature 15 
min to 2 h (monitored by TLC analysis), then it was diluted with EtOAc. The mixture 
was washed with 2M HCl, saturated aq. NaHCO3, and brine solutions sequentially. The 
organic layer was dried over anhydrous Na2SO4, concentrated in vacuo and purified by 
column chromatography (SiO2, hexanes: EtOAc). 
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General procedure for bromoacetylation of oxazolidinone, A: Into a round bottom 
flask containing a suspension of oxazolidinone (1.0 equiv.) in dry THF at 0 
o
C was added 
n-BuLi (2.5 M solution in hexanes, 1.1 equiv.) dropwise. The resulting dark orange 
solution was stirred for 15 minutes when bromoacetyl chloride (1.1 equiv.) was added 
dropwise.  The yellow solution was stirred for an additional 1 h at that temperature 
(monitored by TLC analysis). The reaction was quenched by saturated aq. NH4Cl 
solution and the mixture was allowed to warm to room temperature. The organic layer 
was separated, the aqueous layer was extracted with Et2O, the combined organic layers 
were washed with water and brine, dried over anhydrous Na2SO4 and concentrated in 
vacuo. The crude product was purified by column chromatography (SiO2, hexanes: 
EtOAc). 
General procedure for bromoacetylation of alcohol, B: Into a round bottom flask 
containing a suspension of NaH (60% w/w dispersion in mineral oil, 1.1 equiv.) in dry 
THF at 0 
o
C was added solution of sultam (amide or alcohol) (1.0 equiv.) in dry THF 
while evolution of H2 gas was seen. After stirring for 30 minutes at that temperature was 
added bromoacetyl chloride (1.1 equiv.) drop wise. After 30 minutes, the solution was 
warmed to room temperature and stirred for 2 to 18 h (monitored by TLC analysis). The 
reaction was quenched with saturated aq. NH4Cl solution. The organic layer was 
separated, the aqueous layer was extracted with EtOAc, the combined organic layers 
were washed with brine, dried over anhydrous Na2SO4 and concentrated in vacuo. The 
crude product was purified by column chromatography (SiO2, hexanes: EtOAc).  
General procedure for preparation of acetyl phosphonate (Arbuzov reaction), C: 
Into a round bottom flask containing a solution of acetyl bromide (1.0 equiv.) in dry 
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toluene was added trimethyl (or triethyl) phosphite (1.1 to 3.0 equiv.) and refluxed for 22 
to 80 h (monitored by TLC analysis). The solvent was removed in vacuo and the crude 
product was purified by column chromatography (SiO2, hexanes: EtOAc).  
General procedure for preparation of diene carboxylate esters and 
dienecarboxamides (HWE reaction), D: Into a round bottom flask containing a 
suspension of NaH (60% w/w dispersion in mineral oil, 1.2 equiv.) in dry THF at 0 
o
C 
was added solution of acetyl phosphonate (1.0 equiv.) in dry THF while evolution of H2 
gas was seen. After stirring for 30 minutes at that temperature, methacrolein (1.5 equiv.) 
was added dropwise. After 10 min of stirring at 0 
o
C the solution was warmed to room 
temperature and stirred for additional 5 min to 5 h (monitored by TLC analysis). The 
reaction was quenched by saturated aq. NH4Cl solution. The organic layer was separated, 
the aqueous layer was extracted with EtOAc, the combined organic layers were washed 
with brine, dried over anhydrous Na2SO4 and concentrated in vacuo. The crude product 
was purified by column chromatography (SiO2, hexanes: EtOAc).  
 
(E)-N,N,4-trimethylpenta-2,4-dienamide 2.121: Methacrolein 2.120 (3.0 mmol, 0.25 
mL), sodium hydride (60% w/w in mineral oil, 2.4 mmol, 0.058 g), and phosphono-
acetate
27
 2.119 (2.0 mmol, 0.390 g) were reacted in dry THF (5 mL) following the 
general procedure D to afford dienecarboxamide 2.121 as a colorless oil (0.240 g, 86%). 
IR (neat, NaCl) 2935, 1642, 1608 cm
-1
; 
1
H NMR (CDCl3): δ 7.27 (1H, d, J = 15.2 Hz), 
6.24 (1H, d, J = 15.3 Hz), 5.27 (1H, s), 5.22 (1H, s), 3.07 (3H, s), 2.98 (3H, s), 1.86 (3H, 
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d, J = 0.3 Hz); 
13
C {
1
H} NMR (CDCl3): δ 167.2, 144.9, 140.7, 123.1, 117.7, 37.5, 36.0, 
18.4; HRMS (FAB, M
+
) calcd for C8H13NO: 139.0997. Found 139.0999. 
 
 (±)6-hydroxy-N,N,4-trimethyl-6-phenylhex-2-enamide and (±)2-
(hydroxyl(phenyl)methyl)-N,N,4-trimethylpent-4-enamide (2.122a and 2.122b): 
Benzaldehyde 2.21 (0.20 mmol, 20 µL), Ni(acac)2 (0.02 mmol, 0.005 g), diethylzinc 
(10% w/w in hexanes, 0.48 mmol, 0.59 mL), and dienecarboxamide 2.121 (0.40 mmol, 
0.056 g) were reacted in dry THF (2 mL) following the general procedure of 
homoallylation to afford two regioisomers 2.122a and 2.122b as a colorless liquid (rr, 
2:1.5) (0.024 g, 49% for 63% conversion).  
2.122b: IR (neat, NaCl) 3378, 2969, 1726, 1620 cm
-1
; 
1
H NMR (CDCl3): δ 7.27-7.40 
(5H, m), 4.97 (1H, d, J = 3.4 Hz), 4.68 (1H, d, J = 1. 3 Hz), 4.61 (1H, d, J = 1.3 Hz), 3.12 
(1H, td, J = 3.5, 10.7 Hz), 2.94 (6H, s), 2.56 (1H, dd, J = 10.8, 13.9 Hz), 2.19 (1H, dd, J = 
2.6, 13.9 Hz), 1.58 (3H, s); 
13
C {
1
H} NMR (CDCl3): δ 175.9, 143.5, 141.9, 128.4, 127.5, 
126.1, 112.4, 74.1, 46.6, 37.8, 35.8, 34.4, 22.9; HRMS (FAB, MH
+
) calcd for 
C15H22NO2: 248.1650. Found 248.1658.  
2.122a: (Mixed with column inseparable impurity) 
1
H NMR (CDCl3): δ 7.22-7.31 (5H, 
m), 6.73 (1H, dd, J = 8.2, 15.1 Hz), 6.18 (1H, d, J = 15.1 Hz), 5.27 (1H, d, J = 10.4 Hz), 
2.97 (3H, s), 2.86 (3H, s), 2.22 (1H, app sep, J = 7.2 Hz), 1.62 (1H, broad s), 1.34-1.48 
(2H, m), 1.05 (3H, d, J = 6.7 Hz); 
13
C {
1
H} NMR (CDCl3): δ 167.2, 151.6, 141.6, 128.2, 
127.5, 126.9, 119.1, 75.0, 37.8, 37.1, 36.6, 34.8, 20.0. 
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(E)-3-(4-methylpenta-2,4-dienoyloxazolidin-2-one (2.137): Methacrolein 2.120 (1.5 
mmol, 0.12 mL), sodium hydride (60% w/w in mineral oil, 1.2 mmol, 0.029 g), and 
acetyl phosphono-acetate
30
 2.135 (1.0 mmol, 0.265 g) were reacted in dry THF (3 mL) 
following the general procedure D to afford dienecarboxamide 2.137 as a viscous 
colorless liquid (0.050 g, 28%).  
IR (neat, NaCl) 2912, 1763, 1672 cm
-1
; 
1
H NMR (CDCl3): δ 7.55 (1H, d, J = 15.5 Hz), 
7.30 (1H, d, J = 15.4 Hz), 5.44 (1H, s), 5.42 (1H, s), 4.44 (2H, t, J = 8.0 Hz), 4.11 (2H, t, 
J = 8.4 Hz), 1.96 (3H, d, J = 0.3 Hz); 
13
C {
1
H} NMR (CDCl3): δ 165.8, 153.7, 148.9, 
141.3, 125.9, 117.5, 62.2, 43.0, 18.4; HRMS (FAB, MNa
+
) calcd for C9H11NO3Na: 
204.0637. Found 204.0634. 
 
(R,E)-4-benzyl-3-(4-methylpenta-2,4-dienoyl)oxazolidin-2-one (2.138): Methacrolein 
2.120 (1.5 mmol, 0.12 mL), sodium hydride (60% w/w in mineral oil, 1.2 mmol, 0.029 
g), and phosphono-acetate
30
 2.136 (1.0 mmol, 0.355 g) were reacted in dry THF (3 mL) 
following the general procedure D to afford dienecarboxamide 2.138 as a viscous 
colorless liquid (0.105 g, 39%).  
IR (neat, NaCl) 2984, 1776, 1742, 1680 cm
-1
; 
1
H NMR (CDCl3): δ 7.51 (1H, d, J = 15.5 
Hz), 7.15-7.29 (6H, m), 5.39 (1H, s), 5.36 (1H, s), 4.65-4.73 (1H, m), 4.09-4.18 (1H, m), 
3.28 (1H, dd, J = 3.2, 13.4 Hz), 2.74 (1H, dd, J = 9.5, 13.4 Hz), 1.89 (3H, d, J = 0.4 Hz); 
Paudyal, Mahesh, 2012, UMSL, p.155 
 
 
13
C {
1
H} NMR (CDCl3): δ 165.6, 153.6, 149.0, 141.3, 135.5, 129.6, 129.1, 127.5, 125.9, 
117.9, 66.3, 55.6, 38.1, 18.4; HRMS (FAB, MNa
+
) calcd for C16H17NO3Na: 294.1106. 
Found 294.1098. 
 
(R)-4-benzyl-3-(2-bromoacetyl)-5,5-diphenyloxazolidine-2-one (2.141): n-Butyl 
lithium (2.5 M solution in hexanes, 5.5 mmol, 2.2 mL), bromoacetyl chloride 2.140 (5.5 
mmol, 0.46 mL), and oxazolidinone 2.139 (5.0 mmol, 1.65 g) were reacted in dry THF 
(20 mL) following the general procedure A to afford 2.141 (mixture of acetyl bromide 
and chloride isomer, 4:1) as a viscous brown oil (1.90 g, 85%).  
IR (neat, NaCl) 3065, 1780, 1703 cm
-1
; 
1
H NMR (CDCl3): δ 7.12-7.44 (13H, m), 6.75 
(2H, dd, J = 2.1, 4.9 Hz), 5.65 (1H, dd, J = 3.3, 4.9 Hz), 4.42 (2H, ABq, J = 12.8 Hz, ∆δ 
= 0.07 ppm), 2.94 (1H, dd, J = 7.9, 14.2 Hz), 2.81 (1H, dd, J = 7.9, 14.2 Hz); 
13
C {
1
H} 
NMR (CDCl3): δ 165.4, 151.8, 141.1, 137.2, 135.9, 129.2, 129.15, 129.13, 128.6, 128.5, 
128.5, 126.8, 126.6, 126.1, 89.5, 62.7, 36.5, 28.4. 
 
(R)-diethyl-(2-(4-benzyl-2-oxo-5,5-diphenyloxazolidin-3-yl)-2-oxoethyl) phosphonate 
(2.142): Triethylphosphite (9.9 mmol, 1.7 mL) and acetyl bromide 2.141 (3.3 mmol, 
1.482 g) were reacted in dry toluene (2 mL) following the general procedure C to afford 
phosphono-acetate 2.142 as a viscous yellow oil (1.500 g, 90%).  
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IR (neat, NaCl) 3058, 1784, 1711 cm
-1
; 
1
H NMR (CDCl3): δ 6.99-7.36 (10H, m), 7.00 
(3H, dd, J = 1.8, 4.9 Hz), 6.60-6.64 (2H, m), 5.57 (1H, dd, J = 4.0, 8.6 Hz), 3.88-4.01 
(4H, m), 3.72 (1H, dd, JHH = 14.2, JHP = 22.0 Hz), 3.51 (1H, dd, JHH = 14.2, JHP = 22.5 
Hz), 2.88 (1H, dd, J = 3.9, 14.2 Hz), 2.69 (1H, dd, J = 8.6, 14.3 Hz),1.20 (3H, t, J = 7.0 
Hz), 1.07 (3H, t, J = 7.0 Hz); 
13
C {
1
H} NMR (CDCl3): δ 164.4 (d, JCP = 6.8 Hz), 152.1, 
141.3, 137.4, 136.3, 129.1, 129.0, 128.43, 128.36, 126.7, 126.6, 126.3, 88.6, 62.95 (d, JCP 
= 6.2 Hz), 62.72 (d, JCP = 6.2 Hz), 62.5, 36.5, 34.4 (d, JCP = 131.6 Hz), 16.5 (d, JCP = 6.4 
Hz), 16.39 (d, JCP = 6.0); 
31
P {
1
H}: NMR (CDCl3) δ 19.0; HRMS (FAB, MH
+
) calcd for 
C28H31NO6P:508.1889. Found 508.1881. 
 
(R,E)-4-benzyl-3-(4-methylpenta-2,4-dienoyl)-5,5-diphenyloxazolidin-2-one (2.143): 
Methacrolein (0.513 mmol, 42 µL), sodium hydride (60% w/w in mineral oil, 0.376 
mmol, 0.009 g), and phosphono-acetate 2.142 (0.342 mmol, 0.164 g) were reacted in dry 
THF (1 mL) following the general procedure D to afford dienecarboxamide 2.143 as a 
viscous colorless liquid (0.075 g, 52%).  
IR (neat, NaCl) 3024, 1764, 1693 cm
-1
; 
1
H NMR (CDCl3): δ 7.35-7.40 (3H, m), 7.25 (3H, 
d, J = 7.5 Hz), 7.17 (2H, d, J = 5.1 Hz), 7.13 (1H, d, J = 15.4 Hz), 7.11-7.18 (3H, m), 
7.00 (3H, dd, J = 1.8, 5.1 Hz), 6.62-6.65 (2H, m), 5.62 (1H, dd, J = 4.1, 7.9 Hz), 5.31 
(2H, s), 2.88 (1H, dd, J = 4.3, 14.2 Hz), 2.73 (1H, dd, J = 4.1, 8.1 Hz), 1.84 (3H, s); 
13
C 
{
1
H} NMR (CDCl3): δ 165.2, 152.5, 149.2, 141.9, 141.6, 137.9, 136.7, 129.4, 129.3, 
129.2, 128.62, 128.60, 127.0, 126.8, 126.4, 126.1, 118.0, 88.8, 62.7, 36.9, 18.6. 
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(E)-1-((3aR,6R)-8,8-dimethyl-2,2-dioxidohexahydro-1H-3a,6-methanobenzo[c] 
isothiazol-1-yl)-4-methylpenta-2,4-dien-1-one (2.155): Methacrolein 2.120 (0.945 
mmol, 80 µL), sodium hydride (60% w/w in mineral oil, 0.756 mmol, 0.018 g), and 
acetyl phosphono-acetate
34
 2.154 (0.63 mmol, 0.230 g) were reacted in dry THF (2 mL) 
following the general procedure D to afford dienecarboxamide 2.155 as a colorless 
viscous oil (0.080 g, 41%). 
IR (neat, NaCl) 2962, 1677, 1601, 1329 cm
-1
; 
1
H NMR (CDCl3): δ 7.45 (1H, d, J = 15.2 
Hz), 6.59 (1H, d, J = 15.2 Hz), 5.41 (s, 1H), 5.40 (1H, s), 3.96 (1H, dd, J = 5.4, 7.3 Hz), 
3.49 (2H, ABq, J = 13.8 Hz,  = 0.06 ppm), 2.11-2.15 (2H, m). 1.93 (3H, s), 1.89-1.93 
(3H, m), 1.38-1.45 (2H, m), 1.18 (3H, s), 0.98 (3H, s); 
13
C {
1
H} NMR (CDCl3): δ 164.7, 
148.2, 141.0, 125.9, 118.2, 65.4, 53.4, 48.7, 48.0, 44.9, 38.7, 33.1, 26.7, 21.1, 20.1, 18.3; 
HRMS (FAB, MNa
+
) calcd for C16H23NO3SNa: 332.1296. Found 332.1306. 
 
(2R)-1-((3aR,6R)-8,8-dimethyl-2,2-dioxidohexahydro-1H-3a,R-
methanobenzo[c]isothiazol-1-yl)-2-((S)-hydroxy(phenyl)methyl)-4-methylpent-4-en-
1-one (2.156): Benzaldehyde 2.21 (0.050 mmol, 5.0 µL), Ni(acac)2 (0.005 mmol, 0.001 
g), diethylzinc (10% w/w in hexanes, 0.12 mmol, 0.15 mL), and dienecarboxamide 2.155 
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(0.075 mmol, 0.023 g) were reacted in dry THF (0.5 mL) following the general procedure 
of homoallylation to afford 2.156 as a colorless liquid (dr 1:3) (0.010 g, 48%).  
IR (neat, NaCl) 3517, 2957, 1674, 1335 cm
-1
; 
1
H NMR (CDCl3): δ 7.47 (2H, d, J = 4.6 
Hz), 7.36 (3H, d, J = 4.6 Hz), 5.30 (1H, s), 4.70 (1H, s), 4.65 (1H, s), 3.99 (1H, t, J = 3.7 
Hz), 3.49-3.59 (3H, m), 2.69 (1H, app t, J = 7.2 Hz), 2.06 (2H, app d, J = 4.1 Hz), 1.87-
1.95 (5H, m), 1.59 (3H, s), 1.14 (3H,s ), 0.96 (3H, s); 
13
C {
1
H} NMR (CDCl3): δ 176.1, 
142.6, 140.8, 128.4, 127.4, 126.1, 113.4, 71.9, 65.6, 53.5, 49.6, 48.6, 48.0, 44.9, 38.6, 
34.1, 33.2, 26.7, 22.2, 20.8, 20.1. 
 
(±)-(E)-ethyl-6-hydroxy-4-methyl-6-phenylhex-2-enoate (2.158a) and (±)-ethyl-3-
(hydoxy(phenyl)methyl)-4-methylpent-4-enoate (2.159a): Benzaldehyde 2.21 (0.30 
mmol, 30 µL), Ni(acac)2 (0.03 mmol, 0.008 g), diethylzinc (1.0 M solution in hexanes, 
0.72 mmol, 0.72 mL), and pentadienoate 2.157a (0.60 mmol, 0.084 g) were reacted in dry 
THF (2 mL) following the general procedure of homoallylation to afford two 
regioisomers 2.158a and 2.159a as a colorless liquid (rr, 3:1) (0.056 g, combined yield 
76%).  
2.158a: IR (neat, NaCl) 3448, 2969, 1695 cm
-1
; 
1
H NMR (CDCl3): δ 7.29-7.39 (5H, m), 
6.94 (1H, dd, J = 7.9, 15.7 Hz), 5.79 (1H, dd, J = 1.1, 15.7 Hz), 4.72 (1H, dd, J = 6.2, 7.8 
Hz), 4.21 (2H, q, J = 7.1 Hz), 2.44 (1H, app sep, J = 7.0 Hz), 1.92-2.02 (1H, m), 1.90 
(1H, brd s), 1.66-1.75 (1H, m), 1.31 (3H, t, J = 7.1 Hz), 1.12 (3H, d, J = 6.7 Hz); 
13
C 
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{
1
H} NMR (CDCl3): δ 167.0, 154.2, 144.5, 128.8, 128.0, 126.2, 120.1, 72.6, 60.5, 45.2, 
33.5, 19.5, 14.5; HRMS (FAB, MNa
+
) calcd for C15H20O3Na: 271.1310. Found 271.1301. 
2.159a: IR (neat, NaCl) 3499, 2967, 1731 cm
-1
; 
1
H NMR (CDCl3): δ 7.27-7.40 (5H, m), 
4.97 (1H, d, J = 5.7 Hz), 4.74 (1H, s), 4.73 (1H, s), 3.98-4.09 (2H, m), 2.97 (1H, ddd, J = 
4.2, 5.7, 9.9 Hz), 2.92 (1H, brd s), 2.52 (1H, dd, J = 11.2, 14.3 Hz), 2.34 (1H, dd, J = 4.0, 
14.3 Hz), 1.70 (3H, s), 1.12 (3H, t, J = 7.1 Hz); 
13
C {
1
H} NMR (CDCl3): δ 174.6, 143.2, 
141.5, 128.5, 128.0, 126.4, 112.3, 74.5, 60.7, 51.7, 35.7, 22.4, 14.2; HRMS (FAB, MNa
+
) 
calcd for C15H20O3Na: 271.1310. Found 271.1317.  
 
(±)-(E)-tert-butyl-6-hydroxy-4-methyl-6-phenylhex-2-enoate (2.158b) and (±)-tert-
butyl-3-(hydoxy(phenyl)methyl)-4-methylpent-4-enoate (2.159b): Benzaldehyde 2.21 
(0.10 mmol, 10 µL), Ni(acac)2 (0.01 mmol, 0.003 g), diethylzinc (1.0 M solution in 
hexanes, 0.24 mmol, 0.24 mL), and pentadienoate 2.157b (0.20 mmol, 0.034 g) were 
reacted in dry THF (1 mL) following the general procedure of homoallylation to afford 
two regioisomers  2.158b and 2.159b as a colorless liquid (rr, 3:1) (0.021 g, combined 
yield 78%).  
2.158b: IR (neat, NaCl) 3436, 2984, 1691 cm
-1
; 
1
H NMR (CDCl3): δ 7.29-7.37 (5H, m), 
6.84 (1H, dd, J = 7.8, 15.7 Hz), 5.72 (1H, dd, J = 1.1, 15.7 Hz), 4.72 (1H, dd, J = 6.2, 7.8 
Hz), 2.40 (1H, app sep, J = 7.0 Hz), 1.91-2.00 (2H, m), 1.64-1.73 (1H, m), 1.51 (9H, s), 
1.11 (3H, d, J = 6.7 Hz); 
13
C {
1
H} NMR (CDCl3): δ 166.4, 152.9, 144.6, 128.8, 128.0, 
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126.1, 121.7, 80.4, 72.5, 45.2, 33.2, 28.3, 19.5; HRMS (FAB, MNa
+
) calcd for 
C17H24O3Na: 299.1623. Found 299.1628. 
2.159b: IR (neat, NaCl) 3467, 2965, 1714 cm
-1
; 
1
H NMR (CDCl3): δ 7.27-7.40 (5H, m), 
4.91 (1H, dd, J = 1.7, 5.6 Hz), 4.73 (2H, s), 2.94 ( 1H, d, J = 1.6 Hz), 2.84 (1H, ddd, J = 
4.1, 5.7, 9.9 Hz), 2.47 (1H, dd, J = 11.2, 14.3 Hz), 2.30 (1H, dd, J = 3.8, 14.3 Hz), 1.69 
(3H, s), 1.29 (9H, s); 
13
C {
1
H} NMR (CDCl3): δ 173.9, 143.3, 141.6, 128.4, 127.9, 126.7, 
112.3, 81.4, 74.6, 51.9, 36.0, 28.1, 22.3; HRMS (FAB, MNa
+
) calcd for C17H24O3Na: 
299.1623. Found 299.1614.  
 
(±)-trans-2-phenylcyclohexyl-2-(dimethoxyphosphoryl)acetate (2.177): Trimethyl 
phosphite (10.133 mmol, 1.2 mL) and acetyl bromide
38
 2.176 (4.053 mmol, 1.20 gm) 
were reacted in dry toluene (1 mL) following the general procedure C to afford  
phosphono-acetate 2.177 as a highly viscous yellow oil (1.21 gm, 92%).  
IR (neat, NaCl) 2935, 1726, 1260 cm
-1
; 
1
H NMR (CDCl3): δ 7.12-7.28 (5H, m), 5.04 (1H, 
dt, J = 4.5, 10.7 Hz), 3.63 (3H, d, JHP = 11.2 Hz), 3.54 (3H, d, JHP = 11.2 Hz), 2.61-2.81 
(1H, m), 2.72 (1H, dd, JHH = 9.1 Hz, JHP = 21.7 Hz), 2.69 (1H, dd, JHH = 9.1, JHP = 21.4 
Hz), 2.14-2.17 (1H, m), 1.74-1.93 (3H, m), 1.30-1.58 (4H, m); 
13
C {
1
H} NMR (CDCl3): δ 
164.8 (d, JCP = 6.0 Hz), 142.9, 128.3, 127.4, 126.4, 77.2, 53.0 (d, JCP = 6.3 Hz), 52.8 (d, 
JCP = 6.3 Hz), 49.4, 34.3, 32.2 (d, JCP = 133.8 Hz), 32.0, 25.7, 24.6; 
31
P {
1
H} NMR 
(CDCl3): δ 22.34; HRMS (FAB, MNa
+
) calcd for C16H24O5P: 327.1361. Found 327.1366. 
Paudyal, Mahesh, 2012, UMSL, p.161 
 
 
 
(±)-(E)-trans-2-phenylcyclohexyl-4-methylpenta-2,4-dienoate (2.178): Methacrolein 
2.120 (4.599 mmol, 0.38 mL), sodium hydride (60% w/w in mineral oil, 3.679 mmol, 
0.088 g), and phosphono-acetate 2.177 (3.066 mmol,1.000 g) were reacted in dry THF (9 
mL) following the general procedure D to afford pentadienoate 2.178 as a colorless 
viscous oil (0.650 g, 79%).  
IR (neat, NaCl) 2935, 1709, 1263 cm
-1
; 
1
H NMR (CDCl3): δ 7.09-7.20 (5H, m), 7.05 (1H, 
d, J =15.7 Hz), 5.55 (1H, d, J= 15.7 Hz), 5.17 (2H, s), 4.97 (1H, dt, J = 4.4, 10.5 Hz), 
2.65 (1H, dt, J = 3.7, 11.9 Hz), 2.10-2.13 (1H, m), 1.72-1.90 (3H, m), 1.70 (3H, s), 1.47 
(1H, dq, J = 2.9, 13.0 Hz), 1.29-1.46 (3H, m); 
13
C {
1
H} NMR (CDCl3): δ 166.6, 146.7, 
143.3, 140.7, 128.4, 127.6, 126.5, 124.1, 119.0, 76.0, 49.9, 34.3, 32.6, 26.0, 24.9, 18.1; 
HRMS (FAB, MH
+
) calcd for C18H23O2: 271.1698. Found 271.1694. 
 
(±)-(E)-trans-2-phenylcyclohexyl-6-hydroxy-4-methyl-6-phenylhex-2-enoate (2.179) 
and (±)-trans-2-phenylcyclohexyl-2-(hydroxyl(phenyl)methyl)-4-methylpent-4-
enoate (2.180): Benzaldehyde 2.21 (0.30 mmol, 30 µL), Ni(acac)2 (0.03 mmol, 0.008 g), 
diethylzinc (10% w/w in hexanes, 0.72 mmol, 0.88 mL), and pentadienoate 2.178 (0.60 
mmol, 0.162 g) were reacted in dry THF (2 mL) following the general procedure of 
homoallylation to afford two regioisomers  2.179 and 2.180 as a colorless liquid (rr, 3:1) 
(0.085 g, combined yield 75% ).  
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2.179: IR (neat, NaCl) 3461, 2938, 1705 cm
-1
; 
1
H NMR (CDCl3): (major isomer) δ 7.18-
7.37 (10H, m), 6.68 (1H, dd, J = 7.9, 15.7 Hz), 5.53 (1H, dd, J = 1.0, 15.7 Hz), 5.04 (1H, 
dt, J = 4.6, 10.6 Hz), 4.57 (1H, t, J = 7.0 Hz), 2.74 (1H, dt, J = 3.4, 11.5 Hz), 2.20-2.30 
(2H, m), 1.80-2.00 (5H, m), 1.55-1.68 (3H, m), 1.29-1.52 (2H, m), 1.02 (3H, d, J = 6.4 
Hz); 
13
C {
1
H} NMR (CDCl3): 166.1, 153.4, 144.1, 143.2, 128.6, 128.3, 127.8, 127.5, 
126.3, 126.0, 120.0, 75.9, 72.4, 49.8, 44.9, 33.9, 33.2, 32.4, 25.9, 24.8, 19.3; HRMS 
(FAB, MNa
+
) calcd for C25H30O3Na: 401.2093. Found 401.2090. 
2.180: IR (neat, NaCl) 3459, 2935, 1715 cm
-1
; 
1
H NMR (CDCl3): δ 7.18-7.34 (10H, m), 
4.91 (1H, dt, J = 4.3, 10.9 Hz), 4.67 (1H, app dd, J = 2.8, 5.5 Hz), 4.35 (2H, s), 2.60-2.76 
(2H, m), 2.24-2.32 (1H, m), 2.28 (1H, d, J = 2.9 Hz), 2.01-2.14 (1H, m), 1.76-1.93 (5H, 
m), 1.39-1.53 (3H, m), 1.36 (3H, s); 
13
C {
1
H} NMR (CDCl3): δ 173.4, 143.4, 142.7, 
141.4, 128.7, 128.4, 127.8, 127.6, 126.8, 126.4, 111.9, 77.4, 74.5, 52.1, 49.7, 34.9, 34.7, 
31.9, 26.0, 24.8, 22.1; HRMS (FAB, MNa
+
) calcd for C25H30O3Na: 401.2092. Found 
401.2110.  
 
(1R,2S,4R)-1-((N,N-dicyclohexylsulfamoyl)methyl)-7,7-dimethylbicyclo 
[2.2.1]heptan-2-yl-2-(dimethoxyphosphoryl)acetate (2.182): Trimethylphosphite 
(2.417 mmol, 0.28 mL) and acetyl chloride 2.181 (0.967 mmol, 0.500 g) were reacted in 
dry toluene (1 mL) following the general procedure C to afford phosphono-acetate 2.182 
as a highly viscous yellow oil (0.480 g, 91%).  
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IR (neat, NaCl) 2932, 1748 cm
-1
; 
1
H NMR (CDCl3): δ 4.99 (1H, dd, J = 3.2, 9.2 Hz), 3.80 
(6H, d, JHP = 11.2 Hz), 3.25 (1H, d, J = 13.3 Hz), 3.21-3.27 (2H, m), 2.96 (2H, dd, JHH = 
1.6 Hz, JHP = 21.2 Hz), 2.67 (1H, d, J = 13.3 Hz), 1.96-2.07 (2H, m), 1.71-1.80 (14H, m), 
1.62-1.65 (3H, m), 1.25-1.32 (5H, m), 1.15-1.22 (1H, m), 1.08-1.13 (2H, m), 1.02 (3H, 
s), 0.88 (3H, s); 
13
C {
1
H} NMR (CDCl3): δ 164.2 (d, JCP = 6.1 Hz), 80.1, 57.7, 54.0, 
52.35 (d, JCP = 6.6 Hz), 53.18 (d, JCP = 6.0 Hz), 49.6, 49.4, 44.6, 39.3, 34.21 (d, JCP = 
134.6 Hz), 33.0, 30.4, 27.2, 26.7, 25.4, 20.6, 20.0; 
31
P {
1
H} NMR (CDCl3): δ 23.4; 
HRMS (FAB, MH
+
) calcd for C26H47NO7PS: 548.2817. Found 548.2817. 
 
(E)-(1R,2S,4R)-1-((N,N-dicyclohexylsulfamoyl)methyl)-7,7-dimethylbicyclo 
[2.2.1]heptan-2-yl-4-methylpenta-2,4-dienoate (2.183): Methacrolein 2.120 (0.077 
mmol, 6 µL), sodium hydride (60% w/w in mineral oil, 0.060 mmol, 0.001 g) and 
phosphono-acetate 2.182 (0.050 mmol, 0.027 g) were reacted in dry THF (0.5 mL) 
following the general procedure D to afford 2.183 as a colorless solid (0.017 g, 68%).  
IR (neat, NaCl) 2937, 1712 cm
-1
; 
1
H NMR (CDCl3): δ 7.33 (1H, d, J = 15.9 Hz), 5.84 
(1H, d, J = 15.6 Hz), 5.33 (2H, s), 5.13 (1H, dd, J = 3.2, 9.8 Hz), 3.29 (1H, d, J = 13.4 
Hz), 3.23 (2H, quin, J = 6.6 Hz), 2.69 (1H, d, J = 13.2 Hz), 1.96-2.05 (2H, m), 1.88 (3H, 
s), 1.72-1.84 (14H, m), 1.55-1.66 (4H, m), 1.21-1.29 (5H, m), 0.99-1.11 (2H, m), 1.04 
(3H, s), 0.91 (3H, s); 
13
C {
1
H} NMR (CDCl3): δ 165.6, 146.8, 140.6, 124.3, 119.4, 78.5, 
57.7, 53.9, 49.7, 49.3, 44.8, 39.7, 33.1, 33.0, 30.2, 27.3, 26.7, 25.4, 20.7, 20.4, 18.2; 
HRMS (FAB, MNa
+
) calcd for C28H45NO4SNa: 514.2967. Found 514.2950. 
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(1R,2S,4R)-1-((N,N-dicyclohexylsulfamoyl)methyl)-7,7-dimethylbicyclo 
[2.2.1]heptan-2-yl-6-hydroxy-4-methyl-6-phenylhex-2-enoate (2.184a) and 
(1R,2S,4R)-1-((N,N-dicyclohexylsulfamoyl)methyl)-7,7-dimethylbicyclo [2.2.1] 
heptan-2-yl-2-(hydroxyl(phenyl)methyl)-4-methylpent-4-enoate (2.184b): 
Benzaldehyde 2.21 (0.150 mmol, 15 µL), Ni(acac)2 (0.015 mmol, 0.004 g), diethylzinc 
(10% w/w in hexanes, 0.36 mmol, 0.44 mL), and pentadienoate 2.183 (0.300 mmol, 
0.147 g) were reacted in dry THF (1 mL) following the general procedure of 
homoallylation to afford two regioisomers 2.184a and 2.184b as a colorless liquid (rr, 
6:1) (0.058 g, combined yield 64%).  
2.184a: IR (neat, NaCl) 3502, 2932, 1714 cm
-1
; 
1
H NMR (CDCl3): (major isomer) δ 
7.27-7.36 (5H, m), 6.99 (1H, dd, J = 6.9, 15.7 Hz), 5.77 (1H, d, J = 15.7 Hz), 5.06 (1H, 
dd, J = 2.7, 9.4 Hz), 4.77 (1H, dd, J = 4.5, 9.1 Hz), 3.27 (1H, d, J = 13.3 Hz), 3.23 (2H, 
app quin, J = 9.2 Hz), 2.69 (1H, d, J = 13.3 Hz), 2.59 (1H, app sep, J = 6.8 Hz), 1.94-2.05 
(4H, m), 1.70-1.77 (14H, m), 1.56-1.66 (5H, m), 1.18-1.26 (5H, m), 1.13 (3H, d, J = 6.7 
Hz), 1.05-1.10 (2H, m), 1.01 (3H, s), 0.90 (3H, s); 
13
C {
1
H} NMR (CDCl3): δ 165.5, 
154.1, 144.9, 128.8, 128.0, 125.9, 119.8, 78.4, 72.2, 57.7, 53.8, 49.6, 49.3, 45.1, 44.8, 
39.8, 33.04, 33.00, 32.9, 30.1, 27.2, 26.76, 26.72, 25.4, 20.7, 20.4, 18.7; HRMS (FAB, 
MNa
+
) calcd for C35H53NO5SNa: 622.3542. Found 622.3536. 
2.184b: IR (neat, NaCl) 3525, 2945, 1716 cm
-1
; 
1
H NMR (CDCl3): (major isomer) δ 7.43 
(2H, d, J = 7.7 Hz), 7.34 (2H, t, J = 7.5 Hz), 7.25 (1H, t, J = 7.5 Hz), 5.31 (1H, s), 4.91 
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(1H, dd, J = 3.2, 7.7 Hz), 4.68 (1H, s), 4.59 (1H, s), 3.55 (1H, d, J = 3.4 Hz), 3.32-3.36 
(2H, m), 3.34 (1H, d, J = 13.3 Hz), 2.99 (1H, dt, J = 2.7, 11.1 Hz), 2.66 (1H, d, J = 13.3 
Hz), 2.48 (1H, dd, J = 11.2, 17.0 Hz), 1.93-2.01 (2H, m), 1.72-1.92 (14H, m), 1.64-1.69 
(3H, m), 1.61 (3H, s), 1.36-1.41 (4H, m), 1.11-1.29 (5H, m), 0.93 (3H, s), 0.87 (3H, s); 
13
C {
1
H} NMR (CDCl3): δ 172.5, 143.5, 141.4, 127.7, 126.6, 125.4, 109.1, 78.9, 73.5, 
57.1, 53.9, 51.7, 49.0, 48.8, 43.9, 38.9, 33.0, 31.7, 30.8, 30.7, 26.6, 26.0, 25.9, 24.7, 23.2, 
20.0, 19.2. 
 
(E)-(1R,2R,5R)-2-isopropyl-5-methylcyclohexyl-4-methylpenta-2,4-dienaote 
(2.191c): Methacrolein 2.120 (0.980 mmol, 80 µL), sodium hydride (60% w/w in mineral 
oil, 0.784 mmol, 0.019 g), and phosphono-acetate
48
 2.191b (0.653 mmol, 0.200 g) were 
reacted in dry THF (2 mL) following the general procedure D to afford pentadienoate 
2.191c as a viscous colorless liquid (0.105 g, 64%).  
IR (neat, NaCl) 2957, 1707 cm
-1
; 
1
H NMR (CDCl3): δ 7.34 (1H, d, J = 15.7 Hz), 5.86 
(1H, d, J = 15.7 Hz), 5.35 (1H, s), 5.32 (1H, s), 4.78 (1H, dt, J = 4.4, 10.9 Hz), 2.01-2.04 
(1H, m), 1.86-1.91 (1H, m), 1.88 (3H, s), 1.67-1.70 (2H, m), 1.49-1.53 (1H, m), 1.39-
1.44 (1H, m), 1.08 (1H, dq, J = 2.8, 12.6 Hz), 0.97-1.04 (1H, m), 0.90 (3H, d, J = 6.4 
Hz), 0.89 (3H, d, J = 7.0 Hz), 0.85-0.91 (1H, m), 0.77 (3H, d, J = 6.9 Hz); 
13
C {
1
H} 
NMR (CDCl3): δ 166.9, 147.0, 140.8, 124.3, 119.4, 74.3, 47.4, 41.2, 34.5, 31.6, 26.5, 
23.7, 22.2, 21.0, 18.3, 16.6; HRMS (FAB, MH
+
) calcd for C16H27O2: 251.2011. Found 
251.2013. 
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(E)-(1R,2R,5R)-5-methyl-2-(2-phenylpropan-2-yl)cyclohexyl-4-methyl-penta-2,4-
dienaote (2.192c): Methacrolein 2.120 (0.667 mmol, 55 µL), sodium hydride (60% w/w 
in mineral oil, 0.534 mmol, 0.013 g), and phosphono-acetate
48
 2.192b (0.445 mmol, 
0.170 g) were reacted in dry THF (2 mL) following the general procedure D to afford 
pentadienoate 2.192c as a colorless solid (0.125 g, 86%).  
IR (neat, NaCl) 2952, 1705 cm
-1
; 
1
H NMR (CDCl3): δ 7.01-7.21 (5H, m), 6.85 (1H, d, J = 
15.7 Hz), 5.19 (1H, s), 5.16 (1H, s), 5.13 (1H, d, J = 15.7 Hz), 4.79 (1H, dt, J = 4.3, 10.7 
Hz), 1.96-2.05 (1H, m), 1.80-1.87 (1H, m), 1.69 (3H, s), 1.56-1.71 (2H, m), 1.37-1.46 
(1H, m), 1.24 (3H, s), 1.14 (3H, s), 1.06 (1H, dq, J = 3.1, 12.6 Hz), 0.75-0.91 (2H, m), 
0.79 (3H, d, J = 6.6 Hz); 
13
C {
1
H} NMR (CDCl3): δ 166.4, 152.0, 146.3, 140.7, 128.1, 
125.5, 125.0, 124.0, 119.5, 74.3, 50.8, 41.9, 39.7, 34.8, 31.5, 28.6, 26.7, 24.4, 22.0, 18.2; 
HRMS (FAB, MH
+
) calcd for C22H31O2: 327.2324. Found 327.2312. 
 
(1R,2R,5R)-5-methyl-2-(2-naphthalen-2-yl)propan-2-yl)cyclohexyl-2-bromoacetate 
(2.193a): Sodium hydride (60% w/w in mineral oil, 1.091 mmol, 0.026 g), bromoacetyl 
chloride 2.140 (1.191 mmol, 0.1 mL) and alcohol
43
 2.188 (9.922 mmol, 0.280 g) were 
reacted in dry THF (3 mL) following the general procedure B to afford acetyl bromide 
2.193a as a viscous brown oil (0.350 g, 88%).  
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IR (neat, NaCl) 2958, 1728, 1280 cm
-1
; 
1
H NMR (CDCl3): δ 7.71 (3H, d, J = 8.6 Hz), 
7.54 (1H, d, J = 1.2 Hz), 7.43 (1H, dd, J = 1.8, 8.7 Hz), 7.32-7.38 (2H, m), 4.85 (1H, dt, J 
= 4.6, 10.8 Hz), 2.58 (2H, ABq, J = 12.4 Hz, ∆δ = 0.08 ppm), 2.10 (1H, dt, J = 3.6, 12.2 
Hz), 1.74-1.84 (2H, m), 1.64 (1H, td, J = 2.8, 12.8 Hz), 1.39-1.44 (1H, m), 1.36 (3H, s), 
1.23 (3H, s), 1.07-1.20 (1H, m), 0.87-0.99 (2H, m), 0.82 (3H, d, J = 6.5 Hz); 
13
C {
1
H} 
NMR (CDCl3): δ 166.5, 149.2, 133.4, 131.5, 128.0, 127.5, 127.4, 126.2, 125.5, 125.2, 
122.6, 76.0, 50.1, 41.4, 39.8, 34.5, 31.4, 29.1, 26.4, 26.2, 23.5, 21.9; HRMS (FAB, 
MNa
+
) calcd for C22H27BrO2Na: 425.1092. Found 425.1099. 
 
(1R,2R,5R)-5-methyl-2-(2-naphthalen-2-yl)-propan-2-yl)cyclohexyl-2-
(dimethoxyphosphoryl)acetate (2.193b): Trimethylphosphite (2.114 mmol, 0.25 mL) 
and acetyl bromide 2.193a (0.845 mmol, 0.340 g) were reacted in dry toluene (1mL) 
following the general procedure C to afford acetyl phosphonate 2.193b as a highly 
viscous yellowish oil (0.350 g, 96%). 
 IR (neat, NaCl) 2959, 1726, 1277 cm
-1
; 
1
H NMR (CDCl3): δ 7.79 (3H, d, J = 8.6 Hz), 
7.65 (1H, d, J = 1.2 Hz), 7.53 (1H, dd, J = 1.8, 8.7 Hz), 7.29-7.48 (2H, m), 4.92 (1H, dt, J 
= 4.5, 10.7 Hz), 3.62 (3H, d, JHP = 11.2 Hz), 3.59 (3H, d, JHP = 11.2 Hz), 2.18 (1H, dt, J = 
3.5, 12.2 Hz), 2.02 (1H, dd, JHH = 14.5 Hz, JHP = 21.2 Hz), 1.85-1.90 (2H, m), 1.70 (1H, 
dd, JHH = 14.5 Hz, JHP = 21.2 Hz), 1.63-1.71 (1H, m), 1.45-1.52 (1H, m), 1.45 (3H, s), 
1.32 (3H, s), 1.22 (1H, dq, J = 3.2, 13.1 Hz), 0.96-1.08 (2H, m), 0.90 (3H, d, J = 6.5 Hz); 
13
C {
1
H} NMR (CDCl3): δ 165.0 (d, JCP = 5.9 Hz), 149.3, 133.5, 131.5, 127.9, 127.4, 
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126.2, 125.5, 125.3, 122.8, 75.5, 53.05 (d, JCP = 6.9 Hz), 53.01 (d, JCP = 6.4 Hz), 50.1, 
41.4, 39.9, 34.6, 32.8 (d, JCP = 132.9 Hz), 31.5, 28.9, 26.5, 23.6, 22.0; 
31
P {
1
H} NMR 
(CDCl3): δ 22.81; HRMS (FAB, MNa
+
) calcd for C24H33O5PNa: 455.1963. Found 
455.1965. 
 
(E)-(1R,2R,5R)-5-methyl-2-(2-naphthalen-2-yl)propan-2-yl)cyclohexyl-4-methyl-
penta-2,4-dienaote (2.193c): Methacrolein 2.120 (1.145 mmol, 95 µL), sodium hydride 
(60% w/w in mineral oil, 0.916 mmol, 0.022 g), and phosphonate 2.193b (0.763 mmol, 
0.330 g) were reacted in dry THF (2 mL) following the general procedure D to afford 
pentadienoate 2.193c as a highly viscous liquid (0.246 g, 86%).  
IR (neat, NaCl) 3057, 2956, 1716 cm
-1
; 
1
H NMR (CDCl3): δ 7.69-7.78 (3H, m), 7.60 (1H, 
s), 7.53 (1H, dd, J = 1.9, 8.7 Hz), 7.27-7.40 (2H, m), 6.75 (1H, d, J = 15.8 Hz), 5.09 (1H, 
s), 5.00 (1H, s), 4.94 (1H, dt, J = 4.3, 10.7 Hz), 4.77 (1H, d, J = 15.8 Hz), 2.23 (1H, dt, J 
= 3.5, 12.2 Hz), 1.85-1.91 (2H, m), 1.72 (1H, td, J = 2.8, 12.8 Hz), 1.50-1.55 (1H, m), 
1.44 (3H, s), 1.31 (3H, s), 1.30 (3H, s), 1.20-1.30 (1H, m), 0.94-1.06 (2H, m), 0.89 (3H, 
d, J = 6.5 Hz); 
13
C {
1
H} NMR (CDCl3): δ 166.4, 149.6, 146.2, 140.5, 133.3, 131.5, 128.1, 
127.45, 127.40, 125.9, 125.2, 125.1, 123.7, 122.8, 118.8, 74.0, 50.3, 41.9, 39.8, 34.8, 
31.5, 29.1, 26.6, 23.6, 22.0, 17.6; HRMS (FAB, MH
+
) calcd for C26H32O2Na: 399.2300. 
Found 399.2298. 
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(1R,2R,5R)-2-(2-([1,1’-biphenyl]-4-yl)propan-2-yl)-5-methylcyclohexyl-2-
bromoacetate (2.194a): Sodium hydride (60% w/w in mineral oil, 0.500 mmol, 0.012 g), 
bromoacetyl chloride 2.140 (0.540 mmol, 45 µL) and alcohol 2.194 (0.454 mmol, 0.140 
g) were reacted in dry THF (2 mL) following the general procedure B to afford acetyl 
bromide 2.194a as a viscous brown oil (0.175 g, 90%).  
IR (neat, NaCl) 2957, 1729, 1272 cm
-1
; 
1
H NMR (CDCl3): δ 7.52 (2H, d, J = 8.5 Hz), 7. 
46 (2H, d, J = 8.5 Hz), 7.37 (2H, t, J = 7.2 Hz), 7.19-7.30 (3H, m), 4.82 (1H, dt, J = 4.6, 
10.9 Hz), 2.96 (2H, ABq, J = 12.6 Hz, ∆δ = 0.13 ppm), 2.03 (1H, dt, J = 3.6, 12.4 Hz), 
1.75-1.87 (2H, m),1.65 (1H, td, J = 2.8, 12.7 Hz), 1.39-1.47 (1H, m), 1.28 (3H, s), 1.18 
(3H, s), 1.06-1.17 (1H, m), 0.88-1.00 (2H, m), 0.83 (3H, d, J = 6.5 Hz); 
13
C {
1
H} NMR 
(CDCl3): δ 166.5, 151.1, 141.0, 138.1, 129.0, 127.3, 127.1, 126.8, 126.0, 76.0, 50.3, 41.4, 
39.5, 34.6, 31.4, 29.8, 26.6, 26.4, 23.0, 22.0; HRMS (FAB, MNa
+
) calcd for 
C24H29BrO2Na: 451.1249. Found 451.1244. 
 
(1R,2R,5R)-2-(2-([1,1’-biphenyl]-4-yl)propan-2-yl)-5-methylcyclohexyl-2-
(dimethoxyphosphoryl)acetate (2.194b): Trimethylphosphite (1.022 mmol, 0.12 mL) 
and acetyl bromide 2.194a (0.409 mmol, 0.175 g) were reacted in dry toluene (1mL) 
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following the general procedure C to afford acetyl phosphonate 2.194b as a highly 
viscous yellowish oil (0.175 g, 94%).  
IR (neat, NaCl) 2950, 1725, 1267 cm
-1
; 
1
H NMR (CDCl3): δ 7.59 (2H, d, J = 8.5 Hz), 
7.54 (2H, d, J = 8.5 Hz), 7.29-7.47 (5H, m), 4.88 (1H, dt, J = 4.4, 10.8 Hz), 3.70 (3H, d, 
JHP = 11.2 Hz), 3.69 (3H, d, JHP = 11.2 Hz), 2.39 (1H, dd, JHH = 14.6 Hz, JHP = 21.0 Hz), 
2.20 (1H, dd, JHH = 14.6, JHP = 21.3 Hz), 2.06-2.15 (1H, m), 1.85-1.95 (2H, m), 1.72 (1H, 
td, J = 2.8, 12.9 Hz), 1.46-1.52 (1H, m), 1.37 (3H, s), 1.27 (3H, s), 1.20 (1H, dq, J = 3.2, 
12.9 Hz), 0.96-1.08 (2H, m), 0.91 (3H, d, J = 6.5 Hz); 
13
C {
1
H} NMR (CDCl3): δ 165.1 
(d, JCP = 5.4 Hz), 151.1, 141.0, 138.1, 128.9, 127.2, 127.0, 126.7, 126.1, 75.5, 53.1 (d, JCP 
= 6.2 Hz), 53.0 (d, JCP = 6.2 Hz), 50.5, 41.4, 39.5, 34.6, 33.2 (d, JCP = 134.4 Hz), 31.4, 
29.2, 26.5, 23.5, 21.9; 
31
P {
1
H} NMR (CDCl3): δ 22.78; HRMS (FAB, MNa
+
) calcd for 
C26H35O5PNa: 481.2120. Found 481.2133. 
 
(E)-(1R,2R,5R)-2-(2-([1,1’-biphenyl]-4-yl)propan-2-yl)-5-methylcyclohexyl-4-
methylpenta-2,4-dienaote (2.194c): Methacrolein 2.140 (0.556 mmol, 46 µL), sodium 
hydride (60% w/w in mineral oil, 0.445 mmol, 0.011 g), and acetyl phosphonate 2.194b 
(0.371 mmol, 0.170 g) were reacted in dry THF (2 mL) following the general procedure 
D to afford pentadienoate 2.194c as a white solid (0.130 g, 87%).  
IR (neat, NaCl) 3051, 2948, 1703 cm
-1
; 
1
H NMR (CDCl3): δ 7.48 (2H, d, J = 8.5 Hz), 
7.42 (2H, d, J = 8.5 Hz), 7.16-7.33 (5H, m), 6.92 (1H, d, J = 15.7 Hz), 5.14 (1H, d, J 
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=15.7 Hz), 5.09 (1H, s), 5.07 (1H, s), 4.83 (1H, dt, J = 4.4, 10.7 Hz), 2.02 (1H, dt, J = 
3.5, 12.2 Hz), 1.82-1.87 (1H, m), 1.70-1.77 (1H, m), 1.61 (1H, td, J = 2.9, 12.8 Hz), 1.49 
(3H, s), 1.37-1.46 (1H, m), 1.27 (3H, s), 1.17 (3H, s), 1.09 (1H, dq, J = 3.2, 12.8 Hz), 
0.86-0.98 (2H, m), 0.80 (3H, d, J = 6.5 Hz); 
13
C {
1
H} NMR (CDCl3): δ 166.4, 151.2, 
146.4, 140.9, 140.6, 137.6, 128.7, 127.0, 126.9, 126.6, 126.0, 124.1, 119.3, 74.2, 50.8, 
41.9, 39.6, 34.8, 31.5, 28.7, 26.7, 24.4, 22.0, 18.0; HRMS (FAB, MNa
+
) calcd for 
C28H34O2Na: 425.2457. Found 425.2441. 
 
(1R,2R,5R)-2-(2-(4(tet-butylphenyl)propan-2-yl)-5-methylcyclohexyl-2-bromoacetate 
(2.195a): Sodium hydride (60% w/w in mineral oil, 7.260 mmol, 0.174 g), bromoacetyl 
chloride 2.140 (7.920 mmol, 0.66 mL), and alcohol 2.195 (6.600 mmol, 1.902 g) were 
reacted in dry THF (20 mL) following the general procedure B to afford acetyl bromide 
2.195a as a viscous brown oil (2.400 g, 89%).  
IR (neat, NaCl) 2963, 1754, 1199 cm
-1
; 
1
H NMR (CDCl3): δ 7.33 (2H, d, J = 6.6 Hz), 
7.21 (2H, d, J = 6.7 Hz), 4.91 (1H, dt, J = 4.6, 10.7 Hz), 3.06 (2H, ABq, J = 15.1 Hz, ∆δ 
= 0.4 ppm), 2.04-2.12 (1H, m), 1.93-2.03 (1H, m), 1.70-1.92 (2H, m), 1.44-1.69 (1H, m), 
1.33 (9H, s), 1.32 (3H, s), 1.19 (3H, s), 1.04-1.23 (1H, m), 0.92-1.0 (2H, m), 0.89 (3H, d, 
J = 6.5 Hz); 
13
C {
1
H} NMR (CDCl3): δ 166.7, 148.9, 147.8, 125.1, 125.0, 75.8, 50.4, 
41.8, 40.9, 39.1, 34.6, 34.4, 31.5, 31.4, 30.6, 26.2, 22.1, 22.0; HRMS (FAB, MNa
+
) calcd 
for C22H33ClO2Na: 387.2067. Found 387.2062. 
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(1R,2R,5R)-2-(2-(4(tet-butylphenyl)propan-2-yl)-5-methylcyclohexyl-2-
(dimethoxyphosphoryl)acetate (2.195b): Trimethylphosphite (14.749 mmol, 1.74 mL) 
and acetyl bromide 2.195a (5.899 mmol, 2.408 g) were reacted in dry toluene (1 mL) 
following the general procedure C to afford acetyl phosphonate 2.195b as a highly 
viscous yellow oil (2.100 g, 82%).  
IR (neat, NaCl) 2954, 1719, 1270 cm
-1
; 
1
H NMR (CDCl3): δ 7.23 (2H, d, J = 6.6 Hz), 
7.21 (2H, d, J = 6.7 Hz), 4.75 (1H, dt, J = 4.5, 10.8 Hz), 3.63 (3H, d, JHP = 11.2 Hz), 3.61 
(3H, JHP = 11.2 Hz), 2.21 (1H, dd, JHH = 14.6, JHP = 21.2 Hz), 1.95 (1H, dd, JHH = 14.5, 
JHP = 21.2 Hz), 1.93-2.02 (1H, m), 1.77-1.84 (2H, m), 1.59-1.65 (1H, m), 1.32-1.44 (1H, 
m), 1.23  (9H,s), 1.22 (3H, s), 1.11 (3H, s), 1.11 (1H, dq, J = 3.1, 13.2 Hz), 0.8-0.91 (2H, 
m), 0.8 (3H, d, J = 6.5 Hz); 
13
C {
1
H} NMR (CDCl3): δ 165.1 (d, JCP = 5.4 Hz), 148.9, 
147.7, 125.1, 124.9, 75.3, 53.2, 53.1 (d, JCP = 6.0 Hz), 53.0 (d, JCP = 6.1 Hz), 50.4, 41.4, 
39.1, 34.6, 34.3, 33.2 (d, JCP = 134.4 Hz), 31.5, 31.4, 29.9, 26.3, 22.7, 21.9; 
31
P {
1
H} 
NMR (CDCl3): δ 23.01; HRMS (FAB, MH
+
) calcd for C24H40O5: 439.2613. Found 
439.2621. 
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(E)-(1R,2R,5R)-2-(2-(4(tet-butylphenyl)propan-2-yl)-5-methylcyclohexyl-4-
methylpenta-2,4-dienoate (2.195c): Methacrolein 2.120 (1.164 mmol, 96 µL), sodium 
hydride (60% w/w in mineral oil, 0.931 mmol, 0.022 g), and acetyl phosphonate 2.195b 
(0.776 mmol, 0.340 g) were reacted in dry THF (3 mL) following the general procedure 
D to afford pentadienoate 2.195c as a colorless solid (0.260 g, 88%).  
IR (neat, NaCl) 2953, 1701 cm
-1
; 
1
H NMR (CDCl3): δ 7.22-7.32 (5H, m), 5.50 (1H, d, J = 
15.7 Hz), 5.36 (2H, s), 4.96 ( 1H, dt, J = 4.3, 10.7 Hz), 1.96-2.09 (2H, m), 1.86 (3H, s), 
1.62-1.68 (2H, m), 1.28-1.59 (1H, m), 1.35 (3H, s), 1.32 (9H, s), 1.24 (3H, s), 0.95-1.16 
(2H, m), 0.89 (3H, d, J = 6.4 Hz), 0.83- 0.90 (1H, m); 
13
C {
1
H} NMR (CDCl3): δ 166.5, 
148.4, 147.6, 146.7, 140.6, 125.3, 124.8, 124.2, 119.5, 74.7, 50.8, 42.0, 39.6, 34.8, 34.3, 
31.6, 31.5, 27.1, 27.0, 26.5, 22.0, 18.3; HRMS (FAB, MNa
+
) calcd for C26H38O2Na: 
405.2769. Found 405.2764. 
 
(4S,6S,E)-(1R,2R,5R)-2-isopropyl-5-methylcyclohexyl-6-hydroxy-4-methyl-6-
phenylhex-2-enoate (2.196a) and (1R,2R,5R)-2-isopropyl-5-methylcyclohexyl-2-
(hydroxy(phenyl)methyl)-4-methylpent-4-enoate (2.196b): Benzaldehyde 2.21 (0.10 
mmol, 10 µL), Ni(acac)2 (0.01 mmol, 0.003 g), diethylzinc (10% w/w solution in 
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hexanes, 0.24 mmol, 0.30 mL), and pentadienoate 2.191c (0.20 mmol, 0.050 g) were 
reacted in dry THF (1 mL) following the general procedure of homoallylation to afford 
two regioisomers 2.196a and 2.196b as a colorless liquid (rr, 5:1) (0.024 g, combined 
yield 69%).  
2.196a: IR (neat, NaCl) 3467, 2956, 1717 cm
-1
; 
1
H NMR (CDCl3): (major isomer) δ 
7.19-7.28 (5H, m), 6.84 (1H, dd, J = 7.8, 15.7 Hz), 5.68 (1H, d, J = 15.7 Hz), 4.67 (1H, 
dt, J = 4.4, 11.1 Hz), 4.65 (1H, app q, J = 5.3 Hz), 2.37 (1H, app sep, J = 7.0 Hz), 1.75-
1.97 (3H, m), 1.72 (1H, broad s), 1.56-1.65 (3H, m), 1.26-1.33 (2H, m), 1.04 (3H, d, J = 
6.7 Hz), 0.97 (2H, dq, J = 2.3, 11.3 Hz), 0.83 (6H, d, J = 6.7 Hz), 0.69 (3H, d, J = 6.9 
Hz); 
13
C {
1
H} NMR (CDCl3): δ 166.6, 153.9, 144.6, 128.9, 128.1, 126.2, 120.5, 74.2, 
72.6, 47.3, 45.3, 41.2, 34.5, 33.4, 31.6, 26.5, 23.8, 22.3, 21.0, 19.4, 16.7; HRMS (FAB, 
MNa
+
) calcd for C23H34O3Na: 381.2406. Found 381.2408. 
2.196b: IR (neat, NaCl) 3462, 2953, 1718 cm
-1
; 
1
H NMR (CDCl3): δ 7.27-7 (37 (5H, m), 
4.89 (1H, dd, J = 2.4, 6.4 Hz), 4.73 (2H, s), 4.52 (1H, dt, J = 4.4, 10.9 Hz), 2.90-2.97 
(1H, m), 2.71 (1H, dd, J = 2.6, 13.8 Hz), 2.48 (1H, dd, J = 4.0, 10.4 Hz), 2.30-2.53 (1H, 
m), 1.72-1.82 (1H, m), 1.70 (3H, s), 1.49-1.65 (2H, m), 1.20-1.39 (4H, m), 0.96 (1H, dq, 
J = 2.8, 12.7 Hz), 0.84 (6H, d, J = 6.9 Hz), 0.64 (3H, d, J = 6.9 Hz); 
13
C {
1
H} NMR 
(CDCl3): δ 174. 0, 142.9, 141.5, 128.6, 128.1, 126.7, 112.7, 74.9, 74.7, 52.2, 46.8, 40.4, 
36.1, 34.3, 31.4, 25.7, 23.5, 23.2, 23.0, 22.4, 16.5; HRMS (FAB, MNa
+
) calcd for 
C23H34O3Na: 381.2406. Found 381.2410.  
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(4S,6S,E)-(1R,2R,5R)-5-methyl-2-(2-phenylpropan-2-yl)cyclohexyl-6-hydroxy-4-
methyl-6-phenylhex-2-enoate (2.197a) and (1R,2R,5R)-5-methyl-2-(2-phenylpropan-
2-yl)cyclohexyl-2-(hydroxy(phenyl)methyl)-4-methylpent-4-enoate (2.197b): 
Benzaldehyde 2.21 (0.20 mmol, 20 µL), Ni(acac)2 (0.02 mmol, 0.005 g), diethylzinc 
(10% w/w solution in hexanes, 0.48 mmol, 0.59 mL), and pentadienoate 2.192c (0.40 
mmol, 0.130 g) were reacted in dry THF (2 mL) following the general procedure of 
homoallylation to afford two regioisomers 2.197a and 2.197b as a colorless liquid (rr, 
7:1) (0.065 g, combined yield 75% ).  
1.297a: IR (neat, NaCl) 3444, 2957, 1703 cm
-1
; 
1
H NMR (CDCl3): (major isomer) δ 
7.33-7.39 (5H, m), 7.26-7.32 (4H, m), 7.10 (1H, app t, J = 7.1 Hz), 6.61 (1H, dd, J = 7.5, 
15.7 Hz), 5.20 (1H, d, J = 15.7 Hz), 4.86 (1H, dt, J = 4.1, 10.7 Hz), 4.68 (1H, t, J = 7.1 
Hz), 2.35 (1H, app sep, J = 7.1 Hz), 2.04-2.07 (1H, m), 1.87-1.95 (3H, m), 1.60-1.73 (4H, 
m), 1.50-1.52 (1H, m), 1.33 (3H, s), 1.24 (3H, s), 1.10-1.15 (1H, m), 1.06 (3H, d, J = 6.6 
Hz), 0.96-1.09 (1H, m), 0.89 (3H, d, J = 6.5 Hz); 
13
C {
1
H} NMR (CDCl3): δ 166.2, 
153.5, 151.9, 144.7, 128.9, 128.2, 128.1, 126.2, 125.7, 125.2, 120.5, 74.4, 72.6, 50.8, 
45.2, 42.0, 40.0, 34.8, 33.2, 31.5, 28.1, 26.8, 25.3, 22.0, 19.2; HRMS (FAB, MNa
+
) calcd 
for C29H38O3Na: 457.2719. Found 457.2719. 
1.297b: IR (neat, NaCl) 3466, 2950, 1719 cm
-1
; 
1
H NMR (CDCl3): δ 7.26-7.33 (9H, m), 
7.17 (1H, app t, J = 7.1 Hz), 4.77 (1H, d, J = 4.5 Hz), 4.75 (2H, s), 4.68 (1H, dt, J = 4.1, 
10.7 Hz), 2.63 (1H, app pent, J = 4.6 Hz), 2.46 (1H, dd, J = 9.9, 14.2 Hz), 2.41 (1H, d, J 
Paudyal, Mahesh, 2012, UMSL, p.176 
 
 
= 3.7 Hz), 2.16 (1H, dd, J = 4.2, 14.5 Hz), 1.86-1.90 (1H, m), 1.66 (3H, s), 1.50-1.57 
(2H, m), 1.40-1.43 (1H, m), 1.29 (3H, s), 1.26-1.35 (1H, m), 1.18 (3H, s), 0.80-0.95 (2H, 
m), 0.77 (3H, d, J = 6.5 Hz), 0.71 (1H, m); 
13
C {
1
H} NMR (CDCl3): δ 173.2, 151.6, 
143.4, 141.4, 128.5, 128.2, 128.0, 126.8, 125.8, 125.4, 113.0, 75.9, 75.1, 51.6, 50.4, 41.1, 
40.2, 35.0, 34.7, 31.4, 27.8, 27.2, 25.8, 22.8, 21.9; HRMS (FAB, MNa
+
) calcd for 
C29H38O3Na: 457.2719. Found 457.2699.  
 
(4S,6S,E)-(1R,2R,5R)-5-methyl-2-(2-(naphthalene-2-yl)cyclohexyl-6-hydroxy-4-
methyl-6-phenylhex-2-enoate (1.298a) and (1R,2R,5R)-5-methyl-2-(2-(naphthalene-
2-yl)cyclohexyl-2-(hydroxy(phenyl)methyl)-4-methylpent-4-enoate (1.298b): 
Benzaldehyde 3.21 (0.20 mmol, 20 µL), Ni(acac)2 (0.02 mmol, 0.005 g), diethylzinc 
(10% w/w solution in hexanes, 0.48 mmol, 0.59 mL), and pentadienoate 2.193c (0.40 
mmol, 0.150 g) were reacted in dry THF (2 mL) following the general procedure of 
homoallylation to afford two regioisomers  2.198a and 2.198b as a colorless liquid (rr, 
10:1) (0.068 g, combined yield 68%).  
2.198a: IR (neat, NaCl) 3454, 3057, 2963, 1716 cm
-1
; 
1
H NMR (CDCl3): (major isomer) 
δ 7.72-7.79 (3H, m), 7.61(1H, d, J = 1.4 Hz), 7.54 (1H, dd, J = 1.7, 8.7 Hz), 7.27-7.41 
(7H, m), 6.38 (1H, dd, J = 7.1, 15.8 Hz), 4.92 (1H, dt, J = 4.3, 10.7 Hz), 4.80 (1H, dd, J = 
1.1, 15.8 Hz), 4.51-4.56 (1H, m), 2.18-2.27 (1H, m), 1.86-1.96 (2H, m), 1.79-1.84 (1H, 
m), 1.63-1.79 (2H, m), 1.51-1.61 (1H, m), 1.44  (3H, s), 1.15-1.38 (3H, m), 1.30 (3H, s), 
0.95-1.07 (2H, m), 0.90 (3H, d, J = 6.4 Hz), 0.77 (3H, d, J = 6.7 Hz); 
13
C {
1
H} NMR 
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(CDCl3): δ 166.2, 153.4, 153.3, 149.6, 144.7, 133.7, 131.6, 128.8, 128.2, 127.9, 127.5, 
126.1, 125.9, 125.3, 125.2, 122.9, 119.8, 74.1, 72.3, 50.2, 45.0, 42.0, 40.0, 34.8, 32.7. 
31.5, 28.7, 26.7, 24.2, 22.0, 18.4; HRMS (FAB, MNa
+
) calcd for C33H40O3Na: 507.2875. 
Found 507.2886. 
2.198b: IR (neat, NaCl) 3462, 2945, 1715 cm
-1
; 
1
H NMR (CDCl3): δ 7.69-7.77 (3H, m), 
7.49 (1H, s), 7.45 (1H, dd, J = 1.8, 8.7 Hz), 7.32-7.41 (2H, m), 7.02-7.12 (3H, m), 6.64-
6.67 (2H, m), 4.81 (1H, dt, J = 4.3, 10.7 Hz), 4.57 (1H, broad s), 4.47 (1H, s), 4.43 (1H, 
s), 3.65 (1H, d, J = 1.7 Hz), 2.05-2.19 (2H, m), 1.64-1.79 (4H, m), 1.53-1.62 (1H, m), 
1.31 (3H, s), 1.25 (3H, s), 1.03-1.21 (2H, m), 1.11 (3H, s), 0.74-0.89 (2H, m), 0.78 (3H, 
d, J = 6.5 Hz); 
13
C {
1
H} NMR (CDCl3): δ 172.2, 149.4, 141.5, 133.5, 131.6, 128.5, 128.1, 
127.8, 127.5, 127.4, 126.5, 126.0, 125.4, 125.0, 123.0, 112.9, 81.8, 75.3, 53.1, 50.2, 43.4, 
41.8, 39.9, 34.8, 31.5, 28.8, 28.5, 27.5, 26.9, 25.3, 22.0 HRMS (FAB, MNa
+
) calcd for 
C33H40O3Na: 507.2875. Found 507.2865.  
 
(4S,6S,E)-(1R,2R,5R)-2-(2-([1,1’-biphenyl]-4-yl)propan-2-yl)-5-methylcyclohexyl-6-
hydroxy-4-methyl-6-phenylhex-2-enoate (2.199a) and (1R,2R,5R)-2-(2-([1,1’-
biphenyl]-4-yl)propan-2-yl)-5-methylcyclohexyl-2-(hydroxy(phenyl)methyl)-4-
methylpent-4-enoate (2.199b): Benzaldehyde 2.21 (0.10 mmol, 10 µL), Ni(acac)2 (0.01 
mmol, 0.003 g), diethylzinc (1.0 M solution in hexanes, 0.24 mmol, 0.24 mL), and 
pentadienoate 2.194c (0.20 mmol, 0.080 g) were reacted in dry THF (1 mL) following the 
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general procedure of homoallylation to afford two regioisomers 2.199a and 2.199b as a 
colorless liquid (rr, 6:1) (0.031 g, combined yield 60%).  
2.199a: IR (neat, NaCl) 3456, 2958, 1706 cm
-1
; 
1
H NMR (CDCl3): (major isomer) δ 7.41-
7.53 (6H, m), 7.14-7.35 (8H, m), 6.59 (1H, dd, J = 7.7, 15.7 Hz), 5.14 (1H, dd, J = 1.0, 
15.7 Hz), 4.81 (1H, dt, J = 4.4, 10.8 Hz), 4.84 (1H, app quin, J = 7.6 Hz), 2.10-2.24 (1H, 
m), 1.95-2.08 (1H, m), 1.81-1.90 (1H, m), 1.57-1.76 (3H, m), 1.35-1.51 (3H, m), 1.27 
(3H, s), 1.19 (3H, s), 0.89-1.14 (3H, m), 0.84 (3H, d, J = 6.7 Hz), 0.81 (3H, d, J = 6.7 
Hz); 
13
C {
1
H} NMR (CDCl3): δ 166.0, 153.3, 151.0, 144.3, 140.8, 137.4, 128.7, 128.6, 
127.7, 127.0, 126.8, 126.7, 125.9, 125.7, 120.2, 73.9, 72.2, 50.6, 44.9, 41.8, 39.6, 34.6, 
33.0, 32.0, 31.3, 27.9, 26.6, 25.0, 21.8, 18.7; HRMS (FAB, MNa
+
) calcd for C35H42O3Na: 
533.3032. Found 533.3015. 
2.199b: IR (neat, NaCl) 3456, 2958, 1724 cm
-1
; 
1
H NMR (CDCl3): δ 7.66 (2H, d, J = 8.3 
Hz), 7.60 (2H, d, J = 8.3 Hz), 7.48 (2H, t, J = 7.3 Hz), 7.39 (4H, dd, J = 1.3, 7.2 Hz), 
7.26-7.37 (4H, m), 4.72-4.84 (2H, m), 4.78 (2H, s), 2.66 (1H, app quin, J = 4.1 Hz), 2.51 
(1H, dd, J = 10.3, 14.0 Hz), 2.33-2.48 (1H, m), 2.10-2.19 (1H, m), 2.01 (1H, dt, J = 3.2, 
12.0 Hz), 1.69 (3H, s), 1.56-1.57 (2H, m), 1.24-1.44 (2H, m), 1.38 (3H, s), 1.27 (3H, s), 
0.88-1.10 (3H, m), 0.85 (3H, d, J = 6.5 Hz); 
13
C {
1
H} NMR (CDCl3): δ 173.1, 150.8, 
143.4, 141.3, 140.9, 138.0, 128.9, 128.4, 127.9, 127.2, 127.1, 126.7, 126.5, 126.2, 112.7, 
75.9, 75.0, 51.5, 50.3, 41.1, 39.9, 34.7, 34.4, 31.4, 27.2, 27.1, 26.3, 22.8, 21.9; HRMS 
(FAB, MNa
+
) calcd for C35H42O3Na: 533.3032. Found 533.3038.  
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(4S,6S,E)-(1R,2R,5R)-2-(2-(4-(tert-butyl)phenylpropan-2-yl)-5-methylcyclohexyl-6-
hydroxy-4-methyl-6-phenylhex-2-enoate (2.200a) and (1R,2R,5R)-2-(2-(4(tert-
butyl)phenyl)propan-2-yl)-5-methylcyclohexyl-2-(hydroxy(phenyl)methyl)-4-
methylpent-4-enoate (2.200b): Benzaldehyde 2.21 (0.20 mmol, 20 µL), Ni(acac)2 (0.02 
mmol, 0.005 g), diethylzinc (1.0 M solution in hexanes, 0.48 mmol, 0.48 mL), and 
pentadienoate 2.195c (0.40 mmol, 0.153 g) were reacted in dry THF (2 mL) following the 
general procedure of homoallylation to afford two regioisomers  2.200a and 2.200b as a 
colorless liquid (rr, 7:1) (0.071 g, combined yield 72%). 
2.200a: IR (neat, NaCl) 3468, 2963, 1709 cm
-1
; 
1
H NMR (CDCl3): (major isomer) δ 7.08-
7.29 (9H, m), 6.71 (1H, dd, J = 8.1, 15.8 Hz), 5.17 (1H, dd, J = 0.9, 15.7 Hz), 4.79 (1H, 
dt, J = 4.3, 10.7 Hz), 4.60 (1H, t, J = 5.9 Hz), 2.25 (1H, app sep, J = 7.0 Hz), 1.77-1.96 
(4H, m), 1.45-1.62 (3H, m), 1.33-1.44 (1H, m), 1.22 (3H, s), 1.20 (9H, s), 1.14 (3H, s), 
1.0 (3H, d, J = 6.7 Hz), 0.89-0.95 (2H, m), 0.78 (3H, d, J = 6.4 Hz), 0.76-0.80 (1H, m); 
13
C {
1
H} NMR (CDCl3): δ 166.2, 153.8, 148.4, 147.6, 144.5, 128.8, 128.0, 126.1, 125.3, 
124.9, 120.6, 74.6, 72.5, 50.8, 45.3, 41.9, 39.6, 34.8, 34.3, 33.4, 31.6, 31.5, 26.9, 26.8, 
26.7, 22.0, 19.5; HRMS (FAB, MNa
+
) calcd for C33H46O3Na: 513.3345. Found 513.3331. 
 2.200b: IR (neat, NaCl) 3470, 2958, 1720 cm
-1
; 
1
H NMR (CDCl3): (major isomer) δ 
7.19-7.27 (7H, m), 7.09 (2H, d, J = 8.5 Hz), 4.71 (1H, d, J = 5.3 Hz), 4.68 (2H, s), 4.59 
(1H, dt, J = 4.1, 10.6 Hz), 2.62-2.68 (1H, m), 2.39 (1H, dd, J = 10.2, 14.2 Hz), 2.33 (1H, 
brd s), 2.11 (1H, dd, J = 3.9, 14.1 Hz), 1.72-1.81 (1H, m), 1.60 (3H, s), 1.40-1.49 (3H, 
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m), 1.24 (9H, s), 1.20-1.32 (1H, m), 1.20 (3H, s), 1.09 (3H, s), 0.81-0.97 (2H, m), 0.69 
(3H, d, J = 6.4 Hz); 
13
C {
1
H} NMR (CDCl3): δ 173.2, 148.1,148.0, 143.2, 141.4, 128.5, 
128.0, 126.8, 125.4, 125.0, 113.1, 76.1, 75.1, 51.8, 50.3, 41.1, 39.8, 35.1, 34.7, 34.4, 31.6, 
31.3, 28.4, 27.2, 25.4, 22.8, 21.9; HRMS (FAB, MNa
+
) calcd for C33H46O3Na: 513.3345. 
Found 513.3349. 
 
4S,6S,E)-(1R,2R,5R)-2-(2-(4-(tert-butyl)phenyl)propan-2-yl)-5-methylcyclohexyl 4-
methyl-6-phenyl-6-(((S)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoyl)oxy)hex-2-
enoate (2.202a): To a stirred solution of 2.200a (0.020 mmol, 0.010 g) in dry CH2Cl2 
(0.5 mL) under argon at rt was added N,N-dimethylamino pyridine (DMAP) (0.004 
mmol, 0.005 g), pyridine (0.031 mmol, 3 µL) and (R)-MTPA chloride 2.201a (0.031 
mmol, 6 µL) sequentially. The resulting solution was stirred for 23 h at that temperature 
when the TLC analysis showed the reaction was complete. About 1 mL of water was 
added, the layers separated, the aq. layer was extracted with EtOAc (5 mL, 3X) and the 
combined organic layers were dried over anhydrous Na2SO4. The crude product was 
purified by SiO2 column chromatography to give 2.202a as a colorless liquid (0.01 g, 
71%). 
1
H NMR (CDCl3): (major isomer) δ 7.08-7.28 (14H, m), 6.60 (1H, dd, J = 7.5, 15.7 Hz), 
5.83 (1H, t, J = 6.2 Hz), 5.11 (1H, d, J = 15.7 Hz), 4.79 (1H, dt, J = 4.2, 10.7 Hz), 3.3 
(3H, s), 1.95-2.03 (3H, m), 1.84-1.93 (2H, m), 1.62-1.67 (1H, m), 1.39-1.53 (3H, m), 
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1.21 (3H, s), 1.20 (3H, s), 1.18 (9H, s), 0.89-1.00 (2H, m), 0.96 (3H, d, J = 6.4 Hz), 0.79 
(3H, d, J = 6.4 Hz); 
13
C {
1
H} NMR (CDCl3): δ 166.06, 166.02, 152.2, 148.3, 147.7, 
138.7, 132.5, 129.7, 128.9, 128.8, 128.5, 127.5, 127.3, 125.3, 124.8, 121.1, 76.5, 74.7, 
55.6, 50.8, 41.9, 41.8, 39.7, 34.8, 34.3, 32.6, 31.6, 31.5, 27.0, 26.6, 22.0, 19.1. 
 
(4S,6S,E)-(1R,2R,5R)-2-(2-(4-(tert-butyl)phenyl)propan-2-yl)-5-methylcyclohexyl 4-
methyl-6-phenyl-6-(((R)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoyl)oxy)hex-2-
enoate (2.202b): Alcohol 2.202b (0.032 mmol, 0.016 g), DMAP (0.007 mmol, 0.008 g), 
pyridine (0.049 mmol, 4 µL), and MTPA chloride (0.049 mmol, 9 µL) were reacted in 
dry CH2Cl2 (0.5 mL) following the above mentioned procedure for 2.202a to afford 
2.202b as a colorless liquid (0.018 g, 82%). 
1
H NMR (CDCl3): (major isomer) δ 7.18-7.41 (14H, m), 6.74 (1H, dd, J = 7.5, 15.7 Hz), 
5.85 (1H, t, J = 7.2 Hz), 5.23 (1H, d, J = 15.7 Hz), 4.90 (1H, dt, J = 4.2, 10.7 Hz), 3.51 
(3H, s), 2.13-2.25 (3H, m), 1.92-2.10 (2H, m), 1.75-1.86 (1H, m), 1.59-1.65 (2H, m), 
1.46-1.52 (2H, m), 1.30 (6H, s), 1.27 (9H, s), 1.10 (3H, d, J = 6.5 Hz), 0.93-1.06 (2H, m), 
0.90 (3H, d, J = 6.5 Hz); 
13
C {
1
H} NMR (CDCl3): δ 166.0, 165.8, 152.0, 148.4, 147.7, 
138.7, 132.1, 129.7, 128.9, 128.7, 128.4, 127.5, 127.1, 125.3, 124.8, 121.4, 76.9, 74.8, 
55.7, 50.8, 42.1, 42.0, 39.9, 39.7, 34.8, 34.3, 34.3, 31.61, 31.58, 26.96, 26.91, 26.6, 22.0, 
19.5, 18.9. 
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(4S,6S,E)-(1R,2R,5R)-2-(2-(4-(tert-butyl)phenylpropan-2-yl)-5-methylcyclohexyl-6-
(furan-2-yl)-6-hydroxy-4-methyl-6-phenylhex-2-enoate (2.204a) and (1R,2R,5R)-2-
(2-(4(tert-butyl)phenyl)propan-2-yl)-5-methylcyclohexyl-2-(furan-2-
yl(hydroxyl)methyl)-4-methylpent-4-enoate (2.204b): Furfuraldehyde 2.204 (0.10 
mmol, 8 µL), Ni(acac)2 (0.01 mmol, 0.003 g), diethylzinc (1.0 M solution in hexanes, 
0.24 mmol, 0.24 mL), and pentadienoate 2.195c (0.20 mmol, 0.076 g) were reacted in dry 
THF (1 mL) following the general procedure of homoallylation to afford two 
regioisomers  2.204a and 2.204b as a colorless liquid (rr, 5:1) (0.036 g, combined yield 
75%).  
2.204a: IR (neat, NaCl) 3456, 2958, 1713 cm
-1
; 
1
H NMR (CDCl3): (major isomer) δ 7.08-
7.30 (5H, m), 6.67 (1H, dd J = 8.2, 15.7 Hz), 6.23-6.26 (1H, m), 6.13 (1H, d, J = 3.2 Hz), 
5.13 (1H, dd, J = 0.9, 15.7 Hz), 4.78 (1H, dt, J = 4.3, 10.7 Hz), 4.58 (1H, t, J = 7.1 Hz), 
2.26 (1H, app sep, J = 7.1 Hz), 1.77-1.97 (5H, m), 1.49-1.56 (2H, m), 1.42-1.48 (1H, m), 
1.23 (9H, s), 1.21 (3H, s), 1.14 (3H, s), 1.00 (3H, d, J = 6.6 Hz), 0.97-1.02 (1H, m), 0.89-
0.96 (1H, m), 0.77-0.80 (1H, m), 0.79 (3H, d, J = 6.4 Hz); 
13
C {
1
H} NMR (CDCl3): δ 
164.2, 156.3, 153.4, 148.5, 147.7, 142.3, 125.3, 124.9, 120.8, 110.4, 106.5, 74.7, 65.8, 
50.8, 42.0, 41.6, 39.8, 34.8, 34.4, 33.2, 31.6, 31.5, 26.9, 26.6, 22.0, 19.4; HRMS (FAB, 
MNa
+
) calcd for C31H44O4Na: 503.3137. Found 503.3146. 
2.204b: IR (neat, NaCl) 3463, 2962, 1720 cm
-1
; 
1
H NMR (CDCl3): δ 7.19 -7.27 (3H, m), 
7.10 (2H, d, J = 8.6 Hz), 7.21-7.27 (1H, m), 6.15 (1H, d, J = 4.3 Hz), 4.74 (1H, dt, J = 
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4.3, 10.9 Hz), 4.71 (1H, s), 4.61 (1H, s), 4.53 (1H, brd s), 2.26-2.28 (1H, s), 2.35 (1H, dd, 
J = 8.3, 14.3 Hz), 2.05 (1H, dd, J = 6.1, 14.5 Hz), 1.88 (1H, dt, J = 3.2, 11.9 Hz), 1.70-
1.76 (1H, m), 1.65 (3H, s), 1.43-1.59 (5H, m), 1.23 (9H, s), 1.21 (3H, s), 1.10 (3H, s), 
0.75 (3H, d, J = 6.4 Hz), 0.64-0.81 (2H, m); 
13
C {
1
H} NMR (CDCl3): δ 172.6, 154.0, 
148.3, 148.1, 142.8, 142.1, 125.2, 125.1, 113.0, 110.3, 107.7, 76.2, 68.6, 50.4, 48.6, 41.5, 
39.6, 35.2, 34.7, 34.4, 31.5, 31.4, 27.1, 26.5, 22.7, 21.9; HRMS (FAB, MNa
+
) calcd for 
C31H44O4Na: 503.3137. Found 503.3128.  
 
(4S,6S,E)-(1R,2R,5R)-2-(2-(4-(tert-butyl)phenyl)propan-2-yl)-5-methylcyclohexyl-6-
(4-cyanophenyl)-6-hydroxy-4-methylhex-2-enoate (2.205a) and (1R,2R,5R)-2-(2-
(4(tert-butyl)phenyl)propan-2-yl)-5-methylcyclohexyl-2-((4-cyanophenyl)(hydroxy) 
methyl)-4-methylpent-4-enoate (2.205b): 4-Cyanobenzaldehyde 2.205 (0.10 mmol, 
0.013 g), Ni(acac)2 (0.01 mmol, 0.003 g), diethylzinc (1.0 M solution in hexanes, 0.24 
mmol, 0.24 mL), and pentadienoate 2.195c (0.20 mmol, 0.076 gm) were reacted in dry 
THF (1 mL) following the general procedure of homoallylation to afford two 
regioisomers  2.205a and 2.205b as a colorless liquid (rr, 6:1) (0.036 g, combined yield 
71%). 
2.205a: IR (neat, NaCl) 3482, 2963, 2227, 1701 cm
-1
; 
1
H NMR (CDCl3): δ 7.56 (2H, d, J 
= 8.3 Hz), 7.36 (2H, d, J = 8.3 Hz), 7.19 ( 2H, d, J = 8.4 Hz), 7.09 (2H, d, J = 8.4 Hz), 
6.69 (1H, dd, J = 7.5, 15.7 Hz), 5.12 (1H, dd, J = 0.8, 15.7 Hz), 4.78 (1H, dt, J = 4.2, 10.7 
Hz), 4.66 (1H, t, J = 6.6 Hz), 2.27 (1H, app sep, J = 7.0 Hz), 1.73-1.96 (4H, m), 1.49-
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1.58 (3H, m), 1.34-1.43 (1H, m), 1.23 (3H, s), 1.20 (9H, s), 1.14 (3H, s), 1.02 (3H, d, J = 
6.7 Hz), 0.83-0.96 (3H, m), 0.79 (3H, d, J = 6.4 Hz); 
13
C {
1
H} NMR (CDCl3): δ 166.1, 
152.9, 149.9, 148.4, 147.5, 132.6, 126.7, 125.2, 124.8, 121.0, 118.9, 111.7, 74.8, 71.9, 
50.8, 45.4, 41.9, 39.6, 34.8, 34.3, 33.4, 31.6, 31.5, 27.1, 26.9, 26.3, 22.0, 19.5; HRMS 
(FAB, MNa
+
) calcd for C34H45NO3Na: 538.3297. Found 538.3289. 
 2.205b: IR (neat, NaCl) 3482, 2952, 2221, 1723 cm
-1
; 
1
H NMR (CDCl3): δ 7.54 (2H, d, J 
= 8.3 Hz), 7.33 (2H, d, J = 8.3 Hz), 7.22 ( 2H, d, J = 8.4 Hz), 7.10 (2H, d, J = 8.4 Hz), 
4.73 (1H, t, J = 4.1 Hz), 4.69 (1H, s), 4.65 (1H, s), 4.62 (1H, dt, J = 4.2, 10. 7 Hz), 2.56 
(1H, app quin, J = 4.8 Hz), 2.49 (1H, d, J = 3.5 Hz), 2.34 (1H, dd, J = 9.6, 14.2 Hz), 1.97 
(1H, dd, J = 5.9, 14.2 Hz), 1.78-1.87 (2H, m), 1.57 (3H, s), 1.38-1.48 (2H, m), 1.22 (9H, 
s), 1.19 (3H, s), 1.07-1.14 (1H, m), 1.09 (3H, s), 0.68-0.90 (3H, m), 0.74 (3H, d, J = 6.5 
Hz); 
13
C {
1
H} NMR (CDCl3): δ 172.6, 148.0, 147.9, 146.4, 142.4, 132.1, 127.3, 125.1, 
124.9, 118.7, 113.3, 11.6, 76.3, 73.9, 51.0, 50.1, 41.2, 39.5, 34.6, 34.4, 34.2, 31.4, 31.2, 
27.3, 26.9, 26.0, 22.5, 21.7; HRMS (FAB, MNa
+
) calcd for C34H45NO3Na: 538.3297. 
Found 538.3279.  
 
(4S,6S,E)-(1R,2R,5R)-2-(2-(4-(tert-butyl)phenyl)propan-2-yl)-5-methylcyclohexyl-6-
hydroxy-6-(4-hydroxyphenyl)-4-methylhex-2-enoate (2.206a) and (1R,2R,5R)-2-(2-
(4-(tert-butyl)phenyl)propan-2-yl)-5-methylcyclohexyl-2-(hydroxy(4-hydroxyphenyl) 
methyl)-4-methylpent-4-enoate (2.206b): 4-Hydroxybenzaldehyde 2.206 (0.10 mmol, 
0.012 g), Ni(acac)2 (0.01 mmol, 0.003 g), diethylzinc (1.0 M solution in hexanes, 0.24 
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mmol, 0.24 mL), and pentadienoate 2.195c (0.20 mmol, 0.076 g) were reacted in dry 
THF (1 mL) following the general procedure of homoallylation to afford two 
regioisomers  2.206a and 2.206b as a viscous colorless liquid (rr, 6:1) (0.036 g, combined 
yield 70%).  
2.206a: IR (neat, NaCl) 3369, 2958, 1697 cm
-1
; 
1
H NMR (CDCl3): δ 7.17 (2H, d, J = 8.4 
Hz), 7.09 (4H, d, J = 8.7 Hz), 6.71 (2H, d, J = 8.4 Hz), 6.70 (1H, dd, J = 7.5, 15.7 Hz), 
5.8 (1H, brd s), 5.14 (1H, d, J = 15.7 Hz), 4.79 (1H, dt, J = 4.2, 10.6 Hz), 4.46 (1H, t, J = 
7.1 Hz), 2.17 (1H, app sep, J = 7.1 Hz), 1.83-1.98 (3H, m), 1.73-1.80 (1H, m), 1.48-1.61 
(3H, m), 1.33-1.44 (1H, m), 1.22 (9H, s), 1.20 (3H, s), 1.15 (3H, s), 0.97 (3H, d, J = 6.7 
Hz), 0.77-0.80 (3H, m), 0.79 (3H, d, J = 6.4 Hz); 
13
C {
1
H} NMR (CDCl3): δ 166.6, 
155.7, 153.9, 148.4, 147.7, 136.3, 127.6, 125.3, 124.9, 120.6, 115.7, 74.9, 72.2, 50.8, 
45.1, 42.0, 39.7, 34.8, 34.4, 33.5, 31.8, 31.5, 27.0, 26.8, 21.3, 19.6; HRMS (FAB, MNa
+
) 
calcd for C33H46O4Na: 529.3294. Found 529.3300. 
2.206b: IR (neat, NaCl) 3476, 2949, 1721 cm
-1
; 
1
H NMR (CDCl3): δ 7.29 (2H, d, J = 8.5 
Hz), 7.17 (4H, d, J = 8.5 Hz), 6.78 (2H, d, J = 8.5 Hz), 4.77 (2H, s), 4.72 (1H, d, J = 5.9 
Hz), 4.65 (1H, dt, J = 4.1, 10.6 Hz), 2.71 (1H, ddd, J = 4.2, 5.9, 10.1 Hz), 2.46 (1H, dd, J 
= 10.2, 14.0 Hz), 2.23 (1H, dd, J = 3.8, 14.1 Hz), 1.76-1.97 (2H, m), 1.70 (3H, s), 1.34-
1.65 (3H, m), 1.31 (9H, s), 1.27 (6H, s), 1.09-1.22 (2H, m), 0.81-1.01 (3H, m), 0.77 (3H, 
d, J = 6.4 Hz); 
13
C {
1
H} NMR (CDCl3): δ 173.3, 155.5, 148.04, 148.0, 143.2, 133.6, 
128.3, 125.4, 124.9, 115.2, 113.2, 76.0, 74.9, 51.9, 50.3, 41.0, 39.8, 35.6, 34.6, 34.4, 31.6, 
31.3, 28.6, 27.2, 25.2, 22.7, 21.9. 
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(4S,6S,E)-(1R,2R,5R)-2-(2-(4-(tert-butyl)phenyl)propan-2-yl)-5-methylcyclohexyl-6-
hydroxy-6-(2-methoxyphenyl)-4-methylhex-2-enoate (2.207a) and (1R,2R,5R)-2-(2-
(4(tert-butyl)phenyl)propan-2-yl)-5-methylcyclohexyl-2-(hydroxy(2-
methoxyphenyl)methyl)-4-methylpent-4-enoate (2.207b): 2-Methoxybenzaldehyde 
2.207 (0.10 mmol, 0.014 g), Ni(acac)2 (0.01 mmol, 0.003 g), diethylzinc (1.0 M solution 
in hexanes, 0.24 mmol, 0.24 mL), and pentadienoate 2.195c (0.20 mmol, 0.076 g) were 
reacted in dry THF (1 mL) following the general procedure of homoallylation to afford 
two regioisomers  2.207a and 2.207b as a colorless liquid (rr, 12:1) (0.039 g, combined 
yield 75%).  
2.207a: IR (neat, NaCl) 3472, 2960, 1704 cm
-1
; 
1
H NMR (CDCl3): (major isomer) δ 7.14-
7.21 (4H, m), 7.10 (2H, d, J = 8.4 Hz), 6.87 (1H, t, J = 7.4 Hz), 6.79 (1H, t, J = 7.4 Hz), 
6.75 (1H, dd, J = 7.8, 15.7 Hz), 5.20 (1H, d, J = 15.7 Hz), 4.78 (1H, dt, J = 4.3, 10.6 Hz), 
4.74-4.83 (1H, m), 3.76 (3H, s), 2.44 (1H, brd s), 2.37 (1H, app sep, J = 6.8 Hz), 1.79-
1.94 (3H, m), 1.32-1.67 (4H, m), 1.23 (9H, s), 1.21 (3H, s), 1.15 (3H, s), 1.02 (3H, d, J = 
6.7 Hz), 0.81-0.96 (3H, m), 0.78 (3H, d, J = 6.4 Hz); 
13
C {
1
H} NMR (CDCl3): δ 166.4, 
156.7,154.2, 148.4, 147.7, 132.2, 128.7,127.1, 125.3, 124.8, 121.0, 120.3, 110.7, 74.5, 
69.0, 55.4, 50.8, 43.6, 42.0, 39.7, 34.8, 34.3, 33.5, 31.6, 31.5, 27.0, 26.9, 26.7, 22.0, 19.0; 
HRMS (FAB, MNa
+
) calcd for C34H48O4Na: 543.3450. Found 543.3442. 
2.207b: 
1
H NMR (CDCl3): δ 7.12-7.24 (4H, m), 7.09 (2H, d, J = 8.4 Hz), 6.71-6.95 (3H, 
m), 4.91 (1H, d, J = 5.7 Hz), 4.78 (1H, s), 4.72 (1H, s), 4.64 (1H, dt, J = 4.3, 10.7 Hz), 
Paudyal, Mahesh, 2012, UMSL, p.187 
 
 
3.78 (3H, s), 3.02 (1H, q, J = 7.5 Hz), 2.30 (1H, dd, J = 8.0, 14.0 Hz), 2.16 (1H, dd, J = 
7.1, 14.0 Hz), 1.64 (3H, s), 1.29-1.58 (4H, m), 1.23 (9H, s), 1.21 (3H, s), 1.12 (3H, s), 
0.73-0.89 (4H, m), 0.67 (3H, d, J = 6.4 Hz). 
 
(4S,6S,E)-(1R,2R,5R)-2-(2-(4-(tert-butyl)phenylpropan-2-yl)-5-methylcyclohexyl-6-
hydroxy-4-methyl-6-(naphthalene-1-yl)hex-2-enoate (2.208a) and (1R,2R,5R)-2-(2-
(4(tert-butyl)phenyl)propan-2-yl)-5-methylcyclohexyl-2-(hydroxy(naphthalene-1-yl)-
methyl)-4-methylpent-4-enoate (2.208b): 2-Naphthaldehyde 2.208 (0.10 mmol, 14 µL), 
Ni(acac)2 (0.01 mmol, 0.003 g), diethylzinc (1.0 M solution in hexanes, 0.24 mmol, 0.24 
mL), and pentadienoate 2.195c (0.2 mmol, 0.076 g) were reacted in dry THF (1 mL) 
following the general procedure of homoallylation to afford two regioisomers  2.208a 
and 2.208b as a colorless liquid (rr, 6:1) (0.041 g, combined yield 76%).  
2.208a: IR (neat, NaCl) 3469, 2955, 1704 cm
-1
; 
1
H NMR (CDCl3): δ 8.01 (1H, d, J = 8.2 
Hz), 7.77 (1H, d, J = 7.1 Hz), 7.69 (1H, d, J = 8.2 Hz), 7.55 (1H, d, J = 7.1 Hz), 7.35-
7.45 (3H, m), 7.15 (2H, d, J = 8.4 Hz), 7.06 (2H, d, J = 8.4 Hz), 6.75 (1H, dd, J = 7.8, 
15.7 Hz), 5.41 (1H, dd, J = 4.6, 8.8 Hz), 5.19 (1H, d, J = 15.7 Hz), 4.76 (1H, dt, J = 4.2, 
10.7 Hz), 2.49 (1H, app sep, J = 6.7 Hz), 1.74-1.95 (5H, m), 1.47-1.52 (2H, m), 1.31-1.43 
(1H, m), 1.20 (9H, s), 1.19 (3H, s), 1.13 (3H, s), 1.10 (3H, d, J = 7.8 Hz), 0.86-0.94 (2H, 
m), 0.73-0.80 (1H, m), 0.77 (3H, d, J = 6.4 Hz); 
13
C {
1
H} NMR (CDCl3): δ 166.2, 
153.7,148.4, 147.6, 140.3, 134.0,130.4, 129.1, 128.3, 126.2, 125.7, 125.6, 125.2, 124.8, 
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123.2, 120.5, 74.6, 69.2, 50.8, 44.5, 41.9, 39.6, 34.8, 34.3, 33.7, 31.6, 31.4, 26.9, 26.8, 
26.7, 22.0, 19.0; HRMS (FAB, MNa
+
) calcd for C37H48O3Na: 563.3501. Found 563.3495. 
2.208b: IR (neat, NaCl) 3456, 2962, 1720 cm
-1
; 
1
H NMR (CDCl3): δ 8.10 (1H, d, J = 8.2 
Hz), 7.89 (1H, d, J = 7.1 Hz), 7.81 (1H, d, J = 8.2 Hz), 7.70 (1H, d, J = 7.1 Hz), 7.44-
7.63 (3H, m), 7.30 (2H, d, J = 8.4 Hz), 7.19 (2H, d, J = 8.4 Hz), 5.71 (1H, t, J = 4.0 Hz), 
4.70 (2H, s), 4.73 (1H, dt, J = 4.3, 10.7 Hz), 3.03-3.08 (1H, m), 2.62 (1H, dd, J = 10.6, 
14.3 Hz), 2.44 (1H, d, J = 3.1 Hz), 2.26 (1H, dd, J = 3.1, 14.3 Hz), 1.79-1.86 (1H, m), 
1.57 (3H, s), 1.40-1.50 (3H, m), 1.34 (3H, s), 1.30 (9H, s), 1.28-1.34 (2H, m), 1.20 (3H, 
s), 0.86-0.98 (2H, m), 0.72 (3H, d, J = 6.4 Hz); 
13
C {
1
H} NMR (CDCl3): δ 173.6, 148.0, 
147.8, 143.3, 137.0, 134.0, 130.5, 129.3, 128.6, 126.5, 125.8, 125.5, 125.4, 125.0, 124.7, 
123.2, 112.7, 76.1, 71.8, 50.9, 50.4, 41.1, 40.0, 34.7, 34.5, 31.6, 31.3. 29.4, 27.4, 24.8, 
22.8, 21.9; HRMS (FAB, MNa
+
) calcd for C37H48O3Na: 563.3501. Found 563.3489.  
 
(4S,6S,E)-(1R,2R,5R)-2-(2-(4-(tert-butyl)phenyl)propan-2-yl)-5-methylcyclohexyl-6-
cyclohexyl-6-hydroxy-4-methylhex-2-enoate (2.209a) and (1R,2R,5R)-2-(2-(4(tert-
butyl)phenyl)propan-2-yl)-5-methylcyclohexyl-2-(cyclohexyl(hydroxy)methyl)-4-
methylpent-4-enoate (2.209b): Cyclohexanecarboxaldehyde 2.209 (0.20 mmol, 24 µL), 
Ni(acac)2 (0.02 mmol, 0.005 g), diethylzinc (1.0 M solution in hexanes, 0.48 mmol, 0.48 
mL), and pentadienoate 2.195c (0.40 mmol, 0.153 g) were reacted in dry THF (2 mL) 
following the general procedure of homoallylation to afford two regioisomers  2.209a 
and 2.209b as a colorless liquid (rr, 5:1) (0.062 g, combined yield 70%).  
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2.209a: IR (neat, NaCl) 3475, 2952, 1708 cm
-1
; 
1
H NMR (CDCl3): δ 7.21 (2H, d, J = 8.4 
Hz), 7.11 (2H, d, J = 8.4 Hz), 6.74 (1H, dd, J = 7.8, 15.7 Hz), 5.21 (1H, dd, J = 1.1, 15.7 
Hz), 4.78 (1H, dt, J = 4.3, 10.7 Hz), 3.34 (1H, m), 2.36 (1H, app sep, J = 7.1 Hz), 1.81-
1.94 (2H, m), 1.66-1.73 (3H, m), 1.47-1.61 (5H, m), 1.28-1.45 (5H, m), 1.24 (9H, s), 
1.20-1.24 (1H, m), 1.22 (3H, s), 1.13-1.17 (1H, m), 1.15 (3H, s), 0.88-0.98 (4H, m), 0.97 
(3H, d, J = 6.8 Hz), 0.73-0.79 (1H, m), 0.78 (3H, d, J = 6.4 Hz); 
13
C {
1
H} NMR (CDCl3): 
δ 166.4, 154.5, 148.5, 147.7, 125.3, 124.9, 120.0, 74.6, 73.8, 50.8, 44.2, 42.0, 40.6, 39.7, 
34.8, 34.4, 33.4, 31.6, 31.5, 29.4, 27.7, 26.7, 26.5, 26.4, 22.0, 18.7; HRMS (FAB, MNa
+
) 
calcd for C33H52O3Na: 519.3814. Found 519.3816. 
2.209b: IR (neat, NaCl) 3436, 2957, 1722 cm
-1
; 
1
H NMR (CDCl3): δ 7.21 (2H, d, J = 8.4 
Hz), 7.11 (2H, d, J = 8.4 Hz), 4.70 (1H, dt, J = 4.1, 10.7 Hz), 4.70 (2H, s), 3.37 (1H, t, J 
= 7.4 Hz), 2.28-2.54 (1H, m), 2.37 (1H, app dd, J = 10.8, 14.1 Hz), 2.07-2.14 (1H, m), 
1.81-1.97 (4H, m), 1.67 (3H, s), 1.59-1.73 (3H, m), 1.42-1.49 (4H, m), 1.27-1.37 (2H, 
m), 1.23 (9H, s), 1.22 (3H, s), 1.13 (3H, s), 1.07-1.14 (3H, m), 0.84-1.03 (4H, m), 0.78 
(3H, d, J = 6.4 Hz); 
13
C {
1
H} NMR (CDCl3): δ 174.5, 147.9, 143.6, 125.4, 124.9, 112.8, 
77.4, 76.1, 50.4, 47.3, 41.6, 40.8, 39.9, 34.8, 34.4, 34.3, 31.6, 31.5, 29.7, 28.9, 28.1, 27.4, 
26.5, 26.4, 26.1, 25.0, 23.0, 22.0; HRMS (FAB, MNa
+
) calcd for C33H52O3Na: 519.3814. 
Found 519.3822.  
 
(4S,6R,E)-(1R,2R,5R)-2-(2-(4-(tert-butyl)phenyl)propan-2-yl)-5-methylcyclohexyl-6-
hydroxy-4-methyldec-2-enoate (2.210a) and (1R,2R,5R)-2-(2-(4-(tert-
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butyl)phenyl)propan-2-yl)-5-methylcyclohexyl-3-hydroxy-2-(2-methylallyl) 
heptanoate (2.210b): Pentanal 2.210 (0.10 mmol, 11 µL), Ni(acac)2 (0.01 mmol, 0.003 
g), diethylzinc (1.0 M solution in hexanes, 0.24 mmol, 0.24 mL), and pentadienoate 
2.195c (0.20 mmol, 0.076 g) were reacted in dry THF (1 mL) following the general 
procedure of homoallylation to afford two regioisomers  2.210a and 2.210b as a colorless 
liquid (rr, 2:1) (0.037 g, combined yield 79%).  
2.210a: IR (neat, NaCl) 3471, 2965, 1715 cm
-1
; 
1
H NMR (CDCl3): δ 7.19 (2H, d, J = 8.5 
Hz), 7.10 (2H, d, J = 8.5 Hz), 6.71 (1H, dd, J = 7.9, 15.7 Hz), 5.19 (1H, dd, J = 0.9, 15.7 
Hz), 4.78 (1H, dt, J = 4.3, 10.6 Hz), 3.52-3.58 (1H, m), 2.38 (1H, app sep, J = 7.1 Hz), 
1.83-1.97 (2H, m), 1.12-1.55 (14H, m), 1.24 (9H, s), 1.22 (3H, s), 1.15 (3H, s), 0.75-1.03 
(4H, m), 0.98 (3H, d, J = 6.8 Hz), 0.78 (3H, d, J = 6.4 Hz); 
13
C {
1
H} NMR (CDCl3): δ 
166.3, 154.2, 148.5, 147.7, 125.3, 124.9, 120.2, 74.6, 69.7, 50.8, 43.8, 42.0, 39.7, 37.7, 
34.8, 34.4, 33.5, 31.7, 31.5, 27.9, 27.0, 26.9, 26.6, 22.9, 22.0, 19.2; HRMS (FAB, MNa
+
) 
calcd for C31H50O3Na: 493.3658. Found 493.3662. 
2.210b: IR (neat, NaCl) 3474, 2969, 1722 cm
-1
; 
1
H NMR (CDCl3): δ 7.22 (2H, d, J = 8.5 
Hz), 7.11 (2H, d, J = 8.5 Hz), 4.73 (1H, dt, J = 4.1, 10.8 Hz), 4.70 (1H, s), 4.67 (1H, s), 
3.45-3.55 (1H, m), 2.18-2.36 (2H, m), 1.86-2.07 (4H, m), 1.65 (3H, s), 1.10-1.53 (8H, 
m), 1.23 (12H, s), 1.10 (3H, s), 0.68-0.98 (7H, m), 0.77 (3H, d, J = 6.6 Hz); 
13
C {
1
H} 
NMR (CDCl3): δ 173.7, 148.2, 148.0, 143.3, 125.3, 125.0, 112.7, 76.0, 72.4, 50.5, 49.7, 
41.7, 39.7, 35.0, 34.8, 34.4, 33.7, 31.6, 31.5, 28.4, 27.6, 27.2, 26.2, 22.8, 22.0, 14.2; 
HRMS (FAB, MNa
+
) calcd for C31H50O3Na: 493.3658. Found 493.3666. 
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(4S,6R,E)-(1R,2R,5R)-2-(2-(4-(tert-butyl)phenyl)propan-2-yl)-5-methylcyclohexyl-6-
hydroxy-4,7-dimethyloct-2-enoate (2.211a) and (1R,2R,5R)-2-(2-(4-(tert-
butyl)phenyl)propan-2-yl)-5-methylcyclohexyl-2-(1-hydroxy-2-methylpropyl)-4-
methylpent-4-enoate (2.211b): 2-Methylpropanal 2.211 (0.10 mmol, 9 µL), Ni(acac)2 
(0.01 mmol, 0.003 g), diethylzinc (1.0 M solution in hexanes, 0.24 mmol, 0.24 mL), and 
pentadienoate 2.195c (0.20 mmol, 0.076 g) were reacted in dry THF (1 mL) following the 
general procedure of homoallylation to afford two regioisomers 2.211a and 2.211b as a 
colorless liquid (rr, 6:1) (0.035 g, combined yield 76%).  
2.211a: IR (neat, NaCl) 3505, 2950, 1703 cm
-1
; 
1
H NMR (CDCl3): δ 7.19 (2H, d, J = 8.5 
Hz), 7.10 (2H, d, J = 8.5 Hz), 6.73 (1H, dd, J = 7.8, 15.7 Hz), 5.22 (1H, dd, J = 1.1, 15.7 
Hz), 4.78 (1H, dt, J = 4.3, 10.7 Hz), 3.32-3.41 (1H, m), 2.40 (1H, app sep, J = 6.9 Hz), 
1.83-1.94 (2H, m), 1.49-1.60 (3H, m), 1.36-1.48 (2H, m), 1.27-1.33 (3H, m), 1.24 (9H, 
s), 1.23 (3H, s), 0.98 (3H, d, J = 6.7 Hz), 0.73-0.88 (2H, m), 0.83 (3H, d, J = 6.7 Hz), 
0.82 (3H, d, J = 6.7 Hz), 0.78 (3H, d, J = 6.4 Hz); 
13
C {
1
H} NMR (CDCl3): δ 166.3, 
154.4, 148.5, 147.6, 125.3, 124.8, 120.0, 74.6, 74.2, 50.8, 42.0, 40.6, 39.7, 34.8, 34.4, 
34.0, 33.5, 31.6, 31.5, 27.0, 26.8, 26.7, 22.0, 18.9, 18.8, 17.1; HRMS (FAB, MNa
+
) calcd 
for C30H48O3Na: 479.3501. Found 479.3505. 
2.211b: IR (neat, NaCl) 3456, 2958, 1710 cm
-1
; 
1
H NMR (CDCl3): δ 7.20 (2H, d, J = 8.5 
Hz), 7.11 (2H, d, J = 8.5 Hz), 4.70 (1H, dt, J = 4.1, 10.8 Hz), 4.71 (1H, s), 4.70 (1H, s), 
3.33 (1H, app q, J = 4.6 Hz), 2.48-2.54 (1H, m), 2.36 (1H, dd, J = 10.6, 14.1 Hz), 2.12 
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(1H, dd, J = 2.9, 14.1 Hz), 1.86-1.98 (4H, m), 1.67 (3H, s), 1.59-1.63 (1H, m), 1.19-1.44 
(3H, m), 1.25 (3H, s), 1.23 (9H, s), 1.13 (3H, s), 0.74-0.94 (2H, m), 0.90 (3H, d, J = 6.6 
Hz), 0.82 (3H, d, J = 6.8 Hz), 0.78 (3H, d, J = 6.4 Hz); 
13
C {
1
H} NMR (CDCl3): δ 174.4, 
148.1, 148.0, 143.6, 125.5, 125.0, 112.9, 77.8, 76.2, 50.5, 47.9, 41.5, 40.0, 34.9, 34.3, 
31.6, 31.5, 31.4, 29.0, 27.5, 25.0, 23.0, 22.0, 19.8, 17.9; HRMS (FAB, MNa
+
) calcd for 
C30H48O3Na: 479.3501. Found 479.3520. 
 
(4S,6S,E)-(1R,2R,5R)-2-(2-(4-(tert-butyl)phenyl)propan-2-yl)-5-methylcyclohexyl-6-
hydroxy-4,7,7-trimethylhept-2-enoate (2.212a): 2,2-Dimethylpropanaldehyde 2.212 
(0.10 mmol, 11 µL), Ni(acac)2 (0.01 mmol, 0.003 g), diethylzinc (1.0 M solution in 
hexanes, 0.24 mmol, 0.24 mL), and pentadienoate 2.195c (0.20 mmol, 0.076 g) were 
reacted in dry THF (1 mL) following the general procedure of homoallylation to afford 
single regioisomer 2.212a as a colorless liquid (0.033 g, 70%).  
IR (neat, NaCl) 3501, 2957, 1715 cm
-1
; 
1
H NMR (CDCl3): δ 7.29 (2H, d, J = 8.4 Hz), 
7.21 (2H, d, J = 8.4 Hz), 6.85 (1H, dd, J = 7.6, 15.7 Hz), 5.35 (1H, d, J = 15.7 Hz), 4.88 
(1H, dt, J = 4.3, 10.7 Hz), 3.30 (1H, app dd, J = 3.5, 8.5 Hz), 2.51 (1H, app sep, J = 7.0 
Hz), 1.93-2.04 (2H, m), 1.54-1.63 (2H, m), 1.40-1.47 (4H, m), 1.33 (9H, s), 1.32 (3H, s), 
1.25 (3H, s), 1.07 (3H, d, J = 6.7 Hz), 0.98-1.06 (2H, m), 0.90 (9H, s), 0.85-0.89 (1H, m), 
0.88 (3H, d, J = 6.4 Hz); 
13
C {
1
H} NMR (CDCl3): δ 166.4, 154.7, 148.5, 147.7, 125.3, 
124.9, 119.8, 77.4, 74.6, 50.8, 42.0, 39.7, 38.0, 35.1, 34.8, 34.4, 33.6, 31.6, 31.5, 27.0, 
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26.8, 25.8, 22.0, 18.3; HRMS (FAB, MNa
+
) calcd for C31H50O3Na: 493.3658. Found 
493.3651. 
 
(1R,2R,5R)-2-(2-(4-(tert-butyl)phenyl)propan-2-yl)-5-methylcyclohexyl-2-
((2R,3S,5S)-3-methyl-5-phenyltetrahydrofuran-2-yl)acetate (2.213): To a stirred 
solution of bis-homoallylic alcohol 2.200a (0.035 mmol, 0.017 g) in freshly distilled 
CH2Cl2 at 0 
o
C was added 1,8-diazabicyclo[5.4.0]-undec-7-ene, DBU (0.038 mmol, 6 
µL). The resulting solution was stirred at 0 
o
C for 1 h and then at room temperature for 
another 1h (TLC analysis). The reaction was quenched with few drops of saturated aq. 
NH4Cl solution and extracted with EtOAc (5 mL, 3X). The combined organic layers were 
separated and washed with brine solution (5 mL, 1X), dried over anhydrous Na2SO4 and 
concentrated in vacuo. The crude product was purified by column chromatography (SiO2, 
hexanes:EtOAc) to afford 2.213 as a colorless liquid (0.016 g, 94%).  
IR (neat, NaCl) 2958, 1723 cm
-1
; 
1
H NMR (CDCl3): (major isomer) δ 7.22-7.32 (9H, m), 
4.94 (1H, dd, J = 6.2, 9.6 Hz), 4.86 (1H, dt, J = 4.3, 10.7 Hz), 3.88-3.95 (1H, m), 2.48 
(1H, app quin, J = 3.1 Hz), 2.00-2.07 (4H, m), 1.94 (1H, dd, J = 7.7, 15.2 Hz), 1.71-1.75 
(1H, m), 1.63-1.69 (1H, m), 1.45-1.53 (2H, m), 1.34 (9H, s), 1.32 (3H, s), 1.22 (3H, s), 
0.94-1.16 (3H, s), 1.03 (3H, d, J = 6.5 Hz), 0.86 (3H, d, J = 6.6 Hz); 
13
C {
1
H} NMR 
(CDCl3): δ 171.1, 148.8, 147.6, 144.1, 128.4, 127.1, 125.5, 125.2, 124.9, 82.3, 79.7, 74.6, 
50.4, 44.5, 42.0, 40.6, 39.6, 39.4, 34.8, 34.4, 31.6, 31.5, 28.6, 26.7, 24.8, 22.0, 16.7; 
HRMS (FAB, MNa
+
) calcd for C33H46O3Na: 513.3344. Found 513.3348. 
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(1S,3S)-1-((2R,5R,6R)-5,6-dimethoxy-5,6-dimethyl-1,4-dioxan-2-yl)-3-methylpent-4-
en-1-ol (2.222a) and (1R,3R)-1-((2R,5R,6R)-5,6-dimethoxy-5,6-dimethyl-1,4-dioxan-
2-yl)-3-methylpent-4-en-1-ol (2.222b): Ni(acac)2 (0.008 g, 0.030 mmol), isoprene (0.12 
mL, 1.200 mmol), R-aldehyde 2.216 (0.061 g, 0.300 mmol), Et3B (1.0 M solution in 
hexanes, 0.720 mmol) were reacted in dry THF (2 mL) following the general procedure 
for homoallylation to afford two diastereomers 2.222a and 2.222b as a colorless liquid 
(dr 3:1) (0.047 g, combined yield 57%). 
2.222a: IR (neat, NaCl) 3464, 2941, 1120 cm
-1
; 
1
H NMR (CDCl3): δ 5.77 (1H, ddd, J = 
7.9, 10.2, 17.7 Hz), 4.92-5.06 (2H, m), 3.71-3.86 (3H, m), 3.55 (1H, dd, J = 1.7, 10.1 
Hz), 3.26 (6H, s), 2.35 (1H, app sep, J = 7.2 Hz), 2.20 (1H, d, J = 2.5 Hz), 1.38-1.48 (2H, 
m), 1.29 (6H, s), 1.01 (3H, d, J = 6.7 Hz), 
13
C {
1
H} NMR (CDCl3): δ 144.8, 113.0, 99.3, 
97.9, 70.3, 69.6, 59.3, 48.0, 38.9, 35.0, 19.9, 17.8, 17.6; HRMS (FAB, MNa) calcd for 
C14H26O5Na: 297.1678. Found 297.1689. 
2.222b: IR (neat, NaCl) 3489, 2966, 1135 cm
-1
; 
1
H NMR (CDCl3): δ 5.75 (1H, ddd, J = 
7.3, 10.3, 17.4 Hz), 4.89-5.01(2H, m), 3.66-3.78 (2H, m), 3.49-3.61 (1H, m), 3.42 (1H, 
dd, J = 1.4, 9.4 Hz), 3.27 (3H, s), 3.26 (3H, s), 2.41 (1H, app sep, J = 6.9 Hz), 2.38 (1H, 
d, J = 5.2 Hz), 1.55-1.64 (1H, m), 1.30 (3H, s), 1.28 (3H, s), 1.15-1.1.23 (1H, m), 1.00 
(3H, d, J = 6.7 Hz); 
13
C {
1
H} NMR (CDCl3): δ 144.8, 112.7, 99.3, 98.1, 70.4, 68.8, 60.6, 
48.3, 39.4, 33.9, 19.2, 17.9, 17.7; HRMS (FAB, MNa) calcd for C14H26O5Na: 297.1678. 
Found 297.1672. 
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 (4S,6S,E)-tert-butyl-6-((2R,5R,6R)-5,6-dimethoxy-5,6-dimethyl-1,4-dioxan-2-yl)-6-
hydroxy-4-methylhex-2-enoate (2.224a) and (4R,6R,E)-tert-butyl-6-((2R,5R,6R)-5,6-
dimethoxy-5,6-dimethyl-1,4-dioxan-2-yl)-6-hydroxy-4-methylhex-2-enoate (2.224b): 
Ni(acac)2 (0.006 g, 0.025 mmol), pentadienoate 2.223 (0.084 g, 0.500 mmol), R-aldehyde 
2.216 (0.051 g, 0.250 mmol), and ZnEt2 (1.0 M solution in hexane, 0.620 mmol) were 
reacted in dry THF (1.5 mL) following the general procedure for homoallylation to afford 
two diastereomers 2.224a and 2.224b as a colorless liquid (dr 3:1) (0.041 g, combined 
yield 44%). 
2.224a IR (neat, NaCl) 3478, 2946, 1707, 1641 cm
-1
; 
1
H NMR (CDCl3): δ 6.81 (1H, dd, J 
= 7.7, 15.7 Hz), 5.73 (1H, dd, J = 1.2, 15.7 Hz), 3.70-3.85 (3H, m), 3.53  (1H, dd, J = 1.7, 
10.1 Hz), 3.26 (6H, s), 2.55 (1H, app sep, J = 6.8 Hz), s), 2.06 (1H, d, J = 2.6 Hz), 1.47 
(9H, s), 1.40-1.50 (1H, m), 1.28 (6H, s), 1.25-1.32 (1H, m), 1.07 (3H, d, J = 6.7 Hz), 
13
C 
{
1
H} NMR (CDCl3): δ 166.4, 153.0, 121.5, 99.5, 98.1, 80.4, 69.9, 69.6, 59.3, 48.3, 48.2, 
38.3, 32.9, 28.3 (3C), 18.6, 17.9, 17.7; HRMS (FAB, MNa) calcd for C19H34O7Na: 
397.2202. Found 397.2200. 
2.224b IR (neat, NaCl) 3486, 2969, 1707, 1645 cm
-1
; 
1
H NMR (CDCl3): δ 6.83 (1H, dd, 
J = 7.3, 15.7 Hz), 5.73 (1H, dd, J = 1.3, 15.7 Hz), 3.68-3.74 (2H, m), 3.57-3.63 (1H, m), 
3.44 (1H, dd, J = 1.8, 6.2 Hz), 3.29 (3H, s), 3.28 (3H, s), 2.59-2.66 (1H, m), 2.37 (1H, d, 
J = 5.3 Hz), 1.67-1.75 (1H, m), 1.49 (9H, s), 1.32 (3H, s), 1.30 (3H, s), 1.14-1.23 (1H, 
m), 1.07 (3H, d, J = 6.7 Hz); 
13
C {
1
H} NMR (CDCl3): δ 166.5, 153.2, 121.4, 99.4, 98.2, 
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80.4, 70.6, 68.4, 60.6, 48.3 (2C), 38.8, 32.3, 28.4 (3C), 18.2, 18.0, 17.7. HRMS (FAB, 
MNa) calcd for C19H34O7Na: 397.2202. Found 397.2209. 
 
(4S,6S,E)-(1R,2S,5R)-2-(2-(tert-butyl)phenyl)propan-2-yl)-5-methylcyclohexyl-6-
((2R,5R,6R)-5,6-dimethoxy-5,6-dimethyl-1,4-dioxan-2-yl)-6-hydroxy-4-methylhex-2-
enoate (2.226a) and (4R,6R,E)-(1R,2S,5R)-2-(2-(tert-butyl)phenyl)propan-2-yl)-5-
methylcyclohexyl-6-((2R,5R,6R)-5,6-dimethoxy-5,6-dimethyl-1,4-dioxan-2-yl)-6-
hydroxy-4-methylhex-2-enoate (2.226b): Ni(acac)2 (0.003 g, 0.010 mmol), chiral 
pentadienoate 2.225 (0.076 g, 0.200 mmol), aldehyde 2.216 (0.020 g, 0.100 mmol), and 
Et2Zn (1.0 M solution in hexanes, 0.240 mmol) were reacted in dry THF (1 mL) 
following the general procedure for homoallylation to afford two diastereomers 2.226a 
and 2.226b as a colorless liquid (dr 5:1) (0.041 g, combined yield 69%). 
 2.226a: IR (neat, NaCl) 3517, 2970, 1711, 1642 cm
-1
; 
1
H NMR (CDCl3): δ 7.27 (2H, d, J 
= 8.5 Hz), 7.17 (2H, d, J = 8.5 Hz), 6.78 (1H, dd, J = 8.0, 15.7 Hz), 5.30 (1H, dd, J = 0.7, 
15.7 Hz), 4.85 (1H, dt, J = 4.3, 10.6 Hz), 3.69-3.85 (3H, m), 3.51 (1H, dd, J = 1.8, 10.3 
Hz), 3.26 (3H, s), 3.25 (3H, s), 2.48 (1H, app sep, J = 7.1 Hz), 1.90-2.01 (3H, m), 1.48-
1.62 (3H, m), 1.43-1.48 (3H, m), 1.31 (9H, s), 1.30 (3H, s), 1.29 (6H, s), 1.22 (3H, s), 
1.06 (3H, d, J = 6.6 Hz), 0.89-1.02 (2H, m), 0.86 (3H, d, J = 6.4 Hz); 
13
C {
1
H} NMR 
(CDCl3): δ 166.2, 153.7, 148.4, 147.7, 125.3, 124.8, 120.4, 99.5, 98.1, 74.6, 69.9, 69.6, 
59.3, 50.8, 48.23, 48.21, 41.9, 39.6, 38.3, 34.8, 34.4, 33.2, 31.6, 31.5, 26.9, 26.7, 22.0, 
18.7, 17.9, 17.7; HRMS (FAB, MNa) calcd for C35H56O7Na: 611.3924. Found 611.3934. 
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2.226b: IR (neat, NaCl) 3468, 2945, 1711, 1646 cm
-1
; 
1
H NMR (CDCl3): δ 7.27 (2H, d, J 
= 8.2 Hz), 7.18 (2H, d, J = 8.5 Hz), 6.81 (1H, dd, J = 7.4, 15.7 Hz), 5.35 (1H, dd, J = 1.1, 
15.7 Hz), 4.86 (1H, dt, J = 4.3, 10.7 Hz), 3.70-3.73 (2H, m), 3.52-3.60 (1H, m), 3.39-3.44 
(1H, m), 3.29 (3H, s), 3.28 (3H, s), 2.55-2.61 (1H, m), 2.36 (1H, broad J = 3.3 Hz), 1.92-
2.00 (2H, m), 1.40-1.64 (6H, m), 1.32 (9H, s), 1.31 (6H, s), 1.26 (3H, s), 1.23 (3H, s), 
0.96-1.09 (2H, m), 1.02 (3H, d, J = 6.7 Hz), 0.86 (3H, d, J = 6.4 Hz); 
13
C {
1
H} NMR 
(CDCl3): δ 166.4, 154.0, 148.3, 147.7, 125.3, 124.9, 120.1, 99.3, 98.2, 74.7, 70.7, 68.3, 
60.5, 50.8, 48.3, 42.0, 39.7, 38.6, 34.8, 34.4, 32.2, 31.6, 31.5, 29.9, 27.3, 27.0, 22.0, 
18.01, 17.96, 17.7. 
 
(4S,6S,E)-methyl-6-((2R,5R,6R)-5,6-dimethoxy-5,6-dimethyl-1,4-dioxan-2-yl)-6-
hydroxy-4-methylhex-2-enoate (2.228): Grubbs second generation catalyst (0.024 g, 
0.028 mmol), copper iodide (0.008 g, 0.040 mmol), bis-homoallylic alcohol 2.222a 
(0.110 g, 0.400 mmol) and methyl acrylate 2.227 (0.11 mL, 1.200 mmol) were reacted in 
dry CH2Cl2 (4 mL) following the general procedure to afford 2.228 as a colorless liquid 
(0.088 g, 66%). 
IR (neat, NaCl) 3468, 2941, 1728, 1654 cm
-1
; 
1
H NMR (CDCl3): δ 6.92 (1H, dd, J = 7.7, 
15.7 Hz), 5.80 (1H, dd, J = 1.2, 15.7 Hz), 3.69-3.84 (3H, m), 3.71 (3H, s), 3.52 (1H, dd, J 
= 1.8, 10.1 Hz), 3.25 (6H, s), 2.58 (1H, app sep, J = 6.7 Hz), 2.20 (1H, d, J = 3.1 Hz), 
1.45-1.51 (2H, m), 1.271 (3H, s), 1.270 (3H, s), 1.07 (3H, d, J = 6.7 Hz); 
13
C NMR 
(CDCl3): δ 167.4, 154.6, 119.3, 99.4, 98.1, 70.0, 69.5, 59.3, 51.6, 48.22, 48.17, 38.2, 
33.1, 18.5, 17.9, 17.7; HRMS (FAB, MNa) calcd for C16H28O7Na: 355.1733. Found 
355.1728. 
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Methyl-2-((2R,3S,5S)-5-((2R,5R,6R)-5,6-dimethoxy-5,6-dimethyl-1,4-dioxan-2-yl)-3-
methyltetrahydrofuran-2-yl)acetate (2.229a): To a small piece of sodium under argon 
was added 0.5 mL of dry methanol and then a solution of 2.228 (0.076 g, 0.23 mmol) in 
dry methanol was added on it. TLC analysis after 10 min showed the reaction was 
complete. Ethyl acetate (5 mL) was added followed by 0.5 mL of saturated aq. NH4Cl 
solution, the layers separated, the aq. layer extracted with EtOAc (5 mL, 3X), the 
combined organic layers were washed with brine, dried over anhydrous Na2SO4 and 
concentrated in vacuo. The crude product was purified by column chromatography (SiO2, 
hexanes:EtOAc) to isolate 2.229a as a colorless liquid (0.061 g, 81 %).  
IR (neat, NaCl) 2953, 1744 cm
-1
; 
1
H NMR (CDCl3) δ 3.69-3.89 (3H, m), 3.66 (3H, s), 
3.52-3.65 (2H, m), 3.26 (3H, s), 3.24 (3H, s), 2.50 (1H, dd, J = 4.5, 14.9 Hz), 2.41 (1H, 
dd, J = 7.9, 14. 9 Hz), 2.31 (1H, td, J = 7.1, 12. 4 Hz), 1.83-1.94 (1H, m), 1.43-1.54 (1H, 
m) , 1.26 (6H, s), 1.02 (3H, d, J = 6.6 Hz); 
13
C NMR (CDCl3) δ 171.8, 99.1, 98.1, 81.9, 
77.6, 70.3, 62.1, 51.8, 48.11, 48.06, 39.6, 39.2, 38.0, 18.0, 17.7, 16.6; HRMS (FAB, 
MNa) calcd for C16H28O7Na: 355.1733. Found 355.1736. Optical rotation: -135.5 (c = 
0.65, CHCl3). 
 
Methyl-2-((2R,3S,5S)-5-((2R,5R,6R)-5,6-dimethoxy-5,6-dimethyl-1,4-dioxan-2-yl)-3-
methyltetrahydrofuran-2-yl)acetate (2.229b): To a small piece of sodium under argon 
was added 0.5 mL of dry methanol and then a solution of 2.226a (0.011 g, 0.019 mmol) 
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in dry methanol was added. After stirring for 10 min at rt., the reaction mixture was 
refluxed for a total 2 h. The mixture was then cooled down to rt, diluted with 5 mL 
EtOAc and acidified with 1M HCl (pH 0-1), the layers separated, the aq. layer extracted 
with EtOAc (5 mL, 3X), the combined organic layers were with brine, dried over 
anhydrous Na2SO4 and concentrated in vacuo. To this crude product was added 0.5 mL 
each of dry methanol and dry ether and stirred for 2 minutes at rt before adding 10 µL of 
TMS diazomethane (2.0 M solution in diethyl ether). The reaction was complete in 20 
min (TLC analysis). The solvents were evaporated and the crude product was purified by 
column chromatography (SiO2, hexanes:EtOAc) to give 2.229a as a colorless liquid 
(0.005 g, 79 %). 
IR, proton and carbon spectra: same as 2.229a 
Optical rotation: -116.1 (c = 0.15, CHCl3) 
 
(1R,3R)-1-((2S,5S,6S)-5,6-dimethoxy-5,6-dimethyl-1,4-dioxan-2-yl)-3-methylpent-4-
en-1-ol (2.230a) and (1S,3S)-1-((2S,5S,6S)-5,6-dimethoxy-5,6-dimethyl-1,4-dioxan-2-
yl)-3-methylpent-4-en-1-ol (2.230b): Ni(acac)2 (0.026 g, 0.10 mmol), isoprene (0.4 mL, 
4.00 mmol), aldehyde 2.221 (0.204 g, 1.00 mmol), and Et3B (1.0 M solution in hexanes, 
2.40 mmol) were reacted in dry THF (5 mL) following the general procedure for 
homoallylation to afford two diastereomers 2.230a and 2.230b as a colorless liquid (dr 
3:1) (0.274 g, combined yield 89%). 
2.230a: IR (neat, NaCl) 3472, 2913, 1127 cm
-1
; 
1
H NMR (CDCl3): δ 5.77 (1H, ddd, J = 
7.9, 10.2, 17.5 Hz), 4.91-5.06 (2H, m), 3.70-3.85 (3H, m), 3.55 (1H, dd, J = 1.9, 10.2 
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Hz), 3.25 (6H, s), 2.34 (1H, app sep, J = 7.1 Hz), 2.21 (1H, broad s), 1.42-1.47 (2H, m), 
1.28 (3H, s), 1.27 (3H, s), 1.01 (3H, d, J = 6.7 Hz), 
13
C {
1
H} NMR (CDCl3): δ 145.0, 
113.2, 99.4, 98.1, 70.4, 69.7, 59.5, 48.2, 39.0, 35.1, 20.1, 17.9, 17.7; HRMS (FAB, MNa) 
calcd for C14H26O5Na: 297.1678. Found 297.1670. 
2.230b: IR (neat, NaCl) 3575, 2970, 1266 cm
-1
; 
1
H NMR (CDCl3): δ 5.76 (1H, ddd, J = 
7.3, 10.3, 17.4 Hz), 4.89-5.02 (2H, m), 3.67-3.79 (2H, m), 3.55-3.60 (1H, m), 3.43 (1H, 
dd, J = 1.4, 9.4 Hz), 3.28 (3H, s), 3.26 (3H, s), 2.42 (1H, app sep, J = 7.2 Hz), 2.41 (1H, 
broad s), 1.55-1.65 (1H, m), 1.31 (3H, s), 1.28 (3H, s), 1.16-1.26 (1H, m), 1.00 (3H, d, J 
= 6.7 Hz); 
13
C {
1
H} NMR (CDCl3): δ 144.8, 112.7, 99.3, 98.1, 70.4, 68.8, 60.6, 48.3, 
39.4, 33.9, 19.2, 18.0, 17.7; HRMS (FAB, MNa) calcd for C14H26O5Na: 297.1678. Found 
297.1687. 
 
(4S,6S,E)-(1R,2S,5R)-2-(2-(tert-butyl)phenyl)propan-2-yl)-5-methylcyclohexyl-6-
((2S,5S,6R)-5,6-dimethoxy-5,6-dimethyl-1,4-dioxan-2-yl)-6-hydroxy-4-methylhex-2-
enoate (2.231a) and (4R,6R,E)-(1R,2S,5R)-2-(2-(tert-butyl)phenyl)propan-2-yl)-5-
methylcyclohexyl-6-((2S,5S,6S)-5,6-dimethoxy-5,6-dimethyl-1,4-dioxan-2-yl)-6-
hydroxy-4-methylhex-2-enoate (2.231b): Ni(acac)2 (0.003 g, 0.010 mmol), chiral 
pentadienoate 2.225 (0.076 g, 0.200 mmol), aldehyde 2.221 (0.020 g, 0.100 mmol), and 
Et2Zn (1.0 M solution in hexanes, 0.240 mmol) were reacted in dry THF (1 mL) 
following the general procedure for homoallylation to afford two diastereomers 2.231a 
and 2.231b as a colorless solid (dr 2:1) (0.031 g, combined yield 53%). 
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2.231a: IR (neat, NaCl) 3475, 2972, 1712, 1645 cm
-1
; 
1
H NMR (CDCl3): δ 7.26 (2H, d, J 
= 8.5 Hz), 7.17 (2H, d, J = 8.6 Hz), 6.78 (1H, dd, J = 7.6, 15.7 Hz), 5.29 (1H, dd, J = 1.2, 
15.7 Hz), 4.85 (1H, dt, J = 4.3, 10.7 Hz), 3.66-3.75 (2H, m), 3.50-3.59 (1H, m), 3.40-3.46 
(1H, m), 3.27 (6H, s), 2.50-2.62 (1H, m), 2.32 (1H, brd d, J = 3.3 Hz), 1.90-2.01 (2H, m), 
1.50-1.70 (6H, m), 1.31 (12H, s), 1.29 (6H, s), 1.22 (3H, s), 1.09-1.20 (1H, s), 1.05 (3H, 
d, J = 6.7 Hz), 0.89-1.02 (1H, m), 0.86 (3H, d, J = 6.3 Hz); 
13
C {
1
H} NMR (CDCl3): δ 
166.4, 153.9, 148.5, 147.7, 125.4, 124.9, 120.3, 99.4, 98.2, 74.7, 70.6, 68.4, 60.6, 50.8, 
48.3 (2H), 42.0, 39.7, 38.9, 34.9, 34.4, 32.5, 31.7, 31.5, 27.0, 26.9, 26.8, 22.0, 18.2, 18.0, 
17.7; HRMS (FAB, MNa) calcd for C35H56O7Na: 611.3924. Found 611.3928. 
2.231b: IR (neat, NaCl) 3497, 2962, 1711, 1646 cm
-1
; 
1
H NMR (CDCl3): δ 7.26 (2H, d, J 
= 8.5 Hz), 7.18 (2H, d, J = 8.6 Hz), 6.82 (1H, dd, J = 7.7, 15.7 Hz), 5.39 (1H, dd, J = 1.0, 
15.7 Hz), 4.86 (1H, dt, J = 4.3, 10.6 Hz), 3.71-3.86 (3H, m), 3.54 (1H, dd, J = 2.1, 10.5 
Hz), 3.27 (6H, s), 2.53 (1H, app sep, J = 7.1 Hz), 1.92-2.03 (3H, m), 1.38-1.61 (6H, m), 
1.31 (12H, s), 1.29 (6H, s), 1.22 (3H, s), 1.04 (3H, d, J = 6.7 Hz), 0.89-1.01 (2H, m), 0.85 
(3H, d, J = 6.4 Hz); 
13
C {
1
H} NMR (CDCl3): δ 166.3, 154.0, 148.3, 147.8, 125.4, 124.9, 
120.4, 99.6, 98.2, 74.8, 70.1, 69.6, 59.4, 50.9, 48.32, 48.26, 42.0, 39.8, 38.2, 34.9, 34.4, 
33.0, 31.7, 31.5, 27.6, 27.1, 26.2, 22.0, 18.6, 17.9, 17.8; HRMS (FAB, MNa) calcd for 
C35H56O7Na: 611.3824. Found 611.3929. 
 
(4R,6R,E)-methyl-6-((2S,5S,6S)-5,6-dimethoxy-5,6-dimethyl-1,4-dioxan-2-yl)-6-
hydroxy-4-methylhex-2-enoate (2.232a): Grubbs second generation catalyst (0.023 g, 
0.027 mmol), copper iodide (0.007 g, 0.038 mmol), bis-homoallylic alcohols 2.230a 
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(0.104 g, 0.380 mmol), and methyl acrylate 2.227 (0.10 mL, 1.140 mmol) were reacted in 
dry CH2Cl2 (3 mL) following the general procedure to afford 2.232a as a colorless oil 
(0.102 g, 81%).  
IR (neat, NaCl) 3464, 2945, 1715, 1654 cm
-1
; 
1
H NMR (CDCl3): δ 6.91 (1H, dd, J = 7.7, 
15.7 Hz), 5.78 (1H, dd, J = 1.2, 15.7 Hz), 3.68-3.79 (3H, m), 3.71 (3H, s), 3.51 (1H, dd, J 
= 1.8, 10.1 Hz), 3.23 (6H, s), 2.56 (1H, app sep, J = 6.7 Hz), 2.26 (1H, d, J = 3.4 Hz), 
1.44-1.50 (2H, m), 1.26 (3H, s), 1.25 (3H, s), 1.06 (3H, d, J = 6.7 Hz); 
13
C {
1
H} NMR 
(CDCl3): δ 167.4, 154.7, 119.3, 99.4, 98.1, 70.0, 69.5, 59.4, 51.6, 48.2, 48.1, 38.2, 33.0, 
18.5, 17.9, 17.7; HRMS (FAB, MNa) calcd for C16H28O7Na: 355.1733. Found 355.1729. 
 
 
Methyl-2-((2S,3R,5R)-5-((2S,5S,6S)-5,6-dimethoxy-5,6-dimethyl-1,4-dioxan-2-yl)-3-
methyltetrahydrofuran-2-yl)acetate (2.233a): The unsaturated ester 2.232a (0.100 g, 
0.300 mmol) and DBU (49 μL, 0.330 mmol) were reacted in dry CH2Cl2 (2 mL) 
following the general procedure for cyclization to give 2.233a as a colorless oil (0.094 g, 
94%). 
IR (neat, NaCl) 2962, 1736, 1113 cm
-1
; 
1
H NMR (CDCl3): δ 3.69-3.87 (3H, m), 3.65 (3H, 
s), 3.52-3.64 (2H, m), 3.26 (3H, s), 3.23 (3H, s), 2.50 (1H, dd, J = 4.5, 14.9 Hz), 2.41 
(1H, dd, J = 7.9, 14. 9 Hz), 2.29 (1H, td, J = 7.1, 12. 4 Hz), 1.83-1.94 (1H, m), 1.43-1.53 
(1H, m) , 1.25 (6H, s), 1.02 (3H, d, J = 6.7 Hz); 
13
C {
1
H} NMR (CDCl3): δ 171.8, 99.1, 
98.1, 81.9, 77.6, 70.3, 62.0, 51.8, 48.1, 48.0, 39.6, 39.2, 38.0, 18.0, 17.7, 16.6; HRMS 
(FAB, MNa) calcd for C16H28O7Na: 355.1733. Found 355.1742.  
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Optical rotation: + 124.6 (c = 0.65, CHCl3). 
 
(4S,6S,E)-methyl-6-((2S,5S,6S)-5,6-dimethoxy-5,6-dimethyl-1,4-dioxan-2-yl)-6-
hydroxy-4-methylhex-2-enoate (2.232b): Grubbs second generation catalyst (0.009 g, 
0.011 mmol), copper iodide (0.003 g, 0.015 mmol), bis-homoallylic alcohols 2.230b 
(0.041 g, 0.150 mmol), and methyl acrylate 2.227 (0.04 mL, 0.450 mmol) were reacted in 
dry CH2Cl2 (2 mL) following the general procedure to afford 2.232b as a colorless oil 
(0.039 g, 78%). 
IR (neat, NaCl) 3460, 2948, 1711, 1653 cm
-1
; 
1
H NMR (CDCl3): δ 6.93 (1H, dd, J = 7.4, 
15.7 Hz), 5.79 (1H, dd, J = 1.3, 15.7 Hz), 3.65-3.76 (2H, m), 3.71 (3H, s), 3.55-3.58 (1H, 
m), 3.41 (1H, dd, J = 1.9, 6.2 Hz), 3.27 (3H, s), 3.26 (3H, s), 2.60-2.69 ( 1H, m), 2.41 
(1H broad d, J = 3.5 Hz), 1.64-1.73 (1H, m), 1.30 (3H, s), 1.28 (3H, s), 1.13-1.24 ( 1H, 
m), 1.06 (3H, d, J = 6.7 Hz); 
13
C {
1
H} NMR (CDCl3): δ 167.5, 154.7, 119.2, 99.3, 98.1, 
70.6, 68.4, 60.5, 51.7, 48.3, 38.6, 32.5, 18.1, 17.9, 17.7; HRMS (FAB, MNa) calcd for 
C16H28O7Na: 355.1733. Found 355.1735. 
 
Methyl-2-((2R,3S,5S)-5-((2S,5S,6S)-5,6-dimethoxy-5,6-dimethyl-1,4-dioxan-2-yl)-3-
methyltetrahydrofuran-2-yl)acetate (2.233b): The unsaturated ester 2.232b (0.026 g, 
0.080 mmol) and DBU (13 μL, 0.088 mmol) were reacted in dry CH2Cl2 (1 mL) 
following the general procedure for cyclization to give 2.233b as a colorless oil (0.025 g, 
96%). 
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IR (neat, NaCl) 2954, 1728, 1123 cm
-1
; 
1
H NMR (CDCl3): δ 3.88-3.97 (1H, m), 3.77-3.86 
(2H, m), 3.64-3.71 (1H, m), 3.67 (3H, s), 3.37 (1H, dd, J = 2.8, 10.8 Hz), 3.28 (3H, s), 
3.25 (3H, s), 2.55 (1H, dd, J = 6.9, 15.1Hz), 2.49 (1H, dd, J = 5.5, 15.1 Hz), 1.96-2.09 
(1H, m), 1.88-1.94 (1H, m), 1.36-1.46 (1H, m), 1.29 (3H, s), 1.28 (3H, s), 1.03 (3H, d, J 
= 6.4 Hz); 
13
C {
1
H} NMR (CDCl3): δ 171.9, 99.2, 98.1, 81.5, 77.1, 70.0, 60.3, 51.8, 
48.14, 48.09, 39.7, 39.1, 36.3, 18.0, 17.8, 16.5; HRMS (FAB, MNa) calcd for 
C16H28O7Na: 355.1733. Found 355.1730.  
Optical rotation: +138.8 (c = 0.35, CHCl3)  
 
Methyl-2-((2R,3S,5S)-5-((2S,5S,6S)-5,6-dimethoxy-5,6-dimethyl-1,4-dioxan-2-yl)-3-
methyltetrahydrofuran-2-yl)acetate (2.233c): To a small piece of sodium under argon 
was added 0.5 mL of dry methanol and then a solution of 2.231a (0.015 g, 0.025 mmol) 
in dry methanol was added. After stirring for 10 min at rt, the reaction mixture was 
refluxed for a total 2 h. The mixture was then cooled to rt, diluted with 5 mL EtOAc and 
acidified with 1M HCl (pH 0-1), the layers separated, the aq. layer extracted with EtOAc 
(5 mL, 3X), the combined organic layers were washed with brine, dried over anhydrous 
Na2SO4 and concentrated in vacuo. To this crude product was added 0.5 mL each of dry 
methanol and dry ether and stirred for 2 minutes at rt before adding 10 µL of TMS 
diazomethane (2.0 M solution in diethyl ether). The reaction was complete in total 30 min 
(TLC analysis). The solvents were evaporated and the crude product was purified by 
column chromatography (SiO2, hexanes:EtOAc) to isolate 2.233c as colorless liquid 
(0.006 g, 75 %). 
Paudyal, Mahesh, 2012, UMSL, p.205 
 
 
IR, proton and carbon spectra: same as 2.233b 
Optical rotation: +146.6 (c = 0.15, CHCl3) 
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3. CHAPTER III 
Synthesis of Potent Inhibitors of YopH 
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3.1.     General objective 
Yersinia is the pathogenic bacteria causing human diseases ranging from gastrointestinal 
syndromes to bubonic plague.
1
 Yersinia pestis, one of the three species of genus Yersinia, 
is responsible for the bubonic plague. Also known as the Black Death, bubonic plague 
killed millions of people in the 15
th
 century in Europe.
2
  
The pathogenicity of Yersinia depends on the activity of a bacterial virulence factor 
known as Yersinia outer membrane protein H (YopH).
3
 YopH is homologous to 
eukaryotic protein tyrosine phosphatase (PTP) with potent tyrosine phosphatase activity.
4
 
In humans, protein tyrosine phosphatases (PTPs) constitute a large family of signaling 
enzymes. When YopH is secreted into the body, it disrupts signal transduction pathways 
by removing a phosphate group (dephosphorylation) from a variety of proteins including 
PTPs. This deregulates the PTP activity and decreases immune response. It has already 
been shown that blocking the YopH protein of this bacterium can render it avirulent. 
Therefore, the design and synthesis of potent and selective YopH inhibitors are of prime 
importance to serve as anti-plague agents. The general objective of this chapter of the 
thesis is to report the synthesis of YopH inhibitors and their activity against different 
PTPs including YopH.  
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3.2. Introduction 
Among the three species of genus Yersinia; Y. pestis, Y. enterocolitica and Y. 
pseudotuberculosis, Y. pestis is the most virulent and was responsible for the bubonic, 
pneumonic, and septicemic plague.
5
 Also known as the Black Death, the bubonic plague 
alone reduced the population of Europe by about 25 million in the 15
th
 century.
2
 The 
number of people killed by this bacterium during the course of human history approaches 
200 million.
6
 The plague had long been considered an eradicated disease until an 
outbreak in Surat, India.
7
 Moreover, this pathogen could be misused as a biological 
weapon and an agent for mass destruction in warfare.
8
 The World Health Organization 
(WHO) has recognized the plague as a re-emerging public health concern. 
Y. pestis contains a plasmid that encodes several of the bacterial virulence factors known 
as Yersinia outer membrane proteins (Yops); YopE, YopH, YopM, YopJ/P, YopT, and 
YpkA. This bacterium utilizes a contact-dependent (type III) secretion apparatus to inject 
these six cytotoxic effectors into the cytosol of mammalian cells.
9
 YopH, the most active 
virulence factor, is homologous to eukaryotic protein tyrosine phosphatase (PTP) and has 
potent tyrosine phosphatase activity.
4
  
Protein tyrosine phosphatases (PTPs) constitute a large family of signaling enzymes 
which are involved in the regulation of various cell functions including cell-cell 
interactions, growth, metabolism, neuronal development, and the gene transcription, 
amongst others.
10
 The opposing actions of protein tyrosine kinases (PTKs) and PTPs 
regulate the phosphorylation states of proteins in vivo: PTKs catalyze protein tyrosine 
phosphorylation and PTPs catalyze the dephosphorylation. Several PTKs, PTPs and 
tyrosine substrates form a family of signal transduction enzymes.  
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When YopH is injected into mammalian cells, it dephosphorylates a variety of proteins 
such as focal adhesion kinase and focal adhesion protein p130
Cas
. This deregulates the 
human PTP activity, disrupts the signal transduction processes, and disarms the immune 
responses. In general, deregulation of PTP activity increases the risk of numerous 
diseases including diabetes, cancer, and immune system dysfunction, amongst others.  
Since the PTPase activity is essential for the virulence of Yersinia,
4 
YopH is a valid 
molecular target for 
 
antiplague therapeutics. The specific inhibitors targeted to the 
Yersinia PTPs are expected to make the bacteria avirulent. Therefore, the design and 
synthesis of potent and selective YopH inhibitors is of prime importance to stop the 
spread of Y. pestis, and hence to serve as anti-plague agents. 
Based upon previous results,
11
 a series of salicylic acid derived ligands (inhibitors) were 
designed (Scheme 3.1). These bidentate ligands were designed to achieve higher binding 
affinity and specificity, and thus were expected to increase the inhibitory activity against 
YopH protein of Y. pestis. In this chapter, we report the synthesis of a number of 
heterocyclic building blocks 3.2 and coupling them to a wide variety of amines 3.3 using 
parallel chemistry to obtain the desired inhibitors. We also include the activity of these 
inhibitors towards different types of phosphotases, YopH of Y. pestis, PTP1B of humans, 
etc. 
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Scheme 3.1. General Design of YopH Inhibitors and Retrosynthetic Analysis 
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3.3. Background 
3.3.1. Yersinia PTPase (YopH) and inhibitors design 
YopH is a 51 kDa protein containing 468 amino acids. It is composed of two 
independently folded domains. The N-terminal domain (residues 1-130) binds tyrosine-
phosphorylated proteins in a phosphoryl dependent manner.
12
 The structure of N-terminal 
domain of YopH does not resemble those of eukaryotic PTPs such as Src homology 2 
(SH2), nor does it bind phosphotyrosine in a similar manner.
13
 The C-terminal catalytic 
domain (residues 164-468) is the center of the PPTase activity and is very similar to the 
structures of eukaryotic PTPs.
14
 
The catalytic domain of Yersinia PTP (YopH) is only about 20% identical to the human 
PTP1B but it contains all of the invariant residues present in eukaryotic PTP.
15
 The 
central feature of the Yersinia PTP tertiary fold is a highly twisted, eight-stranded, mixed 
β-sheet flanked by five α-helixes on one side and two α-helixes on the other side (Figure 
3.1).
16 
The PTP signature sequence (Ile/Val)His-Cys-Xxx-Ala-Gly-Xxx-Gly-
Arg(Ser/Thr)(Gly/Ala) is centered within the catalytic domain. Residues 403-410 form 
the PTP phosphate-binding loop (P-loop) containing the invariant Cys 403 thiol centered 
within the P-loop.
17,16a   
Paudyal, Mahesh, 2012, UMSL, p.217 
 
 
 
Figure 3.1. Ribbon Diagram of the Unliganded Yersinia PTPase Structure
16a
  
The main target for PTPs inhibitor design is the phosphotyrosine (pTyr) binding pocket 
(also called phosphate-binding loop, P-loop) that is the highly conserved binding active 
site present in all PTPs. Since this pocket is relatively small, it is hard to achieve high 
binding affinity by targeting this pocket alone.  
Most inhibitors designed and synthesized share a pharmacophore structurally similar to 
the pTyr substrate. These pTyr mimics are often charged bidentate anions that 
competitively bind to the pTyr pocket. Some of these pTyr mimics include salicylic acids 
(SA) and its derivatives (carboxymethylene benzoic acids, CMBA), benzoic acid 
derivatives such as 2-(oxalylamino)-benzoic acids (OBA), difluoromethylene 
phosphonates (DFMP), bis-(para-phosphophenyl) methane (BPPM), etc (Figure 3.2).
18
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Figure 3.2. The Phosphotyrosine (pTyr) Mimics 
3.3.2. Known YopH inhibitors 
Stuckey and coworkers first reported the unliganded and tungstate-bound crystal structure 
of the catalytic domain of YopH protein which was among the first PTP structures to be 
solved.
16a 
Crystal structures of bound protein with vanadate,
19
 nitrate,
20
 sulfate,
21
 and a 
phosphotyrosyl mimetic-containing hexapeptide
22
 were subsequently determined. All 
these structures provided valuable information about the enzyme, revealing Cys 403 is 
positioned at the center of the phosphate-binding loop. This loop is at the hub of several 
hydrogen-bonded arrays that stabilizes a bound oxyanion and may activate Cys 403 as a 
reactive thiolate.
16a 
Several YopH inhibitors have already been identified over the last 
few years. Some of these are discussed below. 
3.3.2.1. Hexapeptide mimic designed by Phan et al.  
Phan and coworkers designed a nonhydrolyzable phosphotyrosine substrate analog, 
hexapeptide mimetic (Ac-Asp-Ala-Asp-Glu-F2Pmp-Lys-NH2) 3.14 (Figure 3.14) and 
determined its co-crystal structure with the YopH (F2Pmp stands for difluoro-substituted 
phosphonomethylphenylalanine).
22 
They noted that the binding mode of this ligand to the 
Paudyal, Mahesh, 2012, UMSL, p.219 
 
 
active site of PTP is similar to the binding of corresponding hexapeptide to structurally 
homologous human PTP1B. The crystal structure of this hexapeptide with YopH revealed 
a second substrate binding site in YopH that is not present in PTP1B. 
 
Figure 3.3. Hexapeptide Mimetic 
3.3.2.2. p-Nitrocatechol sulfate (pNCS) inhibitor designed by Sun et al.   
Sun and coworkers found that p-nitrocatechol sulfate (p-NCS) 3.15 was an inhibitor of 
YopH protein.
23
 The co-crystal structure of p-NCS with YopH was also determined. The 
inhibition activity of this molecule against YopH and a number of mammalian PTPs were 
measured (Table 3.1) that displayed a 13-60-fold selectivity in favor of YopH. 
3.15 
Table 3.1. Selectivity of p-NCS 3.15 Against Different PTPs 
PTPs Ki  (µM) 
YopH 25±0.7 
SHP1 750±56 
HePTP 1500±24 
PTP1B 1200±120 
TCPTP 330±42 
CD45 500±68 
LAR 830±270 
VHR 350±49 
CDC14 1400±60 
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3.3.2.3. Tripeptide inhibitors developed by Lee et al. 
Mono-anionic tripeptide inhibitors of YopH have been reported by Lee and coworkers.
24
 
Several of the tripeptides with the mono-anionic peptide, Fmoc-Glu(OBn)-Xxx-Leu-
amide [Xxx = 4-(carboxymethyloxy)Phe, a pTyr mimetic] showed very good activity 
against YopH (Table 3.2). Interestingly, Glu residues with an unprotected side chain 
carboxyl were inactive towards YopH, but exhibited good IC50 value against PTP1B (a 
versus b values in Table 3.2). Also, the dicarboxy pTyr mimetic-containing tripeptide 
exhibited sub-micromolar PTP1B IC50 values. 
 
Table 3.2. Inhibitory Activities of Tripeptides in YopH and PTP1B Assays 
R
1
 Entry No. YopH (IC50, µM) PTP1B (IC50, µM) 
 
3.17a 
3.17b 
>100 
10.5±3.9 
54.7±15.3 
8.3±2.1 
 
3.18a 
3.18b 
>>800 
3.1±0.17 
0.7 
3.1±1.0 
 
3.19a 
3.19b 
>>800 
142±51 
0.7 
44±13 
 
In a more recent study, Lee et al. synthesized N-terminally modified and pTyr mimetic 
derivatives of the above tripeptides (3.17-3.19) and tested against YopH and human 
PTP1B proteins.
25
 This change in the tripeptide platform resulted in increased inhibitory 
potencies against both proteins but it did not improve the selectivity (Table 3.3). 
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Table 3.3. Inhibitory Potencies of Tripeptides Against YopH and PTP1B 
Entry 
No. 
R
1
 R
2
 YopH (IC50, µM) PTP1B (IC50, µM) 
 
3.20 
 
 
 
1.8±1.0 
 
2.9±1.3 
 
3.21 
  
 
5.6±1.2 
 
4.3±0.7 
 
3.22 
 
 
 
1.9±1.3 
 
3.8±1.8 
 
3.3.2.4. Aurintricarboxylic acid inhibitor designed by Liang et al. 
Liang and coworkers screened a library of 720 commercially available and structurally 
diverse carboxylic acids and identified 26 YopH inhibitors with IC50 values less than 100 
µM.
26
 They identified aurintricarboxylic acid (ATA) as the most potent and specific 
small molecule YopH inhibitor which exhibited a Ki value of 5 nM for YopH and 
displayed 6-120-fold selectivity in favor of YopH against a panel of mammalian PTPs 
(Figure 3.4). 
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Figure 3.4. Structure and IC50 (µM) Values of Some Carboxylic Acid Inhibitors 
3.3.2.5. Furanyl salicylate pharmacophore containing inhibitors 
Tautz et al. developed furanyl salicylate containing YopH inhibitors after screening 
thousands of drug-like compounds of the DIVERSet
TM 
library (Figure 3.5).
27
 The lead 
compounds of this chemical library screening were analyzed and computationally docked 
into the crystal structure of YopH. This identified the furanyl salicylate moiety as a novel 
pharmacophore (a pTyr mimetic) for PTPs inhibitor design.  
 
Figure 3.5. Furanyl Salicylate Containing Small molecule Inhibitors of YopH Protein 
Pellecchia and coworkers designed furanyl salicylate derivative chemically linked to the 
‘spin label’ TEMPO (the 2,2,6,6-tetramethylpiperidine-1-oxyl) as a probe for NMR-
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based second-site screening against different PTPS including YopH (for example 3.29, 
Figure 3.6).
28
 This technique, in combination with molecular docking studies, was used to 
synthesize a series of novel bidentate compounds as potential inhibitors of YopH (for 
example 3.30, Figure 3.6).
29
 
 
Figure 3.6. Small Molecule Inhibitors Containing Furanyl Salicylate Derivatives 
In this context, we were motivated to design and synthesize a new set of small molecule 
inhibitors to achieve higher activity. This project is in collaboration with Dr. Chung F. 
Wong’s laboratory at the University of Missouri-St. Louis. 
3.3.3. Rationale of new design 
3.3.3.1. Previous results: Benzofuran salicylate derived YopH inhibitors 
Huang et al. designed benzofuran salicylic acid based ligands having two chemical 
moieties connected by a flexible hydrocarbon linker.
11
 These two moieties target two 
different pockets in the active site of the protein; the salicylic acid core targeted the 
phosphotyrosine binding pocket and the other moiety targeted the secondary pockets that 
are present adjacent to the catalytic side. Based on the results from molecular docking, 
these bidentate ligands designed to achieve higher binding affinity and specificity 
targeting the primary phosphotyrosine binding pocket and secondary peripheral pocket. 
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Two series of forty salicylic acid derivatives having hydrocarbon linkers with different 
length were synthesized by Huang and coworkers. The benzofuran salicylic acid core was 
prepared in 8 steps from commercially available 4-hyroxysalicylic acid as shown in 
scheme 3.2. The benzofuran was then coupled with azide 3.33 (prepared in two steps 
from commercially available compounds, Scheme 3.2) using click chemistry (Cu(I)-
catalyzed [3+2] azide-alkyne cycloaddition) to complete the synthesis of the inhibitors 
(11 total steps, Scheme 3.3). Out of the 80 compounds synthesized and tested, 16 showed 
micromolar inhibitory activity. Some of these molecules with their IC50 values are given 
in figure 3.7. 
 
 
Scheme 3.2. Synthesis of Benzofuran Salicylic Acid Core and Azide 
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Scheme 3.3. Coupling of the Benzofuran Salicylic Acid Core with Azide   
 
Figure 3.7. Benzofuran Core Containing Small molecule Inhibitors and Their IC50 
Values Against YopH 
3.3.3.2. Limitations of the method of Huang and coworkers and new design 
The synthesis of benzofuran-salicylate core was tedious requiring 11 steps from the 
commercially available compounds (Scheme 3.2). From the docking studies, it was found 
that the phenyl group does not appear to assist in the interaction of these molecules with 
the binding site of the protein, though it aids in the synthesis. Furthermore, these 
inhibitors failed to show potency higher that the most literature reported inhibitors (all in 
low to mid micromolar range). 
This prompted some changes of these inhibitors design, retaining the useful features of 
the above mentioned inhibitors. Many challenges to consider were 
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i) to keep the size of the inhibitors more or less the same (no increase in molecular 
weight), 
ii) to improve the synthetic route for the rapid synthesis of inhibitors and easy 
modification if needed during the course of optimization, 
iii) to incorporate different chemical moieties with possibly more binding affinities and 
hence to increase the inhibitory activity against YopH protein. 
A series of compounds were proposed which retain the salicylic acid moiety which is a 
proven pharmacophore for binding to the active site of the enzyme (Scheme 3.4). Instead 
of fused furan ring (benzofuran), five membered aromatic heterocycles possessing 
oxygen, sulfur or nitrogen atoms in the different positions (or six membered aromatic 
rings) and a carboxylic acid in one of the two orientations were chosen. This synthetic 
design has the following features: a) many salicylic derivatives are commercially 
available inexpensive starting materials, b) the boc-protected amino acids with different 
carbon lengths are also commercial available and ready for coupling, c) several amines 
needed to couple with the acids for the side chain (peripheral binding site) are easily 
available, and d) many five membered heterocycles or six membered aromatics are 
coupled to salicylic acid part in one step following Suzuki cross coupling reactions. 
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Scheme 3.4. Newly Designed YopH Inhibitors and Retrosynthetic Analysis 
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3.4. Results and discussion 
3.4.1. Synthesis of building block acids 
Different building blocks were chosen with various heterocyclic aromatic rings and 
simple arenes with different orientation of the carboxylic acid (Figure 3.8). The syntheses 
of these building blocks were achieved as described below.  
 
Figure 3.8. Building Blocks Containing Different Heterocycles 
3.4.1.1. Isoxazole heterocycles containing building blocks 
The building block 3.45 was synthesized in four steps from the 5-iodo-salicylic acid 3.52 
(Scheme 3.5). The salicylic acid was protected as acetonide (2,2-dimethyl-1,3-
benzodioxan-4-one) by reacting with acetone in trifluoroacetic acid (TFA) and 
trifluoroacetic anhydride (TFAA) to give 3.53.
30
 Sonogashira coupling of 3.53 with 
trimethylacetylene in the presence of a catalytic amount of palladium and copper iodide 
followed by TMS removal produced phenyl acetylene 3.54.
31
 [3+2] polar cycloaddition 
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of acetylene 3.54 with chlorooxime (nitrile-oxide) 3.55 afforded isoxazole 3.56 in 68% 
yield.
32
 Hydrolysis of 3.56 by LiOH in THF/water produced desired acid 3.45 ready for 
coupling. 
 
Scheme 3.5. Synthesis of Isoxazole Heterocycle Containing Building Block 3.45 
A building block containing isoxazole heterocycle with a different orientation of phenyl 
and carboxylic acid 3.45 was also synthesized (Scheme 3.6).  5-formyl-salicylic acid 3.57 
was first protected as described above to give 3.58 followed by the treatment with 
hydroxylamine hydrochloride in ethanol to give oxime 3.59. The oxime 3.59 was 
converted to chlorooxime 3.60 reacting with N-chlorosuccinimide (NCS) in DMF.
33
 
[3+2] cycloaddition of chlorooxime (nitrile-oxide) 3.60 with methyl propiolate
32
 gave 
isoxazole derivative 3.61. However, the cycloaddition step produced with very low yield. 
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Scheme 3.6. Isoxazole Containing Building Block Synthesis 
3.4.1.2. Pyrrole heterocycle containing building block 
The pyrrole derivative of building block 3.66 was synthesized by the reaction of oxime 
3.64 with methyl propiolate in the presence of DABCO, followed by a two stage 
microwave irradiation (Scheme 3.7).
34
 The pyrrole 3.65 was protected by reacting with 
boc-anhydride in the presence of dimethylaminopyridine (DMAP) and triethylamine to 
give 3.66 albeit in very low yield. 
 
Scheme 3.7. Synthesis of Building Block Containing Pyrrol Derivative 
Since the overall yield of building blocks 3.61 and 3.66 were low, these were not 
employed in the inhibitor synthesis. 
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3.4.1.3. Thiophene heterocycles containing building blocks 
The thiophene heterocycle and phenyl containing building blocks were synthesized by 
Suzuki coupling of the acetonide protected salicylic acid 3.53 with corresponding boronic 
acids 3.67-3.70 (Scheme 3.8).
35
 
 
Scheme 3.8. Suzuki Coupling of Iodide 3.53 with Different Boronic Acids 
The ester moiety in 3.71 was hydrolyzed selectively using anhydrous lithium chloride in 
DMF (Scheme 3.9).
36 
 
Scheme 3.9. Suzuki Coupling Followed by Ester Hydrolysis 
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3.4.2. Acetonide group removal from building block acid 
The acetonide protecting groups were removed from the building blocks by treating with 
trifluoroacetic acid (TFA) and water (9:1) to obtain free salicylic acid (Scheme 3.10).  
 
Scheme 3.10. Removal of Acetonide Protecting Groups 
The building block 3.56 was fully deprotected by reacting with 5.0 equivalents of lithium 
hydroxide in THF/water at 0 
o
C (Scheme 3.11).  
 
Scheme 3.11. Full Deprotection of Building Block 3.56 
 
Paudyal, Mahesh, 2012, UMSL, p.233 
 
 
3.4.3. Coupling of amines with linker acids 
The commercially available amines 3.78-3.81 were coupled with the boc-protected α, β, 
γ, δ amino acids 3.82-3.85 in different combinations using 1-ethyl-3-(3-
dimethyllaminopropyl)carbodiimide hydrochloride (EDC·HCl) and N-
hydroxybenzotriazole (HOBt) in DMF to afford amides 3.86-3.92 (Scheme 3.12). Boc-
removal of 3.86-3.92 by trifluoroacetic acid (TFA) in CH2Cl2 produced free amines 3.93-
3.99 that is ready for coupling with building block acids.  
 
Scheme 3.12. Coupling of the Amines and Acids Followed by Boc-Removal 
3.4.4. Coupling of building block acids with amines carrying linker and peripheral 
amines 
The building block acids were coupled with the amines (that carry the linker) by reacting 
with EDC·HCl and HOBt in DMF. Finally, the acetonide group was removed by treating 
with TFA/H2O (9:1) at room temperature to complete the synthesis. A representative 
example is shown below (Scheme 3.13).  
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General Scheme 
 
A Specific Example 
 
Scheme 3.13. EDC Coupling of the Building Block Acid and the Amine  
Following the same procedure as described above, 16 different inhibitors (3.116-3.131) 
were synthesized. 
All the salicylic building blocks (fully or partially deprotected form) and inhibitors were 
tested against different phosphatase enzymes, YopH, PTP1B, and SHP2-D2C, CD45, 
VHR (only in selected cases). 
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3.4.5. Inhibitory activity studies 
3.4.5.1. Inhibitory potencies of fully deprotected building block acids 
Among six different building blocks tested, building block 3.74 containing 3-carboxyl-5-
aryl substituted thiophene showed mild activity against different PTPs (Table 3.4). 
However, there was no selectivity between bacterial YopH and mammalian PTP1B.  
Table 3.4. Structure and IC50 values Building Block Acids 
 
 IC50 value (µM) 
Structure YopH PTP1B 
3.74  
280±9 220±20 
3.75  
>200 >200 
3.76  
>200 >200 
3.72  
No Inh at 500 µM  
3.77  
No Inh at 500 µM  
3.73  
No Inh at 500 µM  
Paudyal, Mahesh, 2012, UMSL, p.236 
 
 
3.4.5.2. Inhibitory potencies of inhibitors 
In an effort to study the structure activity relationship (SAR) study, we synthesized 
inhibitors varying different parameters. The heterocyclic building block, linker length, 
and amine were carried one at a time. 
3.4.5.2.1. Variation in chain length (n = 0 to 4), constant amine and building block 
The linker chain length was varied from 0 to 4 keeping the building block and amine the 
same (Table 3.5). Inhibitor 3.119 with one carbon linker showed very good inhibitory 
activity (in low micromolar range) against both bacterial YopH and mammalian PTP1B 
proteins. This inhibitor, however, was not selective between YopH and PTP1B. The 
inhibitor containing four carbons linker 3.116 also showed good activity, but it was more 
active towards PTP1B than YopH. Other inhibitors showed weak activity towards these 
proteins. 
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Table 3.5. Structures and IC50 Values of Inhibitors with Different Chain Length 
 IC50 value (µM) 
Structure YopH PTP1B 
3.116
 
11.1±0.8 6.9±0.7 
3.117
 
>200 >200 
3.118
 
>50 >50 
 
 
 
 
3.119 
 
5.0±0.2 4.5±0.1 
3.120 
 
>200 >200 
 
3.4.5.2.2. Variation in building block acid, constant amine and chain length 
With the exception of 3.124, all inhibitors with different building blocks and the same 
linker (n=4) and amine were active to some extent against both proteins (Table 3.6). The 
inhibitor with 2,5-disubstituted thiophene containing building block 3.116 was about four 
and five times more active against YopH and PTP1B, respectively than the inhibitor with 
2,4-disubstituted thiophene derivative 3.122. Isoxazole derivative 3.121 also showed 
some potency but, it was about 2 times more active towards PTP1B. 
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Interestingly, the compound in which the five-membered heterocycle was replaced with 
an aromatic hydrocarbon maintained activity against both types of proteins tested. For 
example, inhibitor 3.123 with 1,3-disubstituted benzene showed IC50 value of 22.2 and 
30.8 µM against YopH and PTP1B proteins, respectively. 
Table 3.6. Structures and IC50 Values of Inhibitors with Different Building Blocks 
 IC50 value (µM) 
Structure YopH PTP1B 
3.116
 
11.1±0.8 6.9±0.7 
3.121
 
23±0.4 12.2±0.3 
3.122
 
44.2±14.9 31.8±4.6 
3.123
 
22.2±0.7 30.8±1.0 
3.124
 
>50 >50 
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3.4.5.2.3. Variation in amines, constant carbon chain and building block acid 
Among the four different amines tested, 2-amino-4-phenylthiazole containing inhibitor 
3.116 showed best activity against YopH and PTP1B proteins with respectable IC50 
values (Table 3.7).  
Table 3.7. Structures and IC50 Values of Inhibitors with Different amines 
 
3.4.5.2.4. Miscellaneous Inhibitors (random synthesis) 
Some inhibitors synthesized by the random combination of building block, amine and 
linker length also showed modest activity against YopH and PTP1B (Table 3.8). It was 
interesting to observe that inhibitor 3.129 with 4-morpholino-phenylamine, 4-carbon 
chain and isoxazole containing building block was 5 times more potent for bacterial 
 IC50 value(µM) 
Structure YopH PTP1B 
3.116 
 
11.1±0.8 6.9±0.7 
3.125 
 
>20 >20 
3.126 
 
>200 >200 
3.127
 
>200 >200 
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YopH than mammalian PTP1B which might be a good starting point for the selective 
inhibitor synthesis between YopH and PTP1B proteins. 
Table 3.8. Structures and IC50 Values of Randomly Synthesized Inhibitors 
 IC50 value (µM 
Structure YopH PTP1B 
3.128 
 
66±1 38±3 
3.129
 
63±1 310±40 
 
3. 130 
 
39.5±1.9 31.8±1.7 
3.131 
 
>50 40.9±7.9 
 
3.4.5.2.5. Inhibitory activity of inhibitors against YopH and few mammalian 
proteins  
A few compounds were tested against different mammalian PTPs (SHP2-D2C, CD45, 
and VHR) all of which showed activity to some extent (Table 3.9). In fact, inhibitors 
3.116, 3.121 and 3.128 were active in low micromolar range against all mammalian 
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proteins tested. Inhibitors 3.116, 3.121 and 3.128 were about 1.3 to 6 times more active 
towards the mammalian proteins than bacterial YopH. The fully deprotected building 
block 3.74 was also mildly active against the mammalian proteins with about 2 to 5 times 
more activity than bacterial YopH. 
Table 3.9. The IC50 Values of Inhibitors Against YopH and Few Mammalian PTPs 
 IC50 value (µM) 
Inhibitor YopH PTP1B SHP2-D2C CD45 VHR 
3.74 280±9 220±20 66±2 150±20 142±6 
3.116 11.1±0.8 6.9±0.7 4.4±0.3 6.2±0.1 7.5±0.7 
3.121 23±0.4 12.2±0.3 4.1±0.1 8.4±0.3 5.3±0.2 
3.128 66±1 38±3 23±2 52±3 32±3 
3.129 63±1 310±40 76±5 45±5 137±4 
 
3.4.5.3. Summary of inhibitory activities 
Inhibitor 3.119 containing the 2,5-disubstituted thiophene containing building block, one 
carbon linker and 4-phenyl-thiophene derivative as side chain was the most potent 
inhibitor synthesized (Table 3.10). The four carbon linker derivative of this inhibitor 
3.116 also showed very good activity against PTPs tested. On the other hand, inhibitor 
3.122 with different orientation of the heterocycle (2,4-disubstituted thiophene) compared 
to 3.116 displayed 8 times less activity against YopH.  
Inhibitors 3.121 and 3.123 containing an isoxazole heterocycle and an aromatic ring 
(instead of a heterocycle) were also active towards both proteins in micro-molar range. 
Among the four different amines (present in the side chain) tested, only 2-amino-4-
phenylthiazole containing inhibitors were broadly active, suggesting it to be a necessary 
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moiety for the activity. Also, inhibitor 3.129 with 4-morpholino-phenyl amine was five 
times selective for bacterial YopH protein than mammalian PTP1B.  
Table 3.10. Structures and IC50 Values of the Most Potent Inhibitors 
 IC50 value (µM) 
Structure YopH PTP1B 
3.119 
 
5.0±0.2 4.5±0.1 
3.116
 
11.1±0.8 6.9±0.7 
3.121 
 
23±0.4 12.2±0.3 
3.123 
 
22.2±0.7 30.8±1.0 
 
3.4.6. Expanding the scope of Suzuki coupling towards building block synthesis 
As discussed earlier in section 3.4.1.3, many building block acids were synthesized in 
one step by the Suzuki coupling of acetonide protected iodosalicylic acid 3.53 with 
corresponding boronic acids. In order to expand the utility of Suzuki coupling for the 
rapid synthesis of YopH and other phosphatase inhibitors, some other reactions were 
explored.  
Palladium catalyzed coupling of acetonide protected iodosalicylic acid 3.53 with 5-
formylfuran-2-boronic acid 3.132 was carried out (Scheme 3.14). Palladium acetate was 
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found to be efficient among the different palladium sources used.
35 
The aldehyde 3.133 
can be converted to the acid ready for coupling by treating with silver nitrate and aqueous 
water.
37
  
 
Scheme 3.14. Suzuki Coupling of Iodide 3.53 with Boronic Acid 
Alternatively, the iodide 3.53 was converted to its boronate ester 3.135 by treating with 
pinacolborane 3.134 in the presence of palladium catalyst (Scheme 3.15).
38
 The boronate 
ester derivative 3.135 can potentially be coupled to a wide variety of commercially 
available halides 3.137 to synthesize various building blocks 3.138. 
 
 
Scheme 3.15. Palladium Catalyzed Coupling of Iodide with Pinacol Boronic Acid 
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3.5. Summary 
1) Yersinia pestis is the pathogenic bacteria causing human diseases ranging from 
gastrointestinal syndromes to bubonic plague. Although the plague has long been 
considered as eradicated, it can re-emerge under suitable environmental conditions. The 
available antibiotics can be ineffective as bacteria can develop multi-drug resistant strain. 
Furthermore, the pathogen can be misused as a biological weapon in warfare. 
2) Y. Pestis contains a virulence protein known as YopH. This is similar to protein 
tyrosine phosphatase of human beings. Upon injection into the human body, YopH can 
dephosphorylate many proteins, affects the signal transduction network within the body 
reducing immune response. Specific molecules can act against the YopH protein and 
inhibit its virulence activity.  
3) Many inhibitors are known but all have some limitations: low activity, little selectivity 
between YopH and human phosphatase proteins, cumbersome synthesis, etc. 
4) In order to synthesize active YopH inhibitors rapidly, we designed and synthesized a 
number of inhibitors (bidentate ligands). Most of these inhibitors were synthesized in 6-9 
steps form commercially available starting materials. Many of these compounds showed 
very good potency (in low micromolar range) against phosphatases (YopH and PTP1B).  
5) A rapid method for synthesizing heterocyclic building blocks (a part of phosphatase 
inhibitors) was developed. Palladium catalyzed Suzuki coupling of acetonide protected 
iodosalicylic acid and commercially available boronic acids were employed. 
Alternatively, the boronate ester, synthesized from iodosalicylic acid, can also be coupled 
to various easily available halides following the same chemistry. 
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3.6. General Experimental 
Glassware used for all experiments were oven-dried and all reactions were carried out 
under argon atmosphere unless otherwise mentioned. All reaction solvents were purified 
prior to use: CH2Cl2, MeOH, MeCN were dried by distillation over calcium hydride and 
THF over sodium-benzophenone ketyl. Reagent grade DMF was obtained from Sigma-
Aldrich and used without further purification. 
Proton (
1
H) NMR spectra were recorded at 300 or 500 MHz and 
13
C NMR spectra at 75 
MHz.
 
Proton NMR spectra were referenced to residual CDCl3 (7.27 ppm) and 
13
C {
1
H} 
NMR spectra were referenced to the center line of CDCl3 (77.23 ppm). Crystal 
structure(s) were determined on a Bruker Apex- II CCD single crystal diffractometer. 
Optical rotations were measured on a polarimeter using a glass cell with 2 mL capacity 
and 10 cm path length. Infrared spectra were recorded on FTIR instrument using NaCl 
plates (liquids, oils) or using an ATR attachment (solids). 
General procedure for the EDC-coupling: To a stirred solution of carboxylic acid (1.0 
equiv.) and HOBt (1.5 to 2.0 equiv.) in DMF under argon at room temperature (rt) was 
added EDC.HCl (1.5 to 2.0 equiv.) and amine (1.2 equiv.) sequentially. The resulting 
mixture was stirred at room temperature (unless otherwise specified) for 26-48 hour 
(TLC monitoring). The solvent was removed in vacuo and the residue was dissolved 
EtOAc. The EtOAc layer was washed with 5 % HCl (2X), saturated aq. NaHCO3 solution 
(2X) and brine. The organic layer was dried over anhydrous Na2SO4, concentrated and 
the crude product was purified by column chromatography (SiO2, hexanes:EtOAc) or 
recrystallized with EtOAc and hexanes.  
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General procedure for the Boc removal: To a stirred solution of boc-protected amine 
in dry CH2Cl2 (2 mL/mmol) was added trifluoroacetic acid (TFA) (2 mL/mmol) and 
stirred for 1 to 4 h at rt (TLC monitoring). The solvent was evaporated, EtOAc was added 
and neutralized with aq. solution of NaHCO3. The organic layer was washed with brine, 
dried over anhydrous Na2SO4, concentrated and the crude product was used without 
further purification (or purified by column chromatography, SiO2, hexanes:EtOAc). 
[Note: In some cases, while washing with brine, solids came out from the solution which 
was filtered. From NMR, this was known to be the product and was used without further 
purification]. 
General procedure for the acetonide removal: A solution of acetonide protected 
salicylic acid in TFA and water (9:1) was stirred for 22-24 h at rt. After that, the solvent 
was evaporated, cold water was added in the crude solid and stirred for 10 minutes. The 
reaction mixture was filtered and the solid product was dried in vacuo. In all cases, NMR 
in DMSO-D6 showed only the product peaks.  
General procedure for the Suzuki coupling: To a stirred solution of iodide (1.0 equiv.) 
in dry DMF at rt. was added Pd(OAc)2 (5 mol%), Na2CO3 (2.0 equiv.), and boronic acid 
(1.2-1.5 equiv.) sequentially and the resulting solution was heated to 80 
o
C. After 1-4 h, 
the reaction mixture was cooled to rt. and the solvent was evaporated (Wherever 
necessary, 5-10 mL EtOAc was added in the crude reaction mixture and acidified with 
1M HCl (pH 0-1). Layers were separated and organic layer was evaporated). The crude 
product was purified by column chromatography (SiO2, hexanes:EtOAc). 
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Building blocks: 
 
Ethyl-5-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)isoxazole-3-carboxylate 
(3.56): Acetylene 3.54 (0.700 g, 3.46 mmol), chloro-oxime 3.55 (1.575 g, 10.39 mmol), 
and Et3N (1.4 mL, 10.0 mmol) were reacted in THF (65 mL) following the literature 
procedure
32
 described to give product 3.56 as a colorless solid (0.750 g, 68%). 
IR (neat, NaCl) 3135, 2988, 1749, 1711, 1610 cm
-1
; 
1
H NMR (CDCl3): δ 8.39 (1H, d, J = 
2.2 Hz), 8.02 (1H, dd, J = 2.2, 8.6 Hz), 7.11 (1H, d, J = 8.6 Hz), 6.93 (1H, s), 4.48 (2H, q, 
J = 7.1 Hz), 1.78 (6H, s), 1.45 (3H, t, J = 7.1 Hz); 
13
C {
1
H} NMR (CDCl3): δ 170.0, 
160.3, 160.0, 157.7, 157.3, 133.7, 127.7, 121.8, 118.6, 114.2, 107.3, 100.2, 62.5, 26.1, 
14.3; HRMS (FAB, MH
+
) calcd for C16H16NO6: 318.0977. Found 318.0970. 
 
5-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)isoxazole-3-carboxylic acid 
(3.45): To a stirred solution of ester 3.56 (0.020 g, 0.063 mmol) in THF (0.5 mL) was 
added water (0.5 mL) and the reaction mixture was cooled to 0 
o
C using an ice bath. 
Lithium hydroxide (2.0 mg, 0.083 mmol) was added and the mixture was stirred for 15 
minutes at 0 
o
C when the TLC analysis showed the reaction was complete. EtOAc (5 mL) 
was added to the reaction mixture and it was acidified (pH 0-1) by 1M HCl solution. The 
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layers were partitioned, the aq. layer was extracted with EtOAc (5 mL, 5X) and the 
combined organic layers were washed with brine. After drying over anhydrous Na2SO4, 
the organic layer was concentrated in vacuo. The crude product 3.45 (0.018 g, 
quantitative yield) was used for the next step without further purification. [Note: Large 
scale reactions needed longer reaction time and produced a mixture of mono- and 
dicarboxylic acids (acetonide removal). Extraction of the crude mixture with chloroform 
separated the mono and dicarboxylic acids.] 
1
H NMR (CDCl3): δ 8.43 (1H, d, J = 2.0 Hz), 8.04 (1H, dd, J = 2.2, 8.6 Hz), 7.14 (1H, d, 
J = 8.6 Hz), 7.00 (1H, s), 1.80 (6H, s); 
13
C {
1
H} NMR (MeOD-D4): δ 171.3, 162.4, 
161.7, 159.2, 159.0, 135.2, 128.0, 123.1, 119.9, 115.4, 108.6, 101.5, 26.0. 
 
5-(3-(ethoxycarbonyl)isoxazol-5-yl)-2-hydroxybenzoic acid (3.72): To a stirred 
solution of ester 3.56 (0.100 g, 0.315 mmol) in TFA (0.90 mL) at rt. was added water 
(0.10 mL) and stirred at that temperature for 18 h (off white solids came out of the 
solution). Solvent evaporated, cold water (2 mL) was added to the crude solid, stirred for 
10 minutes and filtered. Proton NMR of crude showed the product and unreacted starting 
material (about 12%). Purification by column chromatography (SiO2, hexanes:EtOAc) 
gave product 3.72 as a colorless solid (0.06 g, 69% or 90% based on recovered starting 
material). 
IR (neat, NaCl) 3135, 2500-3400 (broad), 1722, 1688, 1614 cm
-1
; 
1
H NMR (DMSO-D6): 
δ 8.25 (1H, d, J = 2.2 Hz), 8.03 (1H, dd, J = 2.3, 8.7 Hz), 7.34 (1H, s), 7.10 (1H, d, J = 
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8.7 Hz), 4.37 (2H, q, J = 7.1 Hz), 1.32 (3H, t, J = 7.1 Hz); 
13
C {
1
H} NMR (DMSO-D6): δ 
171.3, 170.5, 163.0, 159.7, 157.1, 133.1, 128.1, 118.7, 117.7, 114.3, 99.9, 62.2, 14.2. 
 
5-(3-carboxy-4-hydroxyphenyl)isoxazole-3-carboxylic acid (3.77): Acetonide 
protected ester 3.56 (0.079 g, 0.25 mmol) and LiOH (0.030 g, 1.25 mmol) were reacted in 
THF (1 mL) and water (1 mL) for 16 h following the procedure described above for 
compound 3.45 to obtain fully hydrolyzed acid 3.77 as a colorless solid (0.072 g, quant. 
crude yield). 
IR (neat, NaCl) 3400-2500 (broad), 3127, 1738, 1680, 1645, 1610 cm
-1
; 
1
H NMR 
(MeOD-D4): δ 8.38 (1H, d, J = 2.2 Hz), 8.01 (1H, dd, J = 2.3, 8.7 Hz), 7.11 (1H, d, J = 
8.7 Hz), 7.08 (1H, s); 
13
C {
1
H} NMR (MeOD-D4): δ 172.8, 172.2, 165.0, 162.5, 159.0, 
133.9, 129.3, 119.5, 119.4, 114.6, 100.2. 
 
5-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)thiophene-2-carboxylic acid 
(3.47): Iodide 3.53 (0.121 g, 0.400 mmol), Pd(OAc)2 (0.004 g, 0.020 mmol), Na2CO3 
(0.085 g, 0.800 mmol), and boronic acid 3.67 (0.103 g, 0.600 mmol) were reacted in 
DMF (5 mL) following the general procedure for Suzuki coupling to obtain 3.47 as a pale 
yellow solid (0.095 g, 78%). 
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IR (neat, NaCl) 3400-2400 (broad), 1740, 1670, 1605 cm
-1
; 
1
H NMR (MeOD-D4): δ 8.16 
(1H, d, J = 2.2 Hz), 7.83 (1H, dd, J = 2.3, 8.6 Hz), 7.71 (1H, d, J = 3.9 Hz), 7.28 (1H, d, J 
= 3.9 Hz), 7.03 (1H, d, J = 8.6 Hz), 1.74 (6H, s); 
13
C {1H} NMR (MeOD-D4): δ 165.5, 
162.7, 157.5, 150.3, 136.0, 135.7, 134.8, 130.1, 128.1, 125.4, 119.6, 115.1, 108.4, 26.9. 
 
5-(3-carboxy-4-hydroxyphenyl)thiophene-2-carboxylic acid (3.73): Compound 3.47 
(0.034 g, 0.112 mmol) was reacted with TFA (0.90 mL) and water (0.10 mL) following 
the general procedure for acetonide removal to afford the product 3.73 as a colorless solid 
(0.019 g, 64%). 
IR (neat, NaCl) 3400-2400 (broad), 1657, 1620 cm
-1
; 
1
H NMR (DMSO-D6): δ 8.06 (1H, 
s), 7.90 (1H, d, J = 8.6 Hz), 7.70 (1H, d, J = 3.7 Hz), 7.50 (1H, d, J = 3.7 Hz), 7.07 (1H, 
d, J = 8.6 Hz); 
13
C {
1
H} NMR (DMSO-D6): δ 162.7, 161.5, 148.8, 1134.4, 133.9, 132.4, 
127.3, 124.2, 123.9, 118.3. 
 
Methyl-4-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)thiophene-2-carboxylate 
(3.71): Iodide 3.53 (0.121 g, 0.400 mmol), Pd(OAc)2 (0.004 g, 0.020 mmol), Na2CO3 
(0.085 g, 0.800 mmol), and boronic acid 3.70 (0.089 g, 0.480 mmol) were reacted in dry 
DMF (5 mL) following the general procedure for Suzuki coupling to obtain 3.71 as  a 
pale yellow solid (0.110 g, 87%). 
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IR (neat, NaCl) 3104, 2949, 1730, 1703, 1600 cm
-1
; 
1
H NMR (CDCl3): δ 8.14 (1H, d, J = 
2.3 Hz), 8.02 (1H, d, J = 1.6 Hz), 7.75 (1H, dd, J = 2.3, 8.5 Hz), 7.62 (1H, d, J = 1.6 Hz), 
7.00 (1H, d, J = 8.5 Hz), 3.90 (3H, s), 1.74 (6H, s); 
13
C {
1
H} NMR (CDCl3): δ 162.6, 
161.1, 155.6, 141.0, 134.8, 134.3, 131.8, 129.9, 127.1, 127.0, 118.1, 114.0, 106.8, 52.5, 
26.0; HRMS (FAB, MNa) calcd for C16H14O5Na: 314.0460. Found 314.0463. 
 
4-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)thiophene-2-carboxylic acid 
(3.48): To a stirred solution of ester 3.71 (0.032 g, 0.100 mmol) in dry DMF (1 mL) at rt 
was added anhydrous LiCl (0.006 g, 0.150 mmol) in one portion and refluxed for 18 h. 
The reaction mixture was the cooled to rt and acidified with 1M HCl (0-1 pH). The 
product was extracted with EtOAc (5 mL, 5X), the combined organic fractions were 
washed with brine, dried over anhydrous Na2SO4, and concentrated in vacuo. The crude 
product was purified by column chromatography (SiO2, hexanes:EtOAc) to obtain 3.48 
as a colorless solid (0.029 g, 97%). 
IR (neat, NaCl) 3400-2300 (broad), 1752, 1674, 1609 cm
-1
; 
1
H NMR (CDCl3): δ 8.04 
(1H, d, J = 2.3 Hz), 7.95 (1H, d, J = 1.6 Hz), 7.83 (1H, dd, J = 2.4, 8.6 Hz), 7.83 (1H, d, J 
= 1.7 Hz),  6.97 (1H, d, J = 8.6 Hz), 1.63 (6H, s); 
13
C NMR {
1
H} (CDCl3): δ 165.2, 
162.7, 157.0, 142.3, 137.1, 135.9, 132.7, 131.6, 128.8, 127.7, 119.3, 115.2, 108.2, 26.01. 
HRMS (FAB, MH
+
) calcd for C15H13O5S: 305.0484. Found 305.0490. 
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4-(3-carboxy-4-hydroxyphenyl)thiophene-2-carboxylic acid (3.74): Compound 3.48 
(0.026 g, 0.085 mmol), TFA (0.90 mL) and water (0.10 mL) were reacted following the 
general procedure for acetonide removal to afford the product 3.74 as a colorless solid 
(0.015 g, 68%). 
IR (neat, NaCl) 3400-2400 (broad), 1657, 1620 cm
-1
; 
1
H NMR (MeOD-D4): δ 8.14 (1H, 
s), 8.09 (1H, s), 8.06 (1H, s), 7.92 (1H, d, J = 8.5 Hz), 7.02 (1H, d, J = 8.6 Hz); 
13
C NMR 
{
1
H} (CDCl3): δ 171.4, 162.9, 160.5, 140.9, 135.5, 133.4, 131.0, 127.4, 126.9, 125.7, 
117.9, 117.8. 
 
3-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)benzoic acid (3.49): Iodide 3.53 
(0.760 g, 2.50 mmol), Pd(OAc)2 (0.028 g, 0.125 mmol), Na2CO3 (0.530 g, 5.00 mmol), 
and boronic acid 3.68 (0.622 g, 3.75 mmol) were reacted in dry DMF (25 mL) following 
the general procedure for Suzuki coupling to obtain 3.49 as  a colorless solid (0.595 g, 
80%). 
IR (neat, NaCl) 3400-2400 (broad), 1734, 1676 cm
-1
; 
1
H NMR (DMSO-D6) δ 8.19 (1H, 
s), 8.11 (1H, s), 8.06 (1H, d, J = 8.5 Hz), 7.96 (2H, d, J = 7.3 Hz), 7.62 (1H, t, J = 7.7 
Hz), 7.26 (1H, d, J = 8.5 Hz), 1.74 (6H, s); 
13
C NMR (DMSO-D6) δ 167.8, 160.8, 155.9, 
139.3, 136.1, 134.8, 132.3, 131.6, 130.2, 129.2, 127.8, 127.6, 118.9, 114.2, 107.4, 26.0; 
HRMS (FAB, MH
+
) calcd for C17H15O5: 299.0919. Found 299.0927. 
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4-hydroxy-[1,1'-biphenyl]-3,3'-dicarboxylic acid (3.75): Compound 3.49 (0.060 g, 
0.200 mmol), TFA (0.90 mL) and water (0.10 mL) were reacted following the general 
procedure for acetonide removal to afford 3.75 as a colorless solid (0.048 g, 92%). 
IR (neat, NaCl) 3500-2400 (broad), 1680, 1579 cm
-1
; 
1
H NMR (DMSO-D6): δ 11.36 (1H, 
broad s), 8.13 (1H, s), 8.06 (1H, s), 7.92 (2H, d, J = 7.5 Hz), 7.89 (1H, d, J = 8.1 Hz), 
7.59 (1H, d, J = 7.7 Hz), 7.09 (1H, d, J = 8.6 Hz); 
13
C {
1
H} NMR (DMSO-D6): δ 172.2, 
167.9, 161.6, 140.0, 134.6, 132.2, 131.3, 131.0, 130.1, 128.8, 128.6, 127.4, 118.7, 114.3. 
 
4-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)benzoic acid (3.50): Iodide 3.53 
(0.152 g, 0.500 mmol), Pd(OAc)2 (0.006 g, 0.027 mmol), Na2CO3 (0.106 g, 1.000 mmol), 
and boronic acid 3.69 (0.099 g, 0.600 mmol) were reacted in dry DMF (5 mL) following 
the general procedure for Suzuki coupling to obtain 3.50 as a colorless solid (0.085 g, 
57%). 
IR (neat, NaCl) 3400-2400 (broad), 1734, 1676 cm
-1
; 
1
H NMR (DMSO-D6): δ 8.22 (1H, 
d, J = 2.3 Hz), 8.13 (2H, d, J = 8.4 Hz), 7.98 (1H, dd, J = 2.3, 8.6 Hz), 7.74 (2H, d, J = 
8.4 Hz), 7.18 (1H, d, J = 8.6 Hz), 1.79 (6H, s); 
13
C {
1
H} NMR (DMSO-D6): δ 167.7, 
160.7, 156.2, 143.0, 136.2, 134.5, 130.8, 130.5, 127.8, 127.3, 118.9, 114.2, 107.4, 26.0. 
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4-hydroxy-[1,1'-biphenyl]-3,4'-dicarboxylic acid (3.76): Compound 3.50 (0.060 g, 
0.200 mmol), TFA (0.90 mL) and water (0.10 mL) were reacted following the general 
procedure for acetonide removal to afford 3.76 as a colorless solid (0.044 g, 82%). 
IR (neat, NaCl) 3500-2400 (broad), 1680, 1579 cm
-1
; 
1
H NMR (DMSO-D6): δ 11.39 (1H, 
brd s), 8.12 (1H, s), 8.00 (2H, d, J = 8.2 Hz), 7.93 (1H, d, J = 8.7 Hz), 7.77 (2H, d, J = 
8.2 Hz), 7.10 (1H, d, J = 8.6 Hz); 
13
C {
1
H} NMR (DMSO-D6): δ 167.1, 161.2, 143.0, 
134.0, 130.0, 129.1, 128.4, 126.2, 118.0. 
 
2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxine-6-carbaldehyde oxime (3.59): Aldehyde 
3.58 (1.03 g, 5.00 mmol), hydroxyl amine hydrochloride (0.695 g, 10.0 mmol), and 
pyridine (1.05 mL, 13.0 mmol) were reacted in EtOH (25 mL) following the procedure 
described below for compound 3.64 to produce oxime 3.59 as a colorless solid (1.00 g, 
90%). 
IR (neat, NaCl) 3297, 2992, 2942, 1730, 1626 cm-
1
; 
1
H NMR (CDCl3): δ 8.13 (1H, s), 
8.10 (1H, d, J = 2.1 Hz), 7.88 (1H, dd, J = 2.2, 8.6 Hz), 7.01 (1H, d, J = 8.6 Hz), 1.76 
(6H, s); 
13
C {
1
H} NMR (CDCl3): δ 160.8, 157.3, 148.6, 134.2, 129.1, 127.2, 118.2, 
113.8, 107.0, 26.0; HRMS (FAB, M
+
) calcd for C11H11NO4: 221.0688. Found 221.0688. 
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N-hydroxy-2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxine-6-carbimidoyl chloride 
(3.60): Oxime 3.59 (0.221 g, 1.00 mmol) and N-chlorosuccinimide (NCS) (0.147 g, 1.10 
mmol) were reacted in dry DMF (2 mL) following the literature procedureError! 
ookmark not defined. described to obtain 3.60 as a colorless solid (0.170 g, 67%). 
1
H NMR (CDCl3): (Mixture of cis and trans isomers) δ 8.72 (1H, s), 8.44 (1H, d, J = 2.3 
Hz), 8.13 (1H, d, J = 2.1 Hz), 8.05 (1H, dd, J = 2.3, 8.7 Hz), 7.68 (1H, dd, J = 2.2, 8.6 
Hz), 7.05 (1H, d, J = 8.6 Hz), 7.00 (1H, d, J = 8.8 Hz), 1.76 (6H, s), 1.75 (6H, s); 
13
C 
{
1
H} NMR (CDCl3): δ 160.7, 159.5, 157.6, 139.5, 137.9, 134.8, 134.0, 129.0, 127.7, 
119.0, 117.7, 114.4, 113.4, 108.2, 107.6, 107.1, 26.00, 25.98; HRMS (FAB, MH
+
) calcd 
for C11H11NClO4: 256.0377. Found 256.0385. 
 
methyl 3-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)isoxazole-4-carboxylate 
(3.61): Chlorooxime 3.60 (0.170 g, 0.666 mmol), methyl propiolate (0.18 mL, 2.00 
mmol), and Et3N (0.28 mL, 2.00 mmol) were reacted in dry THF (22 mL) following the 
literature procedure describedError! Bookmark not defined. to give 3.61 as a 
olorless solid (0.020 g, 10%). 
IR (neat, NaCl) 3123, 2942, 1742, 1715, 1610 cm
-1
; 
1
H NMR (CDCl3): δ 8.35 (1H, d, J = 
2.2 Hz), 8.16 (1H, dd, J = 2.2, 8.6 Hz), 7.29 (1H, d, J = 1.2 Hz), 7.12 (1H, d, J = 8.6 Hz), 
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4.03 (3H, s), 1.80 (6H, s); 
13
C {
1
H} NMR (CDCl3): δ 161.6, 161.2, 160.5, 157.8, 157.2, 
134.7, 128.5, 123.0, 118.6, 114.0, 107.3, 107.2, 53.2, 26.1; HRMS (FAB, MNa
+
) calcd 
for C15H13NO6Na: 326.0641. Found 326.0633. 
 
6-acetyl-2,2-dimethyl-4H-benzo[d][1,3]dioxin-4-one (3.63): To an ice-cold solution of 
5-acetyl salicylic acid 3.62 (0.5 g) in TFA (4 mL) were added trifluoroacetic anhydride 
(2.5 mL) and acetone (0.5 mL), sequentially. The mixture was slowly warmed to rt, 
stirred for an hour and refluxed at 100 
o
C for 22 h. The reaction mixture was the cooled 
to rt and concentrated in vacuo. Ethyl acetate (10 mL) was added followed by the 
saturated aq. NaHCO3 with constant shaking to neutralize the reaction mixture (till the 
bubbling seized). The layers separated and the aq. layer was extracted with EtOAc (10 
mL, 3X). The combined organic layers were washed with water and brine, dried over 
anhydrous Na2SO4 and concentrated. Column chromatography (SiO2, hexanes:EtOAc) of 
the crude solids obtained 3.63 as a colorless solid (0.430 g, 71%). 
IR (neat, NaCl) 3004, 2990, 1739, 1684 cm
-1
; 
1
H NMR (CDCl3): δ 8.45 (1H, d, J = 2.1 
Hz), 8.14 (1H, dd, J = 2.2, 8.7 Hz), 6.99 (1H, d, J = 8.7 Hz), 2.54 (3H, s), 1.70 (6H, s); 
13
C {
1
H} NMR (CDCl3): δ 195.6, 160.2, 159.4, 136.0, 131.9, 130.7, 117.8, 112.8, 107.0, 
26.4, 25.8; HRMS (FAB, MH
+
) calcd for C12H13O4: 221.0814. Found 221.0811. 
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(E)-6-(1-(hydroxyimino)ethyl)-2,2-dimethyl-4H-benzo[d][1,3]dioxin-4-one (3.64): To 
a stirred solution of ketone 3.63 (2.20 g, 10.0 mmol) in dry EtOH (50 mL) at rt was added 
hydroxylamine hydrochloride (NH2OH.HCl) (1.39 g, 20.0 mmol), and pyridine (2.10 mL, 
26.0 mmol) drop wise, and the reaction mixture was refluxed at 80 
o
C for 22 h. The 
solvent was evaporated, water (50 mL) and EtOAc (50 mL) were added, the layers 
separated and the aq. layer was extracted with EtOAc (20 mL, 3X). The collected organic 
layers were dried over anhydrous Na2SO4 and concentrated in vacuo. The crude solids 
were purified by column chromatography (SiO2, hexanes:EtOAc) to obtain product 3.64 
as a colorless solid (2.15 g, 91%). 
IR (neat, NaCl) 3500, 2915, 1691 cm-
1
; 
1
H NMR (CDCl3): δ 8.98 (1H broad s), 8.08 (1H, 
d, J = 2.2 Hz), 7.85 (1H, dd, J = 2.3, 8.7 Hz), 6.90 (1H, d, J = 8.7 Hz), 2.22 (3H, s), 1.67 
(6H, s); 
13
C {
1
H} NMR (CDCl3): δ 161.1, 156.8, 154.6, 134.0, 131.4, 127.6, 117.7, 
113.3, 106.9, 25.9, 12.2; HRMS (FAB, MH
+
) calcd for C12H13NO4: 235.0845. Found 
235.0843. 
 
1-tert-butyl 3-methyl 5-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)-1H-
pyrrole-1,3-dicarboxylate (3.66): Oxime 3.64 (0.117 g, 0.500 mmol), DABCO (0.006 g, 
0.050 mmol), methyl propiolate (44 µL, 0.500 mmol), boc-anhydride (0.218 g, 1.00 
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mmol), DMAP (0.006 g, 0.050 mmol), and Et3N (70 µL, 0.500 mmol) were reacted in 
toluene (1.0 mL) following the literature procedure
34
 described to produce boc-protected 
pyrrol 3.66 as a colorless liquid (0.026 g, 13%).  
IR (neat, NaCl) 2992, 1734, 1709 cm
-1
; 
1
H NMR (CDCl3): δ 8.03 (1H, d, J = 2.2 Hz), 
7.64 (1H, dd, J = 2.2, 8.5 Hz), 6.99 (1H, d, J = 8.7 Hz), 6.91 (1H, d, J = 3.7 Hz), 6.21 
(1H, d, J = 3.7 Hz), 3.86 (3H, s), 1.76 (6H, s), 1.48 (9H, s); 
13
C {
1
H} NMR (CDCl3): δ 
160.7, 160.5, 155.9, 149.4, 137.4, 137.0, 129.7, 126.5, 125.0, 118.2, 117.2, 113.2, 110.9, 
106.7, 86.0, 51.8, 27.3, 25.9; HRMS (FAB, MNa
+
) calcd for C21H23NO7Na: 424.1372. 
Found 424.1378. 
Amines and their precursors: 
 
tert-Butyl (5-oxo-5-((4-phenylthiazol-2-yl)amino)pentyl)carbamate (3.86): EDC.HCl 
(1.150 g, 6.00 mmol), HOBt (0.811 g, 6.00 mmol), amine 3.77 (0.529 g, 3.00 mmol), and 
acid 3.85 (0.717 g, 3.30 mmol) were reacted in dry DMF (9 mL) following the general 
procedure for EDC coupling to afford 3.86 as a colorless solid (0.810 g, 72%). 
IR (neat, NaCl) 3387, 3145, 2933, 1703, 1679, 1550 cm
-1
; 
1
H NMR (CDCl3): δ 10.97 
(1H, brd s), 7.81 (2H, dd, J = 1.4, 8.5 Hz), 7.43 (2H, dt, J = 1.4, 8.4 Hz), 7.37 (1H, tt, J = 
1.4, 8.5 Hz), 7.13 (1H, s), 4.60 (1H, brd s), 3.08 (2H, app q, J = 6.4 Hz), 2.24 (2H, t, J = 
7.4 Hz), 1.61 (2H, quin, J = 7.4 Hz), 1.46 (9H, s), 1.38 (2H, quin, J = 6.9 Hz); 
13
C {
1
H} 
NMR (CDCl3): δ 171.5, 159.8, 156.0, 149.4, 134.5, 128.9, 128.2, 126.3, 107.9, 79.1, 
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39.9, 35.1, 29.3, 28.5, 21.9; HRMS (FAB, MNa
+
) calcd for C19H25N3O3SNa: 398.1514. 
Found 398.1503. 
 
tert-Butyl (4-oxo-4-((4-phenylthiazol-2-yl)amino)butyl)carbamate (3.87): EDC.HCl 
(0.502 g, 2.62 mmol), HOBt (0.354 g, 2.62 mmol), acid 3.84 (0.356 g, 1.75 mmol), and 
amine 3.78 (0.370 g, 2.10 mmol) were reacted in dry DMF (9 mL) following the general 
procedure of EDC coupling to afford 3.87 as a colorless solid (0.350 g, 46%). 
IR (neat, NaCl) 3387, 3145, 2933, 1703, 1679, 1550 cm
-1
; 
1
H NMR (DMSO-D6): δ 12.23 
(1H, s), 7.89 (2H, d, J = 7.1 Hz), 7.59 (1H, s), 7.44 (2H, t, J = 7.2 Hz), 7.32 (1H, t, J = 
7.3 Hz), 6.85 (1H, t, J = 5.5 Hz), 2.96 (2H, app q, J = 6.7 Hz), 2.45 (2H, t, J = 7.4 Hz), 
1.72 (2H, quin, J = 7.1 Hz), 1.37 (9H, s); 
13
C NMR {
1
H} (DMSO-D6): δ 171.2, 157.9, 
155.6, 148.7, 134.3, 128.7, 127.7, 125.6, 107.8, 77.5, 38.6, 32.3, 28.2, 25.0. 
 
tert-Butyl (3-oxo-3-((4-phenylthiazol-2-yl)amino)propyl)carbamate (3.88): EDC.HCl 
(1.92 g, 10.01 mmol), HOBt (1.35 g, 10.00 mmol), acid 3.83 (1.13 g, 5.97 mmol), and 
amine 3.78 (0.881 g, 5.00 mmol) were reacted in dry DMF (15 mL) following the general 
procedure of EDC coupling to afford 3.88 as a colorless solid (1.55 g, 89%). 
IR (neat, NaCl) 3250, 3193, 2980, 1699, 1549 cm-
1
; 
1
H NMR (MeOD-D4): δ 7.89-7.92 
(2H, m), 7.37-7.43 (2H, m), 7.36 (1H, s), 7.27-7.33 (1H, m), 3.42-3.47 (2H, m), 2.69 (2H, 
t, J = 6.6 Hz), 1.44 (9H, s); 
13
C {
1
H} NMR (MeOD-D4): δ 171.8, 159.4, 158.5, 151.3, 
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136.1, 129.7, 128.9, 127.2, 108.6, 80.4, 37.6, 37.2, 28.8; HRMS (FAB, MNa
+
) calcd for 
C17H21N3O3SNa: 370.1201. Found 370.1207. 
 
tert-Butyl (2-oxo-2-((4-phenylthiazol-2-yl)amino)ethyl)carbamate (3.89): EDC.HCl 
(1.92 g, 10.01 mmol), HOBt (1.35 g, 10.00 mmol), acid 3.82 (1.05 g, 5.99 mmol), and 
amine 3.78 (0.881 g, 5.00 mmol) were reacted in dry DMF (15 mL) following the general 
procedure for EDC coupling to afford 3.89 as a colorless solid (1.35 g, 81%). 
IR (neat, NaCl) 3428, 3397, 3227, 3096, 2976, 1703, 1657 cm
-1
; 
1
H NMR (CDCl3): δ 
10.5 (1H, brd s), 7.78-7.81 (2H, m), 7.38-7.43 (2H, m), 7.33-7.36 (1H, m),7.15 (1H, s), 
5.22 (1H, broad s), 3.98 (2H, brd s), 1.47 (9H, s); 
13
C {
1
H} NMR (CDCl3): δ 168.1, 
157.8, 156.3, 150.2, 134.6, 129.0, 128.4, 126.4, 108.3, 81.2, 44.6, 28.5; HRMS (FAB, 
MNa
+
) calcd for C16H19N3O3SNa: 356.1045. Found 356.1052. 
 
tert-Butyl (5-(benzo[d]thiazol-2-ylamino)-5-oxopentyl)carbamate (3.90): EDC.HCl 
(1.15 g, 6.00 mmol), HOBt (0.811 g, 6.00 mmol), acid 3.85 (0.869 g, 4.00 mmol), and 
amine 3.79 (0.721 g, 4.80 mmol) were reacted in dry DMF (12 mL) following the general 
procedure for EDC coupling to afford 3.90 as a colorless solid after recrystallization 
(1.120 g, 80%). 
IR (neat, NaCl) 3358, 3203, 2978, 2925, 1683, 1610, 1520 cm-
1
; 
1
H NMR (CDCl3): δ 
11.20 (1H, brd s), 7.83 (1H, dd, J = 0.6, 7.9 Hz), 7.73 (1H, d, J = 8.0 Hz), 7.44 (1H, dt, J 
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= 1.2, 7.4 Hz), 7.32 (1H, dt, J = 1.0, 8.0 Hz), 4.59 (1H, brd s), 3.12 (2H, app q, J = 6.6 
Hz), 2.52 (2H, t, J = 7.4 Hz), 1.74 (2H, quin, J = 7.3 Hz), 1.52 (2H, quin, J = 7.4 Hz), 
1.44 (9H, s); 
13
C {
1
H} NMR (CDCl3): δ 171.9, 159.7, 156.3, 148.1, 132.1, 126.5, 124.1, 
121.8, 120.5, 79.5, 40.0, 36.0, 29.7, 28.6, 22.3; HRMS (FAB, MH
+
) calcd for 
C17H24N3O3S: 350.1538. Found 350.1549. 
 
tert-Butyl (5-(benzylamino)-5-oxopentyl)carbamate (3.91): EDC.HCl (0.863 g, 4.50 
mmol), HOBt (0.608 g, 4.50 mmol), acid 3.85 (0.651 g, 3.00 mmol), and amine 3.80 
(0.39 mL, 3.60 mmol) were reacted in dry DMF (9 mL) following the general procedure 
of EDC coupling to afford 3.91 as a colorless solid (0.680 g, 74%). 
IR (neat, NaCl) 3317, 2974, 2929, 1695, 1642, 1504 cm-
1
; 
1
H NMR (CDCl3): δ 7.27-7.37 
(5H, m), 5.91 (1H, brd s), 4.61 (1H, brd s), 4.44 (2H, d, J = 5.7 Hz), 3.14 (2H, app q, J = 
6.5 Hz), 2.26 (2H, t, J = 7.3 Hz), 1.71 (2H, quin, J = 7.5 Hz), 1.53 (2H, quin, J = 7.0 Hz), 
1.42 (9H, s); 
13
C {
1
H} NMR (CDCl3): δ 172.9, 156.4, 138.6, 129.0, 128.1, 127.7, 79.4, 
43.9, 40.0, 36.2, 29.8, 28.6, 22.9; HRMS (FAB, MH
+
) calcd for C17H27N2O3: 307.2022. 
Found 307.2017. 
 
tert-Butyl (5-((4-morpholinophenyl)amino)-5-oxopentyl)carbamate (3.92): To a 
stirred solution of amine 3.81 (0.535 g, 3.00 mmol) in dry CH2Cl2 (9 mL) at rt was added 
DMAP (0.073 g, 0.60 mmol) and pyridine (0.73 mL, 9.00 mmol)., and the reaction 
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mixture was stirred for 5 minutes before adding acid 3.85 (0.782 g, 3.6 mmol). The 
reaction mixture was then cooled to 0 
o
C (ice bath), stirred for 15 minutes, DCC (1.24 g, 
6.00 mmol) was added and stirred at 0 
o
C temperature for an additional 1 h. The reaction 
mixture was then warmed up to rt and stirred for additional 22 h. Water (5 mL) was 
added, filtered and the residue was washed with EtOAc. The crude solid was purified by 
column chromatography (SiO2, hexanes:EtOAc) to afford product 3.92 as a colorless 
solid (0.700, 60%, contains some DCC urea). 
 IR (neat, NaCl) 3355, 3272, 2975, 1670, 1637 cm
-1
; 
1
H NMR (CDCl3): (contains some 
DCC urea) δ 7.69 (1H, brd s), 7.42 (2H, d, J = 8.9 Hz), 6.85 (2H, d, J = 8.9 Hz), 4.73 
(1H, brd s), 3.85 (4H, t, J = 4.6 Hz), 3.13 (2H, app q, J = 6.4 Hz), 3.08 (4H, t, J = 4.7 
Hz), 2.35 (2H, t, J = 7.3 Hz), 1.70 (2H, app quin, J = 7.3 Hz), 1.54 (2H, app quin, J = 6.9 
Hz), 1.43 (9H, s); 
13
C {
1
H} NMR (CDCl3): δ 171.4, 156.4, 148.1, 131.2, 121.5, 116.3, 
79.3, 67.0, 49.9, 39.8, 36.7, 34.0, 29.6, 28.5. 
 
5-amino-N-(4-phenylthiazol-2-yl)pentanamide (3.93): Boc-amine 3.86 (0.660 g, 1.76 
mmol) and TFA/CH2Cl2 (3 mL each) were reacted following the general procedure for 
boc removal to produce 3.93 as a colorless solid (0.365 g, 75%). 
IR (neat, NaCl) 3500-2600 (broad), 3387, 1687, 1527 cm
-1
; 
1
H NMR (MeOD-D4): δ 7.66 
(2H, d, J = 7.1Hz), 7.04-7.18 (4H, m), 2.76 (2H, t, J = 7.2 Hz), 2.35 (2H, t, J = 6.8 Hz), 
1.52-1.61 (4H, m); 
13
C {
1
H} NMR (MeOD-D4): δ 173.2, 159.3, 151.3, 136.0, 129.7, 
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129.0, 127.1, 108.6, 40.5, 35.8, 28.1, 23.1; HRMS (FAB, MH
+
) calcd for C14H18N3OS: 
276.1171. Found 276.1172. 
 
4-amino-N-(4-phenylthiazol-2-yl)butanamide (3.94): Boc-amine 3.87 (0.200 g, 0.548 
mmol) and TFA/CH2Cl2 (1 mL each) were reacted following the general procedure of 
boc removal to produce 3.94 as a colorless solid (0.105 g, 72%). 
IR (neat, NaCl) 3500-2500 (broad), 1679, 1664, 1537 cm
-1
; 
1
H NMR (MeOD-D4) δ 7.91 
(2H, d, J = 7.4 Hz), 7.40  (2H, t, J = 7.6 Hz), 7.38 (1H, s), 7.31 (1H, t, J = 7.5 Hz), 3.07 
(2H, t, J = 7.6 Hz), 2.67 (2H, t, J = 7.0 Hz), 2.06 (2H, quin, J = 7.1 Hz); 
13
C NMR 
(MeOD-D4) δ 171.0, 158.1, 150.1, 134.7, 128.5, 127.8, 125.9, 107.4, 39.1, 31.9, 22.6; 
HRMS (FAB, MNa
+
) calcd for C13H15N3OSNa: 284.0833. Found 284.0839. 
 
3-amino-N-(4-phenylthiazol-2-yl)propanamide (3.95): Boc-amine 3.88 (0.868 g, 2.50 
mmol) and TFA/CH2Cl2 (5 mL each) were reacted following the general procedure for 
boc removal to produce 3.95 as a colorless solid (0.510 g, 82%). 
IR (neat, NaCl) 3400-2400 (broad), 1676, 1537 cm-
1
; 
1
H NMR (MeOD-D4): δ 7.88-7.91 
(2H, m), 7.36-7.41 (2H, m), 7.38 (1H, s), 7.27-7.32 (1H, m), 3.31-3.33 (2H, m), 2.91 (2H, 
t, J = 6.3 Hz); 
13
C {
1
H} NMR (MeOD-D4): δ 170.9, 159.3, 151.2, 136.0, 129.7, 128.9, 
127.1, 108.7, 36.8, 35.4; HRMS (FAB, MH
+
) calcd for C12H14N3OS: 248.0857. Found 
248.0861. 
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2-amino-N-(4-phenylthiazol-2-yl)acetamide (3.96): Boc-amine 3.89 (0.833 g, 2.50 
mmol) and TFA/CH2Cl2 (5 mL each) were reacted following the general procedure for 
boc removal to produce 3.96 as a colorless solid (0.495 g, 85%). 
IR (neat, NaCl) 3366, 3200, 3092, 1676, 1545 cm-
1
; 
1
H NMR (MeOD-D4): δ 7.85-7.88 
(2H, m), 7.34-7.40 (2H, m), 7.36 (1H, s), 7.25-7.31 (1H, m), 3.70 (2H, brd s); 
13
C {
1
H} 
NMR (MeOD-D4): δ 169.3, 157.9, 150.1, 134.7, 128.5, 127.8, 125.9, 107.6, 42.7; HRMS 
(FAB, MNa
+
) calcd for C11H11N3OSNa: 256.0521. Found 256.0525. 
 
5-amino-N-(benzo[d]thiazol-2-yl)pentanamide (3.97): Boc-amine 3.90 (0.314 g, 0.90 
mmol) and TFA/CH2Cl2 (2 mL each) were reacted following the general procedure for 
boc removal to produce 3.97 as a colorless solid (0.175 g, 78%). 
IR (neat, NaCl) 3362, 3252, 3203, 2937, 1695, 1597 cm
-1
; 
1
H NMR (DMSO-D6): δ 7.97 
(1H, d, J = 7.7 Hz), 7.73 (1H, d, J = 8.0 Hz), 7.43 (1H, t, J = 7.2 Hz), 7.30 (1H, t, J = 7.3 
Hz), 2.77 (2H, t, J = 6.4 Hz), 2.54 (2H, t, J = 6.5 Hz), 1.61-1.68 (4H, m); 
13
C {
1
H} NMR 
(DMSO-D6): δ 172.7, 158.5, 149.2, 132.1, 126.7, 124.1, 122.3, 121.1, 39.1, 35.2, 27.2, 
22.2; HRMS (FAB, MH
+
) calcd for C12H16N3OS: 250.1014. Found 250.1008. 
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5-amino-N-benzylpentanamide (3.98): Boc-amine 3.91 (0.520 g, 1.70 mmol) and 
TFA/CH2Cl2 (3.5 mL each) were reacted following the general procedure for boc 
removal to give the crude product. The highly polar product remained in the aqueous 
layer while the reaction mixture was neutralized with saturated aq. NaHCO3 solution. 
Therefore, the aq. layer was evaporated to obtain off-white solid, which was extracted 
with EtOAc (10 mL, 3X) to produce 3.98. The product was used for the next step without 
further purification. 
1
H NMR (MeOD-D4): δ 7.20-7.32 (5H, m), 4.37 (2H, d, J = 5.7 Hz), 2.85 (2H, broad s), 
2.29 (2H, t, J = 6.7 Hz), 1.62-1.171 (4H, m) (also contains ethyl acetate peaks). 
 
5-amino-N-(4-morpholinophenyl)pentanamide (3.99): Boc-amine 3.92 (0.430 g, 1.14 
mmol) and TFA/CH2Cl2 (2 mL each) were reacted following the general procedure of 
boc removal to give the product 3.99. The highly polar product remained in the aqueous 
layer while the reaction mixture was neutralized with aq. NaHCO3 solution. Therefore, 
the aq. layer was evaporated and the remaining thick liquid was used without any 
purification for the further reaction. 
IR (neat, NaCl) 3305, 3027, 2970, 1657, 1510 cm
-1
; 
1
H NMR (MeOD-D4): δ 7.36 (2H, d, 
J = 9.1 Hz), 6.84 (2H, d, J = 9.1 Hz), 3.74 (4H, t, J = 4.7 Hz), 3.01 (4H, t, J = 4.8 Hz), 
2.89 (2H, t, J = 6.9 Hz), 2.35 (2H, t, J = 6.6 Hz), 1.60-1.71 (4H, m); 
13
C {
1
H} NMR 
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(MeOD-D4): δ 173.5, 149.7, 132.6, 122.6, 117.4, 68.0, 51.1, 40.4, 36.8, 28.1, 23.5; 
HRMS (FAB, MNa) calcd for C15H23N3O2Na: 300.1688. Found 300.1689. 
Inhibitors and their precursors: 
 
5-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)-N-(5-oxo-5-((4-phenylthiazol-2-
yl)amino)pentyl)thiophene-2-carboxamide (3.100): EDC.HCl (0.366 g, 1.908 mmol), 
HOBt (0.258 g, 1.908 mmol), acid 3.47 (0.290 g, 0.954 mmol), and amine 3.93 (0.315 g, 
1.145 mmol) were reacted in dry DMF (6 mL) following the general procedure for EDC 
coupling to afford 3.100 as a colorless solid (0.180 g, 34%). 
IR (neat, NaCl) 3427, 3252, 2913, 1756, 1687, 1625, 1540 cm
-1
; 
1
H NMR (DMSO-D6): δ 
12.24 (1H, s), 8.59 (1H, t, J = 5.5 Hz), 8.07 (1H, d, J = 2.2 Hz), 8.00 (1H, dd, J = 2.3, 8.6 
Hz), 7.88 (2H, d, J = 7.3 Hz), 7.73 (1H, d, J = 3.9 Hz), 7.57 (1H, s), 7.55 (1H, d, J = 3.9 
Hz), 7.42 (2H, t, J = 7.3 Hz), 7.31 (1H, t, J = 7.2 Hz), 7.19 (1H, d, J = 8.6 Hz), 3.28 (2H, 
app q, J = 6.3 Hz), 2.51 (2H, t, J = 6.4 Hz), 1.68 (6H, s), 1.54-1.66 (4H, m); 
13
C {
1
H} 
NMR (DMSO-D6): δ 171.5, 160.8, 159.9, 157.8, 155.2, 148.7, 145.1, 139.3, 134.2, 134.1, 
129.0, 128.7, 128.2, 127.7, 125.6, 125.5, 124.7, 118.4, 113.5, 107.8, 106.8, 34.5, 28.6, 
25.2 (2C), 22.2, 21.0; HRMS (FAB, MNa
+
) calcd for C29H27N3O5S2Na: 584.1290. Found 
584.1308. 
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2-hydroxy-5-(5-((5-oxo-5-((4-phenylthiazol-2-l)amino)pentyl)carbamoyl) thiophen-
2-yl)benzoic acid: Compound 3.100 (0.090 g, 0.160 mmol) was reacted with TFA (0.90 
mL) and water (0.10 mL) following the general procedure for acetonide removal to afford 
the product 3.116 as a yellow solid (0.055 g, 66%). 
IR (neat, NaCl) 3309, 3300-2300 (broad), 1715, 1679, 1617, 1552 cm
-1
; 
1
H NMR 
(DMSO-D6): δ 12.25 (1H, s), 8.51 (1H, t, J = 5.5 Hz), 8.04 (1H, d, J = 2.3 Hz), 7.89 (2H, 
d, J = 7.4 Hz), 7.86 (1H, dd, J = 2.3, 8.6 Hz), 7.71 (1H, d, J = 3.9 Hz), 7.60 (1H, s), 7.44 
(1H, d, J = 4.0 Hz), 7.42 (2H, d, J = 7.8 Hz), 7.34 (1H, t, J = 7.3 Hz), 7.05 (1H, d, J = 8.7 
Hz), 3.27 (2H, app q, J = 6.5 Hz), 2.51 (2H, t, J = 5.8 Hz), 1.66-1.69 (2H, m), 1.55-1.58 
(2H, m); 
13
C {
1
H} NMR (DMSO-D6): δ 171.5, 171.3, 161.0, 160.8, 157.9, 148.7, 146.2, 
138.4, 134.3, 132.8, 129.0, 128.7, 127.7, 127.0, 125.6, 124.6, 123.6, 118.2, 113.6, 107.9, 
39.0, 34.6, 28.7, 22.3; HRMS (FAB, MH
+
) calcd for C26H24N3O5S2: 522.1157. Found 
522.1158. 
 
5-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)-N-(4-oxo-4-((4-phenylthiazol-2-
yl)amino)butyl)thiophene-2-carboxamide (3.101): EDC.HCl (0.057 g, 0.300 mmol), 
HOBt (0.040 g, 0.300 mmol), acid 3.47 (0.061 g, 0.200 mmol), and amine 3.94 (0.079 g, 
0.300 mmol) were reacted in dry DMF (2 mL) following the general procedure for EDC 
coupling to afford 3.101 as a colorless solid (0.072 g, 66%). 
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IR (neat, NaCl) 3355, 3196, 2930, 1749, 1668, 1614 cm
-1
; 
1
H NMR (DMSO-D6): δ 12.27 
(1H, s), 8.59 (1H, t, J = 5.5 Hz), 8.09 (1H, d, J = 2.4 Hz), 8.02 (1H, dd, J = 2.4, 8.6 Hz), 
7.89 (1H, d, J = 7.2 Hz), 7.75 (1H, d, J = 3.9 Hz), 7.61 (1H, s), 7.59 (1H, d, J = 3.9 Hz), 
7.43 (2H, t, J = 7.3 Hz), 7.31 (1H, t, J = 7.3 Hz), 7.22 (1H, d, J = 8.6 Hz), 3.31 (2H, app 
q, J = 6.3 Hz), 2.55 (2H, t, J = 7.3 Hz), 1.90 (2H, quin, J = 7.0 Hz), 1.74 (6H, s); 
13
C 
{
1
H} NMR (DMSO-D6): δ 171.2, 160.8, 159.8, 157.8, 155.2, 148.7, 145.1, 139.3, 134.3, 
134.1, 129.1, 128.7, 128.2, 127.7, 125.6, 125.5, 124.7, 118.4, 113.5, 107.8, 106.8, 38.6, 
32.3, 25.3 (2C), 24.6; HRMS (FAB, MH
+
) calcd for C28H26N3O5S2: 548.1314. Found 
548.1298. 
 
2-hydroxy-5-(5-((4-oxo-4-((4-phenylthiazol-2-yl)amino)butyl)carbamoyl) thiophen-
2-yl)benzoic acid (3.117): Compound 3.101 (0.045 g, 0.082 mmol) was reacted with 
TFA (0.90 mL) and water (0.10 mL) following the general procedure for acetonide 
removal to afford the product 3.117 as a yellow solid (0.036 g, 86%). 
IR (neat, NaCl) 3301, 2961, 2915, 1688, 1626, 1560 cm
-1
; 
1
H NMR (DMSO-D6): δ 12.27 
(1H, s), 8.55 (1H, brd s), 8.04 (1H, brd s), 7.84-7.90 (3H, m), 7.72 (1H, d, J = 3.5 Hz), 
7.60 (1H, s), 7.45 (1H, d, J = 3.4 Hz), 7.41 (2H, d, J = 7.5 Hz), 7.31 (1H, t, J = 7.1 Hz), 
7.04 (1H, d, J = 8.6 Hz), 3.31 (2H, under HOD peak), 2.54 (2H, t, J = 6.5 Hz), 1.86-1.90 
(2H, m); 
13
C {
1
H} NMR (DMSO-D6): δ 171.9 (2C), 161.8, 161.7, 158.6, 149.4, 147.0, 
139.0, 135.0, 133.5, 129.8, 129.4, 128.4, 127.7, 126.3, 125.3, 124.2, 118.9, 114.4, 108.6, 
39.2, 33.1, 25.4; HRMS (FAB, MH
+
) calcd for C25H21N3O5S2Na: 530.0820. Found 
530.0809. 
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5-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)-N-(3-oxo-3-((4-phenylthiazol-2-
yl)amino)propyl)thiophene-2-carboxamide (3.102): EDC.HCl (0.077 g, 0.400 mmol), 
HOBt (0.054 g, 0.400 mmol), acid 3.47 (0.061 g, 0.200 mmol), and amine 3.95 (0.059 g, 
0.240 mmol) were reacted in dry DMF (2 mL) following the general procedure for EDC 
coupling to afford 3.102 as a colorless solid (0.047 g, 44%). 
IR (neat, NaCl) 3350, 3188, 2930, 1749, 1668, 1612 cm
-1
; 
1
H NMR (DMSO-D6): δ 12.36 
(1H, s), 8.75 (1H, t, J = 5.4 Hz), 8.09 (1H, d, J = 2.3 Hz), 8.03 (1H, dd, J = 2.4, 8.6 Hz), 
7.90 (2H, d, J = 7.2 Hz), 7.76 (1H, d, J = 4.0 Hz), 7.63 (1H, s), 7.59 (1H, d, J = 3.9 Hz), 
7.43 (2H, t, J = 7.3 Hz), 7.32 (1H, t, J = 7.3 Hz), 7.22 (1H, d, J = 8.6 Hz), 3.59 (2H, app 
q, J = 6.3 Hz), 2.78 (2H, t, J = 6.7 Hz), 1.73 (6H, s); 
13
C {
1
H} NMR (DMSO-D6): δ 
169.8, 161.0, 159.8, 157.8, 155.3, 148.7, 145.3, 139.1, 134.3, 134.2, 129.3, 128.7, 128.2, 
127.8, 125.6, 125.6, 124.8, 118.4, 113.6, 107.9, 106.8, 35.4, 35.0, 25.3 (2C). 
 
2-hydroxy-5-(5-((3-oxo-3-((4-phenylthiazol-2-yl)amino)propyl)carbamoyl) thiophen-
2-yl)benzoic acid (3.118): Compound 3.102 (0.035 g, 0.066 mmol) was treated with 
TFA (0.90 mL) and water (0.10 mL) following the general procedure for acetonide 
removal to afford the product 3.118 as a yellow solid (0.026 g, 81%). 
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IR (neat, NaCl) 3500-2500 (broad), 1672, 1606, 1552 cm
-1
; 
1
H NMR (DMSO-D6): δ 
12.35 (1H, s), 8.69 (1H, t, J = 5.1 Hz), 8.04 (1H, brd s), 7.89 (2H, d, J = 7.6 Hz), 7.87 
(1H, d, J = 8.6 Hz), 7.73 (1H, d, J = 3.7 Hz), 7.62 (1H, s), 7.45 (1H, d, J = 3.9 Hz), 7.42 
(2H, d, J = 7.6 Hz), 7.32 (1H, t, J = 7.3 Hz), 7.05 (1H, d, J = 8.6 Hz), 3.58 (2H, app q, J = 
5.9 Hz), 2.78 (2H, t, J = 6.6); 
13
C {
1
H} NMR (DMSO-D6): δ 170.5 (2C), 161.8 (2C), 
158.5, 149.5, 147.1, 138.8, 135.0, 133.5, 130.0, 129.4, 128.5, 127.7, 126.4, 125.3, 124.3, 
118.9, 108.7, 36.0, 35.8; HRMS (FAB, MH
+
) calcd for C24H20N3O5S2: 494.0844. Found 
494.0830. 
 
5-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)-N-(2-oxo-2-((4-phenylthiazol-2-
yl)amino)ethyl)thiophene-2-carboxamide (3.103): EDC.HCl (0.057 g, 0.300 mmol), 
HOBt (0.040 g, 0.300 mmol), acid 3.47 (0.061 g, 0.200 mmol), and amine 3.96 (0.056 g, 
0.240 mmol) were reacted in dry DMF (2 mL) following the general procedure for EDC 
coupling to afford 3.103 as a colorless solid (0.086 g, 83%). 
IR (neat, NaCl) 3405, 3193, 3065, 2988, 1745, 1691, 1637 cm
-1
; 
1
H NMR (DMSO-D6): δ 
12.50 (1H, s), 9.07 (1H, t, J = 5.5 Hz), 8.12 (1H, d, J = 1.9 Hz), 8.06 (1H, dd, J = 1.9, 8.6 
Hz), 7.92 (2H, d, J = 7.6 Hz), 7.85 (1H, d, J = 3.8 Hz), 7.66 (2H, s), 7.45 (2H, t, J = 7.6 
Hz), 7.34 (1H, t, J = 7.1 Hz), 7.24 (1H, t, J = 8.6 Hz), 4.21 (2H, d, J = 5.5 Hz), 1.74 (6H, 
s); 
13
C {
1
H} NMR (DMSO-D6): δ 168.9, 162.2, 160.6, 158.5, 156.1, 149.6, 146.4, 139.1, 
135.0 (2C), 130.6, 129.5, 128.9, 128.6, 126.4 (2C), 125.6, 119.2, 114.3, 108.9, 107.6, 
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43.1, 26.0 (2C); HRMS (FAB, MH
+
) calcd for C26H22N3O5S2: 520.1001. Found 
520.1010. 
 
2-hydroxy-5-(5-((2-oxo-2-((4-phenylthiazol-2-yl)amino)ethyl)carbamoyl) thiophen-2-
yl)benzoic acid (3.119): Compound 3.103 (0.060 g, 0.116 mmol) was reacted with TFA 
(0.90 mL) and water (0.10 mL) following the general procedure for acetonide removal to 
afford the product 3.119 as a yellow solid (0.047 g, 85%). 
IR (neat, NaCl) 3400-2400 (broad), 1695, 1641, 1591 cm
-1
; 
1
H NMR (DMSO-D6): δ 
12.48 (1H, s), 9.00 (1H, brd s), 8.08 (1H, brd s), 7.90-7.93 (3H, m), 7.83 (1H, s), 7.65 
(1H, s), 7.52 (1H, d, J = 3.1 Hz), 7.45 (2H, t, J = 7.1 Hz), 7.34 (1H, t, J = 7.0 Hz), 7.07 
(1H, d, J = 8.5 Hz), 4.21 (2H, under HOD peak); 
13
C {
1
H} NMR (DMSO-D6): δ 171.9, 
169.0, 162.2, 161.8, 158.4, 149.6, 147.5, 138.0, 135.0, 133.6, 130.6, 129.4, 128.5, 127.8, 
126.4, 125.2, 124.4, 118.9, 114.4, 108.8, 43.1; HRMS (FAB, MNa) calcd for 
C23H17N3O5S2Na: 502.0507. Found 502.0491. 
 
5-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)-N-(4-phenylthiazol-2-
yl)thiophene-2-carboxamide (3.104): EDC.HCl (0.043 g, 0.225 mmol), HOBt (0.030 g, 
0.225 mmol), acid 3.47 (0.046 g, 0.150 mmol), and amine 3.78 (0.040 g, 0.225 mmol) 
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were reacted in dry DMF (1 mL) following the general procedure for EDC coupling to 
afford 3.104 as a yellow solid (0.043 g, 62%). 
IR (neat, NaCl) 3405, 3193, 3065, 1745, 1691, 1637 cm
-1
; 
1
H NMR (DMSO-D6): δ 12.94 
(1H, s), 8.30 (1H, d, J = 4.0 Hz), 8.16 (1H, d, J = 2.3 Hz), 8.09 (1H, dd, J = 2.4, 8.6 Hz), 
7.96 (2H, d, J = 7.2 Hz), 7.72 (1H, d, J = 4.0 Hz), 7.71 (1H, s), 7.46 (2H, t, J = 7.2 Hz), 
7.35 (1H, t, J = 7.3 Hz), 7.25 (1H, t, J = 8.6 Hz), 1.74 (6H, s); 
13
C {
1
H} NMR (DMSO-
D6): δ 160.5, 160.1, 158.8, 156.4, 149.9, 148.7, 136.9, 135.2, 135.0, 132.9, 129.5, 128.6, 
128.5, 126.7, 126.5, 126.2, 119.2, 114.3, 109.4, 107.6, 26.0. 
 
2-hydroxy-5-(5-((4-phenylthiazol-2-yl)carbamoyl)thiophen-2-yl)benzoic acid (3.120): 
Compound 3.104 (0.030 g, 0.065 mmol) was treated with TFA (0.90 mL) and water (0.10 
mL) following the general procedure for acetonide removal to afford the product 3.120 as 
a yellow solid (0.023 g, 84%). 
IR (neat, NaCl) 3500-2500 (broad), 1664, 1614, 1556 cm
-1
; 
1
H NMR (DMSO-D6): δ 
12.90 (1H, s), 8.29 (1H, d, J = 3.3 Hz), 8.11 (1H, broad s), 7.93-7.98 (3H, m), 7.70 (1H, 
broad s), 7.60 (1H, d, J = 3.0 Hz), 7.46 (2H, t, J = 7.2 Hz), 7.35 (1H, t, J = 7.2 Hz), 7.09 
(1H, d, J = 8.6 Hz); 
13
C {
1
H} NMR (DMSO-D6): δ 171.9, 162.2, 160.2, 158.9, 150.0, 
149.8, 135.8, 135.0, 133.7, 132.9, 129.5, 128.5, 128.1, 126.5, 125.0, 124.8, 119.0, 114.7, 
109.4. 
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5-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)-N-(5-oxo-5-((4-phenylthiazol-2-
yl)amino)pentyl)isoxazole-3-carboxamide (3.105): EDC.HCl (0.332 g, 1.73 mmol), 
HOBt (0.234 g, 1.73 mmol), acid 3.45 (0.250 g, 0.865 mmol), and amine 3.93 (0.262 g, 
0.951 mmol) were reacted in dry DMF (3 mL) following the general procedure for EDC 
coupling to afford 3.105 as a colorless solid (0.190 g, 40%). 
IR (neat, NaCl) 3409, 3119, 2934, 1740, 1690, 1667 cm
-1
; 
1
H NMR (CDCl3): δ 11.43 
(1H, s), 8.38 (1H, d, J = 2.1 Hz), 7.91 (1H, dd, J = 2.2, 8.6 Hz), 7.79 (2H, d, J = 7.0 Hz), 
7.41 (2H, t, J = 6.9 Hz), 7.36 (1H, t, J = 7.1 Hz), 7.13 (1H, s), 7.04 (1H, d, J = 8.6 Hz), 
7.01 (1H, s), 3.39 (2H, app q, J = 6.6 Hz), 2.22 (2H, t, J = 7.2 Hz), 1.77 (6H, s), 1.66 (2H, 
app quin, J = 7.5 Hz), 1.48 (2H, app quin, J = 6.8 Hz); 
13
C {
1
H} NMR (CDCl3): δ 171.3, 
169.9, 160.3, 159.7, 159.4, 159.1, 157.6, 149.6, 134.4, 133.8, 129.1, 128.4, 127.5, 126.5, 
121.9, 118.5, 114.1, 108.1, 107.2, 99.4, 39.0, 35.3, 28.8, 26.0, 22.2; HRMS (FAB, MH
+
) 
calcd for C28H27N4O6S: 547.1651. Found 547.1641. 
 
2-hydroxy-5-(3-((5-oxo-5-((4-phenylthiazol-2-yl)amino)pentyl)carbamoyl) isoxazol-
5-yl)benzoic acid (3.121): Compound 3.105 (0.065 g, 0.120 mmol) was treated with 
TFA (0.90 mL) and water (0.10 mL) following the general procedure for acetonide 
removal to afford the product 3.121 as a colorless solid (0.035 g, 58%). 
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IR (neat, NaCl) 3347, 3119, 3300-2500 (broad), 2934, 1695, 1676, 1620 cm
-1
; 
1
H NMR 
(DMSO-D6): δ 12.22 (1H, s), 8.82 (1H, t, J = 5.7 Hz), 8.24 (1H, d, J = 2.2 Hz), 8.02 (1H, 
dd, J = 2.2, 8.7 Hz), 7.86 (2H, d, J = 7.3 Hz), 7.56 (1H, s), 7.41 (2H, t, J = 7.3 Hz), 7.30 
(1H, t, J = 7.2 Hz), 7.22 (1H, s), 7.10 (1H, d, J = 8.7 Hz), 3.28 (2H, app q, J = 6.4 Hz), 
2.48 (2H, t, J = 7.2 Hz), 1.56-1.68 (4H, m); 
13
C {
1
H} NMR (DMSO-D6): δ 171.9, 171.3, 
169.9, 163.0, 160.1, 158.9, 158.3, 149.1, 134.6, 133.3, 129.1, 128.2, 128.0, 126.0, 118.8, 
118.1, 108.2, 99.1, 38.9, 34.9, 28.7, 22.6; HRMS (FAB, MH
+
) calcd for C25H23N4O6S: 
507.1338. Found 507.1336. 
 
4-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)-N-(5-oxo-5-((4-phenylthiazol-2-
yl)amino)pentyl)thiophene-2-carboxamide (3.106): EDC.HCl (0.192 g, 1.00 mmol), 
HOBt (0.135 g, 1.00 mmol), acid 3.48 (0.152 g, 0.500 mmol), and amine 3.93 (0.165 g, 
0.600 mmol) were reacted in dry DMF (2 mL) following the general procedure for EDC 
coupling to afford 3.106 as a colorless solid (0.112 g, 40%). 
IR (neat, NaCl) 3413, 3250, 3212, 2951, 1742, 1680, 1622, 1541 cm
-1
; 
1
H NMR (DMSO-
D6): δ 12.26 (1H, s), 8.58 (1H, t, J = 5.1 Hz), 8.29 (1H, s), 8.15 (2H, d, J = 5.0 Hz), 8.05 
(1H, d, J = 8.6 Hz), 7.89 (2H, d, J = 7.8 Hz), 7.60 (1H, s), 7.43 (2H, t, J = 7.5 Hz), 7.32 
(1H, t, J = 7.3 Hz), 7.23 (1H, d, J = 8.5 Hz), 3.30 (2H, app q, J = 6.7 Hz), 2.50 (2H, under 
solvent peaks), 1.73 (6H, s), 1.68 (2H, app quin, J = 7.1 Hz), 1.58 (2H, app quin, J = 7.0 
Hz); 
13
C {
1
H} NMR (DMSO-D6): δ 172.2, 161.5, 160.9, 158.6, 155.4, 149.4, 141.9, 
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140.4, 135.1, 135.0, 130.5, 129.4, 128.4, 126.8, 126.4, 126.3, 126.2, 118.8, 114.1, 108.6, 
107.4, 41.0, 35.3, 29.4, 26.0, 23.0; HRMS (FAB, MH
+
) calcd for C29H28N3O5S2: 
562.1470. Found 562.1466. 
 
2-hydroxy-5-(5-((5-oxo-5-((4-phenylthiazol-2-yl)amino)pentyl)carbamoyl) thiophen-
3-yl)benzoic acid (3.122): Compound 3.106 (0.042 g, 0.075 mmol) was treated with 
TFA (0.90 mL) and water (0.10 mL) following the general procedure for acetonide 
removal to afford the product 3.122 as a purple solid (0.035 g, 90%). 
IR (neat, NaCl), 3400-2500 (broad), 3305, 2938, 1680, 1622, 1606, 1552 cm
-1
; 
1
H NMR 
(DMSO-D6): δ 12.30 (1H, s), 8.64 (1H, brd s), 8.24 (1H, s), 8.11 (1H, brd d, J = 7.8 Hz), 
8.04 (1H, s), 7.94 (2H, d, J = 7.2 Hz), 7.91 (1H, s), 7.64 (1H, s), 7.48 (2H, t, J = 7.2 Hz), 
7.37 (1H, t, J = 7.2 Hz), 7.13 (1H, brd d, J = 6.0 Hz), 3.28 (2H, app q, J = 6.4 Hz), 2.48 
(2H, t, J = 7.2 Hz), 1.56-1.68 (4H, m); 
13
C NMR {
1
H} (DMSO-D6): δ 172.1, 161.6, 
158.6, 149.4, 141.7, 141.2, 135.0, 133.8, 129.4, 128.4, 128.1, 126.9, 126.7, 126.3, 124.9, 
118.8, 108.6, 39.4, 35.3, 29.4, 23.0; HRMS (FAB, MH
+
) calcd for C26H24N3O5S2: 
522.1157. Found 522.1157. 
 
3-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)-N-(5-oxo-5-((4-phenylthiazol-2-
yl)amino)pentyl)benzamide (3.107): EDC.HCl (0.153 g, 0.800 mmol), HOBt (0.108 g, 
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0.800 mmol), acid 3.49 (0.119 g, 0.400 mmol), and amine 3.93 (0.165 g, 0.600 mmol) 
were reacted in dry DMF (2 mL) following the general procedure for EDC coupling to 
afford 3.107 as a colorless solid (0.095 g, 43%). 
IR (neat, NaCl) 3320, 2946, 1749, 1703, 1626, 1541 cm
-1
; 
1
H NMR (DMSO-D6): δ 12.27 
(1H, s), 8.68 (1H, t, J = 5.4 Hz), 8.20 (1H, d, J = 2.1 Hz), 8.15 (1H, s), 8.08 (1H, dd, J = 
2.1, 8.5 Hz), 7.82-7.91 (4H, m), 7.61 (1H, s), 7.57 (2H, t, J = 7.8 Hz), 7.43 (1H, t, J = 7.6 
Hz), 7.32 (1H, t, J = 7.0 Hz), 6.27 (1H, d, J = 8.6 Hz), 3.33 (2H, under HOD peak), 2.50 
(2H, under solvent peak), 1.74 (6H, s), 1.59-1.70 (4H, m); 
13
C {
1
H} NMR (DMSO-D6): δ 
172.2, 166.5, 160.9, 158.6, 155.8, 149.4, 139.0, 136.2, 136.1, 135.2, 135.0, 129.9, 129.8, 
129.4, 128.5, 127.7, 127.5, 126.4, 125.7, 118.8, 114.2, 108.6, 107.4, 39.2, 35.3, 29.4, 
26.0, 23.0; HRMS (FAB, MH
+
) calcd for C31H30N3O5S: 556.1906. Found 556.1902. 
 
4-hydroxy-3'-((5-oxo-5-((4-phenylthiazol-2-yl)amino)pentyl)carbamoyl)-[1,1'-
biphenyl]-3-carboxylic acid (3.123): Compound 3.107 (0.050 g, 0.090 mmol) was 
treated with TFA (0.90 mL) and water (0.10 mL) following the general procedure for 
acetonide removal to afford the product 3.123 as a yellow solid (0.035 g, 75%). 
IR (neat, NaCl) 3550-2400 (broad), 3505, 3266, 2938, 1634, 1595, 1576 cm
-1
; 
1
H NMR 
(DMSO-D6): δ 12.27 (1H, s), 8.65 (1H, t, J = 5.3 Hz), 8.08-8.12 (2H, m), 7.85-7.95 (3H, 
m), 7.80 (2H, d, J = 8.5 Hz), 7.61 (1H, s), 7.53 (1H, t, J = 7.7 Hz), 7.43 (2H, t, J = 7.1 
Hz), 7.32 (1H, t, J = 7.2 Hz), 7.10 (1H, d, J = 8.5 Hz), 3.43 (2H, under HOD peak), 2.50 
(2H, under solvent peak), 1.59-1.69 (4H, m); 
13
C {
1
H} NMR (DMSO-D6): δ 171.7, 
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171.5, 165.9, 160.8, 157.9, 148.7, 139.0, 135.2, 134.3, 134.0, 130.7, 129.0, 128.7, 128.1, 
127.7, 126.0, 125.6, 124.7, 117.9, 113.4, 107.8, 38.6, 34.6, 28.7, 22.3; HRMS (FAB, 
MNa) calcd for C28H25N3O5SNa: 538.1412. Found 538.1403. 
 
4-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)-N-(5-oxo-5-((4-phenylthiazol-2-
yl)amino)pentyl)benzamide (3.108): EDC.HCl (0.096 g, 0.500 mmol), HOBt (0.067 g, 
0.500 mmol), acid 3.50 (0.075 g, 0.250 mmol), and amine 3.93 (0.103 g, 0.375 mmol) 
were reacted in dry DMF (2 mL) following the general procedure for EDC coupling to 
afford 3.108 as a colorless solid (0.085 g, 61%). 
IR (neat, NaCl) 3320, 2946, 1749, 1703, 1626, 1541 cm
-1
; 
1
H NMR (DMSO-D6): δ 12.27 
(1H, s), 8.55 (1H, t, J = 5.3 Hz), 8.15 (1H, d, J = 2.2 Hz), 8.07 (1H, dd, J = 2.3, 8.6 Hz), 
7.96 (2H, d, J = 8.5 Hz), 7.90 (2H, d, J = 7.1 Hz), 7.80 (2H, d, J = 8.5 Hz), 7.61 (1H, s), 
7.43 (2H, t, J = 7.2 Hz), 7.32 (1H, t, J = 7.3 Hz), 7.25 (1H, d, J = 8.6 Hz), 3.32 (2H, 
under HOD peak), 2.50 (2H, under solvent peak), 1.74 (6H, s), 1.58-1.69 (4H, m); 
13
C 
{
1
H} NMR (DMSO-D6): δ 172.2, 166.4, 160.8, 158.6, 156.0, 149.4, 141.3, 136.2, 135.0, 
134.7, 134.3, 129.5, 128.7, 128.5, 127.6, 127.0, 126.4, 118.8, 114.2, 108.6, 107.4, 39.4, 
35.3, 29.4, 26.0, 23.1; HRMS (FAB, MNa) calcd for C31H29N3O5SNa: 578.1725. Found 
578.1718. 
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4-hydroxy-4'-((5-oxo-5-((4-phenylthiazol-2-yl)amino)pentyl)carbamoyl)-[1,1'-
biphenyl]-3-carboxylic acid (3.124): Compound 3.108 (0.050 g, 0.090 mmol) was 
treated with TFA (0.90 mL) and water (0.10 mL) following the general procedure for 
acetonide removal to afford the product 3.124 as a yellow solid (0.040 g, 86%). 
IR (neat, NaCl) 3300-2500, 3284, 2941, 1674, 1634, 1625, 1552 cm
-1
; 
1
H NMR (DMSO-
D6): δ 12.27 (1H, s), 8.55 (1H, t, J = 5.3 Hz), 8.10 (1H, d, J = 2.2 Hz), 7.89-7.95 (5H, m), 
7.72 (2H, d, J = 8.2 Hz), 7.61 (1H, s), 7.43 (2H, t, J = 7.3 Hz), 7.32 (1H, t, J = 7.2 Hz), 
7.07 (1H, d, J = 8.6 Hz), 3.32 (2H, under HOD peak), 2.50 (2H, under solvent peak), 
1.58-1.69 (4H, m); 
13
C {
1
H} NMR (DMSO-D6): δ 172.3 (2C), 166.6, 161.7, 158.6, 149.4, 
142.2, 135.0, 134.5, 133.6, 130.8, 129.4, 128.9, 128.6, 128.5, 126.6, 126.3, 118.6, 114.5, 
108.6, 38.7, 35.3, 29.3, 23.0; HRMS (FAB, MNa) calcd for C28H25N4O5SNa: 538.1412. 
Found 538.1400. 
 
N-(5-(benzo[d]thiazol-2-ylamino)-5-oxopentyl)-5-(2,2-dimethyl-4-oxo-4H-
benzo[d][1,3]dioxin-6-yl)thiophene-2-carboxamide (3.109): EDC.HCl (0.038 g, 0.200 
mmol), HOBt (0.027 g, 0.200 mmol), acid 3.47 (0.030 g, 0.100 mmol), and amine 3.97 
(0.050 g, 0.200 mmol) were reacted in dry DMF (1 mL) following the general procedure 
for EDC coupling to afford 3.109 as a colorless solid (0.022 g, 41%). 
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IR (neat, NaCl) 3325, 3203, 2949, 1736, 1699, 1625, 1552 cm
-1
; 
1
H NMR (DMSO-D6): δ 
12.36 (1H, s), 8.58 (1H, t, J = 5.3 Hz), 8.09 (1H, d, J = 2.1 Hz), 8.04 (1H, dd, J = 2.2, 8.6 
Hz), 7.97 (1H, d, J = 7.6 Hz), 7.72-7.76 (2H, m), 7.59 (1H, d, J = 3.9 Hz), 7.43 (1H, t, J = 
7.5 Hz), 7.30 (1H, t, J = 7.6 Hz), 7.22 (1H, d, J = 8.5 Hz), 3.30 (2H, under HOD peak), 
2.50 (2H, under solvent peak), 1.79 (6H, s), 1.57-1.73 (4H, m); 
13
C {
1
H} NMR (DMSO-
D6): δ 172.9, 161.4, 160.5, 158.6, 156.0, 149.2, 145.8, 140.1, 134.9, 132.1, 129.7, 129.0, 
126.8, 126.2, 125.5, 124.1, 122.4, 121.2, 119.1, 114.3, 107.6, 39.4, 35.5, 29.4, 26.0, 22.8; 
HRMS (FAB, MH
+
) calcd for C27H26N3O5S2: 536.1314. Found 536.1306. 
 
5-(5-((5-(benzo[d]thiazol-2-ylamino)-5-oxopentyl)carbamoyl)thiophen-2-yl)-2-
hydroxybenzoic acid (3.125): Compound 3.109 (0.018 g, 0.033 mmol) was treated with 
TFA (0.45 mL) and water (0.05 mL) following the general procedure for acetonide 
removal to afford the product 3.125 as a yellow solid (0.013 g, 79%). 
IR (neat, NaCl) 3405, 3320, 3181, 3050, 2940, 1734, 1699, 1626, 1564 cm
-1
; 
1
H NMR 
(DMSO-D6): δ 12.35 (1H, s), 8.52 (1H, t, J = 5.2 Hz), 8.03 (1H, d, J = 2.0 Hz), 7.97 (1H, 
d, J = 7.2 Hz), 7.86 (1H, dd, J = 2.2, 8.6 Hz), 7.73 (1H, d, J = 7.8 Hz), 7.71 (1H, s), 7.46 
(1H, s), 7.43 (1H, t, J = 7.7 Hz), 7.30 (1H, t, J = 7.5 Hz), 7.04 (1H, d, J = 8.7 Hz), 3.23 
(2H, app q, J = 6.4 Hz), 2.55 (2H, t, J = 6.8 Hz), 1.57-1.71 (4H, m); 
13
C {
1
H} NMR 
(DMSO-D6): δ 172.9, 172.0, 161.8, 161.5, 158.6, 149.2, 146.9, 139.1, 133.4, 132.1, 
129.7, 127.7, 126.8, 125.3, 124.2, 124.1, 122.4, 121.1, 118.9, 114.5, 38.9, 35.5, 29.4, 
22.8; HRMS (FAB, MH
+
) calcd for C24H22N3O5S2: 496.1001. Found 496.0996. 
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N-(5-(benzylamino)-5-oxopentyl)-5-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3] dioxin-6-
yl)thiophene-2-carboxamide (3.110): EDC.HCl (0.072 g, 0.375 mmol), HOBt (0.051 g, 
0.375 mmol), acid 3.47 (0.076 g, 0.250 mmol), and amine 3.98 (0.077 g, 0.375 mmol) 
were reacted in dry DMF (2 mL) following the general procedure for EDC coupling to 
afford 3.110 as a colorless solid (0.112 g, 91%). 
IR (neat, NaCl) 3270, 3077, 2938, 2857, 1738, 1649, 1560 cm
-1
; 
1
H NMR (DMSO-D6): δ 
8.69 (1H, brd s), 8.41 (1H, t, J = 5.8 Hz), 8.08 (1H, s), 8.03 (1H, d, J = 9.6 Hz), 7.79 (1H, 
d, J = 3.4 Hz), 7.58 (1H, d, J = 3.6 Hz), 7.21-7.33 (6H, m), 4.26 (2H, d, J = 5.7 Hz), 3.24 
(2H, app q, J = 5.6 Hz), 2.17 (2H, t, J = 6.8 Hz), 1.72 (6H, s), 1.48-1.52 (4H, m); 
13
C 
{
1
H} NMR (DMSO-D6): δ 172.7, 161.4, 160.6, 156.0, 145.7, 140.4, 140.3, 134.9, 129.8, 
129.0, 128.96, 127.9, 127.4, 126.2, 125.5, 119.1, 114.3, 107.6, 42.7, 42.5, 35.8, 29.6, 
26.0, 23.6; HRMS (FAB, MNa) calcd for C27H28N2O5SNa: 515.1616. Found 515.1625. 
 
.5-(5-((5-(benzylamino)-5-oxopentyl)carbamoyl)thiophen-2-yl)-2-hydroxybenzoic 
acid (3.126): Compound 3.110 (0.100 g, 0.203 mmol) was reacted with TFA (0.90 mL) 
and water (0.10 mL) following the general procedure for acetonide removal to afford the 
product 3.126 as a yellow solid (0.046 g, 50%). 
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IR (neat, NaCl) 3305, 3077, 2934, 1684, 1622, 1545 cm
-1
; 
1
H NMR (DMSO-D6): δ 10.62 
(1H, s), 8.50 (1H, brd s), 8.32 (1H, t, J = 5.4 Hz), 8.01 (1H, dd, J = 1.9, 5.8 Hz), 7.84 
(1H, d, J = 8.6 Hz), 7.70 (1H, d, J = 3.5 Hz), 7.45 (1H, brd s), 7.21-7.32 (4H, m), 7.01 
(1H, t, J = 9.3 Hz), 4.25 (2H, d, J = 5.7 Hz), 3.91 (1H, s), 3.23 (2H, app q, J = 5.6 Hz), 
2.17 (2H, t, J = 6.7 Hz), 1.40-1.65 (4H, m); 
13
C {
1
H} NMR (DMSO-D6): (rotomers 
present) δ 172.7, 172.0, 169.1, 161.8, 161.51, 164.49, 160.4, 146.9, 146.7, 140.4, 139.2, 
139.1, 133.4, 133.3, 129.7, 129.0, 127.9, 127.7, 127.5, 127.4, 125.5, 125.3, 124.3, 124.2, 
119.2, 118.9, 114.8, 114.5, 53.3, 42.7, 35.7, 29.6, 23.6; HRMS (FAB, MH
+
) calcd for 
C24H25N2O5S: 453.1484. Found 453.1475. 
 
5-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)-N-(5-((4-morpholinophenyl) 
amino)-5-oxopentyl)thiophene-2-carboxamide (3.111):  EDC.HCl (0.077 g, 0.400 
mmol), HOBt (0.054 g, 0.400 mmol), acid 3.47 (0.061 g, 0.200 mmol), and amine 3.99 
(0.111 g, 0.200 mmol) were reacted in dry DMF (2 mL) following the general procedure 
for EDC coupling to afford 3.111 as a purple solid (0.055 g, 49%). 
IR (neat, NaCl) 3328, 2953, 1738, 1657, 1610 cm
-1
; 
1
H NMR (DMSO-D6): δ 9.78 (1H, 
s), 8.61 (1H, t, J = 5.6 Hz), 8.09 (1H, d, J = 2.3 Hz), 8.03 (1H, dd, J = 2.3, 8.6 Hz), 7.76 
(1H, d, J = 3.9 Hz), 7.48 (2H, d, J = 8.9 Hz), 7.22 (1H, d, J = 8.6 Hz), 6.96 (2H, d, J = 8.4 
Hz), 3.76 (4H, t, J = 4.8 Hz), 3.28 (2H, app q, J = 5.9 Hz), 3.07 (4H, app t, J = 4.9 Hz), 
2.31 (2H, t, J = 6.5 Hz), 1.73 (6H, s), 1.56-1.63 (4H, m); 
13
C {
1
H} NMR (DMSO-D6): δ 
171.4, 161.4, 160.6, 156.0, 146.2, 145.8, 140.2, 134.9, 133.5, 129.8, 129.0, 126.2, 125.5, 
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120.8, 119.1, 117.0, 114.2, 107.6, 66.5, 50.4, 39.4, 36.7, 29.5, 26.0, 23.5; HRMS (FAB, 
MNa) calcd for C30H33N3O6SNa: 586.1988. Found 586.1985. 
 
2-hydroxy-5-(5-((5-((4-morpholinophenyl)amino)-5-oxopentyl)carbamoyl) thiophen-
2-yl)benzoic acid (3.127): Compound 3.111 (0.035 g, 0.062 mmol) was treated with 
TFA (0.90 mL) and water (0.10 mL) following the general procedure for acetonide 
removal to afford the product 3.127 as a purple solid (0.024 g, 75%). 
IR (neat, NaCl) 3400-2500 (broad), 3320, 2953, 1702, 1657, 1610 cm
-1
; 
1
H NMR 
(DMSO-D6): δ 9.67 (1H, s), 8.50 (1H, s), 8.05 (1H, s), 7.87 (1H, d, J = 8.6 Hz), 7.71 (1H, 
d, J = 3.6 Hz), 7.45-7.47 (3H, m), 7.06 (1H, d, J = 8.6 Hz), 6.89 (2H, d, J = 8.7 Hz), 3.74 
(4H, brd s), 3.27 (2H, app q, J = 5.8 Hz), 3.05 (4H, brd s), 2.31 (2H, t, J = 6.7 Hz), 1.56-
1.64 (4H, m); 
13
C {
1
H} NMR (DMSO-D6): δ 172.0, 171.2, 161.7, 161.5, 147.6, 146.9, 
139.1, 133.5, 132.5, 129.7, 127.7, 125.3, 124.2, 120.8, 118.9, 116.2, 114.3, 66.8, 49.8, 
39.4, 36.7, 29.6, 23.5; HRMS (FAB, MNa) calcd for C27H28N3O6SNa2: 568.1486. Found 
568.1486. 
 
5-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)-N-(4-oxo-4-((4-phenylthiazol-2-
yl)amino)butyl)isoxazole-3-carboxamide (3.112): EDC.HCl (0.107 g, 0.560 mmol), 
HOBt (0.076 g, 0.560 mmol), acid 3.45 (0.081 g, 0.280 mmol), and amine 3.94 (0.089 g, 
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0.336 mmol) were reacted in dry DMF (2 mL) following the general procedure for EDC 
coupling to afford 3.112 as a colorless solid (0.100 g, 67%). 
IR (neat, NaCl) 3386, 3239, 3208, 1738, 1688, 1641, 1626, 1549 cm
-1
; 
1
H NMR (DMSO-
D6): δ 12.24 (1H, s), 8.88 (1H, t, J = 5.7 Hz), 8.33 (1H, d, J = 2.1 Hz), 8.22 (1H, dd, J = 
2.1, 8.6 Hz), 7.88 (2H, d, J = 7.4 Hz), 7.58 (1H, s), 7.43 (1H, s), 7.42 (2H, t, J = 7.8 Hz), 
7.31 (1H, t, J = 7.8 Hz), 3.34 (2H, app q, J = 6.6 Hz), 2.54 (2H, t, J = 7.3 Hz), 1.91 (2H, 
app quin, J = 6.8 Hz), 1.74 (6H, s); 
13
C {
1
H} NMR (DMSO-D6): δ 171.2, 168.7, 159.7, 
159.5, 158.4, 157.9, 156.8, 148.7, 134.3, 128.7, 127.7, 126.4, 125.6, 121.4, 118.6, 113.6, 
107.9, 107.1, 100.1, 100.0, 38.4, 32.3, 25.34, 25.29, 24.4; HRMS (FAB, MH
+
) calcd for 
C27H25N4O6S: 533.1495. Found 533.1503. 
 
2-hydroxy-5-(3-((4-oxo-4-((4-phenylthiazol-2-yl)amino)butyl)carbamoyl) isoxazol-5-
yl)benzoic acid (3.128): Compound 3.112 (0.055 g, 0.103 mmol) was treated with TFA 
(0.90 mL) and water (0.10 mL) following the general procedure for acetonide removal to 
afford the product 3.128 as a yellow solid (0.030 g, 59%). 
IR (neat, NaCl) 3347, 3119, 3300-2300 (broad), 1703, 1664 cm
-1
; 
1
H NMR (DMSO-D6): 
δ 12.25 (1H, s), 8.55 (1H, t, J = 5.1 Hz), 8.27 (1H, d, J = 1.7 Hz), 8.06 (1H, dd, J = 1.8, 
8.6 Hz), 7.88 (2H, d, J = 7.5 Hz), 7.59 (1H, s), 7.43 (2H, t, J = 7.3 Hz), 7.32 (1H, t, J = 
7.1 Hz), 7.28 (1H, s), 7.13 (1H, d, J = 8.7 Hz), 3.32 (2H, app q, J = 5.9 Hz), 2.50 (2H, 
under solvent peak), 1.89 (2H, app quin, J = 6.8 Hz); 
13
C {
1
H} NMR (DMSO-D6): δ 
171.2, 171.1, 169.4, 162.6, 159.7, 158.5, 157.9, 148.7, 134.3, 132.9, 128.7, 127.7, 125.6, 
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118.5, 117.8, 113.9, 107.9, 98.3, 98.1, 38.3, 32.3, 24.4; HRMS (FAB, MH
+
) calcd for 
C24H21N4O6S: 493.1181. Found 493.1181. 
 
5-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)-N-(5-((4-morpholino 
phenyl)amino)-5-oxopentyl)isoxazole-3-carboxamide (3.113): EDC.HCl (0.146 g, 
0.760 mmol), HOBt (0.103 g, 0.760 mmol), acid 3.45 (0.110 g, 0.380 mmol), and amine 
3.99 (0.211 g, 0.760 mmol) were reacted in dry DMF (3 mL) following the general 
procedure for EDC coupling to afford 3.113 as a purple solid (0.090 g, 43%). 
IR (neat, NaCl) 3313, 3133, 2945, 1752, 1666, 1625 cm
-1
; 
1
H NMR (DMSO-D6): δ 9.76 
(1H, s), 8.87 (1H, t, J = 5.8 Hz), 8.34 (1H, d, J = 2.1 Hz), 8.24 (1H, dd, J = 2.2, 8.6 Hz), 
7.49 (2H, d, J = 8.9 Hz), 7.44 (1H, s), 7.33 (1H, d, J = 8.7 Hz), 6.97 (2H, d, J = 8.9 Hz), 
3.76 (4H, t, J = 4.3 Hz), 3.29 (2H, app q, J = 5.9 Hz), 3.09 (4H, t, J = 4.4 Hz), 2.31 (2H, 
t, J = 6.4 Hz), 1.74 (6H, s), 1.49-1.62 (4H, m); 
13
C {
1
H} NMR (DMSO-D6): δ 171.3, 
169.9, 160.5, 160.2, 159.0, 157.6, 146.6, 135.0, 133.3, 127.1, 122.1, 120.9, 119.4, 116.9, 
114.3, 107.9, 100.8, 66.6, 50.3, 39.4, 36.6, 29.3, 26.0, 23.4; HRMS (FAB, MNa) calcd 
for C29H32N4O7Na: 571.2169. Found 571.2189. 
 
2-hydroxy-5-(3-((5-((4-morpholinophenyl)amino)-5-oxopentyl)carbamoyl) isoxazol-
5-yl)benzoic acid (3.129): Compound 3.113 (0.060 g, 0.110 mmol) was treated with 
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TFA (0.90 mL) and water (0.10 mL) following the general procedure for acetonide 
removal to afford the product 3.129 as a purple solid (0.040 g, 71%). 
IR (neat, NaCl) 3321, 3300-2400 (broad), 1679, 1589, 1556 cm
-1
; 
1
H NMR (DMSO-D6): 
δ 9.72 (1H, s), 8.83 (1H, t, J = 5.2 Hz), 8.28 (1H, s), 8.06 (1H, d, J = 8.6 Hz), 7.47 (2H, d, 
J = 8.7 Hz), 7.28 (1H, s), 7.14 (1H, d, J = 8.7 Hz), 6.92 (2H, d, J = 8.7 Hz), 3.74 (4H, 
under HOD), 3.28 (2H, app d, J = 5.5 Hz), 3.06 (4H, app s), 2.30 (2H, t, J = 6.5 Hz), 
1.50-1.67 (4H, m); 
13
C {
1
H} NMR (DMSO-D6): δ 1171.8, 171.3, 170.1, 163.3, 160.4, 
159.1, 147.0, 133.6, 133.0, 128.4, 120.9, 119.1, 118.5, 116.6, 114.6, 99.5, 66.7, 50.1, 
39.3, 36.6, 29.3, 23.4; HRMS (FAB, MNa) calcd for C26H28N4O7Na: 531.1855. Found 
531.1838. 
 
N-(5-(benzo[d]thiazol-2-ylamino)-5-oxopentyl)-4-(2,2-dimethyl-4-oxo-4H-
benzo[d][1,3]dioxin-6-yl)thiophene-2-carboxamide (3.112): EDC.HCl (0.077 g, 0.400 
mmol), HOBt (0.054 g, 0.400 mmol), acid 3.47 (0.061 g, 0.200 mmol), and amine 3.96 
(0.100 g, 0.400 mmol) were reacted in dry DMF (2 mL) following the general procedure 
for EDC coupling to afford 3.112 as a colorless solid (0.051 g, 47%). 
IR (neat, NaCl) 3265, 2917, 1739, 1697, 1622 cm
-1
; 
1
H NMR (CDCl3): δ 8.03 (1H, d, J = 
1.9 Hz), 7.78 (1H, s), 7.69 (1H, d, J = 7.9 Hz), 7.65 (1H, dd, J = 2.0, 8.5 Hz), 7.43 (1H, 
s), 7.34 (1H, (1H, t, J = 7.3 Hz), 7.23 (1H, d, J = 7.6 Hz), 6.87 (1H, d, J = 8.5 Hz), 6.84 
(1H, t, J = 6.3 Hz), 3.41 (2H, app q, J = 5.8 Hz), 2.54 (2H, t, J = 6.8 Hz), 1.77 (2H, app 
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quin, J = 7.2 Hz) 1.65 (6H, s), 1.65 (2H, under methyl peak); 
13
C {
1
H} NMR (CDCl3): δ 
172.2, 162.3, 161.3, 155.5, 140.9, 140.5, 134.5, 130.2, 127.1, 126.8, 126.7, 124.8, 124.3, 
121.8, 120.5, 118.1, 113.9, 106.9, 39.6, 35.8, 28.9, 26.0, 22.3; HRMS (FAB, MH
+
) calcd 
for C27H26N3O5S2: 536.1314. Found 536.1308. 
 
5-(5-((5-(benzo[d]thiazol-2-ylamino)-5-oxopentyl)carbamoyl)thiophen-3-yl)-2-
hydroxybenzoic acid (3.130): Compound 3.114 (0.045 g, 0.084 mmol) was treated with 
TFA (0.90 mL) and water (0.10 mL) following the general procedure for acetonide 
removal to afford the product 3.130 as a yellow solid (0.032 g, 77%). 
IR (neat, NaCl) 3280, 2913, 1699, 1617, 1556 cm
-1
; 
1
H NMR (DMSO-D6): δ 12.33 (1H, 
s), 8.58 (1H, brd s), 8.20 (1H, s), 8.09 (1H, brd s), 8.00 (1H, s), 7.97 (1H, d, J = 7.8 Hz), 
7.88 (1H, d, J = 8.4 Hz), 7.73 (1H, d, J = 7.8 Hz), 7.44 (1H, t, J = 7.5 Hz), 7.30 (1H, t, J 
= 7.5 Hz), 7.06 (1H, d, J = 8.5 Hz), 3.31 (2H, app q, J = 5.9 Hz), 2.56 (2H, t, J = 7.0 Hz), 
1.71 (2H, app quin, J = 7.3 Hz), 1.60 (2H, app quin, J = 7.0 Hz); 
13
C {
1
H} NMR 
(DMSO-D6): δ 172.9, 161.6, 160.0, 158.6, 149.3, 141.7, 141.2, 133.9, 132.1, 127.9, 
126.9, 126.8, 126.7, 125.0, 124.2, 122.4, 121.2, 118.7, 39.4, 35.5, 29.4, 22.8; HRMS 
(FAB, MH
+
) calcd for C24H22N3O5S2: 496.1001. Found 496.0986. 
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N-(5-(benzylamino)-5-oxopentyl)-4-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3] dioxin-6-
yl)thiophene-2-carboxamide (3.115): EDC.HCl (0.086 g, 0.450 mmol), HOBt (0.061 g, 
0.450 mmol), acid 3.48 (0.091 g, 0.300 mmol), and amine 3.99 (0.093 g, 0.450 mmol) 
were reacted in dry DMF (2 mL) following the general procedure for EDC coupling to 
afford 3.115 as a colorless solid (0.138 g, 93%). 
IR (neat, NaCl) 3297, 3077, 2919, 1745, 1618, 1550, 1515 cm
-1
; 
1
H NMR (CDCl3): δ 
8.07 (1H, d, J = 2.1 Hz), 7.78 (1H, s), 7.69 (1H, dd, J = 2.1, 8.6 Hz), 7.47 (1H, s), 7.15-
7.25 (5H, m), 6.92 (1H, d, J = 8.5 Hz), 6.03 (1H, broad s), 4.39 (2H, d, J = 5.6 Hz), 3.39 
(2H, app q, J = 5.9 Hz), 2.26 (2H, t, J = 6.8 Hz), 1.60-1.75 (4H, m), 1.68 (6H, s); 
13
C 
{
1
H} NMR (CDCl3): δ 173.4, 162.3, 161.3, 155.5, 140.8, 138.5, 134.4, 130.4, 128.9, 
128.0, 127.6, 127.0, 126.6, 124.7, 118.1, 113.9, 106.9, 43.8, 39.6, 35.8, 28.8, 26.0, 22.8; 
HRMS (FAB, MH
+
) calcd for C27H29N2O5S: 493.1797. Found 493.1808. 
 
5-(5-((5-(benzylamino)-5-oxopentyl)carbamoyl)thiophen-3-yl)-2-hydroxybenzoic 
acid (3.131): Compound 3.115 (0.074 g, 0.150 mmol) was treated with TFA (0.90 mL) 
and water (0.10 mL) following the general procedure for acetonide removal to afford the 
product 3.131 as a yellow solid (0.054 g, 79%). 
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IR (neat, NaCl) 3276, 3080, 2941, 1674, 1634, 1603, 1503 cm
-1
; 
1
H NMR (DMSO-D6): δ 
8.61 (1H, s), 8.35 (1H, s), 8.21 (1H, s), 8.10 (1H, s), 8.00 (1H, s), 7.87 (1H, d, J = 8.4 
Hz), 7.22-7.33 (5H, m), 7.06 (1H, d, J = 8.5 Hz), 4.27 (1H, d, J = 5.7 Hz), 3.27 (2H, app 
q, J = 5.8 Hz), 2.20 (2H, t, J = 6.8 Hz), 1.54-1.61 (4H, m); 
13
C {
1
H} NMR (DMSO-D6): δ 
172.7, 161.6, 161.4, 141.7, 141.3, 140.4, 133.7, 129.0, 127.9, 127.4, 126.8, 126.6, 124.8, 
116.6, 49.3, 42.7, 35.8, 29.6, 23.6; HRMS (FAB, MNa) calcd for C24H24N2O5SNa: 
475.1304. Found 475.1293. 
 
5-(2,2-dimethyl-4-oxo-4H-benzo[d][1,3]dioxin-6-yl)furan-2-carbaldehyde (3.133): 
Iodide 3.53 (0.121 g, 0.400 mmol), boronic acid 3.132 (0.084 g, 0.600 mmol), Pd(OAc)2 
(0.004 g, 0.020 mmol), and Na2CO3 (0.085 g, 0.800 mmol) were reacted in DMF (5 mL) 
following the general procedure of Suzuki coupling
35
 to produce 3.133 as a colorless 
solid (0.101 g, 93%). 
IR (neat, NaCl) 3119, 2984, 1734, 1657, 1622 cm
-1
; 
1
H NMR (CDCl3): δ 9.62 (1H, s), 
8.32 (1H, d, J = 2.2 Hz), 8.00 (1H, dd, J = 2.2, 8.7 Hz), 7.30 (1H, d, J = 3.7 Hz), 7.04 
(1H, d, J = 8.6 Hz), 6.82 (1H, d, J = 3.7 Hz), 1.73 (6H, s); 
13
C {
1
H} NMR (CDCl3): δ 
177.3, 160.5, 157.6, 156.8, 152.2, 133.0, 126.7, 124.2, 123.7, 118.3, 114.0, 107.9, 107.1, 
26.0; HRMS (FAB, MNa
+
) calcd for C15H12O5Na: 295.0583. Found 295.0591. 
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2,2-dimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4H-benzo[d][1,3] 
dioxin-4-one (3.135): Iodide 3.53 (0.608 g, 2.00 mmol), pinacolborane 3.134 (0.43 mL, 
3.00 mmol), PdCl2(dppf).CH2Cl2 (0.049, 0.06 mmol), and Et3N (0.84 mL) were reacted 
in acetonitrile (10 mL) following the literature procedure described
38
 to obtain 3.135 as a 
colorless solid (0.450 g, 74%). 
IR (neat, NaCl) 3003, 2984, 1738, 1622 cm
-1
; 
1
H NMR (CDCl3): δ 8.41 (1H, d, J = 1.4 
Hz), 7.92 (1H, dd, J = 1.3, 8.2 Hz), 6.91 (1H, d, J = 8.2 Hz), 1.69 (6H, s), 1.29 (12H, s); 
13
C {
1
H} NMR (CDCl3): δ 161.0, 158.3, 142.6, 137.0, 116.6, 113.1, 106.4, 84.2, 25.9, 
24.9; HRMS (FAB, MH
+
) calcd for C16H21BO5: 305.1560. Found 305.1564. 
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